form10-q_09302010.htm

September 2010

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________

FORM 10-Q

(Mark One)

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the quarterly period ended: September 30, 2010 OR
[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________.

Commission File No. 000-24657

MANNATECH, INCORPORATED

(Exact Name of Registrant as Specified in its Charter)

Texas (State or other Jurisdiction of Incorporation or Organization)	75-2508900 (I.R.S. Employer Identification No.)
600 S. Royal Lane, Suite 200, Coppell, Texas (Address of Principal Executive Offices)	75019 (Zip Code)

Registrant’s Telephone Number, including Area Code: (972) 471-7400

____________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “accelerated filer”, “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]

Accelerated filer [X]

Non-accelerated filer [ ]

Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [ ] No [X]

As of November 1, 2010, the number of shares outstanding of the registrant’s sole class of common stock, par value $0.0001 per share, was 26,490,466.

MANNATECH, INCORPORATED

TABLE OF CONTENTS

Special Note Regarding Forward-Looking Statements	1
Part I – FINANCIAL INFORMATION
Item 1. Financial Statements	2
Consolidated Balance Sheets – Unaudited	2
Consolidated Statements of Operations – Unaudited	3
Consolidated Statements of Shareholders’ Equity and Comprehensive Income (Loss) - Unaudited	4
Consolidated Statements of Cash Flows – Unaudited	5
Notes to Unaudited Consolidated Financial Statements	6

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Company Overview	18
Results of Operations	20
Liquidity and Capital Resources	30
Critical Accounting Policies and Estimates	32
Recent Accounting Pronouncements	36

Item 3. Quantitative and Qualitative Disclosures About Market Risk	36

Item 4. Controls and Procedures	38

Part II – OTHER INFORMATION
Item 1. Legal Proceedings	39

Item 1A. Risk Factors	39

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	39

Item 3. Defaults Upon Senior Securities	39

Item 4. Removed and Reserved	39

Item 5. Other Information	39

Item 6. Exhibits	39

Signatures	40

Special Note Regarding Forward-Looking Statements

Certain disclosures and analysis in this Form 10-Q, including information incorporated by reference, may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and the Private Securities Litigation Reform Act of 1995 that are subject to various risks and uncertainties. Opinions, forecasts, projections, guidance, or other statements other than statements of historical fact are considered forward-looking statements and reflect only current views about future events and financial performance. Some of these forward-looking statements include statements regarding:

management’s plans and objectives for future operations;

existing cash flows being adequate to fund future operational needs;

future plans related to budgets, future capital requirements, market share growth, and anticipated capital projects and obligations;

the realization of net deferred tax assets;

the ability to curtail operating expenditures;

global statutory tax rates remaining unchanged;

the impact of future market changes due to exposure to foreign currency translations;

the possibility of certain policies, procedures, and internal processes minimizing exposure to market risk;

the impact of new accounting pronouncements on financial condition, results of operations, or cash flows;

the outcome of new or existing litigation matters;

the outcome of new or existing regulatory inquiries or investigations; and

other assumptions described in this report underlying such forward-looking statements.

Although we believe that the expectations included in these forward-looking statements are reasonable, these forward-looking statements are subject to certain events, risks, assumptions, and uncertainties, including those discussed below and in the “Risk Factors” section in Item 1A of this Form 10-Q, and elsewhere in this Form 10-Q and the documents incorporated by reference herein. If one or more of these risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results and developments could materially differ from those expressed in or implied by such forward-looking statements. For example, any of the following factors could cause actual results to vary materially from our projections:

overall growth or lack of growth in the nutritional supplements industry;

plans for expected future product development;

changes in manufacturing costs;

shifts in the mix of packs and products;

the future impact of any changes to global associate career and compensation plans or incentives;

the ability to attract and retain independent associates and members;

new regulatory changes that could affect operations and/or products;

the competitive nature of our business with respect to products and pricing;

publicity related to our products or network-marketing; and

the political, social, and economic climate.

Forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terms and other comparable terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals, or targets contained herein are also considered forward-looking statements. Readers are cautioned when considering these forward-looking statements to keep in mind these risks, assumptions, and uncertainties and any other cautionary statements in this report, as all of the forward-looking statements contained herein speak only as of the date of this report.

Unless stated otherwise, all financial information throughout this report and in the Consolidated Financial Statements and related Notes include Mannatech, Incorporated and all of its subsidiaries on a consolidated basis and may be referred to herein as “Mannatech,” “the Company,” “its,” “we,” “our,” or “their.”

Our products are not intended to diagnose, cure, treat, or prevent any disease and any statements about our products contained in this report have not been evaluated by the Food and Drug Administration, also referred to herein as the FDA.

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

MANNATECH, INCORPORATED AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	September 30, 2010			December 31, 2009
ASSETS	(unaudited)
Cash and cash equivalents	$	21,680		$	17,367
Restricted cash		1,282			1,288
Accounts receivable, net of allowance of $14 and $17 in 2010 and 2009, respectively		163			664
Income tax receivable		999			8,075
Inventories, net		25,389			31,290
Prepaid expenses and other current assets		3,515			3,139
Deferred tax assets		2,823			2,662
Total current assets		55,851			64,485
Property and equipment, net		19,963			27,144
Construction in progress		1,507			317
Long-term restricted cash		5,632			7,201
Other assets		2,162			2,503
Long-term deferred tax assets		693			652
Total assets	$	85,808		$	102,302

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current portion of capital leases	$	1,197		$	847
Accounts payable		5,309			11,319
Accrued expenses		13,271			14,231
Commissions and incentives payable		7,097			10,624
Taxes payable		3,265			2,577
Current deferred tax liability		423			274
Deferred revenue		2,881			2,807
Total current liabilities		33,443			42,679
Capital leases, excluding current portion		1,402			1,068
Long-term deferred tax liabilities		1,736			3,923
Other long-term liabilities		5,189			3,348
Total liabilities		41,770			51,018

Commitments and contingencies

Shareholders’ equity:
Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding		—			—
Common stock, $0.0001 par value, 99,000,000 shares authorized, 27,697,560 shares issued and 26,490,466 shares outstanding in 2010 and 27,687,882 shares issued and 26,480,788 shares outstanding in 2009		3			3
Additional paid-in capital		41,934			41,442
Retained earnings		17,869			25,743
Accumulated other comprehensive loss		(977	)		(1,113	)
Less treasury stock, at cost, 1,207,094 shares in 2010 and 2009		(14,791	)		(14,791	)
Total shareholders’ equity		44,038			51,284
Total liabilities and shareholders’ equity	$	85,808		$	102,302

See accompanying notes to unaudited consolidated financial statements.

MANNATECH, INCORPORATED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS – (UNAUDITED)

(in thousands, except per share information)

	Three months ended September 30,						Nine months ended September 30,
	2010			2009			2010			2009
Net sales	$	54,866		$	71,295		$	173,137		$	219,640
Cost of sales		7,924			11,923			24,640			35,944
Commissions and incentives		23,109			35,268			74,617			115,413
		31,033			47,191			99,257			151,357
Gross profit		23,833			24,104			73,880			68,283

Operating expenses:
Selling and administrative		15,811			17,748			47,579			53,403
Depreciation and amortization		2,772			3,085			8,691			9,357
Other operating costs		8,911			11,842			26,292			30,831
Total operating expenses		27,494			32,675			82,562			93,591

Loss from operations		(3,661	)		(8,571	)		(8,682	)		(25,308	)
Interest income		20			39			1			182
Other income (expense), net		400			859			(175	)		822
Loss before income taxes		(3,241	)		(7,673	)		(8,856	)		(24,304	)

(Provision) benefit for income taxes		1,963			(1,534	)		982			4,785
Net loss	$	(1,278	)	$	(9,207	)	$	(7,874	)	$	(19,519	)

Net loss per share:
Basic	$	(0.05	)	$	(0.35	)	$	(0.30	)	$	(0.74	)
Diluted	$	(0.05	)	$	(0.35	)	$	(0.30	)	$	(0.74	)

Weighted-average common shares outstanding:
Basic		26,490			26,464			26,487			26,462
Diluted		26,490			26,464			26,487			26,462

See accompanying notes to unaudited consolidated financial statements.

MANNATECH, INCORPORATED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

AND COMPREHENSIVE INCOME (LOSS) – (UNAUDITED)

(in thousands, except per share information)

	Common stock outstanding			Additional paid in capital		Retained earnings			Accumulated other comprehensive loss			Treasury stock				Total shareholders’ equity
	Shares	Par value		Additional paid in capital		Retained earnings			Accumulated other comprehensive loss			Shares	Amounts			Total shareholders’ equity
Balance at December 31, 2009	26,481	$	3	$	41,442	$	25,743		$	(1,113	)	1,207	$	(14,791	)	$	51,284
Charge related to stock-based compensation	—		—		464		—			—		—		—			464
Proceeds from stock options exercised	9		—		28		—			—		—		—			28
Components of comprehensive loss: Foreign currency translations	—		—		—		—			136		—		—			136
Net loss	—		—		—		(7,874	)		—		—		—			(7,874	)
Total comprehensive loss																	(7,738	)
Balance at September 30, 2010	26,490	$	3	$	41,934	$	17,869		$	(977	)	1,207	$	(14,791	)	$	44,038

See accompanying notes to unaudited consolidated financial statements.

MANNATECH, INCORPORATED ALL SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS – (UNAUDITED)

(in thousands)

	Nine months ended September 30,
	2010			2009
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(7,874	)	$	(19,519	)
Adjustments to reconcile net loss to net cash provided by (used) in operating activities:
Depreciation and amortization		8,691			9,357
Provision for doubtful accounts		28			(7	)
Provision for inventory losses		1,538			821
Loss on disposal of assets		61			94
Accounting charge related to stock-based compensation expense		464			437
Deferred income taxes		(2,024	)		(1,556	)
Changes in operating assets and liabilities:
Accounts receivable		478			12
Income tax receivable		7,079			517
Inventories		4,411			1,265
Prepaid expenses and other current assets		53			2,220
Other assets		428			(1,022	)
Accounts payable		(6,062	)		1,630
Accrued expenses		592			(2,635	)
Taxes payable		699			774
Commissions and incentives payable		(3,697	)		2,505
Deferred revenue		72			399
Net cash provided by (used in) operating activities		4,937			(4,708	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment		(1,529	)		(2,500	)
Change in restricted cash		1,687			389
Net cash provided by (used in) investing activities		158			(2,111	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of cash dividends		—			(1,058	)
Proceeds from stock options exercised		28			66
Repayment of capital lease obligations		(917	)		(273	)
Net cash used in financing activities		(889	)		(1,265	)

Effect of currency exchange rate changes on cash and cash equivalents		107			(284	)
Net increase (decrease) in cash and cash equivalents		4,313			(8,368	)
Cash and cash equivalents at the beginning of period		17,367			30,945
Cash and cash equivalents at the end of period	$	21,680		$	22,577

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Income taxes received, net	$	7,228		$	2,721
Interest paid on capital leases	$	69		$	29

See accompanying notes to unaudited consolidated financial statements.

MANNATECH, INCORPORATED AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Mannatech, Incorporated (together with its subsidiaries, the “Company”), headquartered in Coppell, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the NASDAQ Global Select Market under the symbol “MTEX”. The Company develops, markets, and sells high-quality, proprietary nutritional supplements, topical and skin care products, and weight-management products that are primarily sold to independent associates and members located in the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, Singapore, Austria, the Netherlands, Norway, and Sweden.

Independent associates purchase the Company’s products at published wholesale prices to either sell to retail customers or consume personally. Members purchase the Company’s products at a discount from published retail prices primarily for personal consumption. The Company cannot distinguish its personal consumption sales from its other sales because it has no involvement in its products after delivery, other than usual and customary product warranties and returns. Only independent associates are eligible to earn commissions and incentives.

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the Company’s consolidated financial statements and footnotes contained herein do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) to be considered “complete financial statements”. However, in the opinion of the Company’s management, the accompanying unaudited consolidated financial statements and footnotes contain all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Comp any’s consolidated financial information as of, and for, the periods presented. The Company cautions that its consolidated results of operations for an interim period are not necessarily indicative of its consolidated results of operations to be expected for its fiscal year. The December 31, 2009 consolidated balance sheet was included in the audited consolidated financial statements in the Company’s annual report on Form 10-K for the year ended December 31, 2009 and filed with the United States Securities and Exchange Commission on March 11, 2010 (the “2009 Annual Report”), which includes all disclosures required by GAAP. Therefore, these unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2009 Annual Report.

Principles of Consolidation

The consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of the Company’s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. Actual results may differ from these estimates under different assumptions or conditions.

The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered to be the most significant are described in this note to the consolidated financial statements, Organization and Summary of Significant Accounting Policies.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivables are generally received within 24 to 72 hours. As of September 30, 2010 and December 31, 2009, credit card receivables were $3.6 million and $2.8 million, respectively. Additionally, as of September 30, 2010 and December 31, 2009, cash and cash equivalents held in bank accounts in foreign countries totaled $10.5 million and $10.2 million, respectively.

Restricted Cash

The Company is required to restrict cash for (i) direct selling insurance premiums and credit card sales in the Republic of Korea, (ii) a reserve on credit card sales in the United States and Canada, and (iii) collateral for its Australia building lease. As of September 30, 2010 and December 31, 2009, our total restricted cash was $6.9 million and $8.5 million, respectively. The decrease in restricted cash was primarily related to the partial refund of direct selling insurance premiums in Korea.

Accounts Receivable

Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. Receivables consist primarily of amounts due from members and independent associates. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time they are past due, and writes-off receivables when they become uncollectible. At September 30, 2010 and December 31, 2009, the Company held an allowance for doubtful accounts of less than $0.1 million.

Inventories

Inventories consist of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off.

Other Assets

As of September 30, 2010 and December 31, 2009, other assets of $2.2 million and $2.5 million primarily consisted of deposits for building leases in various locations and certain intangible assets.

Commissions and Incentives

Independent associates earn commissions and incentives based on their direct and indirect commissionable net sales over 13 business periods. Each business period equals 28 days. The Company accrues commissions and incentives when earned by independent associates and pays commissions on product sales three weeks following the business period end and pays commissions on its pack sales five weeks following the business period end.

Other Long-Term Liabilities

In August 2003, the Company entered into a Long-Term Post-Employment Royalty Agreement with Dr. Bill McAnalley, the Company’s former Chief Science Officer, pursuant to which the Company is required to pay Dr. McAnalley, or his heirs, royalties for ten years beginning September 2005 and continuing through August 2015. Quarterly payments related to this Long-Term Post-Employment Royalty Agreement are based on certain applicable annual global product sales by the Company in excess of $105.4 million. At the time the Company entered into this royalty agreement, it was considered a post-employment benefit and the Company was required to measure and accrue the present value of the estimated future royalty payments related to this benefit, and recognize it over the life of Dr. McAnalley’s employment agreement, whi ch was two years. As of September 30, 2010, the Company’s liability related to this royalty agreement was $1.3 million, of which $0.3 million was currently due and included in accrued expenses. As of December 31, 2009, the Company’s long-term liability related to this royalty agreement was $1.6 million, of which $0.3 million was currently due and included in accrued expenses.

Certain operating leases for the Company’s regional office facilities contain a restoration clause that requires the Company to restore the premises to its original condition. As of September 30, 2010 and December 31, 2009, accrued restoration costs related to these leases amounted to $0.4 million. At September 30, 2010 and December 31, 2009, the Company also recorded a long-term liability for an estimated deferred benefit obligation related to a deferred benefit plan for its Japan operations of $1.1 million and $0.8 million, respectively.

MANNATECH, INCORPORATED AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Comprehensive Income (loss) and Accumulated Other Comprehensive Income (loss)

Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company’s comprehensive income (loss) consists of the Company’s net income (loss), foreign currency translation adjustments from its Japan, Republic of Korea, Taiwan, Norway, and Sweden operations, and changes in the pension obligation for its Japanese employees.

Revenue Recognition

The Company’s revenue is derived from sales of individual products, sales of its starter and renewal packs, and shipping fees. Substantially all of the Company’s product and pack sales are made to independent associates at published wholesale prices and to members at discounted published retail prices. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience.

The Company recognizes revenue from shipped packs and products upon receipt by the customer. Corporate-sponsored event revenue is recognized when the event is held. The Company defers certain components of its revenue. At September 30, 2010 and December 31, 2009, the Company’s deferred revenue was $2.9 million and $2.8 million, respectively, and consisted primarily of revenue received from: (i) sales of packs and products shipped but not received by the customers by period end; and (ii) prepaid registration fees from customers planning to attend a future corporate-sponsored event.

We estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six- month period. If actual results differ from our estimated sales return reserve due to various factors, the amount of revenue recorded each period could be materially affected. Historically, our sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days after the original sale. Sales returns have averaged 1.5% or less of our gross sales. For the nine months ended September 30, 2010 our sales return reserve was composed of the following (in thousands):

	September 30, 2010
Sales reserve as of January 1, 2010	$	595
Provision related to sales made in current period		1,591
Provision related to sales made in prior periods		112
Actual returns or credits related to current period		(1,128	)
Actual returns or credits related to prior periods		(710	)
Sales reserve as of September 30, 2010	$	460

Shipping and Handling Costs

The Company records freight and shipping fees collected from its customers as revenue. The Company records inbound freight as cost of sales and records shipping and handling costs associated with shipping products to customers as selling and administrative expenses. Total shipping and handling costs included in selling and administrative expenses were approximately $2.7 million and $3.6 million for the three months ended September 30, 2010 and 2009, respectively, and $8.8 million and $10.6 million for the nine months ended September 30, 2010 and 2009, respectively.

Reclassifications

Certain reclassifications have been made to the financial statements for prior periods to conform to the current period presentation.

MANNATECH, INCORPORATED AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

NOTE 2: INVENTORIES

Inventories consist of raw materials and finished goods, including promotional materials. The Company provides an allowance for any slow-moving or obsolete inventories. Inventories at September 30, 2010 and December 31, 2009, consisted of the following (in thousands):

	September 30, 2010			December 31, 2009
Raw materials	$	9,223		$	10,819
Finished goods		18,156			21,844
Inventory reserves for obsolescence		(1,990	)		(1,373	)
	$	25,389		$	31,290

NOTE 3: INCOME TAXES

For the three months ended September 30, 2010, the Company recognized a tax benefit of approximately $1.9 million. This was the result of changes to management’s estimates for 2010 annual operating results, including the mix of income between tax jurisdictions, the change in the valuation allowances associated with certain deferred tax assets, and the change in reserves related to uncertain income tax positions. For the nine months ended September 30, 2010 the Company recognized a $0.9 million tax benefit. For the three and nine months ended September 30, 2009, the Company’s effective tax rate was (20.0)% and 19.7%, respectively. For the three and nine months ended September 30, 2010 and 2009, the Company’s effective income tax rate was determined based on the estimated annual effective income tax rate.

The effective tax rate for the nine months ended September 30, 2010 was lower than what would have been expected if the federal statutory rate were applied to income before taxes. Items reducing the effective income tax rate included reductions due to changes to management’s estimates for 2010 annual operating results, including the mix of income between tax jurisdictions, the change in the valuation allowances associated with certain deferred tax assets, and the change in reserves related to uncertain income tax positions. The effective tax rate for the three months ended September 30, 2010 was higher than what would have been expected if the federal statutory rate were applied to income before taxes due to changes in management’s estimates during the quarter for 2010 annual operating results, including the mix of income bet ween tax jurisdictions.

NOTE 4: LOSS PER SHARE

Basic Earnings (Loss) Per Share (“EPS”) calculations are based on the weighted-average number of the Company’s common shares outstanding during the period. Diluted EPS calculations are based on the calculated weighted-average number of common shares and dilutive common share equivalents outstanding during each period.

The following data shows the amounts used in computing the Company’s EPS and their effect on the Company’s weighted-average number of common shares and dilutive common share equivalents for the three months ended September 30, 2010 and 2009. For the three months ended September 30, 2010, approximately 1.6 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average closing price of $2.41 per share, as their effect was antidilutive. For the three months ended September 30, 2009, approximately 1.6 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average close price of $3.73 per share, as their effect was antidilutive. The amounts below are rounded to the nearest thousands, except for pe r share amounts.

MANNATECH, INCORPORATED AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

	For the three months ended September 30,
	2010							2009
	Loss (numerator)			Shares (denominator)	Per share amount			Loss (numerator)			Shares (denominator)	Per share amount
Basic EPS:
Net loss available to common shareholders	$	(1,278	)	26,490	$	(0.05	)	$	(9,207	)	26,464	$	(0.35	)
Effect of dilutive securities: Stock options		—		—		—			—		—		—
Diluted EPS:
Net loss available to common shareholders plus assumed conversions	$	(1,278	)	26,490	$	(0.05	)	$	(9,207	)	26,464	$	(0.35	)

The following data shows the amounts used in computing the Company’s EPS and their effect on the Company’s weighted-average number of common shares and dilutive common share equivalents for the nine months ended September 30, 2010 and 2009. For the nine months ended September 30, 2010, approximately 1.6 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average close price of $2.93 per share, as their effect was antidilutive. For the nine months ended September 30, 2009, approximately 1.5 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average close price of $3.48 per share, as their effect was antidilutive. The amounts below are rounded to the nearest thousands, except for pe r share amounts.

	For the nine months ended September 30,
	2010							2009
	Loss (numerator)			Shares (denominator)	Per share amount			Loss (numerator)			Shares (denominator)	Per share amount
Basic EPS:
Net loss available to common shareholders	$	(7,874	)	26,487	$	(0.30	)	$	(19,519	)	26,462	$	(0.74	)
Effect of dilutive securities: Stock options		—		—		—			—		—		—
Diluted EPS:
Net loss available to common shareholders plus assumed conversions	$	(7,874	)	26,487	$	(0.30	)	$	(19,519	)	26,462	$	(0.74	)

NOTE 5: STOCK-BASED COMPENSATION

The Company currently has one active stock-based compensation plan, which was approved by shareholders. The Company generally grants stock options to employees, consultants, and board members at the fair market value of its common stock, on the date of grant, with a term no greater than ten years. The stock options generally vest over two or three years. Shareholders who own 10% or more of the Company’s outstanding stock are granted incentive stock options at an exercise price that may not be less than 110% of the fair market value of the Company’s common stock on the date of grant and have a term no greater than five years.

In February 2008, the Company’s Board of Directors approved the Mannatech, Incorporated 2008 Stock Incentive Plan (the “2008 Plan”), which reserved, for issuance of stock options and restricted stock to employees, board members, and consultants, up to 1,000,000 shares of common stock plus any shares reserved under the Company’s then-existing, unexpired stock plan for which options had not yet been issued plus any shares underlying outstanding options under the then-existing stock option plan that terminate without having been exercised in full. The 2008 Plan was approved by the Company’s shareholders at the 2008 Annual Shareholders’ Meeting. As of September 30, 2010, the 2008 Plan had 321,088 stock options available for grant before the plan expires on February 20, 2018.

At the 2010 Annual Shareholders’ Meeting the Company obtained approval from the Company’s shareholders for an amendment to the 2008 Plan to permit a one-time stock option exchange program (the “Exchange Offer”). On July 16, 2010, the Company commenced the option exchange program (the “Exchange Program”) whereby employees (including officers), directors and consultants were able to elect to exchange their “out of the money” stock options for fewer options at a lower exercise price. The Exchange Program expired on August 13, 2010.

The Company filed with the Securities and Exchange Commission (the “SEC”) the Tender Offer Statement on Schedule TO on July 16, 2010, (as amended, the “Schedule TO”), and the Offer to Exchange filed with the Schedule TO as Exhibit (a)(1)(A), (as amended, the “Offer to Exchange”).

Pursuant to the Exchange Program, an aggregate of 784,930 eligible options were tendered and accepted by the Company in exchange for the grant of an aggregate of 440,558 replacement options.

All of the replacement options that were granted on August 16, 2010 have an exercise price of $2.46 and were granted under the 2008 Plan, as amended. Each replacement option vests annually in ⅓ installments starting one year from the grant date and has a term of 10 years. Incremental stock option expense resulting from the exchange was minimal because the fair value of the replacement options was approximately equal to the fair value of the surrendered options they replaced. The foregoing description of the Exchange Program is qualified in its entirety by reference to the Schedule TO and the Offer to Exchange.

The Company records stock-based compensation expense related to granting stock options as selling and administrative expenses. During the three months ended September 30, 2010, the Company granted 465,558 stock options, of which 440,558 were a result of the Exchange Program. During the three months ended September 30, 2009, the Company granted 30,000 stock options. During the nine months ended September 30, 2010, the Company granted 772,194 stock options, of which 440,558 were a result of the Exchange Program. During the nine months ended September 30, 2009, the Company granted 305,000 stock options. The fair value of stock options granted during the three months ended September 30, 2010 ranged from $1.26 to $1.40 per share. The fair value of stock options granted during the three months ended September 30, 2009 was $2.01 per share. The fair value of stock options granted during the nine months ended September 30, 2010 ranged from $1.18 to $2.03 per share. The fair values of stock options granted during the nine months ended September 30, 2009 ranged from $1.24 to $2.01 per share. The Company recognized compensation expense as follows for the periods ended September 30 (in thousands):

	Three months					Nine months
	2010		2009			2010		2009
Total gross compensation expense	$	123	$	125	$	514	$	437
Total tax benefit associated with compensation expense		10		24		67		97
Total net compensation expense	$	113	$	101	$	447	$	340

As of September 30, 2010, the Company expects to record compensation expense in the future as follows:

	Three months ending December 31, 2010		Year ending December 31,
	Three months ending December 31, 2010		2011		2012		2013
Total gross unrecognized compensation expense	$	112	$	375	$	184	$	71
Tax benefit associated with unrecognized compensation expense		16		49		20		6
Total net unrecognized compensation expense	$	96	$	326	$	164	$	65

NOTE 6: SHAREHOLDER’S EQUITY

On September 16, 2010, the Company entered into an Investment Agreement (the “Investment Agreement”) with Dutchess Opportunity Fund, II, LP, a Delaware limited partnership (the “Investor”). Pursuant to the Investment Agreement, the Investor committed to purchase, subject to certain restrictions and conditions, up to $10,000,000 of the Company’s common stock, over a period of 36 months from the first trading day following the effectiveness of the registration statement registering the resale of shares purchased by the Investor pursuant to the Investment Agreement (the “Equity Line”). The aggregate number of shares of common stock issuable by the Company and purchasable by the Investor under the Investment Agreement is 5,000,000.

The Company may draw on the Equity Line from time to time, as and when it determines appropriate in accordance with the terms and conditions of the Investment Agreement. The maximum amount that the Company is entitled to put to the Investor in any one draw down notice is the greater of (i) 200% of the average lowest daily volume of the Company’s common stock traded on the NASDAQ Global Market for the 3 trading days prior to the date of delivery of the applicable draw down notice, multiplied by the average of the closing prices for such trading days or (ii) $500,000. The purchase price shall be set at 96% of the lowest daily volume weighted average price (VWAP) of the Company’s common stock during the 5 consecutive trading day period beginning on the date of delivery of the applicable draw down notice. Before the closing of an exercised put, the Company (not the Investor) has the right to withdraw all or any portion of the put; provided that the Company may not withdraw any portion of a put that the Investor has already committed to resell to a third party. There are put restrictions applied on days between the draw down notice date and the closing date with respect to that particular put. During such time, the Company shall not be entitled to deliver another draw down notice. In addition, the Investor will not be entitled to purchase shares if the Investor’s total number of shares beneficially held at that time would exceed 4.99% of the number of shares of the Company’s common stock as determined in accordance with Rule 13d-1(j) of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the Equity Line unless there is an effective registration statement (as further explained below) to cover the resale of the shares.

The Investment Agreement further provides that the Company and the Investor are each entitled to customary indemnification from the other for, among other things, any losses or liabilities they may suffer as a result of any breach by the other party of any provisions of the Investment Agreement or Registration Rights Agreement (as defined below), or as a result of any lawsuit brought by a third-party arising out of or resulting from the other party’s execution, delivery, performance or enforcement of the Investment Agreement or the Registration Rights Agreement.

The Investment Agreement also contains customary representations and warranties of each of the parties. Investors should read the Investment Agreement together with the other information concerning the Company that the Company publicly files in reports and statements with the SEC.

Pursuant to the terms of a Registration Rights Agreement dated September 16, 2010 between the Company and the Investor (the “Registration Rights Agreement”), the Company is obligated to file one or more registration statements with the SEC to register the resale by Investor of the shares of common stock issued or issuable under the Investment Agreement. On October 28, 2010, the SEC declared effective the Company’s Registration Statement on Form S-3 (File No. 333-169774), which registers up to 5,000,000 shares of common stock that may be resold by the Investor pursuant to the Investment Agreement. As of November 3, 2010, no shares of common stock have been issued pursuant to the Investmen t Agreement.

In connection with the preparation of the Investment Agreement and the Registration Rights Agreement, the Company paid the Investor a document preparation fee in the amount of $15,000.

NOTE 7: LITIGATION

Patent Infringement Litigation

Mannatech, Inc. v. Country Life, LLC, et al., No. 3:10-cv-00533-O, United States District Court, Northern District of Texas, Dallas Division

On March 16, 2010, Mannatech, Inc. filed a patent infringement lawsuit against Country Life, LLC; Country Life Manufacturing, LLC; EvenBetterNow, LLC; Micro Health Solutions, LLC; New Sun, Inc.; Oasis Advanced Wellness, LLC; Roex, Inc.; VDF FutureCeuticals, Inc.; and John Does 1-20, alleging the defendants infringe United States Patent Nos. 6,929,807, 7,157,431, 7,196,064, 7,199,104, and 7,202,220, all entitled “Compositions of Plant Carbohydrates as Dietary Supplements” (“Patents-in-Suit”), and seeking to stop their manufacture, offer, and sale of infringing glyconutritional dietary supplement products. On May 14, 2010, Mannatech amended its complaint to add patent infringement claims against Angel Care USA, Inc.; Florida Nutri Labs, LLC; and Wy’s Enterprises of Springfield, Inc.

Agreed Judgments have been entered against seven of the eleven defendants: EvenBetterNow, Oasis Advanced Wellness, Micro Health Solutions, Wy's Enterprises of Springfield, Florida Nutri Labs, Angel Care, USA, and New Sun. In each of the Agreed Judgments, the defendant is enjoined, for the term of the Patents-in-Suit, from making, using, offering to sell, or otherwise distributing the accused infringing products or colorable imitations thereof (the “Enjoined Products”); inducing infringement of the patents by encouraging or assisting others in selling the Enjoined Products; or supplying or causing to be supplied all or a substantial portion of the components of the Enjoined Products.

On June 25, 2010, Mannatech filed an unopposed motion to drop defendant Country Life Manufacturing, LLC because Mannatech discovered that Country Life Manufacturing was no longer active or associated with Country Life, LLC. On June 29, Mannatech’s motion was granted and Country Life Manufacturing, LLC was dismissed from the lawsuit without prejudice.

The lawsuit is now proceeding against the remaining three defendants: Country Life, Roex, and VDF FutureCeuticals. All three have filed answers, and two of the defendants, Roex and VDF FutureCeuticals, have filed counterclaims challenging the validity of Mannatech’s patents and seeking recovery of their attorneys’ fees. In addition, on June 25, 2010, Roex filed a motion to sever and motion to transfer venue to its home district of the Central District of California. On July 16, Mannatech filed its response in opposition, after which VDF FutureCeuticals filed a motion to join Roex’s motion to transfer. On July 21, Mannatech filed a motion to strike VDF’s improper joinder. On July 26, 2010, the Court denied Roex’s motion.

On July 16, 2010, the court entered a Scheduling Order, setting trial for November 1, 2011. In order to permit the parties to engage in direct settlement discussions, the parties have twice filed joint motions seeking extensions of the Scheduling Order deadlines. The court granted both motions and the current Second Amended Scheduling Order, issued on October 12, 2010, reset the trial date for December 5, 2011. Mannatech intends to vigorously prosecute this matter in the event settlement cannot be reached, as this lawsuit continues Mannatech’s enforcement of its patent rights. Based on the previous successful patent infringement lawsuits against Glycobiotics International, Inc., Techmedica Health, Inc., IonX Holdings, Inc., Boston Mountain Laboratories, Inc., Green Life, LLC, and Xiong Lo, Mannatech believes it could 0; obtain permanent injunctions against the manufacture and sale of any infringing products for the duration of Mannatech’s Patents-in-Suit.

Business Arbitration and Litigation

Marinova Pty. Limited v. Mannatech, Incorporated & Mannatech (International) Limited, Case No. 50-122-T-00635-09, International Centre for Dispute Resolution, a division of the American Arbitration Association

On December 10, 2009, Marinova Pty. Limited (“Marinova”), a company duly organized and operating under the laws of Australia, filed a Notice of Arbitration and Statement of Claim with the International Centre for Dispute Resolution, which is a division of the American Arbitration Association, against Mannatech Incorporated and Mannatech (International) Limited (collectively, “Mannatech”). Marinova’s claims stem from the parties’ April 27, 2007 Purchase Agreement, which was entered into between Marinova and Mannatech (International) Limited and executed by Marinova and Mannatech, Incorporated. Through the Purchase Agreement, Marinova agreed to sell and Mannatech agreed to buy set quantities of glyconutrient powder that Mannatech uses in the manufacturing of some its products. Marinova cla ims that Mannatech breached the Purchase Agreement by not buying certain quantities of Marinova’s product. Marinova alternatively claims that Mannatech, Incorporated tortiously interfered with the Purchase Agreement. Finally, Marinova claims that Mannatech, Incorporated made fraudulent representations to Marinova upon which Marinova claims it relied in executing the Purchase Agreement. Marinova claims that Mannatech’s actions have caused them over $5,000,000 in damages, as well as attorneys’ fees and costs.

On January 15, 2010, Mannatech filed its Answering Statement and Counterclaims, through which Mannatech asserted affirmative defenses in response to Marinova’s claims, including that Marinova’s own actions or omissions contributed to or caused Marinova’s alleged injury. Mannatech also filed a counterclaim for breach of contract, through which Mannatech alleges that Marinova sold Mannatech non-conforming powder and then refused to reimburse Mannatech the amount it paid for the non-conforming powder, thereby breaching the Purchase Agreement. Mannatech further alleges that Marinova separately breached the Purchase Agreement by marketing its powder to one or more of Mannatech’s competitors in violation of an amendment to the Purchase Agreement’s exclusivity clause. Finally, Mannatech requested dec laratory judgments from the arbitration panel, including a judgment that Mannatech is not obligated to purchase any additional product from Marinova because Marinova breached the Purchase Agreement. Mannatech is seeking damages in the amount it paid for the non-conforming product, as well as damages from Marinova’s breach of the parties’ exclusivity agreement, attorneys’ fees, and costs.

On August 25, 2010, the panel of three arbitrators held their preliminary hearing, during which Mannatech requested the opportunity to brief a motion to strike certain portions of Marinova’s Statement of Claims that Mannatech thought were brought solely for the purposes of prejudicing the panel against Mannatech. Those portions of Marinova’s Statement of Claims related to lawsuits filed against Mannatech several years ago, all of which have now settled and bear no relation to Marinova’s claims. The panel granted Mannatech leave to file a motion to strike.

In response, Marinova sought leave and was granted the opportunity to re-plead its Statement of Claims. On August 31, 2010, Marinova filed its Amended Statement of Claims, in which it claims that, in addition to its other claims against Mannatech, Mannatech breached the Purchase Agreement because Mannatech allegedly falsely warranted that it was not the subject of any lawsuits or investigations. Accordingly, on September 15, 2010, Mannatech filed its Motion to Dismiss and Strike, through which it seeks to strike Marinova’s newly-added claim because (a) Marinova never raised the claim prior to its re-pleading; (b) Marinova accepted millions of dollars from Mannatech after it became aware of Mannatech’s alleged breach; and (c) Marinova is asserting its claim solely in an attempt to prejudice the panel. Marinova s ubsequently filed a response and Mannatech filed a reply in support of its Motion to Dismiss and Strike on October 12, 2010. The panel has not yet ruled on the Motion to Dismiss and Strike.

Mannatech intends to vigorously defend against Marinova’s claims and prosecute its counterclaim.

Litigation in General

The Company has several pending claims incurred in the normal course of business. In the Company’s opinion, such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows.

The Company maintains certain liability insurance; however, certain costs of defending lawsuits, such as those below the insurance deductible amount, are not covered by or only partially covered by its insurance policies. Additionally, insurance carriers could refuse to cover certain of these claims in whole or in part. The Company accrues costs to defend itself from litigation as incurred or as they become determinable.

The outcome of litigation may not be assured, and despite management’s views of the merits of any litigation, or the reasonableness of the Company’s estimates and reserves, the Company’s financial statements could nonetheless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from the above legal matters where an outcome was deemed to be probable, and the loss amount could be reasonably estimated. While it is not possible to predict with certainty what liability or damages the Company might incur in connection with any of the above-described lawsuits, based on the advice of counsel and a management review of the existing facts and circumstances related to these lawsuits, and related legal fees, the Company has accrued $0.5 million as of September 30, 2010 for these matters, which is included in accrued expenses in its Consolidated Balance Sheet.

MANNATECH, INCORPORATED AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

NOTE 8: RECENT ACCOUNTING PRONOUNCEMENTS

In October 2009, the FASB issued Accounting Standards Update No. 2009-13, “Revenue Recognition—Multiple Deliverable Revenue Arrangements” (“ASU 2009-13”). ASU 2009-13 updates the existing multiple-element revenue arrangements guidance currently included in FASB ASC 605-25. The revised guidance provides for two significant changes to the existing multiple element revenue arrangements guidance. The first change relates to the determination of when the individual deliverables included in a multiple-element arrangement may be treated as separate units of accounting. The second change modifies the manner in which the transaction consideration is allocated across the separately identified deliverables. The revis ed guidance also expands the disclosures required for multiple-element revenue arrangements. The revised multiple-element revenue arrangements guidance will be effective for the first annual reporting period beginning on or after June 15, 2010. The adoption of ASU 2009-13 is not expected to have a material impact on the Company’s financial position or results of operations.

In January 2009, the Securities and Exchange Commission issued Release No. 33-9002, “Interactive Data to Improve Financial Reporting.” The final rule requires companies to provide their financial statements and financial statement schedules to the Securities and Exchange Commission in interactive data format using the eXtensible Business Reporting Language (“XBRL”). The rule was adopted by the Securities and Exchange Commission to improve the ability of financial statement users to access and analyze financial data. The Securities and Exchange Commission adopted a phase-in schedule indicating when registrants must furnish interactive data. Under this schedule, the Company will be required to submit filings with financial statement information using XBRL commencing with our June 30, 2011 quarterly report on Form 10-Q. We began furnishing financial information in XBRL format starting with our quarterly report on Form 10-Q for the period ended September 30, 2009. As an early XBRL adopter, the Company may choose to discontinue furnishing XBRL data in the future until the required compliance date of June 30, 2011.

NOTE 9: FAIR VALUE

Fair Value Measurements and Disclosure Topic of the FASB ASC establishes a fair value hierarchy that requires the use of observable market data, when available, and prioritizes the inputs to valuation techniques used to measure fair value in the following categories:

· Level 1 – Quoted unadjusted prices for identical instruments in active markets.

· Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which all observable inputs and significant value drivers are observable in active markets.

· Level 3 – Model-derived valuations in which one or more significant inputs or significant value drivers are unobservable, including assumptions developed by the Company.

The primary objective of the Company’s investment activities is to preserve principal while maximizing yields without significantly increasing risk. The investment instruments held by the Company are money market funds and interest bearing deposits for which quoted market prices are readily available. The Company considers these highly liquid investments to be cash equivalents. These investments are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The table below presents the recorded amount of financial assets measured at fair value (in thousands) on a recurring basis as of September 30, 2010. The Company does not have any material financial liabilities that were required to be measured at fair val ue on a recurring basis at September 30, 2010.

MANNATECH, INCORPORATED AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Asset	Level 1		Level 2		Level 3			Total
Money Market Funds – Fidelity, US	$	6,029	$	—	$	—	$		6,029
Interest bearing deposits – various banks, Korea		4,969		—		—			4,969
Total assets	$	10,998	$	—	$	—	$		10,998
Amounts included in:
Cash and cash equivalents	$	6,345	$	—	$	—	$		6,345
Long-term restricted cash		4,653		—		—			4,653
Total	$	10,998	$	—	$	—	$		10,998

NOTE 10: SEGMENT INFORMATION

The Company conducts its business as a single operating segment, consolidating all of its business units into a single reportable entity, as a seller of proprietary nutritional supplements, topical and skin care products, and weight-management products through its network marketing distribution channels operating in sixteen countries. Each of the Company’s business units sells similar packs and products and possesses similar economic characteristics, such as selling prices and gross margins. In each country, the Company markets its products and pays commissions and incentives in similar market environments. The Company’s management reviews its financial performance by country and analyzes consolidated revenues by packs and product sales. The Company sells its products through its independent associates and distributes its pro ducts through similar distribution channels in each country. No single independent associate has ever accounted for more than 10% of the Company’s consolidated net sales.

The Company operates in nine physical locations and sells products in sixteen different countries around the world. The nine physical locations are the United States, Canada, Switzerland, Australia, the United Kingdom, Japan, the Republic of Korea (South Korea), Taiwan, and South Africa. Each of the Company’s physical locations services different geographic areas. The United States, Canada, Australia, United Kingdom, Japan, and South Africa offices provide administrative support to their respective local markets and serve as meeting locations for independent associates. The United States location processes orders for the United States, Canada, and South Africa. The Australian location processes orders for Australia, New Zealand, and Singapore. The United Kingdom location processes orders for the United Kingdom, Denmark, Germany, Au stria, the Netherlands, Norway, and Sweden. The Japan, Republic of Korea, and Taiwan locations process orders for their local markets only. The Switzerland office was created to manage certain day-to-day business needs of our international markets.

Consolidated net sales shipped to customers in these locations, along with pack and product information for the three and nine months ended September 30, 2010 and 2009 are as follows (in millions, except percentages):

	Three months									Nine months
Country	2010					2009				2010				2009
United States	$	23.9	43.5	%	$	34.0	47.7	%	$	77.7	44.9	%	$		109.7	49.9	%
Japan		8.9	16.2	%		9.9	13.9	%		25.8	14.9	%			31.4	14.3	%
Republic of Korea		5.1	9.3	%		6.9	9.7	%		16.2	9.4	%			19.2	8.8	%
Canada		4.6	8.4	%		5.8	8.1	%		14.0	8.1	%			17.5	8.0	%
Australia		4.7	8.6	%		5.7	8.0	%		14.8	8.6	%			16.7	7.6	%
South Africa		3.0	5.5	%		3.9	5.5	%		9.0	5.2	%			9.4	4.2	%
Taiwan		1.4	2.6	%		1.4	2.0	%		5.0	2.9	%			4.8	2.2	%
New Zealand		0.7	1.3	%		1.1	1.5	%		2.5	1.4	%			3.3	1.5	%
Germany		0.6	1.1	%		0.9	1.3	%		1.8	1.0	%			2.6	1.2	%
United Kingdom		0.4	0.7	%		0.8	1.0	%		1.6	0.9	%			2.5	1.1	%
Denmark		0.1	0.2	%		0.5	0.7	%		0.4	0.2	%			1.5	0.7	%
Singapore		0.5	0.9	%		0.4	0.6	%		1.5	0.9	%			1.0	0.5	%
Austria(1)		0.2	0.3	%		—	—			0.9	0.5	%			—	—
Norway(1)		0.5	0.9	%		—	—			1.2	0.7	%			—	—
The Netherlands(1)		0.2	0.3	%		—	—			0.4	0.2	%			—	—
Sweden(1)		0.1	0.2	%		—	—			0.3	0.2	%			—	—
Totals	$	54.9	100	%	$	71.3	100	%	$	173.1	100	%	$		219.6	100	%

________________________

(1) Austria, Norway, the Netherlands, and Sweden began operations in September 2009, and had a combined total net sales of $0.1 million for the period ended September 30, 2009.

	Three months					Nine months
	2010		2009			2010		2009
Consolidated product sales	$	45.5	$	52.3	$	140.8	$	159.1
Consolidated pack sales		7.0		15.5		25.1		50.2
Consolidated other, including freight		2.4		3.5		7.2		10.3
Consolidated total net sales	$	54.9	$	71.3	$	173.1	$	219.6

Long-lived assets, which include property and equipment and construction in progress for the Company and its subsidiaries, reside in the following countries (in millions):

Country	September 30, 2010		December 31, 2009
Australia	$	0.3	$	0.3
Canada		0.1		0.1
Japan		0.2		0.3
Republic of Korea		0.9		0.6
Switzerland		0.4		0.5
Taiwan		0.1		0.1
South Africa		0.1		—
United Kingdom		0.1		0.1
United States		19.3		25.5
Totals	$	21.5	$	27.5

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion is intended to assist in the understanding of our consolidated financial position and results of operations for the nine months ended September 30, 2010 as compared to the same period in 2009, and should be read in conjunction with Item I “Financial Statements” in Part I of this quarterly report on Form 10-Q. Unless stated otherwise, all financial information presented below, throughout this report, and in the consolidated financial statements and related notes includes Mannatech, Incorporated and all of our subsidiaries on a consolidated basis.

COMPANY OVERVIEW

Since November 1993, we have continued to develop innovative, high-quality, proprietary nutritional supplements, topical and skin care products, and weight-management products that are sold through a global network marketing system operating in the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, Singapore, Austria, the Netherlands, Norway, and Sweden. The United States, Canada, Australia, United Kingdom Japan, and South Africa offices provide administrative support to its local markets and act as meeting locations for independent associates. The United States location processes orders for the United States, Canada, and South Africa. The Australian location processes orders for Australia, New Zealand, and Singapore. The United Kingdom location process es orders for the United Kingdom, Denmark, Germany, Austria, the Netherlands, Norway, and Sweden. The Japan, Republic of Korea, and Taiwan locations process orders for their local markets only. The Switzerland office was created to manage certain day-to-day business needs of our international markets. We review and analyze net sales by geographical location and by packs and products on a consolidated basis. Each subsidiary sells the same type of products and exhibits similar economic characteristics, such as selling prices and gross margins.

We conduct our business as a single operating segment and primarily sell our products through a network of approximately 422,000 independent associates and members who have purchased our products and/or packs within the last 12 months, which we refer to as current independent associates and members. New recruits and pack sales are regarded as leading indicators for the long-term success of our business. New recruits include new independent associates and members purchasing our packs and products for the first time.

Because we sell our products through network marketing distribution channels, the opportunities and challenges that affect us most are: recruitment of new and retention of existing independent associates and members, entry into new markets and growth of existing markets, niche market development, new product introduction, maintaining competitive compensation plans, and investment in our infrastructure.

During calendar year 2008, the U.S. and foreign economies slowed dramatically because of the global financial crisis. The difficult conditions affecting the overall macro-economic environment continued to impact our business in 2009 and 2010. Significant reduction in consumers’ disposable income impacted our customers’ spending practices, causing a decline in our revenues.

During 2008 and 2009, in response to adverse market conditions, we implemented various initiatives to reduce expenses, including the temporary suspension of matching contributions under our 401(k) employee savings plan, reduction in our workforce, and reduction in other discretionary costs such as outside services, travel and overtime. We also suspended our quarterly cash dividend in August of 2009. By establishing a culture of expense control and accountability, we achieved a decrease in operating expenses and maintained that level of expense control through 2010. Our intent is to systematically review all expenditures with the goal of prudently managing our business. At the same time, we remain committed to our strategic plan of developing new, innovative, and scientifically-validated products, international expansion, strengthening fi nancial results, and adding value to our shareholders and independent associates.

We continue expansion into new international markets and are scheduled to begin selling products in Mexico in early 2011. Our expansion into Mexico will complement our existing presence in North America while highlighting our continued focus on global expansion.

We continue to focus on new product development. In the first quarter of 2010, we launched the Simply Delicious snack bar. The Simply Delicious bar is USDA (United States Department of Agriculture) Organic certified and is offered in two flavors – cherry pie and chocolate raspberry truffle. In late September 2010, we launched our exclusive, age-defying product line, the Mannatech LIFTTM skin care system. The Mannatech LIFTTM skin care line is an innovative system formulated to reduce the signs of aging and improve the youthful radiance of skin in three easy steps. The line is paraben-free and features the company’s Jeunesse 7™ proprietary blend – a combinatio n of Mannatech’s signature glyconutrients and a French green clay. These features collectively make the Mannatech LIFTTM line a natural, age-defying skin care system unique to the industry. The easy-to-use system is formulated with more than 30 natural and botanical ingredients and is currently available throughout the United States and Canada.

In addition to our innovative product development, we continue to invest in research for our existing products. Recent results of a randomized, double-blind, placebo-controlled study validated that Ambrotose® has beneficial effects on cognitive functioning. Additional preclinical studies suggest that Ambrotose® can exert positive effects on the immune system and the digestive tract. Ambrotose®, a glyconutrient product originally launched in 1996, is still our best-selling product.

MannaRelief and Mannatech have partnered together to launch the new Give for RealSM program. This “donation-through-consumption” initiative was designed to allow consumers and associates to help undernourished children around the world. For every purchase on an automatic order containing Ambrotose® complex powder, Advanced Ambrotose® powder, MannaBears™ gummies, PhytoMatrix® caplets, PhytoBurst® nutritional chews or Optimal Support Packets, a donation of Mannatech’s nutritional supplements is provided through MannaRelief to children in need worldwide. For the three months ended September 30, 2010, Mannatech has provided an additional $90,000 in donations to MannaRelief as a result of the Give For RealSM program. MannaRelief and Mannatech’s goal is to connect one million sponsors to one million undernourished children.

Subsequent to the end of the second quarter 2010, the board of directors of the International Sport Karate Association (ISKA) certified Mannatech as its official dietary supplement provider. Several of our products will feature the “ISKA Certified for Elite Athletes” seal on the label, which will be the only health supplements on the market to feature this seal on its packaging. The certification program was developed by ISKA to recognize high-quality dietary supplements. ISKA and Mannatech’s exclusive initial partnership will last until 2012, with an option to renew.

We believe our aggressive cost reduction, new product introduction, international expansion, and financial discipline will enable us to effectively manage through the challenging economy. We believe these recent changes will position us to support future long-term profitable growth.

RESULTS OF OPERATIONS

The table below summarizes our consolidated operating results in dollars and as a percentage of net sales for the three months ended September 30, 2010 and 2009 (in thousands, except percentages).

	2010					2009					Change from 2010 to 2009
	Total dollars			% of net sales		Total dollars			% of net sales		Dollar			Percentage
Net sales	$	54,866		100	%	$	71,295		100	%	$	(16,429	)	(23.0	)%
Cost of sales		7,924		14.4	%		11,923		16.7	%		(3,999	)	(33.5	)%
Commissions and incentives		23,109		42.1	%		35,268		49.6	%		(12,159	)	(34.5	)%
		31,033		56.6	%		47,191		66.2	%		(16,158	)	(34.2	)%
Gross profit		23,833		43.4	%		24,104		33.8	%		(271	)	(1.1	)%

Operating expenses:
Selling and administrative expenses		15,811		28.8	%		17,748		24.9	%		(1,937	)	(10.9	)%
Depreciation and amortization		2,772		5.1	%		3,085		4.3	%		(313	)	(10.1	)%
Other operating costs		8,911		16.2	%		11,842		16.6	%		(2,931	)	(24.8	)%
Total operating expenses		27,494		50.1	%		32,675		45.8	%		(5,181	)	(15.9	)%
Loss from operations		(3,661	)	(6.7	)%		(8,571	)	(12.0	)%		4,910		57.3	%
Interest income		20		0.0	%		39		0.1	%		(19	)	(48.7	)%
Other income, net		400		0.7	%		859		1.2	%		(459	)	(53.4	)%
Loss before income taxes		(3,241	)	(5.9	)%		(7,673	)	(10.8	)%		4,432		57.8	%
(Provision) benefit for income taxes		1,963		3.6	%		(1,534	)	(2.2	)%		3,497		228.0	%
Net loss	$	(1,278	)	(2.3	)%	$	(9,207	)	(12.8	)%	$	7,929		86.1	%

The table below summarizes our consolidated operating results in dollars and as a percentage of net sales for the nine months ended September 30, 2010 and 2009 (in thousands, except percentages).

	2010					2009					Change from 2010 to 2009
	Total dollars			% of net sales		Total dollars			% of net sales		Dollar			Percentage
Net sales	$	173,137		100	%	$	219,640		100	%	$	(46,503	)	(21.2	)%
Cost of sales		24,640		14.2	%		35,944		16.4	%		(11,304	)	(31.4	)%
Commissions and incentives		74,617		43.1	%		115,413		52.5	%		(40,796	)	(35.3	)%
		99,257		57.3	%		151,357		68.9	%		(52,100	)	(34.4	)%
Gross profit		73,880		42.7	%		68,283		31.1	%		5,597		8.2	%

Operating expenses:
Selling and administrative expenses		47,579		27.5	%		53,403		24.3	%		(5,824	)	(10.9	)%
Depreciation and amortization		8,691		5.0	%		9,357		4.3	%		(666	)	(7.1)	%
Other operating costs		26,292		15.2	%		30,831		14.0	%		(4,539	)	(14.7	)%
Total operating expenses		82,562		47.7	%		93,591		42.6	%		(11,029	)	(11.8	)%
Loss from operations		(8,682	)	(5.0	)%		(25,308	)	(11.5	)%		16,626		65.7	%
Interest income		1		0.0	%		182		0.1	%		(181	)	(99.5	)%
Other income (expense), net		(175	)	(0.1	)%		822		0.4	%		(997	)	(121.3	)%
Loss before income taxes		(8,856	)	(5.1	)%		(24,304	)	(11.1	)%		15,448		63.6	%
Benefit for income taxes		982		0.6	%		4,785		2.2	%		(3,803	)	(79.5	)%
Net loss	$	(7,874	)	(4.5	)%	$	(19,519	)	(8.9	)%	$	11,645		59.7	%

Consolidated net sales shipped to customers by location for the three months ended September 30, 2010 and 2009 were as follows (in millions, except percentages):

Net Sales in Dollars and as a Percentage of Consolidated Net Sales

Country	2010				2009
United States	$	23.9	43.5	%	$	34.0	47.7	%
Japan		8.9	16.2	%		9.9	13.9	%
Republic of Korea		5.1	9.3	%		6.9	9.7	%
Canada		4.6	8.4	%		5.8	8.1	%
Australia		4.7	8.6	%		5.7	8.0	%
South Africa		3.0	5.5	%		3.9	5.5	%
Taiwan		1.4	2.6	%		1.4	2.0	%
New Zealand		0.7	1.3	%		1.1	1.5	%
Germany		0.6	1.1	%		0.9	1.3	%
United Kingdom		0.4	0.7	%		0.8	1.0	%
Denmark		0.1	0.2	%		0.5	0.7	%
Singapore		0.5	0.9	%		0.4	0.6	%
Austria(1)		0.2	0.3	%		—	—
Norway(1)		0.5	0.9	%		—	—
The Netherlands(1)		0.2	0.3	%		—	—
Sweden(1)		0.1	0.2	%		—	—
Totals	$	54.9	100	%	$	71.3	100	%

________________________

(1) Austria, Norway, the Netherlands, and Sweden began operations in September 2009, and had a combined total net sales of $0.1 million for the period ended September 30, 2009.

Consolidated net sales shipped to customers by location for the nine months ended September 30, 2010 and 2009 were as follows (in millions, except percentages):

Country	2010				2009
United States	$	77.7	44.9	%	$	109.7	49.9	%
Japan		25.8	14.9	%		31.4	14.3	%
Republic of Korea		16.2	9.4	%		19.2	8.8	%
Canada		14.0	8.1	%		17.5	8.0	%
Australia		14.8	8.6	%		16.7	7.6	%
South Africa		9.0	5.2	%		9.4	4.2	%
Taiwan		5.0	2.9	%		4.8	2.2	%
New Zealand		2.5	1.4	%		3.3	1.5	%
Germany		1.8	1.0	%		2.6	1.2	%
United Kingdom		1.6	0.9	%		2.5	1.1	%
Denmark		0.4	0.2	%		1.5	0.7	%
Singapore		1.5	0.9	%		1.0	0.5	%
Austria(1)		0.9	0.5	%		—	—
Norway(1)		1.2	0.7	%		—	—
The Netherlands(1)		0.4	0.2	%		—	—
Sweden(1)		0.3	0.2	%		—	—
Totals	$	173.1	100	%	$	219.6	100	%

________________________

(1) Austria, Norway, the Netherlands, and Sweden began operations in September 2009, and had a combined total net sales of $0.1 million for the period ended September 30, 2009.

Net Sales

For the three and nine months ended September 30, 2010, our operations outside of the United States accounted for approximately 56.5% and 55.1%, respectively, of our consolidated net sales, whereas in the same period in 2009, our operations outside of the United States accounted for approximately 52.3% and 50.1%, respectively, of our consolidated net sales.

Consolidated net sales for the three months ended September 30, 2010 decreased by $16.4 million, or 23.0%, as compared to the same period in 2009. This change in consolidated net sales was comprised of a decrease in domestic sales of $10.1 million and a decrease in international sales of $6.3 million.

Consolidated net sales for the nine months ended September 30, 2010 decreased by $46.5 million, or 21.2%, as compared to the same period in 2009. This change in consolidated net sales was comprised of a decrease in domestic sales of $32.0 million and a decrease of international sales of $14.5 million.

The global financial crisis continues to be a major factor for the decline in both our domestic and international sales and recruiting. Sales in domestic and international markets have also been adversely affected as a result of direct competition.

Fluctuation in foreign currency exchange rates had an overall favorable impact on our net sales of approximately $1.5 million and $7.4 million for the three and nine months ended September 30, 2010, respectively. The net sales impact is calculated as the difference between (1) the current period’s net sales in USD and (2) the current period’s net sales in local currencies converted to USD by applying average exchange rates for the same periods ended September 30, 2009.

Net sales by country in local currency for the three and nine months ended September 30, 2010 and 2009 are as follows (in millions, except percentages):

		Three months
				Change
Country	Currency	2010	2009	Local currency		Percentage
Australia and Singapore	AUD	5.8	7.4	(1.6	)	(21.6	)%
Austria(1), Germany, the Netherlands(1)	EUR	0.7	0.6	0.1		16.7	%
Denmark	DKK	0.6	2.4	(1.8	)	(75.0	)%
Japan	JPY	753.5	921.0	(167.5	)	(18.2	)%
Republic of Korea	KRW	6,032.8	8,540.1	(2,507.3	)	(29.4	)%
New Zealand	NZD	1.0	1.6	(0.6	)	(37.5	)%
Norway(1)	NOK	2.1	0.2	1.9		950.0	%
South Africa	ZAR	21.8	30.2	(8.4	)	(27.8	)%
Sweden(1)	SEK	0.7	0.1	0.6		600.0	%
Taiwan	TWD	43.5	46.1	(2.6	)	(5.6	)%
United Kingdom	GBP	0.4	0.5	(0.1	)	(20.0	)%

________________________

(1) Austria, the Netherlands, Norway, and Sweden began operations in September 2009. Austria and the Netherlands had net sales of less than $.01 million Euros for the period ended September 30, 2009.

		Nine months
				Change
Country	Currency	2010	2009	Local currency		Percentage
Australia and Singapore	AUD	18.2	23.7	(5.5	)	(23.2	)%
Austria(1), Germany, the Netherlands(1)	EUR	2.2	1.9	0.3		15.8	%
Denmark	DKK	2.4	7.6	(5.2	)	(68.4	)%
Japan	JPY	2,279.9	2,945.3	(665.4	)	(22.6	)%
Republic of Korea	KRW	18,849.1	25,012.7	(6,163.6	)	(24.6	)%
New Zealand	NZD	3.5	5.5	(2.0	)	(36.4	)%
Norway(1)	NOK	5.8	0.2	5.6		2,800.0	%
South Africa	ZAR	67.2	80.7	(13.5	)	(16.7	)%
Sweden(1)	SEK	2.1	0.1	2.0		2,000.0	%
Taiwan	TWD	157.8	159.0	(1.2	)	(0.8	)%
United Kingdom	GBP	1.3	1.6	(0.3	)	(18.8	)%

________________________

(1) Austria, the Netherlands, Norway, and Sweden began operations in September 2009. Austria and the Netherlands had net sales of less than $.01 million Euros for the period ended September 30, 2009.

Our total sales and sales mix can be influenced by any of the following:

·	changes in our sales prices;

·	changes in consumer demand;

·	changes in the number of independent associates and members;

·	changes in competitors’ products;

·	changes in economic conditions;

·	changes in regulations;

·	announcements of new scientific studies and breakthroughs;

·	introduction of new products;

·	discontinuation of existing products;

·	adverse publicity;

·	changes in our commissions and incentives programs;

·	direct competition; and

·	fluctuations in foreign currency exchange rates.

Our sales mix for the three and nine months ended September 30, was as follows (in millions, except percentages):

	Three Months
					Change
	2010		2009		Dollar			Percentage
Product sales	$	45.5	$	52.3	$	(6.8	)	(13.0	)%
Pack sales		7.0		15.5		(8.5	)	(54.8	)%
Other, including freight		2.4		3.5		(1.1	)	(31.4	)%
Total net sales	$	54.9	$	71.3	$	(16.4	)	(23.0	)%

	Nine Months
					Change
	2010		2009		Dollar			Percentage
Product sales	$	140.8	$	159.1	$	(18.3	)	(11.5	)%
Pack sales		25.1		50.2		(25.1	)	(50.0	)%
Other, including freight		7.2		10.3		(3.1	)	(30.1	)%
Total net sales	$	173.1	$	219.6	$	(46.5	)	(21.2	)%

For the three and nine months ended September 30, 2010 compared to the same periods in 2009, the decrease in our pack sales was primarily a result of fewer new associates. Pack sales generally correlate to new independent associates who purchase starter packs and continuing independent associates who purchase upgrade or renewal packs. However, there is no direct correlation between product sales and the number of new and continuing independent associates and members because independent associates and members utilize products at different volumes.

Product Sales

In order to evaluate new product sales as compared to existing product sales, we calculate our product sales that are either (i) newly developed products, or (ii) existing products that are newly introduced to a country within the last twelve months as of quarter end. We then compare this total to our existing product line, or products that have been available in a country over twelve months. This analysis is a valuable tool to help determine the success of our new products, as well as the timely expansion of our existing products.

Product sales for the three months ended September 30, 2010 decreased $6.8 million, or 13.0%, as compared to the same period in 2009. This change in product sales was comprised of a decrease of new product sales of $1.7 million and a decrease of existing product sales of $5.1 million.

Product sales for the nine months ended September 30, 2010 decreased $18.3 million, or 11.5%, as compared to the same period in 2009. This change in product sales was comprised of a decrease of new product sales of $5.0 million and a decrease of existing product sales of $13.3 million.

We implemented a 2-5% price increase in most countries in late January 2010. We believe the decrease in product sales for the third quarter ended September 30, 2010 as compared to the same period in 2009 was largely due to several factors, including macro-economics and competition, which directly impacts our company.

We have introduced the following new products since September 30, 2009:

·	Simply Delicious™ Snack Bars in the United States and Canada;

·	Essential Source™ Omega 3 in the United States and all of our international markets;

·	PhytoBurst® Nutritional Chews in the United States, Canada, Japan, Taiwan, and South Africa;

·	Health Solutions Starter packs in several international markets;

·	GlycoSlim® drink mix in certain international markets;

·	BounceBack® capsules in Japan and Taiwan;

·	GI-Pro Balance™ powder in South Korea;

·	Mannatech LIFT™ products in United States and Canada;

·	Immunostart® tablets in the United Kingdom, Germany, Denmark, New Zealand, Australia, Austria, the Netherlands, Norway, Sweden;

·	Various promotional packages in the United States and international markets; and

·	Various Optimal Health, Weight and Fitness products in Austria, the Netherlands, Norway and Sweden.

Pack Sales

Packs may be purchased by our independent associates who wish to build a Mannatech business. These packs are offered to our independent associates at a discount from published retail prices. There are several pack options available to our independent associates. In certain markets, pack sales are concluded during the associate registration process and can provide new independent associates with valuable training and promotional materials, as well as products for resale to retail customers, demonstration purposes, and personal consumption. Business-building independent associates can also choose to purchase an upgrade pack, which provides the associate with additional promotional materials and eligibility for additional commissions and incentives. Many of our business-building independent associates also choose to purchase renewal packs t o satisfy annual renewal requirements to continue to earn various commissions.

Pack sales associated with the number of independent associates and members can be further analyzed as follows, for the three and nine months ended September 30 (in millions, except percentages):

	Three Months
					Change
	2010		2009		Dollar			Percentage
New	$	5.1	$	11.0	$	(5.9	)	(53.6	)%
Continuing		1.9		4.5		(2.6	)	(57.8	)%
Total	$	7.0	$	15.5	$	(8.5	)	(54.8	)%

	Nine Months
					Change
	2010		2009		Dollar			Percentage
New	$	17.2	$	32.1	$	(14.9	)	(46.4	)%
Continuing		7.9		18.1		(10.2	)	(56.4	)%
Total	$	25.1	$	50.2	$	(25.1	)	(50.0	)%

Total pack sales for the three months ended September 30, 2010 decreased by $8.5 million, or 54.8%, as compared to the same period in 2009. This reduction in pack sales was comprised of a decrease of $5.9 million related to fewer new independent associates purchasing starter packs, and a decrease of $2.6 million related to a decline in the number of continuing associates purchasing renewal and upgrade packs.

Total pack sales for the nine months ended September 30, 2010 decreased by $25.1 million, or 50.0%, as compared to the same period in 2009. This reduction in pack sales was comprised of a decrease of $14.9 million related to fewer new independent associates purchasing starter packs, and a decrease of $10.2 million related to a decline in the number of continuing associates purchasing renewal and upgrade packs.

The number of new and continuing independent associates and members who purchased our packs or products during the twelve months ended September 30, 2010 and 2009 were as follows:

	2010			2009
New	93,000	22.0	%	151,000	28.3	%
Continuing	329,000	78.0	%	383,000	71.7	%
Total	422,000	100	%	534,000	100	%

There was an overall decrease of 112,000 associates and members for the twelve months ended September 30, 2010. We are experiencing increased competition in certain domestic and international markets where competitors have launched operations, and in some cases have attracted some of our independent associate field leaders. We will continue to address new independent associate recruiting and associate retainment through additional incentives, new promotional support materials, and cause-related charitable activities.

During 2009 and 2010, we took the following actions to help increase the number of, and retain our existing, independent associates and members:

·	registered our most popular products with the appropriate regulatory agencies in all countries of operations;

·	focused on new product development;

·	explored new international markets;

·	launched an aggressive marketing and educational campaign;

·	strengthened compliance initiatives;

·	concentrated on publishing results of research studies and clinical trials related to our products;

·	initiated additional incentives;

·	explored new advertising and educational tools to broaden name recognition;

·	implemented changes to our global associate career and compensation plan;

·	introduced new products in many of our global markets;

·	introduced the $499 Premium-All-Star pack into United States, Canada, and South Africa in January 2009;

·	introduced similar All-Star Packs into all other markets in January 2010;

·	expanded into four new international markets in early fall of 2009;

·	revamped our website to increase user-friendliness; and

·	launched three new effective online tools (MannacastSM,which includes StoryCastTM, Mannapages®, and Success Tracker) in the United States and Canada that offer support to our independent associates in managing and expanding their business.

Other Sales

Other sales consisted of (i) sales of promotional materials; (ii) training and event registration fees; (iii) monthly fees collected for the SuccessTracker tool, a customized electronic business-building and educational materials database for our independent associates that helps stimulate product sales and provide business management; (iv) freight revenue charged to our independent associates and members; and (v) a reserve for estimated sales refunds and returns.

Other sales for the three months ended September 30, 2010 decreased by $1.1 million to $2.4 million as compared to $3.5 million for the same period in 2009. Other sales for the nine months ended September 30, 2010 decreased by $3.1 million to $7.2 million as compared to $10.3 million for the same period in 2009. The decrease in both periods was primarily due to a decrease in freight fees for product and pack shipments.

Gross Profit

Gross profit for the three months ended September 30, 2010 decreased by $0.3 million, or 1.1%, to $23.8 million as compared to $24.1 million for the same period in 2009. Gross profit as a percentage of net sales increased to 43.4% as compared to 33.8% for the same period in 2009. The increase in gross profit as a percentage of net sales was due to lower commissions and incentives for the period.

Gross profit for the nine months ended September 30, 2010 increased by $5.6 million, or 8.2%, to $73.9 million as compared to $68.3 million for the same period in 2009. Gross profit as a percentage of net sales increased to 42.7% as compared to 31.1% for the same period in 2009. The increase in gross profit for the nine months ended September 30, 2010 compared to the same period in 2009 was primarily due to the modification of our bonus structure associated with the $499 Premium-All Star pack. This alteration in the bonus structure allowed commission and incentive rates to return to more historical levels.

Cost of sales during the three months ended September 30, 2010 decreased by $4.0 million, or 33.5%, to $7.9 million as compared to $11.9 million for the same period in 2009. Cost of sales as a percentage of net sales for the three months ended September 30, 2010 decreased to 14.4% as compared to 16.7% for the same period in 2009.

Cost of sales during the nine months ended September 30, 2010 decreased $11.3 million, or 31.4%, to $24.6 million as compared to $35.9 million for the same period in 2009. Cost of sales as a percentage of net sales for the nine months ended September 30, 2010 decreased to 14.2 % as compared to 16.4% for the same period in 2009.

The decrease in cost of sales, and cost of sales as a percentage of net sales, for the three and nine months ended September 30, 2010 compared to the same periods in 2009 was primarily due to improved economics associated with pack sales, including a reduction in the cost of packs and modification of bonus and pack components, as well as a decrease in the cost of finished products sold.

Commission costs for the three months ended September 30, 2010 decreased by 34.6%, or $11.9 million, to $22.5 million as compared to $34.4 million for the same period in 2009. Commissions as a percentage of net sales for the three months ended September 30, 2010 decreased to 41.0% from 48.2% for the same period in 2009.

Commission costs for the nine months ended September 30, 2010 decreased by 33.6%, or $36.2 million, to $71.6 million as compared to $107.8 million for the same period in 2009. Commissions as a percentage of net sales for the nine months ended September 30, 2010 decreased to 41.4% from 49.1% for the same period in 2009.

Incentive costs for the three months ended September 30, 2010 decreased by 33.3%, or $0.3 million, to $0.6 million as compared to $0.9 million for the same period in 2009. The costs of incentives as a percentage of net sales for the three months ended September 30, 2010 decreased to 1.1% from 1.3% for the same period in 2009.

Incentive costs for the nine months ended September 30, 2010 decreased by 60.5%, or $4.6 million, to $3.0 million as compared to $7.6 million for the same period in 2009. The costs of incentives as a percentage of net sales for the nine months ended September 30, 2010 decreased to 1.7% from 3.5 % for the same period in 2009.

The decrease in commission and incentive costs for the three and nine months ended September 30, 2010 compared to the same periods in 2009 was due to modification of our pack bonus structure and commission rates, as well as a decrease in the number of new and continuing independent associates and members who purchased our packs or products. As a result, there was a decrease in the number of independent associates who qualified for the annual incentives to 715 as compared to 2,374 in 2009. The alteration in the bonus structure allowed commission and incentive rates to return to more historical levels.

Selling and Administrative Expenses

Selling and administrative expenses include a combination of both fixed and variable expenses. These expenses consist of compensation and benefits for employees, temporary and contract labor, outbound shipping and freight expenses, and marketing-related expenses, such as monthly magazine development costs and costs related to hosting our corporate-sponsored events.

Selling and administrative expenses for the three months ended September 30, 2010 decreased by $1.9 million, or 10.9%, to $15.8 million as compared to $17.8 million for the same period in 2009. The decrease in selling and administrative expenses consisted primarily of a $1.3 million decrease in contract labor, payroll and payroll-related costs and a $0.8 million decrease in freight costs, partially offset by an increase of $0.2 million in marketing costs and costs related to corporate-sponsored events. As a percentage of net sales, selling and administrative expenses increased to 28.8% from 24.9% for the same period in 2009.

Selling and administrative expenses for the nine months ended September 30, 2010 decreased by $5.8 million, or 10.9%, to $47.6 million as compared to $53.4 million for the same period in 2009. The decrease in selling and administrative expenses consisted primarily of a $3.3 million decrease in contract labor, payroll and payroll-related costs, a $0.7 million decrease in marketing costs and costs related to corporate-sponsored events, and a $1.8 million decrease in freight costs. As a percentage of net sales, selling and administrative expenses increased to 27.5% from 24.3% for the same period in 2009.

Depreciation and Amortization Expense

Depreciation and amortization expense for the three months ended September 30, 2010 decreased by 10.1%, or $0.3 million, to $2.8 million as compared to $3.1 million for the same period in 2009. As a percentage of net sales, depreciation and amortization expense increased to 5.1% from 4.3% for the same period in 2009.

Depreciation and amortization expense for the nine months ended September 30, 2010 decreased by 7.1%, or $0.7 million, to $8.7 million as compared to $9.4 million for the same period in 2009. As a percentage of net sales, depreciation and amortization expense increased slightly to 5.0% from 4.3% for the same period in 2009.

Other Operating Costs

Other operating costs generally include travel, accounting/legal/consulting fees, royalties, credit card processing fees, banking fees, off-site storage fees, utilities, and other miscellaneous operating expenses. Generally, changes in other operating costs are associated with changes in our net sales.

Other operating costs for the three months ended September 30, 2010 decreased by $2.9 million, or 24.8%, to $8.9 million as compared to $11.8 million for the same period in 2009. This decrease was due to a $1.5 million reduction in legal expenses, a $0.4 million reduction in credit card fees, a $0.3 million reduction in accounting/consulting fees, a $0.2 million reduction in travel expenses, a $0.2 million reduction in research and development costs, a $0.2 million in miscellaneous operating costs, such as mailing services, office supplies, telephone, insurance, and lease/rental costs, and a $0.1 million in repairs and maintenance fees. As a percentage of net sales, other operating costs decreased slightly to 16.2% from 16.6% for the same period in 2009.

Other operating costs for the nine months ended September 30, 2010 decreased by $4.5 million, or 14.7%, to $26.3 million as compared to $30.8 million for the same period in 2009. This decrease was due to a $1.2 million reduction in credit card fees, $1.2 million reduction in accounting/consulting fees, a $0.7 million reduction in legal fees, a $0.5 million reduction in travel expenses, a $0.5 million reduction in miscellaneous expenses, a $0.3 million reduction in research and development costs, and a $0.1 million reduction in repairs and maintenance. As a percentage of net sales, other operating costs increased to 15.2% from 14.0% for the same period in 2009.

Other Income (Expense), Net

Other income (expense), net primarily consists of foreign currency gains and losses related to translating our foreign subsidiaries’ assets, liabilities, revenues, and expenses to the United States dollar and revaluing monetary accounts in United States, Switzerland, Japan, and the Republic of Korea, using current and weighted-average currency exchange rates. Net foreign currency transaction gains and losses are the result of the United States dollar fluctuating in value against foreign currencies.

Other income, net for the three months ended September 30, 2010 was $0.4 million, as compared to $0.8 million for the same period in 2009.

Other expense, net for the nine months ended September 30, 2010 was $0.2 million, as compared to other income, net of $0.8 million for the same period in 2009.

(Provision) Benefit for Income Taxes

(Provision) benefit for income taxes includes current and deferred income taxes for both our domestic and foreign operations. Our statutory income tax rates by jurisdiction are as follows, for the three and nine months ended September 30:

Country	2010		2009
Australia	30.0	%	30.0	%
Canada	30.0	%	33.0	%
Denmark	25.0	%	25.0	%
Japan	42.0	%	42.0	%
Mexico	30.0	%	—
Norway	28.0	%	28.0	%
Republic of Korea	22.0	%	24.2	%
Singapore	17.0	%	17.0	%
South Africa	28.0	%	28.0	%
Sweden	26.3	%	26.3	%
Switzerland	16.2	%	16.2	%
Taiwan	17.0	%	25.0	%
United Kingdom	28.0	%	28.0	%
United States	37.5	%	37.5	%

Income from our international operations is subject to taxation in the countries in which we operate. Although we may receive foreign income tax credits that would reduce the total amount of income taxes owed in the United States, we may not be able to fully utilize our foreign income tax credits in the United States.

We use the recognition and measurement provisions of FASB ASC Topic 740, Income Taxes, to account for income taxes. The provisions of the Income Tax Topic require a company to record a valuation allowance when the “more likely than not” criterion for realizing net deferred tax assets cannot be met. Furthermore, the weight given to the potential effect of such evidence should be commensurate with the extent to which it can be objectively verified. As a result, we reviewed the operating results, as well as all of the positive and negative evidence related to realization of such deferred tax assets to evaluate the need for a valuation allowance in each tax jurisdiction. As of September 30, 2010 and December 31, 2009, we maintained our valuation allowance for deferred tax a ssets totaling $3.6 million and $2.3 million, respectively, as we believe the “more likely than not” criterion for recognition and realization purposes, as defined in FASB ASC Topic 740, cannot be met.

Country	September 30, 2010		December 31, 2009
Mexico	$	0.6	$	—
Norway		0.1		0.0
Sweden		0.1		0.0
Switzerland		0.6		0.3
Taiwan		0.9		0.9
United States		1.3		1.1
Total	$	3.6	$	2.3

LIQUIDITY AND CAPITAL RESOURCES

Our principal use of cash is to pay for operating expenses, including commissions and incentives, capital assets, inventory purchases, international expansion, and to pay quarterly cash dividends. In August 2009, the quarterly cash dividend was suspended and remained suspended as of September 30, 2010. At September 30, 2010, we had $21.7 million in cash and cash equivalents that can be used, along with normal cash flows from operations, to fund any unanticipated shortfalls in future cash flows. Although our cash has been impacted by net losses for most of 2009 and 2010, we saw our costs, particularly commissions and incentives, return to more historical levels. Although we are contemplating alternative liquidity sources, remaining at these historical cost levels will be a key factor in our ability to generate sufficient cash from operati ons. In addition, in April 2010, we received a federal income tax refund of $8.1 million.

Cash and Cash Equivalents and Investments

As of September 30, 2010, our cash and cash equivalents increased by 24.8%, or $4.3 million, to $21.7 million from $17.4 million as of December 31, 2009. The increase in cash and cash equivalents is related to the federal income tax refund of $8.1 million we received in April 2010 which is offset by the current period loss, adjusted for noncash items, purchases of property and equipment, and decreases of payables due to the timing of payments.

Working Capital

Working capital represents total current assets less total current liabilities. At September 30, 2010, our working capital increased by $0.6 million, or 2.8%, to $22.4 million from $21.8 million at December 31, 2009. The change in working capital primarily relates to an increase in cash and cash equivalents, a decrease in short-term tax accounts, a decrease in inventories, partially offset by a decrease in operating liabilities.

Net Cash Flows

Our net consolidated cash flows consisted of the following, for the nine months ended September 30

(in millions):

Provided by (used in):	2010			2009
Operating activities	$	4.9		$	(4.7	)
Investing activities	$	0.2		$	(2.1	)
Financing activities	$	(0.9	)	$	(1.3	)

Operating Activities

For the nine months ended September 30, 2010, our operating activities provided cash of $4.9 million compared to using cash of $4.7 million for the same period in 2009. This increase in cash is due to the $8.1 million federal income tax refund received in April 2010, as well as the significant decrease in operating costs that we achieved through establishing a culture of expense control and accountability.

We entered into an Investment Agreement with the Investor on September 16, 2010. The Investor committed to purchase, subject to certain restrictions and conditions, up to $10 million of our common stock, over a period of 36 months from the first trading following the effectiveness of the registration statement, which was October 28, 2010. We may draw funds from the Equity Line by selling shares of common stock to the Investor from time to time. We will not receive any proceeds from the resale of these shares of common stock offered by the Investor. We will, however, receive proceeds from the sale of shares to the Investor pursuant to the Equity Line. The proceeds will be used for general working capital needs and for other general corporate purposes.

We expect that our net operating cash flows in 2010 will be sufficient to fund our current operations. There can be no assurance, however, that we will continue to generate cash flows at or above current levels. Certain events, such as the uncertainty of the worldwide economic environment, could impact our available cash or our ability to generate cash flows from operations.

Investing Activities

For the nine months ended September 30, 2010, our net investing activities provided cash of $0.2 million compared to using cash of $2.1 million for the same period of 2009. For the nine months ended September 30, 2010, we used cash of $1.5 million to purchase capital assets as compared to purchasing $2.5 million in capital assets for the same period in 2009. In 2010, we had a decrease in restricted cash of $1.7 million as compared to a decrease of $0.4 million for the same period in 2009.

Financing Activities

For the nine months ended September 30, 2010, we used cash of $0.9 million for repayment of capital lease obligations as compared to $1.1 million to fund the payment of cash dividends to our shareholders for the same period in 2009. In August 2009, the quarterly cash dividend was suspended. See “Risk Factors—We are not required to pay dividends, and our Board of Directors could decide not to declare a dividend or could reduce the amount of the dividend at any time” in item 1A of our annual report on Form 10-K for the year ended December 31, 2009, for further discussion related to future payment of dividends.

Our quarterly cash dividends were $0.02 per share for the first and second quarters of 2009. In 2009, we declared and paid the following dividends:

Declared date	Date of record	Date paid	Total amount of dividends			Dollar amount paid per common share
May 20, 2009	June 3, 2009	June 29, 2009	$	0.5	million	$	0.02
February 18, 2009	March 9, 2009	March 26, 2009	$	0.5	million	$	0.02

General Liquidity and Cash Flows

We believe our existing liquidity and cash flows from operations are adequate to fund our normal expected future business operations and possible international expansion costs for the next 12 to 24 months. However, if our existing capital resources or cash flows become insufficient to meet current business plans, projections, and existing capital requirements, we may be required to raise additional funds, which may not be available on favorable terms, if at all.

Contractual Obligations. The following summarizes our future commitments and obligations associated with various agreements and contracts as of September 30, 2010, for the years ending December 31 (in thousands):

	Remaining 2010		2011		2012		2013		2014		2015		Thereafter		Total
Capital lease obligations	$	440	$	1,154	$	711	$	344	$	239	$	1	$	—	$	2,889
Purchase obligations(1)(2)		8,766		4,956		2,535		1,050		1,050		1,050		—		19,407
Operating leases		799		2,174		2,036		1,572		897		815		955		9,248
Post-employment royalty		152		492		492		492		369		—		—		1,997
Employment agreements		584		1,379		—		—		—		—		—		1,963
Total commitments and obligations	$	10,741	$	10,155	$	5,774	$	3,458	$	2,555	$	1,866	$	955	$	35,504

____________________________

(1) Purchase obligations for the years 2010, 2011, and 2012 include $4.7 million, $2.1 million, and $1.5 million, respectively, of purchase commitments under a contract terminated by the Company for an asserted breach. Pursuant to the terms of the contract, we are engaged in the arbitration process with the supplier.

(2) Purchase obligations for the remainder of 2010 include $0.2 million of purchase commitments under a contract terminated effective December 31, 2010, by the supplier. The Company is negotiating a new agreement with this supplier.

We have maintained purchase commitments with certain raw material suppliers to purchase minimum quantities and to ensure exclusivity of our raw materials and the proprietary nature of our products. Currently, we have four supply agreements that require minimum purchase commitments. We terminated one of these contracts for an asserted breach in 2009 and are now engaged in the arbitration process with the supplier. We also maintain other supply agreements and manufacturing agreements to protect our products, regulate product costs, and help ensure quality control standards. These agreements do not require us to purchase any set minimums. We have no present commitments or agreements with respect to acquisitions or purchases of any manufacturing facilities; however, management from time to time explores the possibility of the benefits of pur chasing a raw material manufacturing facility to help control costs of our raw materials and help ensure quality control standards.

Off-Balance Sheet Arrangements

We do not have any special-purpose entity arrangements, nor do we have any off-balance sheet arrangements.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The application of GAAP requires us to make estimates and assumptions that affect the reported values of assets and liabilities at the date of our financial statements, the reported amounts of revenues and expenses during the reporting period, and the related disclosures of contingent assets and liabilities. We use estimates throughout our financial statements, which are influenced by management’s judgment and uncertainties. Our estimates are based on historical trends, industry standards, and various other assumptions that we believe are applicable and reasonable under the circumstances at the time the consolidated financial statements are prepared. Our Audit Committee reviews our critical accounting policies and estimates. We continually evaluate and review our policies related to the portrayal of our consolidated financial position and consolidated results of operations that require the application of significant judgment by our management. We also analyze the need for certain estimates, including the need for such items as allowance for doubtful accounts, inventory reserves, long-lived fixed assets and capitalization of internal-use software development costs, reserve for uncertain income tax positions and tax valuation allowances, revenue recognition, sales returns, and deferred revenues, accounting for stock-based compensation, and contingencies and litigation. Historically, actual results have not materially deviated from our estimates. However, we caution readers that actual results could differ from our estimates and assumptions applied in the preparation of our consolidated financial statements. If circumstances change relating to the various assumptions or condi tions used in our estimates, we could experience an adverse effect on our financial position, results of operations, and cash flows. We have identified the following applicable critical accounting policies and estimates as of September 30, 2010:

Inventory Reserves

Inventory consists of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. We record the amounts charged by vendors as the costs of inventory. Typically, the net realizable value of our inventory is higher than the aggregate cost. Determination of net realizable value can be complex and, therefore, requires a high degree of judgment. In order for management to make the appropriate determination of net realizable value, the following items are considered: inventory turnover statistics, current selling prices, seasonality factors, consumer demand, regulatory changes, competitive pricing, and performance of similar products. If we determine the carrying value of inventory is in excess of estimated net realizable value, we write down the value of inventory to the estimated net realizable value.

We also review inventory for obsolescence in a similar manner and any inventory identified as obsolete is reserved or written off. Our determination of obsolescence is based on assumptions about the demand for our products, product expiration dates, estimated future sales, and general future plans. We monitor actual sales compared to original projections, and if actual sales are less favorable than those originally projected by us, we record an additional inventory reserve or write-down. Historically, our estimates have been close to our actual reported amounts. However, if our estimates regarding fair market value or obsolescence are inaccurate or consumer demand for our products changes in an unforeseen manner, we may be exposed to additional material losses or gains in excess of our established estimated inventory reserves.

Long Lived Fixed Assets and Capitalization of Software Development Costs

In addition to capitalizing long lived fixed asset costs, we also capitalize costs associated with internally-developed software projects (collectively “fixed assets”) and amortize such costs over the estimated useful lives of such fixed assets. Fixed assets are carried at cost, less accumulated depreciation computed using the straight-line method over the assets’ estimated useful lives. Leasehold improvements are amortized over the shorter of the remaining lease terms or the estimated useful lives of the improvements. Expenditures for maintenance and repairs are charged to operations as incurred. If a fixed asset is sold or otherwise retired or disposed of, the cost of the fixed asset and the related accumulated depreciation or amortization is written off and any resulting gain or loss is recorded in other operating co sts in our consolidated statement of operations.

We review our fixed assets for impairment whenever an event or change in circumstances indicates the carrying amount of an asset or group of assets may not be recoverable, such as plans to dispose of an asset before the end of its previously estimated useful life. Our impairment review includes a comparison of future projected cash flows generated by the asset, or group of assets, with its associated net carrying value. If the net carrying value of the asset or group of assets exceeds expected cash flows (undiscounted and without interest charges), an impairment loss is recognized to the extent the carrying amount exceeds the fair value. The fair value is determined by calculating the discounted expected future cash flows using an estimated risk-free rate of interest. Any identified impairment losses are recorded in the period in which t he impairment occurs. The carrying value of the fixed asset is adjusted to the new carrying value and any subsequent increases in fair value of the fixed asset are not recorded. In addition, if we determine the estimated remaining useful life of the asset should be reduced from our original estimate, at that time the periodic depreciation expense is adjusted prospectively, based on the new remaining useful life of the fixed asset.

The impairment calculation requires us to apply judgment and estimates concerning future cash flows, strategic plans, useful lives, and discount rates. If actual results are not consistent with our estimates and assumptions, we may be exposed to an additional impairment charge, which could be material to our results of operations. In addition, if accounting standards change, or if fixed assets become obsolete, we may be required to write off any unamortized costs of fixed assets; or if estimated useful lives change, we would be required to accelerate depreciation or amortization periods and recognize additional depreciation expense in our consolidated statement of operations.

Historically, our estimates and assumptions related to the carrying value and the estimated useful lives of our fixed assets have not materially deviated from actual results. As of September 30, 2010, the estimated useful lives and net carrying values of fixed assets were as follows:

	Estimated useful life	Net carrying value at September 30, 2010
Office furniture and equipment	5 to 7 years	$	2.0	million
Computer hardware	3 to 5 years		4.0	million
Computer software	3 to 5 years		10.7	million
Automobiles	3 to 5 years		0.1	million
Leasehold improvements	2 to 10 years(1)		3.2	million
Construction in progress	2 to 10 years(2)		1.5	million
Total net carrying value at September 30, 2010		$	21.5	million

___________________

(1)	We amortize leasehold improvements over the shorter of the useful estimated life of the leased asset or the lease term.

(2)

Construction in progress includes leasehold improvements and internally-developed software costs. Once placed in service, leasehold improvements will be amortized over the shorter of an asset’s useful life or the remaining lease term. Once the internally-developed software is placed in service, it will be amortized over three to five years.

The net carrying costs of fixed assets and construction in progress are exposed to impairment losses if our assumptions and estimates of their carrying values change, there is a change in estimated future cash flow, or there is a change in the estimated useful life of the fixed asset. We determined that no impairment indicators existed for the nine months ended September 30, 2010.

Uncertain Income Tax Positions and Tax Valuation Allowances

As of September 30, 2010, we recorded $2.1 million in other long-term liabilities on our consolidated balance sheet related to uncertain income tax positions. As required by FASB ASC Topic 740, Income Taxes, we use judgments and make estimates and assumptions related to evaluating the probability of uncertain income tax positions. We base our estimates and assumptions on the potential liability related to an assessment of whether the income tax position will “more likely than not” be sustained in an income tax audit. We are also subject to periodic audits from multiple domestic and foreign tax authorities related to income tax and other forms of taxation. These audits examine our tax positions, timing of income and deductions, and allocation procedures across multiple j urisdictions. As part of our evaluation of these tax issues, we establish reserves in our consolidated financial statements based on our estimate of current probable tax exposures. Depending on the nature of the tax issue, we could be subject to audit over several years. Therefore, our estimated reserve balances and liability related to uncertain income tax positions may exist for multiple years before the applicable statute of limitations expires or before an issue is resolved by the taxing authority. We believe our tax liabilities related to uncertain tax positions are based upon reasonable judgment and estimates; however, if actual results materially differ, our effective income tax rate and cash flows could be affected in the period of discovery or resolution.

We also review the estimates and assumptions used in evaluating the probability of realizing the future benefits of our deferred tax assets and record a valuation allowance when we believe that a portion or all of the deferred tax assets may not be realized. If we are unable to realize the expected future benefits of our deferred tax assets, we are required to provide a valuation allowance. We use our past history and experience, overall profitability, future management plans, and current economic information to evaluate the amount of valuation allowance to record. As of September 30, 2010, we maintained a valuation allowance for deferred tax assets arising from our operations in various jurisdictions because they did not meet the “more likely than not” criteria as defi ned by the recognition and measurement provisions of FASB ASC Topic 740, Income Taxes. In addition, as of September 30, 2010, we had deferred tax assets, after valuation allowance, totaling $5.3 million, which may not be realized if our assumptions and estimates change, which would affect our effective income tax rate and cash flows in the period of discovery or resolution.

Revenue Recognition and Deferred Revenue

We derive revenues from sales of our products, sales of our starter and renewal packs, shipping fees, and corporate-sponsored events. Substantially all of our product and pack sales are made to independent associates at published wholesale prices. We also sell products to independent members at discounted published retail prices. We record revenue net of any transaction taxes. We recognize revenue from shipped packs and products upon receipt by the customer. We recognize revenue related to future corporate-sponsored events when the event is held. Our deferred revenue primarily consists of (i) revenue received from sales of packs and products shipped but not received by the customers at period end; and (ii) revenue received from prepaid registration fees from customers planning to attend a future corporate-sponsored event. At September 30 , 2010, total deferred revenue was $2.9 million. Significant changes in our shipping methods could result in additional revenue deferrals.

Product Return Policy

We stand behind our packs and products and believe we offer a reasonable and industry-standard product return policy to all of our customers. We do not resell returned product. Refunds are not processed until proper approval is obtained. All refunds must be processed and returned in the same form of payment that was originally used in the sale. Each country in which we operate has specific product return guidelines. However, we generally allow our independent associates and members to exchange products as long as the products are unopened and in good condition. In addition, in August 2007, we changed our sales return policy from 90% to a 100% satisfaction guarantee policy. Our return policies for our retail customers and our independent associates and members are as follows:

Retail Customer Product Return Policy. This policy allows a retail customer to return any of our products to the original independent associate who sold the product and receive a full cash refund by the independent associate for the first 180 days following the product’s purchase if located in the United States, Canada, and South Africa, and for the first 90 days following the product’s purchase for the remaining countries. The independent associate may then return or exchange the product based on the independent associate product return policy.

Independent Associate and Member Product Return Policy. This policy allows the independent associate or member to return an order within one year of the purchase date upon terminating their account. If an independent associate or member returns a product unopened and in good condition, he/she may receive a full refund minus a 10% restocking fee. We may also allow the independent associate or member to receive a full Satisfaction Guarantee refund if they have tried the product and are not satisfied for any reason, excluding promotional materials. This Satisfaction Guarantee refund applies in the United States, Canada, and South Africa only for the first 180 days following the product’s purchase, and applies to the remaining countries for the first 90 days following the pr oduct’s purchase; however, any commissions earned by an independent associate will be deducted from the refund. If we discover abuse of the refund policy, we may terminate the independent associate’s or member’s account.

Historically, sales returns estimates have not materially deviated from actual sales returns. Based upon our return policies, we estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six- month period. If actual results differ from our estimated sales returns reserves due to various factors, the amount of revenue recorded each period could be materially affected. Historically, our sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days after the original sale. Sales returns have averaged 1.5% or less of our gross sales.

Accounting for Stock-Based Compensation

We grant stock options to our employees and board members. At the date of grant, we determine the fair value of a stock option award and recognize compensation expense over the requisite service period, which is generally two to four years – the vesting period of such stock option award. The fair value of the stock option award is calculated using the Black-Scholes option-pricing model, (“calculated fair value”). The Black-Scholes option-pricing model requires us to apply judgment and use highly subjective assumptions, including expected stock option life, expected volatility, expected average risk-free interest rates, and expected forfeiture rates. For the nine months ended September 30, 2010, our assumptions and estimates used for the calculated fair value of stock options granted in 2010 were as follows:

	February 2010 grant			May 2010 grant			June 2010 grant #1			June 2010 grant #2			September 2010 Grant #1			September 2010 Grant #2
Estimated fair value per share of options granted:	$	2.03		$	1.86		$	1.23		$	1.18		$	1.26		$	1.40
Assumptions:
Annualized dividend yield		0.00	%		0.00	%		0.00	%		0.00	%		0.00	%		0.00	%
Risk-free rate of return		2.16	%		2.07	%		1.91	%		1.91	%		1.91	%		1.24	%
Common stock price volatility		71.1	%		70.8	%		71.5	%		71.5	%		72.40	%		72.3	%
Expected average life of stock options (in years)		4.5			4.5			4.5			4.5			4.5			4.5

The assumptions we use are based on our best estimates and involve inherent uncertainties based on market conditions that are outside of our control. Therefore, the stock-based compensation expense reported in our consolidated financial statements may not be representative of the actual economic cost of stock-based compensation. For example, if actual employee forfeitures significantly differ from our estimated forfeitures, we may be required to make an adjustment to our consolidated financial statements in future periods. As of September 30, 2010, using our current assumptions and estimates, we anticipate recognizing $0.7 million in gross compensation expense through 2013 related to unvested stock options outstanding.

If we grant additional stock options in the future, we would be required to recognize additional compensation expense over the vesting period of such stock options in our consolidated statement of operations. Gross compensation expense would equal the calculated fair value of such stock options, which is dependent on the assumptions used to calculate such fair value, but generally ranges between 34% to 69% of the exercise price multiplied by the number of stock options awarded. As of September 30, 2010, we had 321,088 shares available for grant in the future.

Contingencies and Litigation

Each quarter, we evaluate the need to establish a reserve for any legal claims or assessments. We base our evaluation on our best estimates of the potential liability in such matters. The legal reserve includes an estimated amount for any damages and the probability of losing any threatened legal claims or assessments. The legal reserve is developed in consultation with our general and outside counsel and is based upon a combination of litigation and settlement strategies. Although we believe that our legal reserves and accruals are based on reasonable judgments and estimates, actual results could differ, which may expose us to material gains or losses in future periods. If actual results differ, if circumstances change, or if we experience an unanticipated adverse outcome of any legal action, including any claim or assessment, we would be required to recognize the estimated amount which could reduce net income, earnings per share, and cash flows.

RECENT ACCOUNTING PRONOUNCEMENTS

See “Recent Accounting Pronouncements” in Note 8 of the Notes to our Consolidated Financial Statements, which is incorporated herein by reference.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We do not engage in trading market risk sensitive instruments and do not purchase investments as hedges or for purposes “other than trading” that are likely to expose us to certain types of market risk, including interest rate, commodity price, or equity price risk. Although we have investments, we believe there has been no material change in our exposure to interest rate risk. We have not issued any debt instruments, entered into any forward or futures contracts, purchased any options, or entered into any swap agreements.

We are exposed, however, to other market risks, including changes in currency exchange rates as measured against the United States dollar. Because the change in value of the United States dollar measured against foreign currency may affect our consolidated financial results, changes in foreign currency exchange rates could positively or negatively affect our results as expressed in United States dollars. For example, when the United States dollar strengthens against foreign currencies in which our products are sold or weakens against foreign currencies in which we may incur costs, our consolidated net sales or related costs and expenses could be adversely affected.

We believe inflation has not had a material impact on our consolidated operations or profitability. We expanded into Canada in 1996, into Australia in 1998, into the United Kingdom in 1999, into Japan in 2000, into New Zealand in 2002, into the Republic of Korea in 2004, into Taiwan and Denmark in 2005, into Germany in 2006, into South Africa and Singapore in 2008, and into Austria, the Netherlands, Norway, and Sweden in September 2009. Our United States location processes orders for the United States, Canada, and South Africa. The Australian location processes orders for Australia, New Zealand, and Singapore. The United Kingdom location processes orders for the United Kingdom, Denmark, Germany, Austria, the Netherlands, Norway, and Sweden. The Japan, Republic of Korea, and Taiwan locations process orders for their local markets only. We translate our revenues and expenses in foreign markets using an average rate.

We maintain policies, procedures, and internal processes in an effort to help monitor any significant market risks and we do not use any financial instruments to manage our exposure to such risks. We assess the anticipated foreign currency working capital requirements of our foreign operations and maintain a portion of our cash and cash equivalents denominated in foreign currencies sufficient to satisfy most of these anticipated requirements.

We caution that we cannot predict with any certainty our future exposure to such currency exchange rate fluctuations or the impact, if any, such fluctuations may have on our future business, product pricing, operating expenses, and on our consolidated financial position, results of operations, or cash flows. However, to combat such market risk, we closely monitor our exposure to currency fluctuations. The foreign currencies in which we currently have exposure to foreign currency exchange rate risk include the currencies of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, Singapore, Austria, the Netherlands, Norway, and Sweden. The current (spot) rate, average currency exchange rates, and the low and high of such currency exchange rates as compared to the United Stat es dollar, for each of these countries as of and for the nine months ended September 30, 2010 were as follows:

Country (foreign currency name)	Low	High	Average	Spot
Australia (Dollar)	0.81520	0.97010	0.89710	0.97010
Austria, Germany, the Netherlands (Euro)	1.19440	1.45130	1.31694	1.36120
Canada (Dollar)	0.92880	1.00340	0.96556	0.97190
Denmark (Krone)	0.16060	0.19520	0.17687	0.18270
Japan (Yen)	0.01057	0.01202	0.01118	0.01196
New Zealand (Dollar)	0.66310	0.74190	0.70967	0.73860
Norway (Krone)	0.14970	0.17800	0.16471	0.17100
Republic of Korea (Won)	0.00080	0.00092	0.00086	0.00088
Singapore (Dollar)	0.70340	0.75990	0.72309	0.75990
South Africa (Rand)	0.12600	0.14390	0.13451	0.14390
Sweden (Krona)	0.12370	0.14870	0.13638	0.14870
Switzerland (Franc)	0.86000	1.02450	0.93956	1.02450
Taiwan (Dollar)	0.03074	0.03225	0.03136	0.03189
United Kingdom (British Pound)	1.43380	1.63820	1.53432	1.58090

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Co-Chief Executive Officers (principal executive officer) and our Chief Financial Officer (principal financial officer), have concluded, based on their evaluation as of the end of the period covered by this report, that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports filed or submitted under the Securities Exchange Act of 1934, as amended (as defined in Exchange Act Rules 13(a) and 15(d)-15(e)), is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and include controls and procedures designed to ensure that information required to be disclosed by us in such reports is accumulated and communicated to our management, including o ur principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

During the quarter ended September 30, 2010, there were no changes in our internal control over our financial reporting that we believe materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

See “Litigation” in Note 7 of the Notes to our Unaudited Consolidated Financial Statement, which is incorporated herein by reference.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2009, which could materially affect our business or our consolidated financial position, results of operations, and cash flows. The risks described in our Annual Report on Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be insignificant also may become materially adverse or may affect our business in the future or our consolidated financial position, results of operations, or cash flows.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Removed and Reserved

Item 5. Other Information

None.

Item 6. Exhibits

See Index to Exhibits following the signature page of this Quarterly Report on Form 10-Q.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Mannatech, Incorporated
Dated: November 4, 2010	By:	/s/ Stephen D. Fenstermacher
		Stephen D. Fenstermacher Co-Chief Executive Officer and Chief Financial Officer (principal financial and accounting officer)


Dated: November 4, 2010	By:	/s/ Robert A. Sinnott
		Robert A. Sinnott Co-Chief Executive Officer and Chief Science Officer (principal executive officer)

INDEX TO EXHIBITS

		Incorporated by Reference
Exhibit Number	Exhibit Description	Form	File No.	Exhibit (s)	Filing Date
3.1	Amended and Restated Articles of Incorporation of Mannatech, dated May 19, 1998.	S-1	333-63133	3.1	October 28.1998
3.2	Fourth Amended and Restated Bylaws of Mannatech, dated August 8, 2001 (Corrected).	10-K	000-24657	3.2	March 16, 2007
3.3	First Amendment to the Fourth Amended and Restated Bylaws of Mannatech, effective November 30, 2007.	8-K	000-24657	3.1	December 6, 2007
4.1	Specimen Certificate representing Mannatech’s common stock, par value $0.0001 per share.	S-1	333-63133	4.1	October 28, 1998
10.1	Investment Agreement by and between Mannatech, Incorporated and Dutchess Opportunity Fund, II, LP, dated September 16, 2010	8-K	000-24657	10.1	September 21, 2010
10.2	Registration Rights Agreement by and between Mannatech, Incorporated and Dutchess Opportunity Fund, II, LP, dated September 16, 2010	8-K	000-24657	10.2	September 21, 2010
10.3	Amendment to Investement Agreement, by and between Mannatech, Incorporated and Dutchess Opportunity Fund, II, LP, dated October 4, 2010	8-K	000-24657	10.1	October 5, 2010
10.4	Form of Indemnification Agreement between Mannatech and each of the following directors: J. Stanley Fredrick, Patricia Weir, Alan D. Kennedy, Gerald E. Gilbert, Marlin Ray Robbins, Larry A. Jobe, and Robert A. Toth	*	*	*	*
31.1*	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, of the Co-Chief Executive Officer of Mannatech.	*	*	*	*
31.2*	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, of the Co-Chief Executive Officer of Mannatech.	*	*	*	*
32.1*	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of the Co-Chief Executive Officer of Mannatech.	*	*	*	*
32.2*	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of the Co-Chief Executive Officer of Mannatech.	*	*	*	*
101.INS**	XBRL Instance Document	**	**	**	**
101.SCH**	XBRL Taxonomy Extension Schema Document	**	**	**	**
101.CAL**	XBRL Taxonomy Extension Calculation Linkbase Document	**	**	**	**
101.LAB**	XBRL Taxonomy Extension Label Linkbase Document	**	**	**	**
101.PRE**	XBRL Taxonomy Extension Presentation Linkbase Document	**	**	**	**
101.DEF**	XBRL Taxonomy Extension Definition Linkbase Document	**	**	**	**

_____________

* Filed herewith.

** Furnished herewith. In accordance with Rule 406T of Regulation S-T, the information in these exhibits shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to liability under that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

10-Q 2 form10-q_09302010.pdf QUARTERLY REPORT FOR PERIOD ENDING SEPTEMBER 30, 2010 begin 644 form10-q_09302010.pdf M)5!$1BTQ+C0-"C$@,"!O8FH-"CP\#0HO0W)E871O1XZ=BN5$4FKM MM5TN2:.1E.@QUDAVO+]^^X%'`T/)$U7MQ972A"2`1K^^[D:3_K2]]:^#[6:" M_]V<;F_!_PZ.\>?+Y)_/U439F6TG!XMM13/41!LSZ=IV,CFXW'Y7[9_44U,M M;^N^@BNEJ\O:54?U%&]-=5-_./@YKFQU(U;J>JJK)I_06C%!`;W&S]@YV-[Z M;7OKT_968O1J>\NZ6>=@23-3=F)Z/>N[R;29F6YR<[*]=;:]M0C+TF0]S%KU M\&301ZF%=N9845^/B=4C/`19VT^<"D[Z#MSH32:`Z^)P M]6&$RY*<:I2@]QN[.W!*"-G#JX-Z2OYKX1:>_8)7;X'WMN-Q&OH5)7@MU^BV MYZ>_QZ?[?#M5/9/?%5-IE]>(HL9##V+7L[@_H*X/V*`Y"IVR13LV_'P/GRM^ M;O$'-&ZJ.5W5J.J!YSW/[0U1-(E/6[WP0FFK"TY^]_L@:I&OGOY/\N_S?+I^ M@[+1@A>L2>;:0""`@1V6EYX&^7#I"'.V<8(YQ3!DL3M`Y0;.HA50:-J(@9X# M`#J@41`1#`0*=#T.C9_P^@XF'?I)/4TY@=QQ`W\7%/F_LLZ7O(Y'SFF$2,]9 M/!PAKYZ'>73Q0ZY\@%/B;C_,)-*\,7!PB;`_2KME!"!:)P(M1ZULPJ#%A"<, M>[T^SS16S%-I0J'?,@:W30^`##'X-8;0O0U!;#L503SM6@MH'0GZZW!M8:66 M_KH7X;H;049P@5$UK"/'@[8/F"6?QG3(?G@/9J,?IYD(@->!`@Y5VP:6%9]E-YZ?/8$3\=(?A.!1[2>T@H2ZZ<`_`1/+ZSSL>TY"SZ* MQ`BY1D^L4Q%RH+[KVD-.!\A!^$?,Z8X>W,#?(?HZ)>85`;E)'D`]'AC_BNH\YB-3(A/59KL&29F^''P>^7MU#,;F`7W6!F-:DN\RG\+Q3L$!1\ M7&/Z(;C2UH<@FU-9R M;%VRN7A;3J0+0K8):1-QC;?>R"DVK#B-4Y@Z"]S3ICSNP\2(3E0SZTR&'L2% M5PI&W]);UU.?3@4'>/T6]9W1P#QNL7+!6_Q$N=< MQ=EA=P4&L^(N\-D%6GR^0DM'AAU6^<9S<\KZ0=JJ\QC^KZ#D(JZ)DJ)DN$$I M@C$KV:/CI)H%-94FY"@W>$R/2S5A.QP`>[@;\K#QK4!L[9I-7_K#):5H%2[W MZ;B):=ERD",L7"3QO]9MDVSK/)UYM/@5+&0O0!LO\!$K[[A4:&9ECHKP#,^] MFVFW!VQR43N-!S+%UQYDXW#[E3V88C$&C%^8'30H.G,X>^_?>8[9EUL0 M*NM'0/&:-M5B4\OAL0/H>TF6RPC`"U:B"W,>"TT\&9I6979\&@JT>0``,JU4 M2$K)[SV*?J4I-S@EM2.._2T8:DDL*>*:*S1+;!*_9,4[5H\C$W_FH8"H!5%? M1"T>1U%7OHKE`]D6(R>S[I*(H:K+&5=Q<9?WQ^R9TG$:K>:ZTEX+%&3;MXLQUP>Y`]B,*N MXF!W)N"3519W7)W0^-[@ENU]X<.RC,.^.47;/\7M;Z(!#SGH2Y71 MYD#IAXU.9ETG1&1[4!SK:DLACHX8((BA,H9,G4=+F_171$MIHHYK(AN@N4GC M3C64;]=K4/I1W5JU>=_=HZ;:]2TWHRK5`]IM71#A)<$0+3V/;BHC3I4^9>+-4=`WP,>'QLBG7P*QZ(C3%"[8IYSD:Z)I-W*N M2$=WG95A*I0*A*\6:*LN`LNG@:RAU4-UX.+)CBR5F!5\W`'A&Y$<0U$4<@TF MU9`JDA\=QI*-&MXGH4=OHG!HX%#C.14.\A9DHS8WRHHNG&\OH]0:T\O<(#X# MD3\$**!SG;+6%04?NKR,D8V=SS'9%7/!7B@KR$7V`)1/?GP7T]X9,[A*`3OW M*EDB+V7-K$3E.B^E#`A&A4<>'PNM+]3G(`N67A'/F(GH)Y;/COF\98U=L[(6 M7$^XF+A(R'']"%0M6>QX3K@-$J`'!)32(H/WC5ARE'4[XE/ MS\CQBCQKVA'V_L@#W^T(D*4`B@6P5E0[%Z&TE0[ZD/Z\W)>"L2Q&.6D(KXVH M7^EZ.0K(H:QX^>3]Q1\;B.NYGV"XIL\=P-A6;#PKQB13;V.-`AO91F/O%,1Z M`X[U(5\V=&*9+_C-T.`"V_3%;,QF\4W-]Y/-K%E/72M?AG$&N,QB;`@4*B:6 MK!PDL8(*;CA\6=HL%=^'J=2[$-J);'D,+6/$63&O(CF%'.-1<\Z,=2'L;W0: M3UT#>B]ZXM\A1%2=1ZV=!*@;ZP^196A2(6N'2*`;=F*_BNOXS])R+LB=F@AQ M,R,,E=3);O99I*T?0[!D<7P]G'?XS'`/WE4<4"-%`J7_!-Y56$@/+^-9[=;_ M2)^P-K`KA74#W@Q)X;WVM"90'/-Y%^F8Z?! M<#RDD@GGWU,@-38OD"+.4>BBV%EF&B<-A_)K'D0.A^^\$BF3^=);J+VGCLFS MC/(2AO!F[JEDP+"LE6LF_[<*&2_]=>0L`=:OE'6,BG6,S3U^I(XILI>0^S0U MY:(W\[`_:-N0JK]@*HJ1U1I)Q4-1C=3KF7\YG9M[+?>/81+WXE0:0`CF7`;1 M?3XHG$H/XK`_HFQ95`1O2J506^1D?`F9*/J9=/UB9.AD0M0*1:)>NAE"1LG`*U+W2'Z, MJ6&10D2ROV_EY!5B*U0=\R&]U2@V1_\L:!TF3A)BOKJ*#% MW(W*[H&+<3Z%ZE0OI19[C&5?,485X.ZMX)'/Y-[#4N-=M-JO8I@K,VKV5KP= M(E604O8BC2UUDN=$;5U:^E[K-EOM&K'Z'@AL9+OU`%A^)MEF;)CL/:GNTN"3 M_`VJN9_[5FCEG:A-,F@[]5BY"G"E^1DP'I(+JZA"O1Q:,PKF`0,9*RFLHA\> M1ES]#?^>=EDI4B++AE0Z[O.A%/^:+1S:N'!-?-4T@FK8&L,Q=>9#19E.&[XN MPK2=80HU9,=>O2DSB!UT5AB.YI`=A-O];:^8#:B=GGIZLS5EQ0]Z?T&*(L$] ME%)D+#1Y5._6\)1U2*>Q^31Z`E=](UB*+;MLV]%,UA7N/LT[06LP!IW&C8`5 M&4JL2B-O\A&Q)BL]]-`)MG=1Y^NQKU5M6IY_7J'D\@>U_0B41VUK579'!$?X MX9T*5;Q'96FU!$JEQ'EO')4C6<>D]WSA_)RYH]:"G?M:.ECFJ?`Y[W=>YJW$ M1BK%26RB2LVJ(K9I_CQ3]?[4%8\GKLN2=_8V5CK2.7^L(@[APJU%)(=\"I_2V+_;UI&G'[3F-[5-^O3,M7^^0RSKY=1%]/_.$.F+BXZ(GH47F M^"?_FL%$&OPMI?^G1_\#S[1(C@T*96YD]*V)[O_?@$2?*A;K99H54VEHG2W!(H$/@`?0.;'ZNB7 M]:HI\,_F>G4$_ZS/\?*S^/L)*QBKM2G65RMFGV`%;TQAA"F*]=WJ7^4_JV-> MOJI$^1O]Q<_KZIBQ\BU5\=B_(3//&A M4O#%P&?XU8_@!GA3_7O]C_AR(0O#!;W?_P4?/24AKEH[V@E\E-Q.`;_^ MUI^9_UI^MF]XNUX=?5P=_5@=-75;^+^HD/O5D6ID+=O",)A#+64!@]1,%YO+ MU='-ZNAJ3++#!U%02E4+OD^43,!V3<"+KM9=:@'5%:9AI(//%>/E']6Q*2]Q M,>=XN85+5YY5L-3O3N]6YP^@Y2=ZDFL&VH8'K-0UW#G##QN\7.`SMWBYA]^O M>P9@2B8O/WFHI)41Y4_XE`[1$VI-$"J/J_5_XIVN288[A=<]X'OMY1M\HUG` MY=H9\S,L@#?N34]AU7=XL9_N[1IU^;AMU*#<:)2FJ;D!/'>UT<5Q@Q:>8E&A M:DY0V&_/01"ING.2O*MYNP@46!LURU"S^Y;,VKJ1?LVR[MB>%??>OC')@>]=#1*O#\^57SG6*B4XD8YU4S(#LL7$0?E5)'S^D^_D5 M?CM%<'3^.8F>CR&`(<:EC5',/;C&W^QC$'L8CK7M^T85\=)W?]T:C(7C$6!0 MWN*-Q)>+`S"8-EY1[W8\`C7"\(<:8P"&0X@4T:'.G+O`IW-4RJW[C4*&UBZP M/(4GT:F"K\G4V>")46_3IE:P>F/J3D$Z`:]1>[UM4'O6X8+RQWQNV'C6[4A^ M4<_SVB_Y8<^C]4_UO`-O[^#EVN?@UVBUAV#81Q=!%1A24RJX",:-"+E`5"B7 M.;W=^ZAP,16=UV+A)HA>AI$>^]F9B3"M';?FO$GF_`7\,L+P&3]=V'BO>U,< M@57GU*IU#59@6M2L6T"QUJQ^"5/,ZMX_8M;QD*(!VR(_I#CQY4(*X@J<=0%< M[82/L5P-(*.D?X5Q"V.W3$C-QF'4#X,@>?#T9`N!BH<%[")0-\GJ$@2R703" MXB9#4*E:(2_FM10(`C'9B"ZR>0SD1C8GOVQD\SH4$US`K=^[P,#JYR)0JK\> M@3'D!58KG-"-9:DXB3`!&Q`M2K?A&%>#<.1].,IDJ6^1Z/S`P9X#_78X_!_2 MES:)S+2^U_B#G;)=T!^!<=$L_7*=ERA2V)_PZ3+0I336QZ$N>XN033K/KZ4K MM8BI/X;+UZHO)5A<>H_S2R@>XWA?D);=4_TA8?&*W-"M?T8FD!*9A3!=K?81 MC-ENX!<@)[B!>W]V)I#<)C*?"1HQ+Q,X\203#`PPUP^AV/[+_="^^LRY%OQZ MXYXXJ;@D![0/8_6Y[7HJ+&`@$XAD==M9R7(^! M_28-<7,A'**H,8Y6A<8 M-^;^A:(=:;O4$TSMWI\=[3C(O*"4=N+CO'?4T_S[+0^W3JW8H"0,>%^=!T?@-#NPP_1C:!<\.I^0X M"2.W(N0/D:N\ZCGF=^(UHD%Q^'A+607]&9WPRI6='0MSZ>VI-S7*2S"WI$)A`Q4*19/[*=T1P)/J@+5TEKS` MMR7<644KL]3$"LMP?Z<==72@]6%F76VR'%U!N(*Y!$?G9I:CDWCBZ`,#S$PJ M*C078PJ(#-J#C#<`T)[CB%3TO7V"R#39_T\/./O3S\-!7+4M$@73SE:N#6)! MM_M5,QK$2#X&L1?J%D'G-;0+NG!G"NB<8D9`-]?FIB7#Q4V/QU!L??=1(O!/ MU7?SQ,K"9W#MO;S7B!BWMS&H\%;ZG+V`OL/";'YH1K<]2+EN%D&YTU'C/-HH ME,Q-W22^:,M*A;;B:TKJ,Q<+?,'\M-T83Q,%5<'/ MH?8^3^!U&`]:%XRK6LL<[_=VR*0P)+]@VT@EAA"3T0@Z6-#/5:]UM(ET/)*` M\[3CC6G=[@R=A]U3]/YG[]7!S]--R`\/*!$KA4A'0F$R1(+>>KH4YW(7YI+6 M-8>!HV3=BH)IO4RI96T75&=MQZ?8SDTCFQLH48NDY<$GR[M(XL13;O!R_$BY MDR?.J\BF70#!*(",-L4,!9O[Q+Y;H+')8^,1=A^2AQ-3R7ONMM]X8#^;0"&% MW2&34)F9G(#BS;%?F^,!Q'4:28;IZ*Q6Y>Y M'-:)+\=A82F*\]%B423%XL=*NG@6`U(`:$QN,28E'>*=!/D1`]]SDA%ULF&R M,PX+1TW>P!RV2\COOD@*]=8FR:PVA**3_1Z3K/+.%^O?#8[TS1.T)Y^A&4M? M]VU"`<:9W431"I&2X3P>([E9QXVM?>'6"F\\AN_-"$3)RGWR5\"CPOM`JI-;"3[#]L;"OF(6RO4!-Y`.H' MP2DAP&-?.)LJ>AOL5^$X.)U\TE=^F0T0G-$(-E:U$^@&J6$J6YQS>$D:3USW M'%Y26P>8NB;([!Y@,LEX>,[(G3/\M;+'$^VA)`N1>*SIQ)Y_1+Q\PJ`)X:VS ML<_*A>-*\TXK2>#WCI;G/'`(M5DGEQY M9XUMUP0"9?(KD%^537I>[*2':"S4?4M@3K[GDG<07 M)>^2LU&PI3L]84=STSNL[3=,TC,2FY1E('NV&^\^2OIM[-XN2_^0MDQFAKV* MM(/F&V'4.;-#Q^HX]+_$]HY+8/-#'.F+W;5W\\>%I_O^R)_XWF`^Q:%X@P=! MD-%GE<,!.)F,GN079?3>/@,>Y>],\2BGF6R/:HQM/F4V@$E\T6/0X@"C3\MA M+$7MO:O0>QO_\;.B]V&8*_Y_>":N,M7SB(7('[ M,K@9J\;^8$(YXIV*:\"WW(L"MYL;/3O?U?>88&>HQ@#=N:AP_A$72-[9\PSK%@ MG`_=8*',$U`DO^`)*!5T-`!=,YTSDV:RH:M9K44VC2'Q16F,4.,]2)4$W??A M;---REA?'/1,]TSO M%3X`1']G"A"=9K*!*#H\XY=;O)'XHL6;$.,GIW0"1'O,^K\0T6["[MWOO:WA M*?D9K`HUK^88:N;W!8(&,TLUDE^T5/,J'("6OS,%6DXQN7T!P33^F$LL27Q9 M8MGXXQ6?XY'/:]JP\^>]X*?9+5T!'`O;:[GAR:LJD^*1_+(4+^A*3MW$RWL MBT7_!U`I:<$-"F5N9'-T5BI69L;SU>TODKV>O_N/U67/> MG+OSCS=GK_*W!KZE_UX?\L>7\]_\Z,_[B\&?O[X^<^=XLQ_C>>_/SU]_.-NX M[>M?SLS][MPU%WW0#X3QO`\M//!F\S_;TX_I/M_VFY_SC_#,3?[(MW_,7Z[R6##"7?KI9OOWU_\E M$[NH9_YQ.^"H'].7+^F)J$-&%\YV[:/KSC\>S5V_/7EWS8XFGW^'?$!+[>`L_I#4<$PEB6D1: MX[NMZV!-T6?*=FD_>67=YG";K^1MYK^>\J7T5-KPT5(N-#)XNE-1SH6HIMW? MI7FO@2#H8!+;B^>9\WVU>(^^T`RT, M>5/.J4U]R4*Q!_&Q&A2ZL$#FT/6*S+=(B5U'&D02IRF:Y0W8OH=UP5?\ MF&.ZMP?A_617D%38!9HFK1.)GN\C\2&F=KT2JKS+SB.OCONLE7=S2\IKO(6&R1&[Z7;FM%JM=VB1 M'2X7'CD\)0T&DIV/A4T\^YFOYYIIJL(<_YIE:36]AX`S- M1B&9$83@E"042A(E\A2;K^E9%'L8>V\'Z%LU`,G!R`NHF##.\R!H'A`/:VEM M(AM'PY>\UZO\E8@WPQ.A1MG,V_S$'H8PBTWFZX!&B%?#TZ!Y5=1-+/[O;=!B M^!F(`RR;$]DD&B0$\R*;#/6?MWX@(?'P?U[VTGT#Q3_8ADC'-=U%FR4>?Q(A";>&\#1]XIN!W`JMRA9P(:]R%IH*[E,8&`H1$2BC7D3 MXN:O4"XUU`C@[/:9I/"7E;8VV3)>C?7+;=^I=9[DEW'G6381G%0N14B7)1\N MWC%P:BUF@=F,TI'4)MP/U[[A,\G/I'$_9K?/X),1#CV7-11<#\R7*3&QL]W0 MLYV]W.),3VH$H.63")TR:\25X^=LEVI)TX`60)*0"ZXLC"1()$2J('*GR?=/ M8C?C M12*%C:FZ#A?]NZ89VM\KJ@V#OM;`M>^$:*YQ\LP;"AV`5ON;+'SK%'2A/+SY M/^^]#<."&IDH`6X#:(JS5.X*A#KS^-+.HS;VQC@!P'\Y/,OJR$#+.)TLKR"4 M3^S1GMA\V8`RQ;IJDONMT1Y@M(8-;)5^>RK/8K/,LW+M=)[1,V\VQZ_;08)G M<8NB&XF@Z`KRY;=L-K)NI@@3`2\:+Q#_C$N.XO])M_8%K1]_39,](9(2[_&( M=#'$](U:8J%_!AS:=J'1(_LWBJT%2`@<9!Y$PP)V^6#G$GJ!/XY@PC!:SIL] MF35M6&9-N78Z:]HPV3?*W8ZL(-%M01F4M0`6(:D%-R,!,#`?E6D"\/VX=1/X MM>AB$HU1-![(ERD#2L`![T6FD[E2RT.;IQQ4QYD,-"2H.^]Q80"@20B-3R!J MW`#_R7MDD10L39LQ1F(OLX)(@-=[$+F\TH)O=R>>D3'I%%>2+K!W'!E(3`U3 MZ*-B]RV'HS>\D`DL/EDFW8J)=R\P\:Z7L+2*Y$CG""["#M+'/[8NBB\UMKB- M:C2CCT@C2@ZTK)4T!H@3VI`Z>\124&`F^-:OUJ(TO9H7H@>TP(#,V-L^QR(G MLBR2N%P[G<3TS`R)$_S;H63BA!C^0:$?XHXGD<^2+;UEQ#IG%Q4< MRKC^:YX1;BK!O2B!3JIF0IY*LC@L6TIU[622\3-O\K([=DC99EQ*_`L6OE71 M#^RWV#3"FFTLQ`39@52^2F@2-C#6*]LH<78J^4I$?!(_0TD.B0$PT4$I4G)'X\6CTE\Q6[)P@,0 M;@`K#XSDD:E%U.4!S(-`U))7(@$G0).;DK@IZ<`Z#?T-!>"1'5;A'4Y:/*M. M"3X/.,2X;$'4M=/9&1_Z=M6W4 M.6W.WNMXM!@[E=DO:9]WA*9$2%`EJ^+L:#:3GT"3]/'Y;F`%2,87`,FX#"3_ M543VDO:\896^K9)K]\4(4LZTRD:WG>PD#:QS>Z%1>_Q5I^JELL=80JU<.*+AP&V1QKA`!<<5?%Z>XY0&3#9S=9A?'I2`(-@H&IORG>&Q*E_O*;5*) MXXEAL]@PDQ3FLL$D)=RZ1@A5E0V<5R2\9=M-&>%)AT15:@$=:=U_+5BK5EU@!;5U)!F`6'Q54E8-T6#S1\P*35:)S M4;Z!D29Q#?,GK_5D&6=!F!$)D"')X4^*/)2Q-@H^1J%4E;P?>T7#V>1]U4-AS`N;#A$;S:,82PE M0[ZS8R.;OIO!/'H-T>F9%!U:IZ,I+"]+">3P6)>F0NBTCR'LBI!:EX)+&$"^ ME*2Y%,.\QOH&Y*J2=/K&23P$5LK*.4=6;L9N\T.3FMZ3H#8JZ7(1DF,;14'R M)Y%'*^U'T&E6=&2:`3!JCU4N&Z8X14G;Q5:R."I$024T]JYIU1!@/G)_&H(] M[""8B9^LZMH!8R\#YII,:VQHUZC9?M[N!AN1=#TVN.TE%RIFP,IA.XYFEF#4 MH8EJ%MCX?-^2:DA+>_M3%@53N(-``WOKI*MIVI_#XN;[QK3GM5&UYW55=UYT MA>Y6F:/3J_]IKH.E5J:6@>01)`IV_`5Y`P&WA%:KKIC6+K!J>?'.ETGMXEWK MU7)^PJAMM?'F2@P5UKP73&Y1FGM,N?A&`X:UMD$I.5P#+8@B:$&*`@.%WFJ, M$;@29?5%;_"BNA;5-1`G%8Y5X_A&\ZW`Z[RU+B(9"F11-USC#2OM-\;F5DTXI;8"Y`9:OA/'"9Y'Y3/`ZT7)D2**]IHH3V9)XPS2"Q!N M$5,31`E/AJ[@UQC4I"HR`/0UKLNM&Y6?6HP6 MO)]#8X-3SU=A1%27K&7/47C&]]P9ZQP3-FFO:9VFY+JDJQ']APAS\-6D`^@I^2T9KIZJVX/KW+P#V*$E>X8`#,YVD'>30%S M(``GLOSIQ=!V\,M<+==.YRH]\T99`Q7X$(8PJ12V)"93X"7U,^W^Z"R<46[7 M1T68`]4LV.L-!&RI\KRKB)S]P\E4Z[IEJI5KIU.MDX;728V6L!G&?$X.8=2M MCT^8MR?3)R5R4[+1H3NX=B4[S\D5MV'%%(07F(*@W==;JY[-H*XC\'-N3BGL M>2DK38VT[BG91;A1;>\=$I?>KC3DY+D'RJDC>U0G`-8]()L1>GF?^5,NP[ MFR/DSF[PRK@!R>[$AO5$NO$.]U4HU2DB22KZ2'UJG:VW>-,"I"RRZ6NKHA#5 M=FSCG,^2GSM9/-R*47$O,"JN6Q*/9[7R*"*51@33A:]C#&12C@U,<1YIQ<;X MP:3?REDJ(B$(HHK`0#R@((JHUAS*4NQ7J4<0[LLMMQ<]KZG*KT`=_P*HXP5> M<$'+6+C$IW*'5*Q\T"6K1_%` MXU1?!$G:AOB@-B32T6U^,SGIX0T(M!C6V-N\5S*XS^+D"KSQ+X`W?E@TN0>P M?)PH8%9P0IC_5VF!.UU!F1CIUG:^U#A?NF;YJ,N=V!OB/I[AE)+P6ZV>&#G# M*A>.;M5.3X$J-W>&0WB6UW)0O=>VX:!P)+&P)OD\!U>@EG\!U/*=/I-%=096 M,^["S=G2QZU7B3_/1>>Y9F9IFUF/Q@QTF/$G=Y*QRD-^X0/D.,#[JB[=RTZJ MLE5HU!ZECRW@`WP)ELY&[-8HJ'2DYPLRP^7WJP#@DQUR`:!E8WIJYQ*HI+G\XLZ MTR\UNYVOZ\G.-?)0E2IWK1IN+FMD&R(`,V]63Z%)*A]C#_@5#]$I@MUJN$#4 MOL.`[5+EY>7D8AF\9`0Q_S:3:!?#-NT(><""-;M!``EUFT4;))?"&18AP[WH M>K[[!H[,$;15V5XN^>^K>M'0%S9,JE)CHSAAWA?@8WTVM(EF(%MX56=JP,DO;JUGDN$,YN\O087+HM6M6INSBRI3)EI0I2Q,> MYYTG,PUKFQO;E9G&OB+AO6",I=FB6YWMW+N%6F7TJ'E7#`S2W^`F3NNS=VMD#L?:U7D?B#152EH[+\[;1VM<\OKR)'J MXCIRC5,+M>G0+AT/AW)HS,P;NI5YHU^9-\:Y>><.6DTF79.R=DW*6B-E+,D#MH/8%S?*2@H\3S:K?NC`L+SH$;>0*5M+'.-FK`[RMSICW M*]0*O99"\YZ#467AJ:Q8CA2`1.)7[OEL'3];0>LK*#96);5\4FLRZ?2E+H39 MY5"TX&L5Z"GX,E\_+)4?`"MSI=NZV9+KB[G9NG30/E!]B2/U;*:XJ("=>S4L MXJRP(&F"11W"E@N$S?DH/=/5%>/US77^*0'_90['J M#C-Q8ZEC.GHKD\T.M]E(-0MGM]N^*1<_V2NQ8C#`3RF7Z7B=]T*E>`6@Z4A. M.:E_0V>8Y?[8Z3((UD&K%WS\[>'`S-&RZ4 MOY/<]1P51TW$=WFG\[U]SV]];4>_0-YV#`ODW=E>A%GR?N]5$C'JE,E[V>$Q MHS=?RJQ=7\5N^O!XW;/4-_*9_F>V^3ZM244\7+&P\4E$23S\8T3`2>]:F1:93,O@)OVX#]L M!]6%_`A!:7F56NRJ)((I.=F&-);EDVQ%KJ`RC2IA[C3#3[<5V=NM6PNRO0KM M*,-+U6N&)ZZ1-U+P%!`(0F'K/7.=.,7)%1N!5G(K'F*F:Z:6]X'/J5Q1.4"4 M1N>8IVR-W,+X0&_^41U^DZR6Z_@MA?_+5$#LP7U:0##]&B0E>0;F*%07)<)K(5DEIX3;>RZ<9P`QKKE&D0[DVC MW6&PK*6W$M^5/1XRN]_.I/^\';?*;3;+DX:V59-.([H?V(&5_@AN8)SF<5-T MNKR*P:^L8NC4*K0\39*!88S+D\1F9:NQ"6H2..!5IS77AO9K0WL]M*Y[A3IU MVG8K-!JA!50'VN;97BY/5M`UZM'B,T`6T=Y:#]7;L6Q.-6W&PG$NS`O0>SC)+]A6>/VR4J-@TD`CYW#V-_E6*3Y15S0Y0G[#7U94^DEZ M-([58>'0JTTR,+-19DGPF;?V82&PF!0JF*@.;RK6.'HC)K>9:)1<>MH$@>J7 MH:S#K.FK!T.KO/$\IW;=`JM605M42:OJ#=H:ZP(HVO76GR(2&X>(>9Q"3[DZ?=+^5ENW[TB5CN/*?6SK7\L0`N*5W M]")W*8^F7NP\Z3>=>:M<*:=RAIS3!=%/G4V)I/$=2K6W:;O:VXC'5(UG&BO! MOO/6\M'7"_VB^/\'Q?<:#PT*96YD7!E("]086=E#0HO4&%R M96YT(#,@,"!2#0HO365D:6%";WA;,"`P(#4Y-2`X-#)=#0HO4F5S;W5R8V5S M/#P-"B]0-VW3>+49,N;9&Q-I;8V^Z#87[\`^@*`!'G0 M8"KE$Y%$LW%I?-WH;H#_N'CVU?5%<^G^>_SUXIG]W_5K]_//RW_Y5E\.IU%? M7K^]4+Z`NM13=SGHR\OK^XN#/E[_ST527EU.IWY*RBMU.;2M)_BOPX_'[O!O MQZOQ\/+8'JZ/5[J=#M\=__OZWT/YMN?RAY^U[AT/?MBUTB]>^/#C:O1P^NC:N#& MC7UR9U_>]X=7EIVV-V:,6_CCX>FHU.&C9S(;#J5._1"/A^KL>-@Q`>:N_;;Y MQK87_KF_75>HP_.TSBHF^]J6^NMQ.'SI.M>X#M&>^FM+.=H.'*!W?_1]C1?T M9OMB^_--\G9C>R.\G>KSC7M[>WAUO)H.?[?77SG"5T<%_+XY(F-7_"5=/(U:6&RWZD6OY\L&]T8J"L7#CYTG;<]>'=\:H__':<#I_< M'Q^/O16)R1:8#F^\(+L[;DQT=[C]P[7FM>7?6R%1W>&#(W%BI$=?SK_KQOT\ MVD*-DR0[]Y(7FMY1V??>/KJ'[OWV(B;4*M#9&_>V`Z!Z[B6>G_;,?C[Z/GA^ M??'L;Q?/_G'Q3+F!\7CSQO>R'TX&O,W>>'?Q[*>_7#XL.9G>G+KITB+%:;Q\O/4EWVY5$*I@>GU2G25KSI&E M5;F/;JB3A5%76=W,KT)#M)JU#&]D6Y;RZDM:E=:F/76N4>;4#&?(!MOPD3@I M(#O/+*E\.[F+?!=:;30#L?E<:;5V@X%SY96#P0]V%EKAMG\Y5/S%(Z,5^L<$ M"=J^B>B,$]!F5F#D`G8B652$-2*RMT1A?)7F=L M50([$*+SW.(&=,VI,?6B-TZ1"'UC\>[VM0/:6P^T]T<+VE[X4L'K=)<(WF0' M\LI!]=9(0J5!PK#2-1+6->VVA'5*1P4:6[EI$ZR-[<8Q1FNZ00+5M18NE]$;O1O=NZ"8%C?"B"#L+&YDARCEV"E9 M-7TE@IZ;U-DAZC**SJIRJP`2H_"3Q9<'^\];7)^.RMMJO;45G8UH[<7;-\?Q MC,$50;YHY)+>"JA]EHX5"HX<7M,X$:HO;O`XT71>W,@/7,S/3IAV%%73UR*H MB8TE(E7@(TQ&+"-:V'IG!N]=9@E267>J1U5]/(@%B/; M`*L,8N,"Q^8\BZBW1E("!52)HFE.:]5JW+O##_<92R".ZA)E\Y0X2$`KP&B] MP&@[`+WI>.EZY69]3\LWW1E_^>#<`FZ]UC9VP>>78EK'A6X=2/S#E?KD?M[[ M]=[OQ\%3W^'J#]_S9)'EXPP[5OK'87]5_Z2:$C5`,;'N3X,.G#T&E1.KB'-W MTF/EP-@7\<@3TWH,7T:36W%W7J"14J[(5?NYTN[@.K= M'Z.5B_D28Z52J$7J9"!1Q:1+BJDG*S61$+3Y[EBKMX<@H!W6&!=TI8-2D0RD M>DW:8U-WFKB[K4U=+;R=,I$,^.$?0`:L^6#<7_W1W2H1`M1^=3B9:'74@4OB MF2:SW(S9Y);3F$"R&XPUN6U?>F<#@O&3Q]!'"YWO[;_7SC7XA+`*YIE#881F M\KZ=LZHE;21`!9I50)TQ`1PE/BO3(&O<`LTJ?&;=1<2GK&X`=]B>/7`7#9J5 M]"B6T-J*\),OTR=#>**3)[V.1&!T,T67V-FBL41@1)I58$R)$`^94;Z_5XQ8&M26_]ER7`!2B;`#`0K!8PV@-NQ'.V&J M[4>@W0U945SEJO4HY/[]=D1K,++ZO(__T<5$;AU.>1SS".90[7<(2?6'7]P? M9#4F@18[-H$;QH;\Z_U+7.QA:#SCMQ`R`_.SQ9>Y!_\D$]>3805\M8!L$==! M=J!^V;/1A&:GDUXW77C2)D^<%XPK'YG5213,K<>YT!=@/*6!PJA.0_)^-Z>9 M%$SPAY2VB[O/"W7#YEDSBR":?&7]&D"G9:>X88K/Y8N*JDE#.A"(*Q<5Q+EJ40'$JUIQ>UE` MG*N6!=CF77IR6)DR7N>Q$/@E@A$M#^I&$[4@$EZ4&.B[BHWZ9M);-(#R5[]V$T4E_G..U:]WG'Z MT?YQ[_(J4`$!LCFL_0/L>524?:(GP;.2:LH6]>26M2]I/B$=T,BL?>(CL?:! M1F;M$Q^)M8_MV8EB83PGU_WX4V"DBX8`X0EI9$8Z,RHWTH%$9J2+VH/0@T.P MTT@/0S""D9[&0MNH0,/.AZ[`=A>!!"(1HH3<=N^F(>9V$IKO2![@*?>",H0: MASE"!>.*S7=G((,'(K+/+#`%.YSLM*=B2ZRZ"Q"BD)X@2D`/<,7\0>XE]"KB M3]`EH`<88_[R^GM(H_83I-6)@'/9D@S,_!&1=-@)-/-N\).%=X.?F+FE%V3- M^8'GN+EIZ-4+"X`IT1OY:`.PA@JL=O:6Q8?D@Y@]`FY]^P%\25C4AK26^7;# M()K(OT^>DJG8P0^H6X^#@,`$A(C`.?J%.=A9D6H&D3F()+O-P8'\XC]"BB-X M>3^03>>6MFZ=W2/^_N$>?$CA^",8A+UWJ71=ND"WEJ.#:@?9[P(F/X)'Q%F> MWBOC^+*!B1AO<5QS_.\C&YU@F,YC=@L34]2EA-]`(S(QF8_`Q$0:D8G)?`0F M)K5GIT.99&0&GPYRZ_*V?P/A M+@LW;PF5/#PA1H4HU].QQ45R;/1/8_2N+(19F[4\[:"N:PC4@+C.0\B<:SR$ M2%SG(63.-1Y":O->X.,QU)0S@$$PJ5>P<@01WY"XSBL86,N]@DA;YQ6L;#-B M(([@7@R?INUXZ;@K!I0@/M;A/:C'-_@EO^H\<`;CC0_YS) MY_6INWV2N=L")0:FHIS=76[>JFXB:0;B2G.:.%>9TT!<:4X3YRIS&MN\,P\W MR(8**]#$G8`%,NX$)IW`3$NW,89W@X^BU"JO$P1$$"2NM,J9=855#K255GE= MFQ'34!!V)N.&T=1I,JX")2B+W%>B'L(MPMZ:'BP#/4U[EKX&XW@@QVB<*_N) M8NU/$+;"'+`'R&*B%"E_\0%\HE<3&-J_NHWGP?4`%G0Z>>)*<()[QTE5PW+A MP\6#T[PL!=IK&MV>VEIG#=#NUC2*#L9X<;SJ0J?_FC1U:+C@X2I&E<%$;W@* M043?S?=P&D#(#?R(P^;O0-)S'U,E.<^XOIGG/&\HI*K>)(4$Q)4*B3A7*20@ MKE1(Q+E*(6&;]_IW2#*6L41ZLM1$]*1?Q!+IR2S*V(`(`T-$,*$W$HWG3Q6>->*9E4Z## MLT8*2$B.@>2T1A0+H2_*(&,-N.W"C1&$1%)!)[)B@>VB!(;:#R!YDKC0V'7^-*PRTPTB:Q8QGS5(%I3(BNMT!_7],=S/"?+G'[67X]7 M!E[STCWW)VGY>S_X,^)>0'EZ\I+/W?I9:PV&@G_P-T?R]X3_?YY+#!!U))1',7(0(G[T9&9'<9?F*DZ)I-;GE*A`R@W>W,:)LXLC'/U0X; M^C9MCG#Z9\4SD>M`!1%4/ M$E(`\99G(LL6((,XKZ]1L\0JXKSSO"8:N\Q9/3G6"$%4;V&C`8NPQW:ZY;GB MBP-,^,G"S;A"T^M(A*>5&%>N08B3=?*#@(G$6PZ2'#4B)[->=9!DZ^TA%&AW MGO4DDQ]"XKH>0TA&^=GK7N$1'SFIJFS8$>7KSB?1(2:\7>?S MV5-+VNCUR[@7/UE.,#UFHULZJFRS3.MPX?Y00*7[LS#RG-UXMZ83+;Q&8[.R M.VM=+0+YG[!+M55];H@PT*^CL[`*MD[YZ$NQ4JOM`M)K0']FE^J&:B/^FQL' M-[0;T)_9I;JAHHB_O/Z@I;#]^W>I!AE0P?>>3"QL MOMJ:`FOTR:C*11W0[EW4F4F'X$U'9[RL]F=J4/@56;&JJFHLZ2D@KEQ_$>>J M]1<0;T6&-]03<:Y:06&;=ZZ@:(27.W;YR4(C!:G0G*@QWWRPK7SJ!ALU#Q)7 M+I:8=<5B"6BWHLD;"J>NS:AM<+!W)BS-!NY+R)U)8YIC5&H0KX?J(`M5#V+6 MKO60&25NJ#0]9HKR9]+MNSY!Q@%:=,K5'1YJ&S3(>W]B8QNYJ#[/],D0U:^= M[0^-UZ6A5$A[+E<<9ABK%0?2[E8(Z M3<*<:S0)$M=I$N9[=%FZX+IG3MMN@[7M9XLE_@\S9M=/^)MAW<\M:/C;"HJ#L((H%&%!9E M/H*P*-*(PJ+,1Q`6I?;LW"\=QM?PR2ENM=C21J5YOF4NVBH;#T0QI!%%6P.C MXF@KDHBBK;+V($+A>.S<+QW&(QA:R_R]4*H'X"HZ[D:&(@A5"".";=2F[\$6 MHVW4F726_`SU='T1"4TV(#FM$<7SQ1?=2C#*BZDGXVW49\E0Z#P5;:/>S.>A MBFTD_^0'I@?#2ZW5JUG=1&`ZLRD(>4H<7:#=;6FWB:,MBI.WTL[Y-/)JLTK*YSBL50N56-X(('TACA5ZW*=Q-4PAWB+.+=/O>."7F)FUNFJ.!B MRU1XPY^X9-)ZSM1:/IRC9K*YK29%N'TW6-!36A6Q!( M-E3T"4'6<0B22"-SBS&CS":W+6<(TNXU&/5H8F=()NL(C'X\ M)2[-%L(,V1OPN5]%7XZV-WBE$8P^7'C$L#.==X-ZC-JSBRZ8JH[&Y`%B*N@RZD] M(ETNZSB<<4@CTN6!4;$N1Q*1+I>U!V<3=IQ$E\O$&N<.RG7YW.FGF$GA1GBD MDFV5R$7M+G5'GS_S&W_?N9\;B"[T?H7B[_Q&Z;IOCK@EXA$/)@H[A?%X6(RG MOP]GR0Z'?ST7%9?V`DUO(),>;<'<9$=;()GT:`OF)CO:@MHF/=I"W)4XX9%, M>K1%8"(%KJ_PNN"7\\ M]!<&%`M^#>&3R[O@?B^%N&+8OSQ&/!P->X; M$W*A[BWBZRZ./`_+#+RQB0KAR93)\Y&?'X8D>FO"@R1B-W71&SM.%ISN@FFXN`&ON_/C^--?G$0N>/4R!9S6J^9C MXVK64+P1-0ULX\6-J'5@H2YNY)N;5='W82Z4?1\G:=Q]N!$Z"!<+BQNA@\!BGU_G M^ROAA]GDHOY*ZE?S3?6X=O=\'9J':Y;%C=`^7#HL;N1;'/.#1'A1>^/JR3_A MGE;M/MS@YM'B:7&#FT/NPXW00;"( MFU^'[FF-U_.+&]G^2OG!-@;1*BVIGLQ1"#44.0J!9'>@OZ%`OS]3Z4UBG880 M/4?MHST0T0?K7;&9Y=[T_.XT850U4\3U_5&-9/5N'D]XSGDEZ4%2YT`C87MV?C..AZU-4SB#L"Q/">0GB[3/,-3XL83E!ORL2TPT MGHFE('2),:-REQB0R%QBHO8D>FWOI]_"",2IA_3!T_:XW'V2\Y2)$"K14S6> MLJ;9Y+:YJ@/:O<"H)H6]]I(/7N!%/"W5YT?.];P.>X@75U?X/3E!&E-5!Q"N M`7%E&A-QKDIC`N+*-";B7)7&A&W>B7TTZG.$"_*0^L\<]O&3!?8%&1K!#9`] M=G$CNZI."A`-D;@RNXI95V17`6UE=E5=FQ$Q40IV(B:/:'("ATM[#R/:,8P. M!*-E'P)"/*U#.`16A+CB=!0UCE+[$DEVP^@PQ?8EG=D)P<[[H^[`0W7'DW)CC5J078#74L]C:1!*1M2GK#L!.&MM=V-E& M`V@'MXVLS7`0\>8!'@"/,L`"5"3$VK$OUHSKP]FL;O!40Q]7UGD/,G"^NL<3 MR>.LO^4+RL"VI]00OZDW^G*QCP?0=Y$QCD(?(?S$R/DYA%WBD*Y%QSBF>Y,N M]/40\7T*'QIPM!_YD[U(&\0A1!'<'$^/`VU+K1186#]&9C>`IU#DEF(4BA\N'ZKW;N M6ON](@+R02Q:$28*]Q5=O,.!>- MA"*[^U5U=*K%^N[7C\>2'/*K'NWSDAQRKV[FNV1#7=IH3`Q]DGB^:]ROU9@D MWB4[/YXJE-*48S#W0D8HU+?)+EFSC`!$4HF%^;"D;+A@S7)P%L#V5T77S0:@ MW7>)@$%$ M-[])6ZK%ZV0`53@2UYT8$5C+3XQ`VN(/#&6ZTG\R4B(#I+CK>@SQ$65@SRF$ M30Q39S\E'(JN?DIX4Y/783*J<01EV9?G"-"U.S0OG%*8.7#A#$#Y%_0R6H(8 MH#VM4<>SVA?=.D3BS!SR]'R`83D]3@1/3B<9;AYA057=.,+BS'!Z>CK2<*U; M_*14EF28+EWVP!JON/#DZG^NL&V%$VA\L_$B>;8PO'FC\'S&M MU2ORO-Y&FCU\(,M[8*WI@/D`5Y@I\/E(*:V06]B%G3$#>WG15L#=1*Y,^-C6 M#:4OOCG&Z0C1P6',/WS8B0V)]T?,9KAA#W+D5G[K2Z@Q<,)C!S"X-S=^:6=- M5/5["`OVR9?!QL,IAIK_!WWS3YH-"F5N9'-TW@;=?[H9TE2K8<$B6+H^!"]&)$)!*H_W[YXE>O7C9/_G_OOW[YPOW? MJR_\/__S],^_[9[FV](]O7KSL@T-VJ=N'9_F[NGIU?_F-^_?R:_?QWZ[SY2/7 M;N@OO_/-?;-?NQ^7RQ_=+W^^/B^7/UW'^`&/H"=\?/W/5_\NO?=]G_2.CC_V M3Q\NGUZ?U\M?W.=?><)/KRWU]_&5._;-_XP/OZ$VZ%33S.%9__6_]F%/_]T?9Y" MRS8,6+H)(T\&M6'-&D=_^;SKI@=ICH_2')H^F?+GE^L0&$B2=!W^Q?<3IAJZ M?H5Q!:9^?@T#V/0Q/&J8%UF;=/$\7+Z]=I>W[H']=/G@_OS&/_:=8^I/_H\? MK]/EM?_CK?OF2WSC-:@;+U_]P_4^7[[XZMH.EQ_\CQ_\#PO]_97[<;J\]]\, MCNJY;>C9K]V3WE_#[Y[;W/UT>7-USWKG__*_?G]MN6<_J&_YMZX-`^')_N;5 MRQ?_\?+%?[]\T7J-"2;V]N6+>;I-R].TSK=Y?/I>/B^SY_=W+U]TRWAKNYTO MYE&^F&[CM/,%/=-]\.;Z^*U M>'$*RTK;.NUT!NCT<2;5_7`=2+=_]-H^^U:+^V4AB_%T7Y84%L-W:I@,O]F; MMN=1ZP8MTAL:SR2G_D;?GM_-P,_ MDJF]]3(2Y\^:BI%,;3*2WK.T\?]\5&)8[S1Z2&R`/XO&#\W@NWG\0C1^:*9; ML^Q\L6L"F_Z<8":=@6^&M=[Z\=@`1J]_1NW?#KUMFMO:5JK_T#6)^G]"X6$@ M)?]J$^&&(6T95"5C#\Y\:!04QD]'^[ M+F0=._8PS-UI>QB":1OM8?3!(S4(?"$&,+;S_A=B`*-S*\NR\\6N16Q[;!NM MKFX'MFKBG<1FAUO()HYH.+`2B3JPQBA)'1F",=$H0UP_WU;CA)*`[6B3%W"3\>;L3IP.B]8I3F)'U8/&TZ4>:-RB.+9_0+% MC?TY:)+6N_EP1L!_E^SM_9IBZ+RWR#9./(-KW`3=+[6-<'<-V#C;-GJ"\%S7 M*M_6V5(34<.8'T3&:HDG'@KFNMB"3-=%:>R)PA^.?1B[S2":TB"BCA\_U[5= MIV3`V<8Y?3Q0E,:'V/C/78QWO8]B`ZV/%SIZCO=$+O%^]P%B#$[ZLW/XG8X1(X?(+GU\[8C"05^T$^Z8/7HOH M^R&H>7:*?=L'<9Z8HGM$G.*XG2(G`DXR,>0!T,/PV(-#]%ZEJ(?.!W%S#UT7 M>_AHIX'?JP;&LL9MC[X&IV./B;6^Z^O\T5@=@"Z7HK5;#H8SH&>1:Z,20!ZL+*^6L3G+C,QHSK%:S8TA?/<-Q3,RV7VY-R;OWTQIZ8Y4=O(78 M. MMB>TRSW"J%U8$M5JU]!2SD:TR_FXPA0[BI%GIMBU<8KM@T,:(24VZVR/UYVUM@=( M#N/KK,8SS;?AA&HRDM(VT;+*\&I85Y2*!(^ MV'.K2Z),G?CU59R[QPT#K=LU"H;%>RT+L'!B!3.O>KQR])3D+"SJ#Y8+X0'* MU3TUGLH+=@>3!QG9P2*\86P0VO8^U%GF(.`+,7Y--P/B[4C(!44TQ?M]VB>,/ZT;#%,1):O1(7!IDD-/9U#]@#L4D MQYK,USX),<3#2>QN3G"$X^3=3;D_P:Y,]B?VZ.Z=6K>;C!@:J9-IF\L[Y\1^ MY(3$.(6/;^A/SDTLDIMHUX?DQ.ZFB$PP.]#=S"&185_DD`P9"",[[Y,)BZXS MS@88.T,2@/-'G`2HE%U8?HOP9@I#/<6C$)X&S9X,9M`KN*]9*QR\#13KM=AG(,GJ$UKO[0E8145B`^?19 M%=MVQFL]H['>+]MTYH-UEU%`"$PBH+#5SPUC?S13KCZ(#!1)^_])][%/[,ER]"W9N#"N'3AT#L M?_R[_[B+(F6ERM$G"VU*&]M5(D)\(*(ATSM17G+H:IC0`TB%JA1 MA3-Z41#G)Q,_&!`(?NDWO_C$/7[Y:/O+D*A;F]OF+N?;P9%,+4!YO4?$V8J2 M&-*P%@#2U>$;D=N=C.VR;+*:T=IT8"=[`E#.5 M+^6$=I43`=2I,64`GBHA`O:($`GVU&(>$>*U>SG^+_>Q6D\@P"83"/,Q+5>#* MT=UBQ@CJ!O-"++>(`R%S`7$T?UKB`UUNT*4EO=KB"U+>P*YOS_J-X,5`T].N+CH=-F M((\\-X",FQS5>X`8MF8/4#-LW@/$L//;9SDO<:PLB:V/VJT_&;IBZ\\X]L2> M#L9>SOSY*L^^,O-'M(;,WWXILL,%Y)'^U>?[_.'I=Y36D_-W/^!4=?CAC3^: M3SG`#Z;$G4=RUGCML M:(K,)I+9)MF^J%TOU@M54P+081':4(J7P$!YN.H"0WJ`@+]TIR=C2B2R6 M^QV0`=P;)P=70612KW34&0-Z8V>`\D26E/L=T3%:1G>]DB7L;X@LUN8=D3%" MMDZ.'18XB=J\(S)&Q=;>V.4Q*V-MW@$=$*N5E>3YH).]3FY`J48+@.NTZ220 MJ9&1\+W"2-30'=$Q$C0R$OX7G.R4+"'T9YT;^V]12=T8`^(S=T7N/[)1IR)` M8\;N$`&8C4K'&MS_N*S^9@K+]BF3G*TJ&V?<%?A'7U7V@U1\O?GN1CT7!>CHT7<[ M8:.;'FJ07X>K`D,ILU0QA]]]_3&?<7)?O7>?7LNGI#99$5Z$.8;P0C2V\&(1 M`L(+T9C"BZ4;A!>B.5LQ%(6=5JAM;D7V84E:+2A`+!:>()IA7I9H1C2V:&;B M'T#=*F@1"41)F8XF2%O-$E#28 M#:*D11R(DB*.4Y5`41Q#+!Q)]P30X'%/())RSN$(G447'4ET-+?<[]/*G)Y1ZY8X@@$8)D`$``+P[0+3U!@&HN] ME26_NGQ-]VLS3L`7 MX;B3;^7A0%R7_I__;>]1AM*'R+>*T@DFG/P]X M34),J>.ZEA]"3N0XT=Y-X7#V.TFL?PAI$4760QAANM"%R:P7NEC9#O1"9,8+ M7:R=`;$0V<]PH4L4\I))@4B#54X/J'(@F)GMHAEZ*$R&%D9A`E1`FJ:+7LS\92`AYJ:_Z,7>%8&' M*,J3%[U$>:3OMX&M]4,8+<[?(U[;-LMNL!/>[WZRWY$N%3=IKEE`G1 MEX!&.6M2*R=`#Z(O^,AR[J2V>X`1HC\-1OI$3;HDV?^`2*35``>I.TT`9(+Y MYCUE.6M"]"6(4DZ<5/.;00O$G0/P.,$4GV\0 MV!(IU8(E8`,SS@.;!`B7H.2<#KDT/JF;YB=#J>0XPDQW,(!THPA=P`CAQ[GYQ6W^\G M\<)]/*V>:1M=YN'XZ4")C)_/8JBGD#BF8SU*W$@?CZWGVHK5]_'8>J[MFLS7 M/HG$$/7&T"T>X:A.5W%;U>DJ;ELX794HLVH,K,RJ,9`R\Q`*Q[.@C1B`XGB3 M:@"LC1A`_F10HDW"A./C27$,Q\>3%(/838NWDT=8I@)!(CE[=\'8X#:5W\NM MI&F@O#N;=QGVG7\WNT?XGNIP_8^KW]I=_^9WT.L2H7+Y`T%@$1C*P"T M,!D&2S2F`D!+-UAN$LVYBPI&$>;E\\O]307RT\--!?++XT:^Z,9$P%6;)@<' M+*6"1)/=MER(#K]NTIN_EUDZ#8>4(?+)6&IG[8\;)"G+FS8&X3"3J- M<):\;%'K?"A1K$)-$B6``@O-[.(K)K".2H%BL6IQ)`A&!@/'HM0B3\0QD>>) MZPOFG(&'O7_\]+CWOVO@866Z-?!D97N0E[>H`\`>]"&STZ]@P-AJ]8$6KB8Y M,2X0^]:6/]HZ(4`1E:'^`541\J@BR6T78=T60?1]_:53OX61XA"E5 ME3<2<65Y8QTS&?I`BE7EC74],QAB,9XI;US&Q&;[>..G-@U?)S-"0C"\JGK& M*I,'N*DQ/*"<*HD![HC$ZNL9ARBQ^[=TEM/E5:("2H&L:NH1ZSC&P$.LRUR/ M6-DM09$HJ.IZQ+5/3*O-`LER.KQJ$@`B+#1U%>*P=FEORBI$IOH9JA"'!:_` MS%G(O-Q,Y92I3 M9#)KF:)5+HPOF,Q8IFCMC#$%DYVM#'`X(&I!\L+3#;K@!O?H8B_G(K.QE28R MF;4TT1@=6D3`NB"(YM1_?1^-YR(3,B;3:G?.<0W2_3I"E'$)`$U81,HX0 M&>;WW!7S]'6%,L_CA(=9*`0]HE7J*QCM706XD8NF*@81TX M0PS(LZIF<9C7VSH6+RHJI2R8O'R+G&JS9YC6TF;/W["C$W9]WO&1T"4@CFZ. MB&3:1R14_>B^_`=A&6/%8N12=I+%_`;3ERZ_*Z8XJJ4$%$+TA:O'BHF.ZNZ! M2XB^>$&>;A<)6K*SBR0_/>PBR2\/NTA1Z>*]R;I2&4`;<"9_75HQ9<+TI;O\ M=+M+D3&J;"6P4K5@&31!K_*7`Q93+_7],XQBQ2I=%ZC;C8J:0(N7>/'%)+M1 MNOMX@:^J-8.`%CQ&_FI"W2Z543$`V&H='I!;I<,!A*O5"V`YT8O\[8>Z7:V, MP_&[6O+3PZ[6OL,)^$_4+*+UR5)P6:U6`'_0J_Q%C;K=+JM>$0JLEBO#0?$W MQMD'7%C?.0'$J%0G;-+OCMT[F[M+^V5W3%=F#_18.SW`2-:,^JGY73.C6H2B M3\>26]^>*/KD!^CJW+BQJNB3VZJ*/KEM;=%GG(.BZ%,W!XZ1JCF$.CE,(3>` MO83`X=,?B)9%.5G$$LT$?-O(F/$VEZHV.4BHGAOJ]X0Q^4+,W96VC3G#V$6. M.MXTQ0K13JV@ONV:\&8IMB5?)\\]KE*U,@?^QL8<3Q596N+.;E;=A9_%5L3( M),9WC,:.]`6#3&,J-")Z/:"P%@Z9NL-HC&MN%M-*1H2Z/:4Q7^-DFQ-X6 M?#,4UMGZ84_-C#-=2&MC'/ELZ)OAJCV37L-Q&_0-P-_"-OAQ89OA0EH3V^#. MP3?]-7>V^;!/%W53UGD9.R$''YFFOY#6U!'3ME->RFAW="&L5M"&]'80IN)1QS:(`I+:#/UPZ&-97'J%KCVP4+C12SQ MELW[1?-NT#2)A((FC$-9,[XS`9^Y&`PUXR8;1LPUV!9BKD6>B+DBSQ.7PLV) M/%=3D;=)?HC>$*`A>ILXP]%;+$H;O6V=4/2.[#]S55MD?TP^S=E+%7<1@67P M0`0L"$,Q%:#!T'OSJRJN9MJS9]*&'K?3?'(-)=43XCI=7>\#>X`(MOU%F5A% M\303UQ5/U[$4@9R(<\[FF*'N.<+1RR]4&U>,!ZJ!`Q&=/M,G`=_8B\5/[ ML!?9Y]Z]&S4K7L9R?SRBO!<)GM34;C/QR3-ND26F7<@Z83*"@0YF$(QBX&-C M54(&0G7C9D3$2GCR%%W4&D)$\<[-3F[/TMVY"6A4IT6$D>")3IVK,RH1P%*5 M"P5J.NO(W'.,.@3P5:5#0&&B0Z=.[F4<6=CC[#?O)/Y([F&;]Z!V>>>R2K$` MWJ!9IT[H636+0&"=A!@-BG?:G[1BW%-GU*P`*BL'3>@RJM69,X#WKJF5.YSC MBJW=>2M%>9>S:F)`GJQ%E9,*^YLV%:+]3==M2$_5OB69'Z![2S(W5MWCP6U5 M]WAPV]JW), MB<:6>;5,"+Z!:$R95TLW6&`1C7$'$!U9TJ1$8TN3FB;$_@A\LZ1)3?VP+V/& MV78`38PC9P9]L^P`6O0:?M"@;P#$%K;!A0K;+#N`%K;!@8)OAARB:3[L>D7= MM#E$6R?DLR/3##N`EH[@L)EI*K?K$59+B3I"2ZVW/Y4/)3J."[MDB2.DQF6` M(6V;](:]PWBS<;6@TGC.5/O[+D.5M.4)<]LRT*,Y'+4=(O^]\RX$?K0-CRVU MO9MEH(KA85+Q9N/L"[PI`]!#=AV0'W$PEZ8*G[AWBE0UY*'W`OE=V&H2*`(J M6[`C1Y_506X+I@X%H"MMF8/%MF&9WL9%<[EA>&*AX5V0;;>N5<&235P^,$MN MJS)+M-68Y3@'?,1V24'NL#$99J'QW3SG!(,)F0E-V`V3J&OMDJDKS7*=;K,( M:\W[]@/RT'N!_(Y=1)6BKV,F;[$4A=Z<#J*MF&7ASDUI"[,LMIUO8Q MI]F252P3Z*R`<`#WG!;%6_05L.;M@\P7&6?TMAFGR`SVN<6MA;8 M4TX;''+L@/R(B3GR/HG;JS^34$7.)IHEO^-8NH(%E0VW'Z@AMU6I(=IJU'#J M$V&5@Z>T-<5/4-E"Z':Y4485:*M!%=)6@2J&N;EUB]9$T=AHHDQF--'M(LEL MHB"O-%$AKS/1T2W2EJ7:1(7<9**@LIDHTH!N'9LL8+77ZQ"5[7J=_?J19M;6 MCX3RS_0FXVXEV/L M#&E*(BM>EW.W0*),);HSWF=#9.;[;*R3X]46.&F\S\;:&R]DF)6E^VSNX![E M+JVL)-`/G33>0F.T``!DFTXBCVED)!"G,#)_"\U=>*5LII&1P&;@I.EU=.:Y M,8P1E31H2'QC=R*HQ(F5:#P#%,_50:HTP2$ M=HM'0EP_ZRE\T9]*$0`)+(H`/""*4%_BYQZ3483M[7-MTJR/USX>',6PZ`=0 M!Q3D5#6?4D$(L9A8SW!%/,69VCV5@@2D8QLBP9RH'?65>DO!3>R6>>X")\OH M@9I8#4Z4XV5U(%=/%Z!7OW;5YTB8]C0&DSL"/_88S!\"I03`3WA943CJ^:7E M%$F<5L4I$B:N.T52QU!&;$Q\$K'A+DK+*9*Z83.&8^+3&$X4H8CAI-4NALOM M'0ZFT$S?!.\JQ4,X3[3J',ZSJ14!OLIQ$_*#6IU%?JE: M'2._S!8*0!8IU6,($6MSB%(HUH%*%DI'L*4T2N=PI0FM?+@LG;0 M`64F.G4*969=DN$P$X['2T54.KV1QC:]$7QR-/9]JJ-9W%'UB5\S5CB)YF2I M4M2BD41$.,>2H$HBE;N1M@J/(X!%X1L3<'/H&[FV1ZDY:&S3'`$G)LU)((U! M<[B$QJ@Y0G6D.7O;G?V\5!3>,%6Y\&9OBS)V9ZIV83)KM8MUI,'R:L6EW3'-`V<[$[K9CIL;K5-3U6VAY>Z2Y436\^TW?,F_+NQ"&[RN2' M',QM,=!RG7JO/=/'O8/\D,^1JHDY`G5\9#XKSO0)4S69!7"0VF9T,*1:&]V9 M/GXB&AYRA4F:WGJF3V>6W%9EEO&YQV;)60FV2UT*@PT3C8]9(V1-L@[1@HY* MPR3J6KN4OJO,DG,BU'GMF3[N?56&AH2JZ:UG^J)9'I_IBV:I2-^(6>;>19*D M9&"9FO0-C'-6O2(DH6IZZYD^'6^XK8HW\;G'O.'LC\H^T=AHGPF9Q3X%RQZQ MI[R!=LBQ,ODA$W/D?1*W:\_TB8D2^2&C(U736\_TZ=20VZK4,#[W6`TY]Z4) MGFAKBY\)E2&$RKI#@2K05H,JDN<>H@JDV70FRHVM)AK)+"8JZZ0Z$P5YI8DF MO=>8*+)\E28*_.C+1S@U_36W##JW/3UTZT+?T3/OJ76(Q=YL2A/YXXCM3P)TSEQ^L4 MW[0;7L;[I?^'WW`Q4;>:LXI1HOH#)DQC.F!BTAPD`8C&:J1ND:XG&=H>: M=&0XM\$TICO4;!/BI2+X9KA#S=8/K[^8<:8[U&R,HU4*],UPAYI)KX'E#?J& M;*R%;8#%PC;#'6HFM@$Z@F_Z.]1L\V%\)>JFO$/-V`D!E<@T_1UJIHX0S)EI M&F](,7$3YTNC$,W.'^BL3E_"XO@_(G&Y/PMW<#Y$\VYVO(^ M$44G;RSR[R\:Z";F@P,^B"D8OR6F$(TMIICXQ#$%XK#$%%,_'%-8'F>*LJ3P?B6.ZJ MG6/[RUP\;T:1T2(D1$9(R1`93=SCR"A&HXV,MDXH,D81U=<,YSQ8:C'%UT4A MXEHF@(C+PC"=I*+0.R1W\:B).08/[<]RNJQO?_[393*MFM-E`VX(JCE=5L50 M1.RA+9WCR.T/SO4=(X8/(P5SS*CJ+-B0W&&J)^;P7L=+ MCO,08B;.YS9T*.#7](';W^.%W&$;`@Y5H@6"@&PS""+7\WP; M:CG,F$(,U#+J`"XJNR64$05["F4<6N<]RLC,A^%&U92`.UB$-NC@)=!M3Q>- MVH2_A.AN<[IHASZ-JIW^=)&;4?ETD2:`%XJN\F$X=1R:ZBMF@:KZBF:E.MM$ MC]557]%C2VUSTP5Y6NAE#_%0`O^6GIP22%16*$$2P6N48`L`[$JPB>*Z6A^5 M$L3GJH\KL1;H:GU8#0J-$YQ7VK$L8P2H@7_944X-)*RS&A1?=A0A0/G% M2!H$`?)*'*`K*8$::$I*H`::TTI@>`)34P0#`!W4'QA5)=X MST);#=P`>25LT-4MB!XHZA9$#Q1GB71Z@,:U>A#IJ_1`0(D.&_B7K/6=6VG. M3_.M*1QB1=.`5,M-^Z8+JDQMRS8F;<,0CMH.MPY-^['LE;EM&,)1VX%T0<,& M::OA@PLY7<*&XE'>,4[MJ.ETFV2T_9)_0V':F/A0;NQO=^I%%M-M+9Y0Y;;A MP0=MV_:F5`\/HZTZWI+DW*/^!9E,]_1;>!4 M2N,?\#H=>IBS_^,MO@T#N*7+T_\'NH=%5`T*96YD7!E("]0 M86=E#0HO4&%R96YT(#,@,"!2#0HO365D:6%";WA;,"`P(#4Y-2`X-#)=#0HO M4F5S;W5R8V5S/#P-"B]0ELJU6W?`$.P&V#`'B^Q`?L` M,^/+,CUC!IO%_WXE94J969*J4]4$X>$H6ZJ\*"6EOI2J_OKRQ4]?O;P^A?]] M_/KE"_]_KUZ'?_[OZ=]^89_FRV*?7GWUTL0*YLFNX]-LGYY>W5Z>W/G5_[X4 M]?G(>3I_A?^'O5^=G8TX_]_^>?N:+OSS/ MIT]\/3><_B-4#]5^YG]<3K_QOWQ^?EY.OSV/5$B/@"=\>OZ?5_^9N0_#P+@G MQI^&I[O3%^?G]?2E+_\T-/SB;(#?IV=D'*I_G@H_ASK\X<9Z^]@5'QY$#S)] M%F2*CPZE7X5F^;%;49_M&,3PVH,--M;X=6)LHMBO0`0O^Q2?_8OPIP5>P6@_ M"9R#P+'Q+\_/`XGP*9)-K"#U<&;->IS^:*T-_9I_M!-3$A[Q.__4+Y-A0-[_ MEI9QUZ?93(7919UI8752!YLY:&UL[.+/L]!!O:C59U%Z$VWJ:_T7U+#CPGT% M]$;K"7>PG.W>G;LSV]]P\1_/\=?@E2C!=/HJ=.2'\%?X]78VH>HSR!4JQ9^"(*CMSU^]?/&[ MER_^^O*%":X19Z+W+U^X]3+8IVF8+W9^NN7R=7EZYVLNYC).F]*XSI?K#`1[ M69:2@$_SA&]>OOC]OSZ]+SF980C/>G;7BQ\:']_&JE_M2>AE,(.]6/?DK7Q9 M[7XC*,:3,-E&<"<93N_9&T6GNT`,7ZAFOS3TO1BP.=N?EJYG>TU M>2`?Z39PQ2;>Q=DD:(U@8%OB`UW_9<]^DD)TNPY@4*FUW7QE[]?P-SM`? MA&17EW_Y@Q_I#J7[V]D:_Z>?*/VX\W^^][^\.8\HDS>:+VV5U<2ZNXI^:T7MZC<4TJU7*Z#SCV%*#N8^-F,-PY/_?C MYJWW@RNY:!@L;]_L.P2(@\X)XAQQSL%8YIQOHW-^?.^#QB3'USZD^MNN*&3K M&Y;("\=K7*ZV!-93H]GX)1`:O4>\IE!+U7,DT1AXJSQ2"'%C!(<.Z*X^Y)E* M`BGB?-\L1;FAE^`WQME/I9L0RZ]=4S-<5+A"6/CL2-.Y#T9BB/[Z!^\/,<0) MT<`[[Q@8>?L)'H+X?5]%(:WWTC$)N02!#\CHMTZTY'S(8GQS-NOI[4>-&+"V MH!B'ALPXL.'[^D-83\`\85;_&"PRHT!A((6=31A,?_<#Z:U&0!C3CP@X\S'] M#C=./F0+HNR.9>&CMUS.P]?Y;6D(P[<$YN7&RDT3$AI[),YOO,S*'1*72KW* M2$%N1+!+V+P$4?W>9*X1S!RB[4C`!6Y+J&LG.,Y^-VE4NQ8IV!P-\FQBB-?O M#,Y:%LZ_.MLA;+G]F(6Y/KA$&-4?PQ;]QX![V$B+HTJQ(9$&N#$391=9UK`Z M%03F(JL1L0J4&S85_.;8^1J7$5+%V%?E,UR26R[G('[TK*>B3)J,/C!?;4EH M(0:,FU\H@[NH``,FE%O!6XY%)J.7DJ;75^>%3;'WHU04!"98%.3(_.56/L$" MS/1-"N'#_&IA>OT`$MFXY7@;@*3HNA%OO"\F3+,/B#E>1QXZ_=7/]3^D_3!L MF7_<$T.ZPHT(>:",SE4)W)VF@!`5A+I_28Y..W:D7+H-<<(I(%R^$0&@->OI MQFY*;&?OYU?G2@+%_Q*)XKRL[]`I3K/E`*B*Z&6PY6#G6VJT;E\98=XHH3+-NFM0TS[6`+J#`2[1V MJW(>I%`9!FFS6GB-_-?A)_3G_&O.7KE,L, M."\$ABZD[B-VDG]>O#/[V>S//N*.I8_08@B/,>&?F%5=3S;\?)REZY(=^(C3'?J&X\S1>W'.4LTJFN M-2DH##8-G3TM4Y_=QP2?%S8K.#;5#E!R?K[>(@DMC5BVK7.: MDWE?U]G8.#9'=II2Y@3=\<'N']3K`B)_YRU6[\26TB.3VR\,C35)(;A9MPO# MF%Q@3BXPZ%Q`9+9Z>X*REYBC4K<<)\&VSWM$\NT1!QA-IP.XZY4-XUYSC3/- MN-Z3&DHKY&930#CRQM;[83',-7!B,#A%Q']T?B'S@IW!E_,S)34^.D/[IS`M MSZKN$7F=SNX1F<_."4T"%KWF$LFG!#T<,IF9J[U/\?>LZWUGC\>`$JOI-:3? MZ8SVJ"$%Z`'G/X[9T?4&!Q*GZ-W=^4F84DN#N=2G4H775(J\5U3P3K*/:.70NU2.RYEM*:K7;O\B(2<=T0 MP1P`(EI>#LL]AL=D+QI%A!EGDN4\XP;TOD).K)==&LDT9'TBV.1&`&)91N)F M;?A;<70YM9'\ZQS/CZ^EK;[L`K-@YHB5# M.&6^9O@%CIHC\0V<,?\^_O8A'3A_7C)E#B==EM-?Y'6"@'JA!*=G'AN886&R M_3F)%1^)#.\>01]G&X[#)"NMH5`!R\8E5O9[++>$6&T-HS'4^WT`9A56])). M2=(`-GT(TM[.-A[(MU>0]ST09$*'H,OIW'FP#CMC+DM> M&7;<7);@0?6SYO@CG#57N".3I8E;U5*"7!L@@/P)S9(ED#_A-;+4T(9S031: MI4X61@^&E1X1(2YTB9`KG^5\6DOYD4$2`4V`")[4SYTP7)"3Q`?"3I20_X&*R5-=&<(%X4J,-R=*$"S<-N!`W M(H#\"0:4)9`_@6*RU-"&$6A;@W!8U8#BB1)$_:NG.UGJD`994P23:AJK=.4B&Z-I%-X2JE9`NX+2%+5:)_-G"[ M%XRP]NIQR$ICA)-#VP<1]W"B<1SHI'P`VAVAXV_C446`TR-:;,?Q]%6\._:\ M)EPYOBL&+Y!E:'TZ_<7_,,VQ^%VHN(68XP.+/$A;6S])+C,'SZ+Y&P,+% M%W[`%-R-GWN;Y+<]1>W_0;!Y,,_K>+TS:-*&_UN];M-"SX#ST09A&5I>$$`= MAID7!'#P&H(>SFIE^%SK85*TO2.@U<99)@:H9Z42BEX0LE()YBT(-2TS+P:K MZ]7DLCT$L8>SH@Y&TFDM\I45WDPGAK*341!:+PAD%,21"T)I)<:+L':MD:1H M/8[`!&+H.VF$D'M!((V&HE11CK@0!J]63@C5Q.,;C8>!ZXA^()`&B%: M7!`J6A(OALVKU12R/8S3)TU*+H?5D%\#HMV6R"L+0!:%B)N)$F+W: M2D*PO:.YM<8D$T/QF4X`W1<$IA2@TP6AHB7Q(@1*K:40K8GKMQIGF1BZGY5* MD'Y!R$HEL+D@U+3,O!C&KU>3R_80WK\REQ?O-;3K0K\LFI'`M&4Y`&:NB/QO MR\Q8@&\7A-)ZC!-E`K3&DX+MG4.K-LXRL=P`Z80)@8)`2B'X71!J6F9>G?XA MY6J"LHW&)!#+&9!&F"@H"*11`+9EJ:(<<6&9`[6"0JJ'LPB]42R!:8 M0"@(9`X$RPM"Q43(A3(*:O.04'L'L&LM21J68V#J3%O]IJU^LUC?1/*AEFPX M-,]+P7H=/(M$N8>L4$HX%(2L44+%"T)-Q\2)H1%Z'9ED#VEV<*<5R$LPJ M8YW`K!)!]VVY-!+C1)D)-5P@!.M9[4D>RE60-IB@*`BD#J+P!:&F8.(T=CN! M$*QSK6(2L1P&J82)BX)`*B&R7A`J.A(OELE0:RED>SBKT>WKI!;+;9!=W&8O MEPAD%P3M"T+%4,3K@#<(T7K=P?$=72HQI2#141!(*<3R"T)%2^)%F0^UED*T M9A:DT9AD8KD04@H3(`6!E%HV0;S,DM22(B&(IXR(6DTAVZ/9D6Z?7WBPGDK, M+.O6<.NF\R$#L"U7K$21*'=""F'"I"`PC2`O4!`J.F9. ME$'1(]Y,L&8VI=4V2\1R*EDES*1LRUFA!/`7A)J&F=.!6$9*]E"696!@I-BP MCC'\Z-FP,FU9YH59R]4)S%R0="D(I?T8+]<]"J1H'3<>0+#>&P_8:C?_0K7M M$FO;Z2DG+JK9"%>YP!.[,W_@`+(SM_!'3*OD9$K(U;R'1`NF)L(]B9BC^0K> M0,'N`J36\-K]">Y9Y"?$M,:W9W?Z.[W)XEW,"^'K`V.%?U?<>/!ZSZOVQH-9 M`OYN?+1Z\-:#O:*=?@%?+9ACNB;F9[Z-5T.^/L>WF#_;<8C6^`%LX/AUDFB! M\../4._[^+.+UR3(.N^0`L;^%I-FU:Q6]8("N`]+`@W7H#S+^10$,`_+^12$ M/,1J>2#XL?LF!8C1=YF"*0>$K$M*]12$K$O*-A2$AG*<8__%"I#CX;L5UG3= MKA1[,X2K^6JK!$#3-'3,QLR\P8 MD%TH"%7K2'[=%S=2U_?..Q[+R6C=F?1(V1@R`29?"@)9`?,(!:%N M&>+5=\L#!.B[Z$$Z(8%I,6W5FK9JS6(EVB9E:GF8SJE92M5U[X-I-HL%-*5: M"D)6),']!:&A&N/7?0<$-7LD\;)0_/R']):=>"QT]Z,%7".6>V%6&>L$9I68 M-=B6JT:2_+KOAN#BI;X>PM2*95(",RP%@;3`+$%!:.C%^/5>%>E9=:04+--" MFF!BI2"0)@CL%X2Z:H)C_\T1G*$?3;,H9VBI"DNPD#G<9O^4"&0.3`D4A+I] M!,?NBR1=G>\VNZA$8+I`&J4@D"Z8""@(=>4$Q^Y[)6DIZKE:0LHA@73![$E! M(%V632A=Y%=J&15^QKGGF@G.1@_F4K2.O6PBZ41@UEBW]EHW70W@_[9<-X[@ MUWWK)/5\Q\43T@S*I`?F2@H"4P00_X)05XWSZ[V$DG>''?=0F&9`R)I@CF1; MSGHD++X@-!3C_/KOI.0@Y+%K*;U!B-2))4>865R=P.P"N9""4#64Y-A]164O M#*GG5%**!)%YG.UKJ8Y62HL#^X^^'6I]&J_IJT:?A;=#1;P^O/1IG/`M4"Q# MH;N/P:'U],8\O7X))(?V"237MY?H=[]]928@P]C'[!N1[.O:>;);X-/I+7<] M%N!P?Z_Y!(2X'U'E!^X!%;!FT/=E_`;;N[C\.Q!Q00V'8" M5CO:"\3T`'^!'KON\2M!S2/\.<";TZ$"!._9/(!+$=?WM!338;T`) MD[KN$2@!O/2NRA[Y.9*9\;AC'3A8PSI0OEK8LKZ=Y2\+_?*)^&6XL@5O@3?0 M5N[*-C03,-Z!GB$D-&%R!ZT2'I2M4KZ!M"K[)&3O]DJ!6/9[E834#MB.0XL9 M'#MHOB!([ZP@P:[^N$9"B+V-!2;5;ST!S/5/21(W.J"[0-`R`'3P?K4]$%-) M9.>``050=L""`GPY8$$!1"48I:.]P$<.[#H$5I2`CH,=&+".[@X4",:!#A1X M4$(C>K9=H]C6]*Z*`G!QW>(+-.#(II&C(GE;?W#3:.;6FAR.B]77Y-&.C35Y M9..Y?TV6V_]^RTA8Y8&]@G]0>TVN'I+T<[(=VB^AKIW]PR;Z#VY5M_QNE=^F M3><;P^&[=^EY0 M4-H,]_&!#3!Z=?-XSH91W+/V>'7:IR9]5&UP;]JC3]J/)CZJC#WN0;,^&A/@ MOC./4LUTD+9T70K%W5=LH#U:,0DF*DOC?JO':FF/U:4,[*N03?/0P88/;(5Z MYNJT_4&OUJ2W3?>4@]N<'H].6YLN77`[@Y[6S&=O$J&V>SU(NXXNA7"GT:60 MXU.U,DF+.XJN*`9W$>@$K73IAL_*VBCMMO"I39MZ'$4`HIER,*C/*X)"-`SD M^V(_"-[S&#V>D_.1>PK^*I%[_JF(W/,O1>1.L>2<4WS+?HK/B4E*8X$4I.]- M'KH(G;3?B]#]$,*AZM=>,X#%J]_6;<6C<[H6HFF5H\O9['Y6N14KSND:@J(5 M!7]S.NBO:#60-=8P]6G:4%@VIW/EBE849,WI5*"F50Z9YGP2^GXS%@'-Z;R. MIM6:)HH.$5ET,N?3K8IF&&O,Z>BGH@E%#CWRY3A@SN<%[K=BJ_J<#O%I6J5E MNL/L;-&=S>[WN5M+:`\S6A#G=-A)T8J6MSF?(E(T6[@;POD:1:N\]LSIZ$KS M4^&T@-SIW'V,!-KO?):\U=R2I$/[Z^[UUHB6N'4(.NY]LJMY6"*U??`[Y6Y) M;_7L^$XY_Q36>F7/^")4#]=#OPM_?!]>_AE*M[,QX5M8\-O'S:>T!O:``3ZB M*"HXRRK(CYV+>G[L4#U#%92'.W)G=+WG#)=';-SY`DS$;8ZY`2ZQV/C1;Z"3 MY>Y]`SW5A+=7\O=:YE^N'2="R.P]=_4Q4,#&738'="FS[7N1(T0:V/C!;Z!G M!2^_@=X\.G)0;HBWL''WBQ8C'G:0,\1LV/C! M;Z#W]33B:T?ECE%CFH\>_`9Z%MR)L;[0?.$G6O$+\XY/Y"]\K5EA6Z4^HQ"! MP&/3),;#N2/[&@,T>*PK$"/,G!_ZAGJG"P'42!9K?IJU?=:%%I:'OJ%>=Y2! MSW_%.9>Z"X5S+N1""RQ3X4N['<=<#O:D&U/+[E<`3H)MG_?!IN>?X$"CZ70@ M1%T/FBMNNY+8CWR#?:&0KO@&^[R=3^9S]=/;[6,OQR(^W!ZF&?9HZ'UE?##ZYL`_Y.['UYO'YLY:$?8>A\T),#8 M!PWI>`SWX(?7.V<#@,4/;E/##Z[T3 M`:#ZQU9W@%@HKGWDP^M]7@19@J.81T1[:$UYZ,/K];`V9@L:OXR-F"1F"[)/ M7E-8NTT6M`SBQ"+;91'$KW:7H98M8?IS<.QF)Q%0;Y\A#P>)J&9&@(,4L>Y> M'J"QG4G[?`?G.IJB\LUYK+N3!D#P'RM>PVJ^5Q%6>["6?VI+VSL[6!2J"3/R M/:>C#%^[+N[S4(?]YZZ7_%BOS]1Z[IT=%(K5!%HICZ!2(>\S%"H,QL?1V8WB MR^*Z5(@!?&R\DW'@(;=&?@QS->*/"S.ABYO*'OESS.GHF$Y7]G+'0J M^+J3TSA,+:=\G\6FE67S0SN7$>?S.;K'<@VSB)_/]P9(KFPN\&6"W0DM;`WR MD]>(9M^M&Q]\IZY?X"*D$.N:W<[,=:,,]^JZ2Q;7++M62W5!A#MU)QO3._!@ MO_%25(W/O5-UN5BE$;"JQ@83[&>@[N#:DP6O'&6X4SFL(T9GA5SUOA7\BD,V MV`LEH"):8+_B%*<:'`_+OE*I,HR'.Y4C9J-0/]93Z#[.NOZ'BHK>'^!UK%C7 MSU'7/4.ERE&"O*=R:\4?8JKH[OBXT_S>J&G'&\O]P;[?^/X,X-8K,Y)I!Y&\;NJIW;J6S=5C M3-+=K1MEN%=W8N'#_ER4ZRKFK1!;+0N?MW:%P,IYWFI5OO^*;C/[?RT[*S'C MAU/Q:`6^3[KR^NUT%F,^_1@OI3A?F$]?PXNGW\/KO?'3J6_AM=OAB=_#J[A# MG1_R`\()CEAZX_\(3X)K,J'9F]#L2OSI+=8?X%B(BPW>I,?(EI[+5[&&68@3 MOB0;7Q.>3I>$RSCT(=@_<=&CSNP5Y0X$N'!`Y?\!5^51(PT*96YD7!E("]086=E#0HO4&%R96YT(#,@,"!2#0HO365D:6%";WA;,"`P(#4Y M-2`X-#)=#0HO4F5S;W5R8V5S/#P-"B]0:O@*JBJI]\\KV MG3=DV2>/SP_K>QAI-)9VI9$\DGWK^^L/R`^H+YJDM.'0N+N+)!-(?IDD6?#K MQ:._7%\TE_Z_AU\N'KG_7;_T?_[W\M^_UI?V-.C+Z[L+%0JH2SUVEU9?7EZ_ MNSATQ^N_7TS*JTNE3KU-"52G+FT+%'\[?'N\4OKPQ=$[>'Q\4JWYO"-^U\H]N1X-1R^.UZ9PW/W[?OC5>^^6??%_3RIXO#E M\7^N_\KLC6D3]K[D4U_HJ:]^./QP5(J6[UI=5X5?%S['`M\PX5'H-(CC1 MH?5?^X\Z,/:$[LGH.N]*F]$_ZJ&ION!/QRL[D]V,4?;#SUKWB\'LEH/9-B9I M\,\'S^1''L@KZ,POO:BAQ=?^.;;4''X^!@$F/-JE@EFG8"IEH9O#FZ.RAWO? M6_KPR7]^[6M^?QP/O[D?U>'CL3_/%)^ MR(*2WU\\ZES;'*/F\AU];M1)JG?IV^8.OS7U[ M??'HIW^[O)]R,;8]NTPLB!W@SV)IK8=LY+6P:U,)G;C*C"K:'5Y-IU%J3%'QW[)Q6.OWS M!3\=KUJGJ*U31C=-F\.K>S<);GT-MSG%Y*$8?0]A.X;3L.RM@F;TQE6D4+H? M/.\/3HA/85*]>G=4X^&%__'!@X8^F#"9FDD#NV;D*APJ.Y#8FE#&"H<`TL\!'CA1.Q!#!0A@@89Z=*``!@ICQI":NI^,E4 M+IN8L1_Y!^ZYH3GIM1]BUPVNG78MG[L19(&.=KMWO1E7<_S:%L/ M-(.G]25_\F*4P(QR]`/.3^V1HYEA0^`S1BY#!9,Q8:*YD^SW:X6I(^#1..\:LVX2H+02.Z9!$]#T/;99- MA+'0Z8VG+H(IH/->RBK-_=SO09C8+(PJ#H5=*9LKJT^*C9ESI+N<%*A;116/ M;5*QDW@82KJ$!@#(NF!;2CJ2[)DKCX.]=*=6K!%0D#4J\<`&K\<3O;SL^XZ7 M5LZ5^N*H&K_&Z<,:I_5KG,$O<5I8%_[T`ZP/_*_/^==O8:$7/G_OGGSEGSR' MZMR?:U_G-W[!\LQ_^@^H.#QZXG^X]I_"\_^&3SW]U$-5TT65=B-'4A_^G'&6 MT/Q*.C;Q)3P-VMYS1.T@YH-30L8G6FM@U);(-B:,3+.A*JO&B?@$XW16-G8< MH$'!,IU3XZ:=-*CK2H0S4T8E1-&:%7=1H5ST?P.SS ML]^R2R0';*`K`>R"DE&]7,E0:KMLYV`QRJV"SA>(/7%)L\)$U0@E_>)^LW`< MWR"X=U"VB_;!&J#@6F@-@"QC#1HO=?PS-0M]FU6F=5JP#T"Z;1^X8.>ZJO,= MYM0J+(4W71N]:D*ZEM?P5W[M[E:\GV;^S?F*^CZIZ*U;,+_W\;2/WBQ\G%6V MT6$`]U4=1G,#B3?Q>(,:#$`=9YQKYSB?[\#6\:4>//QI:A*-!8<'7<7&K MT6,B^*9E*9"[LU'NGP]>\!A::>(C.WW2Q2>/IT]LHDB#5R+K_[1E2H2VC[ID MP_9M]2=`%8_EAA$LZ)-!)7UR+!E,,J8D^89=W&JVF4J^05T@^3@*M1"-8&.W M7(6"QIIQ6[G6EB;./@B7)D!18'K:)E3==;Y?\K:G7;4]R;;35>?W)>SA[\YX M_,;&XY/[]@[LD@\9V_!#B!:K\/&]7]&8PX-[ZDN\//9@>>[]'__MS?'*+5+> MAJATH`I/?%D?XNWZA;'"JCW5>XA*3RA:[:IU!6^`I#^\/F,KEPW7/E[,+?_@ M*WH@N7_W=;]Q(MT2TUMHX0O__0^0SJDX]U%/A:Q7AB"?)[^?+KJ&/N$8&'V@ M^A_"QM`5]"R0NB^_0--OH!MQ(/Q3%A!^\-WD:_&"_#D?L^^ERDAF'6E$RSD1 M'S3B,CYH?9F18#F'\TNTG",^DN4<-TBRG"-&DN5<[+GRY9RDX]!08+^)EG,B M]$.,1CY%RSD$641"`<@"17G\9\7G=J(:VE?[DIUW!)2K$1$1Y^L-`)AJPK?W M1]PM-N%!F/.W/.<'C[DF%'J83/7_`^A;UG1^YDMZB&8^THAFOH@/SGP9'YSY MS$@P\W'0=[C;WJ?&07?N\=RGIB=+GYH5I6=W]V_-\$;)"^/0,V!V)W?KD<`"TY1\)#\]^`W MO0"'QQ/=D2_U%@K>H!L)KB26OX_E1>&,VAXD`$1Z`B9!!0"&U?P1&.OY(TBR M`*U4_C$1@`"S3H=:JUB)#GJ"C+:+3X:BH`O"(K4+8%'2+P"1W+$`D8*YA7!) M`@#R"01`Z(PC*ZP`8;1V8!%2<5P14NO&M7.(&L$A+(KF,)I?R%?C&V(K-@*Q MM;818U3!DN6\ZOR.@<33!(J]GF;3?P84AA+WN-*UX+#>T^H3"XZPSO6K=JKO M8UAB.M\3UIKGO4U)+Q'8(HW(VQ3Q05"5\4$@948";Q,'?J>WR0.OIH&SX+P, M)3XDR2[Q(;F3)#XD,9+XD'$TRGU(R6`@X.%8[/`A=3H)0V1E$H('H MAA)7>8Z-R?++N8U`NA.MNI%"OD]]8#&!$-UUZ>(WN(6$7Q_(1X1D:05^/6%=M"L5!DU`CT%6-&2(>#MD>Q!N2(1O+ MMP$)]>I0".$/Q1<$`;M1"5TSI-@+=D.RB])F%Z_S^/[+L('AOM\K="6FAC%IQPL2 M*6(L<@N5A@V,=T?=><363>)%?HSQR7;BCDYV0WJ=\`K$_\0MD7EE6N/+#%EO M4S3P".-$(_$V97P`M(5\`*LCHW)ODW1YC[=IDW%I_1#T:Y-^S<=DB04^9NP: M@8_)C`0^9C(&Q3ZF:`@`<6D$]OF8LQ$PI=%)&?H!R)+$-3YF9\>4GS`ZB=3[ MHY.=7>[`W-'F2T#0"*.(80S"O%L==EM>I5O/'L/^&?%(XEU6=PPA$]+7!AWK M^2-BU?-']&(!ZH*.I!O[@HZ=9=U8R8OB1WJ^A\-/%GLX4=4:7OV)\J*X8RJC MEG%DMJ.69=E1L6[0MZJFY+K_PN4]216;2F M`W,J<)_K`1;!'9N[.SRZJ2QK/GAO3W84^>!`4>Z#KV8R=1W%H9_`.ZW!@0W. M=W"V+48N`\2C`?"V()N+`['2:3(.AAYZ3$CB9*@;]O31RKS%A)T;WN^B5"@U MX,>J%!Y1#Y-)01J1LROB@Z9#Q@?-!3,2.+NH-%O.[JJ+2GPD+BHW2.*B$B.) MBQI[KMQ%E70<0B#VFR2%1S:E$7N0CV3UWG52Y`"*O:OWMBM=O8<%*>REF)C< M$QQ$3,VS$)]\`?O9;='B5=)NFL]((YK/(CXXGV5\<#XS(\%\QJ'M6T;Q'>$%A MJ]:MK4GXJ;53*W+K5J`FS%DE=V7[P,F$U;6UI_9R/`V9=Y[7@C5@KVA4`(=Y6`,.2^8S8C()$.!5(@#B<]0K806(U;5JA;B- M6@6XO:55G8.^3N\:[1";Y-'&5W=68I/Y-6TU^"+P8VL!^%?IUUQ+H\ZMI%>\ M2Z,^4X12ZSF.YW)OWL0=GH)$&VG3"(R-.AOC6_,AI=P0>L7<$'&-.A?O674F MC?H,\4./HCARSIVU6:Z,UMW8X-KKJA1IT-":YZHD:="^6M M.J-&G8W@K?FCPH%$:#/J<\3KAF1,8E!.\_965^*D2A$$X:-"M3PJFH^4;,.'7=) MC4,71V/7@4&Q3R0I,2QYC3^8Z)'<'ZQ3(\!KTJ)]_F`<]HC4/> MM+T$L<-DSZ2`#L!5R@UA5$7#=>H_]",_^!MM8EO:_@CAPL39G&Y@AR0<@;-9U0&$A$A="VL>WGCTC6B+F-M0Y1UR]]6$^YAUE7L71Z["O:L:.$11'+=] M+Z+$<;.\M2]Z_Z\2<1`LL0WU"W*OP&V\^>JJ35)GPA]X[1C3>2=G)]BMK8K) MJR/I!BZ]W/=[!KUF2^68@#-9FK7CYM*,'IG%THR>+)=FW`-Q\MDI4[_V8:;' M>4)[K"":T`[\^Y6]LZP!:FVU`0+2O0;(4'RI^%4AWG.:[=B3FRZP/E6M)^N# MQ'76IXXS6I]*SFA]F'6-]<%!WV%]_/4I/.A6'I8@\:L,#_=$AUE6&)PY: MA>&I&C,T/#AD.PT/#YD1.@QD>.J0!@T/MJ'4\"SO!?&`JBDT\HP.S^7#:_OY MV;7QKL8N(?QP'#S\#'0NK:6]=CYQ5IM@2X)I\6!%Q]+VZ;&TNN_):O%]@\QP MM`E#>A6FWWX59CC\,GV3VZ02WY!A_`1Y3"U*'5]U:9-XQ<2R81W+1!M^LK1L MS'>+[;UJMD\N."C/N642 MM.;SQGIFX5;&>'F,@\&R*1#HE"ZB(47.TZ0Z"%(1RIQE0,HD$8HT`FGPDIAU MN6A`02P"M',L>&0"&5W\2#%SFO`6KY>=?3`Z$^4I`I.3?O#I+&/E!6K/_M0YHX MVV(TZH_D-/DTA!6*_8I!#'+//QSYG;(8TRH/;M3U)R('$5<%-RHY`Y;4<@90 MB:PK@AND1CN"&YUE-5H)%D8-FQU$H<7Q=VYH31@D]O&N[(S84DEV!DM>$T5) MM$,>1:E3#D!0THU]V711`>8[H#%\*\K1J`1-0&MJT[[\NID6I(!J^]0#8PC% MP_;X3+WDZ(\8[(WGYCUPL./E\K"]WE+T9EB)WH1)9V=G]4X+V*1`#_FERZ"% M3AMCN%3AC`7S9EOOF.?VIW,6#JA%:2ZK03#3MV5!L!"D^A?%NZ;'7O>AXE>4 M<9UHE,T>G0PS$)72S=#)102ING9KN=]Y$TG-VT[ER5M)[M_MG)Z\I2,! MMI-T\L8N#K"P`K1WM>.+)@^'5Y#WL[80[Y)!)*LW!5<=%6`240ZPVT_N*5Q] M=3-O(:MQ%XTD]H(@06BE%[R=[&677X:HEN?>G;G#_BQ(=9G+[,\B3(YX"@5> MSDPT_>Q6?50='G[G[>"4$9GH5[F\69;8B4=;DK\2) MI+Q(3Y!,F%4JYH:*)>:&%HO9B;)*J2LSAFHM<(2(4S!*GJ MZ23Z?ZYJ4J!B64@%=!+W7Q6'AD\G0?\SE?,@Z!CQ/]N9`>YDPT@C"??+^*#JR_@@=#.C\G`_J84DW,]\!.'^V"!!N)\9"<+]2<\5A_M% M'8?3'/M-$NZ735J$!N13%>YWC=H,' M8-!.P.O9C3DQN>9V=G'"+816!.&)J@XB*$#BNOA]'6<$ATK.B!+,NB9^CWJQ M(W[O0PZ:WA?6V@JN/V31JR+RW&LUB8G,NBJD'@>L(J1>-5Z(4CA<.T/J.ON" M>K=()N/Q+;K;DM"Q#JT0)K&A.^/LVF[%V567(AE?0\A'35*TG%/H[\+1/9Q\ M?Z5-3P%WO)O0@]P_(+Z.NYF6([/SA'QZ'3(]*,B$&CB;'P+!D\A[2"@BP9.3 M'=*C2V.!'EYB%L3;E:FV+T"ZU[XT]+;;\^DUY&&O0F9J/I!]B>>*XLV\;SGT MC4>6A/=/PX$`OI[DM08P2[\>"\U35?^2>4+B.O-4QQG-4R5G-$_, MNL8\H5KM,$^)6BVVEVVB<7B5>>E!D&3!J'55%HP[=M^>90"C M2E08P"J-0`.("K$G,U\EHQ[VWC1L7Y:>WD7VK0XMT;YA.W;:M^G(G]_*U&,C MV,K\[3BDIBAL7/(6I(\#W,6#/N]A06#A`QDRWI"D:R=>IMN5\[3ZZ8YD.H-) M[I49')LT@$&D/>9TBD3ZV8MA74(_=X9TM)^I,\1U=9.JW'#,N*RET)M&A7$O M2:&GLIFX>ZQ8#V.X1+JD8BHK#NB#FZ!M[W6^\N1QI#YW\CB4[5L/,":@I?B@ M7W]#'R4@?.6#4]Z%N^-L"\%5TDB13R%(TG0@\0ZW7!^B<8DOO2B1M=/[32K+TE)6=R(&ZZ$ MQ"L4`X*\)@R8OH>:%$+4LV`[^ MX(Q%`>K.?J?)VYPY^SVU1;Q9E>(N>,6UMY)GOL[LHSV5F`RC/9 MD_&N.I.]>KC13N!HGSN37?G!(YRL.)`]`C7:]PD,^C/?^U2;F@I;H%,LUN0H MB(X!J#=[X/)1;V;.?$\*5_>F]T.X-V=^R/DM(>NH.\,^(CIDGR9.T-@E9BD!!P)A5XDNYC3$P.4M@E%<,HQ8\[1O<37.%^!L4@.8IZ_!^JG3")9 M2WXJFIG$N^TTWW3&KNVRE`$VOV)N^^0"$IO$$4(MT1BEJ90DS_*54'ZR>"4T MML%P`L_LI!^5T"]O[XL5#.S-&C[2#F)&)7K4;:3?)`8!];3([21/JM+M="ZA M4[V:Z!22[HE.>6^RI>/7P\;E;#]CXMK@E=@W(;:4%%I]:2'Q;J(^D7.#E_*Q MJYH>,!Z>O8`3'7H(4_'!'O>Q?KZH6_>S5R^2Z./(8:U;B4-5-2;D32%Q542K MDC/Z496UW$XM9`V+;?$9K#TP[\8FR=;V71%Q!T$W$KA=R711=3Q!+9( M(TETD?%!:#W'IR"]W5@>N\.?N73\G M-S25&%6@V#:J:Q9$PH6&'FE$%D3$!]5%Q@=M`#,2V`#LN"T;L`JVQ$<"MMP@ M"=@2(PG8QIXK3I44=1Q.!^PW2:JD3*UQ_B`?":QI"PXFP%IH59EN!SJ/(`4T MI*=YFE310*I\D(0+]R>3?RUH7*B/%2Z#8F3BO.84@I*?_Z%XA M]?VI7P\H.,#3)[J'2L)RYJE__)VC\S\.4/%SK%`;"RGW7T,(\PEGVF=R]OV/ M?7(>S]='K9'!RYD*]Q,J MB0<%W\)"QJ&(P3P!O-M-$":NZD'"BD;EYW`V3%S'&='C'.>"8*V)PS=?O.:# MS(W*SJ5\D+E1630JNS8XJDER^7H:L(@%XHI7=-P`-[(J[MRH/!3FX\Z-RF)B M/N[^]5=[-H:!;H_HG#S8O3??C4M!L^[1^CVI1\Q>?[E";! M3^[L++B%2=I?".1$)CPY5\P-P+N$6R%^XP"5Q**CL*)S=TF9FEU7O?N#8UF9 M^K73EM;<4!99=GAO[%_9X;W,3G9X;S*R[_D8_J M>HM9Z;=4S932<;D+)0BC;^@5H.`Z>\H;?'/(XVL\B^TF%?T=I=VGVXC#X90. M[?\#X1-#W`T*96YD7!E("]086=E#0HO4&%R96YT(#,@,"!2 M#0HO365D:6%";WA;,"`P(#4Y-2`X-#)=#0HO4F5S;W5R8V5S/#P-"B]0/A?7_E#WQ^- MX^')Q8'/=\0?NO%P"N'P\.3ZX(?%7Y=N6+Q<=HNW^9_W^N!=^O;=TOD^?@_Q:T>/+=>+U\O_/?FSS-;W&YCM97HN MS?0ZC=POCN/(W\>O7QS'/VF:U_G_M(IW2S?E7[\\SF/6._-'XX0[FU:'4[^F MJ=XNT]JFQ4E++].?8+,S[#NY.=_FTMRZLXHKZ_/C+O#J7MM3'=;@.!LL; M&")%RBQOTVW'2Y^__"4/EA]X3=(/?TDWYD$]+<\. M%#GGN_+Q+5^P6QS"*%M<_-AUX_+D)[TX#K#_'Q?+LIE/B;V[N)'[^,/'..8J M?WN(_[:1)>?Q_S\NY]R(M#Q:=\B,;A,.IZ[,G2=^CGMA'1GH]W`O4<+'[_\= M/X[ETKM$\C?Q`U/O3YD@_UANXB_Q4GXT4Y,8E,C.]Q(7$L<2M_^:;BL$37>\ MB__^)_XT#/G9K\JDF1-YP#=+)U-VZ?)8/KT"7IZ41;_,;(W+*9+B>I$N7=_; MLA/7]9ND5*,($6U)Q`+$N*+^YFC<(#$W_>&X]JKCW>(T/;N+4I?^G::MW"?U MVJ9/9^G/A_0U:?P0B@JF&\_24Y_BA]OTRTVZ1;[Q('Y31CE/SW9)E'CP3^G/ M9;Q_6WX:RR3YVVVZ>[UX7/HIRME8'OB0B+!*RX.G>])6^I['36N(8VV2'O3%EM'.KM.'O+-3WO6_EG$1\<8A M78KBGNS<'ZU9F]9`8!K>%R*?IRW]PDO6Y:4-Y;LR]8AD1E_[`(.FO>WL]0&O MTP;B%#=QKAO9^U5\[HJ,=Y_%;%VF_2M9`[)FO&MID5)OYXQ((7#+]KA0M"\&X5YW.=7R>"3F7!PLLKGO\F4>H.>%BXW*3" M:&X4O4[\"L6"@*JXB;G$9N4)(F7:?\?K,K[0:BT<.A*>S\!_8KF>V6HV+B4);/!U(=>>`^BR<12@Q\XEBW29N+,S\P M"6\*+]EJ9VYLF4+W).-H/,7&I)G.Q/*3/`!Q:Y$:)A2IGXNEQYNBB=&;=H4Y M9V)-;LO*LNYF8T/$\E.6ZP%A6+49HJ(W,W9%[?6T0X!5F.9;"? M<#N*1>+ER%0B:5V!X758?S.+)1!8?.(E1%`H+,:(FW;`)SBR_!H+Q M;U=%A_.@B3!%?T>F![-5?*W:"C;L6]"9:;8=,L1!!C^3J4_5U7DQUD8#X_,J M=&1CU$QY)H8HODJ$##N7M7ZTWJILTWJ<[Y=#7@1KS+9XZRQVV>*B.Q(DH:CH M59%]PE&GY`&(671/,O$/1)A[$=I3MC8?Z_O+&H,NT:W;:XP4^:9`\JG(]B4K M@MA44MH_"QMNV&=F.:49WQ9`$)?P6+;^CZ(=NDR$0N=@1VMZOA,NWB!`8U]Y M5NX2;Q[5^)LTMV"&K="3EG;"9,V[?!3EVF7=KEG><5297.N6[[LV]J//7H'6 M_X;ONQ7)D^'%,(=I$]A5/JNU$+#!C*RA-DF?[/:1D)4(W0=#E=J+'C\N!X%!8"*. M#)%2(+)B&OT)Y]\R";9@KH,R\KYXKU/1PCLU"$*-6E>+K247F7=#L4V`@;8S M,$0`Q1.@OA8SJ*[D7V9;70QM>5$^'3H+KKD2&339`)OA(_J`M2!C<92@M-( M^RA*13CBCGR7`-!04/P',/-JN52C&[XC>L(S"47NYJYARW1&2=/0K891;'(_ ME45IE',O*R'G5&ERB$)2:)551R5_5-O&$\M"25S30LZ$<3MZ]$$?RT'?C6C& M+7LN`NV3VN8K`;Y'1>(SRD8O913J#IG$AAZDS8&T1=-7QZ&OEMT@VQL,'JZ% MK?=*HYFP]9T'`L*B;H4J%=Z8RUK^G,6C!-4$I\[L*C8#3/2)MPVJ>I$-KLCX M-=/^,Z58S:#X808S:71`R*PWVV;D&M8=+5)U+LVI!E]^NB)0GJ'UA1#LEG6E M9G@#8$?:[9,_16)T;-(J`$2[TUHSJ_9N221R4Y]1Z),;"S\ M\^NRV'ORQ.IW'@A:W'&VA<)<1*$WBL8^8]W,U#7%8N+,B2JRNNIB=%1=*04E8>$IK+70'-%S_/-K M(B_%R7&3OXK%N2Z2Z@R`!I3*2$_\1$`W0:ZLJ;H7X/Z4&(+C2=GRV@(84'3J M2E$T[N@<)4@/%-;>E35AQB*[:6?0P9D2E2TY2P>#LVYDH7[:-^8-$RBQZ>T` M3+U5R"=(A>7_J5"D/")FYX')SU)]-).C<453?DOQ!$9;HF[-<`I_9VD(DH'C M<(JWCA"'P_4[#L`P)APVZH@_BJZGQ\7H`N8A_ZR(_Y99'`=66W8MPLL&^XZ= M@VJ]1H-`4D@8UKF%CZ0<&5VPAYPAQC"LI"X3T&F>BH\]4U/1PFI&-2\+:\1= MD<(3,\3(B"^*]\KPNZ4&N>*]-.J#B#03]8+IM8,5S<)C3+Z\/@U83:UC[7*5T* MT?VD90J4@.-E!GLF6.A[V)^5&\AF4\8[%Z^N!=[48)V`V@7P*'V7-(Z,#`]> M%Y]VP>G"G547:VRNF`)YP!SU)@LI>7\-L,'%.TGSUXY@3X%G9`,R:2;3.+J6 MH8%-U^+C.3OW50K>;TF/$HCP\?Z5M3!>[K=YOH1P92!*U!M_,::R8U>"HJK*+"N5IGIF+BDN2XH!R;N:B-`ZM?*CDR1K5U5P0JB1HV'#FJ=;*[SE@G$.> MIS/@E7%*ZX:@JF;(JTD_6DQ@!34PEP*145S<4-[.--+IWF0FKB&,P<\D6&W1:8>PL1U-Y2HXG9J8%Y"T\[RF-#(T=T.W> MHA9,B'R^!W53P^I;"VM3<+6W+.&-V-I:=*9.H#G%.S^1*Q1->K)*;IT`NE&` M39EU.X[O!4D/AI0:LTDF_!:Q/`@"D^LW+G<(C73E1Y.8T$6<*VK8VICICL$[ M5-HDC5K"A8(?D[\X+;;T0H``^>-TS4:J=Y`KL3;,IE"+0W)3&XS\QEK.L!E% M!F96(*Q6("`SN#:,O@77K*K9A,%,TPQKGS'MK)(F5VUCLCFE,'?YB1^67@F; MN['8K5EIY':,K95,3MUA%4ZQ6(.S6]8VFP['*,(_E>/11,UI418VNA"2RG)L M/A/P+V:^SZK\X@;X:Q2F,J.SADJI:'C0EP=ZJ.%XDR2%%ZYV?")^!2MB%-F3=* M-_23HI%&4CIO1*61"QEZ[-Q$^59;7*S+.!:\H8VLF5TV.>O]`./GWE*` M$K#&]3AK/ M2J&2'Y0FRUR1<&LUK0:H5>$T3@OWJ5FR^6V+Z#A3@'45T/JI\C/[!-Q*T3"- M1DPJ[]-`>K6,==HNVFCC;00;->RF`>+S&/>M/`S]1"O7,\VD1F03(.W6;??N MQV#V,@M>;=IVQZ;J81D6#>#FN*F'DF!/*UVRS=]- M/:SIFY*BI+1H`0-S.#1LYHJ=[5BC*$52]EJB.4U!S'H@,B/Z9;"*[*:&)@\= M<-QH\M#W32*?L\5RXC%L:/-H,O"45ZZ;+.8=?[[1/#AX3BX=W\\5B%PKM60S M21X$WHB1-97&1EDL-4K_D\W+!V-QN(91=P&X607.80;-%AD\;`0$SO:*]W+8 M(UWSE=B-,D2\9'(6*QA<>%UGZ?26%1MX*P?]:M(9;#ZH]_@\,=+7G>I]-\`` M56:E[Y"7>T2Q'WH=P8AB'W`%+TETBK8C#`\#I.=ON.Q/ZFZDWNRV3J=XY->/ M2\;D89)V+NFWED8-B3/%OZ#R8A2=]86,$SL3B&*\ M;ZA0V M!8D2L[^?6,ADJ37(Q2)?TQB[QFF3U$OV_QDVUR#%MN;X>2;*Y!SKVM;>J%0/ MLNS%@L'(Q!-0L`V)^VX$XFVJH[8]7'O),8B<&&D8,%^?ZG>DX"7FSN^-,QNZ.VY!)F>)H19NDFXP#TN+ZOCPY M>/&W@Q>_'+S0T\^[@Q=A?=3%M75'FP0H-T?3YM"MCC;CX>WVX,6'@Q<7_-07 M)Y]QC+(/O$ESH&F44I'F&6:6`*2WG&Z;B:_?4(:U-/2I_&J?7.87V`--U]IJ MQ@A+Q52TTZ.4X[384V]SG&)EL6V6UF92S0>+^-S63%]&/Z^MD3@:E8,6B`A, M+7XU0C)/DY/24>O!@)LS\>\X57W2:?%4R;;IP(U0TH+O$.-1I3&5/08NZLVJ M0$E#!FC,G>HSK.)EF*]XBM5Y:C^CZGQ4#2[$AJ&9S"G@SC7RGJXBU'OY&0-? MI]T]7L4%`3E7;TR;'6<3M']HWO`J#4Q\GVE@XBVPP);N-(\=C->H+Y53<.#% MG+BDI[4SFQ9TKVA;PN=;P(XSPRG2$$0Q>LU117'^DIDI$W'FW^J8M6EBR3I_ M%,5H'(]BV/R?&+)5M\>0Z>&ZK16:ZF0OTLBFX&PT&),)736:;6/ MR7V.-('>NM%#;UTFJSTF/@$YWA!.<)_B/FB+,'RGE<\82:W1V8-5 M]JW;F/3X!><5G,<&=!#X5F3=./4X4HGT0OYH4>R>G[)NIL[`.,W``'(<2R)9 M;=\#>"[9`W>^2,B]E9'P/"`C),$EHY*!<+H$F`J7: M74/.F)>E\J_3D->PH=,=\%3\BRJVZ>O#=N,PJ#7HF5;J0I1`YV`59FTI*87` M;TMP>@BDS"4!=)7^I[QT8]=:H5`BH/Y8QQ6"LMU6K!XJ!&*D7S)E%Y(Z(Q$< M0<+V4!R#A19PL!!15*]`TM.:]J_?L47HN,KBXR M#FV/2:<#C"#69XU'$3''9_6YIR,N?2:FM?C(ZRAFUJ4TN,Y>08$(9M].WZL$ M!$VOZ`PH_I#)TR*7LD<]'3?K:E\^'1`!B]M+S#MS(=KB*.?(J.A?M[UDJ2&Z MV#QZ%T&"4HQD\VL^/BQZSVK7S_4NBU3OJQ.@J@"N/@,RCM:58!$MT0->L6`0 MX.BU*X),_TQ5,7@*H6&IC%J;_!<>[RJGTQ25U"(6)IM]?`[+N#:6\7XE8\T+ M#KZ'B4A&P1KOE>A9!LZ;)3>`>O-5'WZ]@:?:YJD.%\Z9/Q@9&*:QQ#Z(0&GV MC8'1K`V?K=JD&L,ME#72HC@RL8(TE=[B8,UH/P;8W,?BSE$CX<"W+-M[B$M* M,EXD$_,S'V6YE669%G#ZS9DS?^3:H$*O,,4T=+>-9BV@P]@04/3L(^K?L^9Q M,M&EOHWB-RBV),STI1B#>9D+,2&)Q(5L_;8L]4+TED4P,?BW[&VJG1)*:/LM M.*.7U&YC6=5)O7&L@&#-933')?3;D1-]5U6R:8. M&'RCNQ_9)5L/."O"I"YF:%Y$Q/L;,7X=4`<@/W2Z(-(7;)>;*90<,R9?\]@< M23,[/K*P[,2L*U/G!IOC0CSYJ.^,TJ86>3&2)I@@XUZ09T#YWY6"GIN$ M1+JE3[!MFPE6&2[%LVSX^:0,U(5<.QGL1(Q#0XIGN6#W=#:BJF=,].X4DR(: M6NFL;L7)S6_+(:K<:IH52P\._+O\TLC)<]6;K2X=*P"SF0ZVE;S7+:.!DEC5]Q]A%LX'2[P)J]DQ.K5]YH5@T MV_4K+IL)0P^O[_.TD3L2IP)RXK*S=5NW[N!D(J5P\FMERH%:5Y[5-HE=.<[A MN-5PGECTZ]51GQ"I/_(^9Q;#[\LL>FF2K#W44_C2MG"B!^`JDFJVO'!CM#%O M8C[KK[@<$PNK`A+-3``U#+!XJCBBE9@T/6-ZJQLY/RHOF)..`=[OHY@5:L!. ME+IRSMA>XA#*B==NIU\#@!CB@=A>48 M*\?DI4FQD72TN8F&YVVE4RIYVE/>*,57KA-PG6HR92JAH-PYZP9FA\@@OZ0H M))MKWG0`MTW\OBC:-+TS8?^FG:G.G8%S\PQ4T]S48:L>D8]F5MUG6L!APQ`X M.^E9,[!7Y%R$;?L4)O]8A_&X4"<+E0@>U^D;=3$OO8?X8C]G"U"`!J49/3R3 MT-&)A1G!O&G1S"%KE_9I>($-[9X!?+W9L=HKHPZ"IC.6L"H#1X)1.9MHK<+V MU#BE1+ME`?3&)8*;V7^ZF&"OC%G4Y)LKKR MV72@S)*C+PD&IFE*3*Y$]'B>.XKE'-W]98"U5TD>8^XMMY\2(UTW;L9M: MY[;MK[:IT.%OG#XE'?L=<0XEZW\P?3>K>RW$L.H%^, M5>M+#_=<+QTTALJ;.3`?#8;:OKIYM6\54X`9.I)<-S$-ZH"E0IW%D0Z;E)\1.28^SE MP@^5JHYKN+1/4PW4><"?8:7[@RZ%"C@4OK7$F)H2[%6-&R:#`B"Z8822$*_T++># M!B8.G:N@^P]U2ZH^3]Z@&*$P-_ARH_1F7T$P:5K45#YQ@KWN!+9A39-/RE@O MT!Y6T!M*,(H'[>6*K46L.[,99PR9VA5[)F>$9W:@%562^`G[%C`!3N8-0M3_ M`Z:$\[D-"F5N9'-T[+WP+^?6#5V9^"521E!0; M#E/=77@D$OGX,I&HW_=>_7"TM]F/_]U?[KT*_QR=QC]?]O_KSV;?V+7W^T<7 M>R:U"#_T?G]T;G__Z-/>+P=_6W7#P>&J/_@I_6],^G+T[LU_K_S!GU9=[Z:# MOZQL?O0F//HY=G@?O_U]U1D;OKOPM2_=5MN#MZO_._HKSV;M!+,=QGYQIK=Q M9'OP(8S\O^'K#Q_"GSC-V_1OH>+]JAO3K^\^I#'KE9FU'W%EXV9_M-LRU4^K M2-MX525]^3(.E#F_+,$W'/P>VI18T4?SW#'BCLG.GS MQY_H@5[BX#PO\>#7OO>KHW_*0S_`^G\]6.7%W,;MO0D+>0@_7(4Q-^G;8_C_ M/&S)6?CWUU6[&X&7ZVV/F]%/;G_L\]QCG%BU=_O3VD_8WFWW1V,+.4F^SN.* M=E$&'L*GZ>`^L.PJ?CV-3_-OJ?4Q4OCO:>_6/O5>_ M[[T2#;G9>^6VZT"RZ=<;N^_[]7;<[S;KR>_?G^^]^KCWZH(Z!PPAC5V9>&_ MQU\?:%*!`$2\NB@B(3S\:6'>>*`A&&&X;2-14AS](PRXS*-!W'0B]CM]2 MZ\23RTQ1^8'V,O(AK_(X]KO)4I`'[XWKK<_;"_J1-G'4\5;5]QB(55[P'1;>YV3#)",=J@&!; M9`"20)*K\\RS0-'GP-&R2;?$'#_^/_%=R>YH@<"'8A*:W>BWR(AD[6](?!]X M*6>9ZN"EAC+4<;%!(Z\ZBQ=)9Z$Y&0#1^.,R6/RDO*2B(KE=-!1GVJQOIJ5M M'8Q5V^K+_T4[U2C]"$U/LZ$R4?!BXVOF-=E94S8C476=V8YV(PEFWD,?V*&F M"G9"ICH,CN5QY=BRCS0N;>Q587"M-)Z+F76;>7_/N'+-I M/&\P@`R[SFR/]!6Q*CJG-<)`EP]1M(/JFA']43(X)UGP3652S=9!?QLGV.@& M$S:(HC"X@[YMUT"H+X-BQ3#+%;S!+0W[6BBT,0_FI1Z M.@OD'$PHD]8,U8+QU?>[;8U4<-VH[;(S*O[ M-`IG7R-GW0;%=QN[9O)9^4@[+$T#!PP73BVEI+*H@505PTFP@=XWSB`A_R1K6J47#?1?SS MR"BJK"QNZD4>[BP*[U5AB*`RLXS*0LNXK`J5%1.[`_U%!U?,22U^@R\[?:=! MRR=!J7&P3^1*8:[TI0`>UTC"N@U%9D,+WZL0])1%*QNBFP)/&8<++A,#F2GZ MO"I11C3PUV5+=:1!\87OAQBA;FV,,D)\L;7?$E^$<38>?&=-.R%E)C]L9@6\ MSX7-GTFLD/RD.5(/L">1U.>)_E3TK:%9^]K7A(7:E8"%'0#\*W0IBP9 MH4(-,T':><8; MPLA.P@^,;-+FGC(Z?#F:YUAX"#8S6,PL#>=L21X@$`2I+LS[YXQ$9&]53"NC M4NOS8FY5S."+H2R0(_80F_[`ENPCV>3V5T8\!3S2`9BA.N&]$3_K>B1\^" MY"&,&AWT>DZWBV_'V(15*MMO`LS%44;^WO&JE'Y2*%><7/+R76^V$I)Z\Q6: M%Z5O2XF>,VY<.'O!=2=0D M6.:ZAB2I)XO(-3,>[5`54=<`[LG:\&VW<^8=C.)5248 M3=3(:DYHTAVBJEK.2@+R%\D].% M5^)YK57D27V:<+) MLD0UP.AA@-K\V+ABEM77IO,M]VWF7VSBAJTC&9TIW$G@?"V7:(1;&GS(F MN,G;X0CHLQ/$\PY),GS)DOJ)?;%8"0!%+,@[4+\+(>6F)$-&SOA`$!9T//JW M6Y;<,Z)L)B^?FDM2XY:2&+?,A>@X9*6('YY:!!YTL+!ZD%7$`1AE[E0.M4UV M<6<<$;T\:SV;,F\PD53TTXR$GRK='SA&^?4@-GU4&\S9).->8IZC60F-:[1]$G=J1*C/"`B[">%G.MA#3"JA,GZI#E]YO MZ\F+LX!D2-*9WV@ZS6`;5&^`V+$$$U7Z]`W*XD`.P50.H8TG6.#=0CCA4]\@ M\I`>_DS<.R\*NJU/0Z-U,&-K'CJ,-N=PU82+73JDCC*W51#KA$3NM@E(1H6X MT:-97[(1<$K2\@R7-&/PR`[@B@HK/$2<%!A34@4[H)[N!%[#FA!KB9S:VACX M(DG-J2P*\QG-()*8=I`#_@=>'>-*RJYD`)#,ZDL]VN!IHWY>T4GJQ^C+Q-B, M.4,K4759IU]T:X,WT:&YS=J9[RGC&`8\HMP!9RID849H^QQ@[9H3P(#GI+MM M0*$9-_!\$3O&@T1I9EK<:R8DLW%:;^,VO_`(<`['MC@;"-(G@/U4KVAPV9ZK M8_DR(PGRCB2>!'VL4[@#[MG,1EDG#?3)F8VR2$]Z]<1#G[5^XI;ZC$@(PK]N ME/3%W`'@QK9;Q+4IKZOS^@':]AE'VNJH;[!32XF'Z`W0B.JG9.XK\H"U(>XG M+BCH6H2'.1QB1X_7*DY8ZAS('Q53B51]$.!PQJDEF"@:2'!,DE[GF2!W05<#J MDIBC3DP\GGO*J@6^O-BN;^@4NJIXR[+#.R]IYR(:P?3+BL,/R3C9$N^<2KSS M0/1_9CXLNH/-N'93L-+#>OPN?V"WO@ES7IXU%B"*"6*G\\-=G7GU*(?W!#^< M@X@ILU2LS(Y0)UH95PD2&Q61_3KUZ/%`OV-R3EB0Q!N#VLXDFHBPXCYFJP&K M"`8E'3+TRQVIE%%+&C*D$K2"J)I3SQN0^LJ8Q1.7O/^E\JRK*\\('V!L$/U7 M\I:6^.>DW$FXST4*4%Z`6-Q7L6>!^N_(T/#QE'-4#]75<5:3[V@3U2,=(+#D M_1[%]U$ON)BPY'2VN>U9(:2-=ZN\D+W'%'.G&R) M)(AJ@.M!9S1C8Y/U]/.JT8V-;M2RXBE,F M_+(4U?Y88O>;2XU,-])7GQV9S19&/1+_D(_%QR$,::1:MF"[ZL1TYB2P14S6 MA@`Z(R9COKU0*2`FLZD04^3T812/1T*A6/H;MPFBR>0T'06(397)_&4*Y3'H MF)MR,JIR&3.\%5"^S;\>YXD27\5=7%:B._$Z]8;U4P\<.&*EN"_P)`[]]Z(0 M'>6Z]5VI?F%H:ST,_8ZRS(D%E+5-+*@+:=@WO"_&@UJ)1LW+VD^6Y6/MI5/1OI@%(`\,G^4`+[+L'8>:: MKO2D1,`?@D/E-2IVEK%NVKE?XO!B[LN@[,I7W*PIK'U?@;[!L[W;% M9:],UFDFLCU*?J9DI1LUE&FJ$O%RDU2D&BR,S=!=N<,VWQ!O;SPK8-SF96(S M*+G!PA7F2UF/EG?C#,QUSL)\3XBAC$@8J-;$=+#1Z7.\F0(:*C%C>.DCLX>^ MP9B%2$GG72I_>P_Z"QL#);>YEKDGZJV"(@9\89(UI?_#-?4S#>454HY\5^I*19WE/EMXSE MA51^RWA8(@"-%[JM(-1+(_L-C/R.6)"-+23$%I@3Q??]@K:D!E**J/R6!3`Z M,VIS;!HB]A/>U)DL1\>E8U*F`WM_3$E1+J/HX/117>0S3<%P+6K>-4IS(W9; M#H\O:0@^',*GWQML23@*H9$3RZ]S4>@ZI=L5\"V-_<<*TY@(U77]73]ZX$,I M`7B==92TM2AJ+,485J4D0%==-!=;UAE6'N:#)WUX7*1`["]70PW3'!#MAV<] M7XM#NQJ'2CI.PU!A^-5<]6PL:))KER]0CFR!6E37*H?R9SU.54`YE'77%V30 MJ%-UP!5+'R[?\+GC\8JO[RX9E]XS%95QZ2>@3]9S)YJA,'%K!:2D[(:,7HEO MO3(4%)K#ULS#H.7B*[AEUMSS+EZ)P8*MH1"#,UF&I'H>85NY$!N=[5,IM"S> MOBAW+6<#!>C5K1TQD0`B9RJ+BU9A)4^C2W!9BS1VKBZFJ,L%$Q^;/R)9?-[] MO#Y\JUMN2[KU97R%@(P!!H*O;DO98J)4FIX``+"AZ%\&GZEYP8-U+!+S%7>L9F@XS! MEW+[/[9(U.0E"Z;)55+@[Y:O,UN+W)VO93#+M0QV'*'[3/&MW6(#OD)<%S,, M&P/-VIKVR:PPZ74U@SHYUY"AAVX8QQ5\G:725 M54H@=9;J?FL5U9V"I=WR=7"K=JKHOAS4G&;?Y^0RID4G++=]="`^P9AG!!B6 ML`+#T=,B4^5B[AD(+C:4$O(",$QS1H?I=GU9AN\1SUUM,'Y!7%R/[#W,Y8:U M,FTH'8?;_J**)ZTZ!H8J;T)PU8L0&I,7"\^IEZZ#,H.#\6;3W,%Y/I57(Y5/ M%DO0Y+4H0M?DJR-,)G(T@`XF3LC1-<@I8]E;>AV('"">K+#*IB`#@5;JWGO[ MFI0FO/1_WUS"\*K&R'AAB5E3L[YNW/4BKY6+_ MKD3N7._&-4Y/N7RX9Z"$&O9*FYL@[F::>?=$-_-VA[GW&K1F14'[D`I'JM4H+D8CK88RVJMIZ?+[\6J48T4B[-A*QVPF>:^L7./;"JNK@!!;@ M1!/Y`#T:3<1+#WI%[GDL5HLJUV!@=L>Q@W;:_NEB5:7*+*W-6=_LJ\26SS/` M5M37C[N9^EQ]Q&%@1?A&`GV!N@$C=?*FC\+"`RVXY'XJM,4.^APD+$S?RIM!]R:: MAV&V?"ANV*#NVG\CNI?J$`UF((#,Z,R@\="OR6I57_#@!>^TBFQ5<>1,2M1P M2E2`RHDZ<+M<\>N)6LN%F5VOB43;X"GW7G:C(=L0Q4V-44-V-T.VI!=GKB!' MJ;,4ZBZ\;%%,[E]9#G5I%)UA2@FI@D]EKZ!LL*YJ$!KF;D-Y:5`E@[R7)SH9 M-$(?G0P:[5*?+1*R?,FFR089[/?T'9O>6F@[8_)#:,_4;97)'T9%W4P8-A,3 M:J>+[]CKVG?L=5Q;$#1QC:5\_P%;(<2`#0IE;F1S=')E86T-"F5N9&]B:@T* M,S0@,"!O8FH@-34R-R!E;F1O8FH-"C,U(#`@;V)J#0H\/`T*+U1Y<&4@+U!A M9V4-"B]087)E;G0@,R`P(%(-"B]-961I84)O>%LP(#`@-3DU(#@T,ET-"B]2 M97-O=7)C97,\/`T*+U!R;V-3970@6R]01$8@+U1E>'1=#0HO1F]N=#P\#0HO M1C$@-B`P(%(@+T8R(#<@,"!2("]&-2`Q.2`P(%(^/@T*/CX-"B]#;VYT96YT M^JTC_P84\5676&&6``S$SRY.S:Y3@YF\2KE!_L/'!%49*/EI)%R7;R M]<&M;\#P(JW/PRF7N>),`VCTO1L-_G1^]L>+\W86_GN\/C_S_UQ+?UY\@ZMUWY,+5W/=]:W ML[X;\E+O%P&W?G[AL9Q_&3X^",24T@PZ0*FP-VU;CU$7AW\1L6O"ECJ/1Z/9 M9'$#QE,DK?(^@'U8J/CE+W&R..!=GJ8:^)4G6X2`A<*_;V&=\.`O`3!.JC)Z MX^)%>.L/V_\-\D39S']B[]1MY\@]N_9QM M_/;L_[_R+%G[?W]8U-SPM%P.FC-#CW;6Z[3V$!86\'8V+MW(X>TPZY7.Z+P- MF[X/[/_D43#S!T^MQ_#U*NSRYBK0:+OS#P.&X_SG\#0\-$%8/=CV,D#<>X`T M/K_SN_3SW@6(\&X7_H@??DL>8)BOXN!UH+SUY/:S7N*')X$.TVF7_HS3K/PT M3XA8'OA73[KX,"'Z"*+2*$3)[\B_W[>E_B4[$MK6$Q4]@HS=W:`8?=GN*U;: MF6J7O>&\Z49#TWI:^7F_O#@_^_OYV4_G9V1YMN=G=EAZ4?":J<:@^LO.SIIV M.;K9X]7YV9-5"%`I$&,WZ1'17"5W_US6]#BMMT\@XXT_^U7/5'_EW^KAD2* M#0IMV.+'\.B9[S\A%I&Q@%"<=DM2Z]\^)HI&>80][0BG=<;A46SX&O8:81Z` M!($I$=M`QTR/35JD009RB?5J[WJP0D]^8`1<$2\CJ:(.*A4!8/;\.J@6T3(L MV;7Q?8"]89N,M(I(_@QTV6:PB6F$JQ@XDI=(AT?$ZQDE
DQ2U<)CDCF=@@ MH;(8ZB[1-.V*KZR'%E>>-UR?]=`QG")A?UD88GG>[RY/^YP5IL"&-HW<0@Y? M)EOIXEB2^QT3\F@"[]*#.'&0]%62L"C82@X"\;89R9]`9+-\]U&\/?^2S)%$ M.I@0A4Z;)+(DP;=@UM>5@/DP(=$ILO]7P92'Q+"DK%EBP`AD#6"69I=I>1<1 M=LRN7"?%G&0NTO3G1)%&)<$.,WQ"3%`K=XD('QE!PF2_A!AC*S>]3P'6F:@H MCDA(-!/Q<:E,?NA3HD"D2%K6D(E[3+C;^5+Z'6<9E2_"+K/J12_UEFPNF!K` M6+=^BWY5'Y[H3)>PHP_FWI(=XU%`(BX9TLQG[C5+T?`A$D9`BKL`$1J` MY2926;*33^0>T"QWCMN?^)WY_Y((@]T@#8BH2/8BG'KEF-H4+\]HPY<(2 M^G[&$,@;FX3S7EJ8P#DD`M'X%A5XR_3[.3Q(ZA`%Z@HW$%]GYY0\5018<38% MY%;)C`O1(X,2Q/9'[L>8AL2)5"]49$.H@+J9,5L39,HWT2C5-,]$^18W\@!6 MYV-$-N-XF>B;65O*CX'4YL\+$W%X1&Q7C/(7@,,M6&JD3(9XS\<#@$G*D4&$ MJ79]2`UT!,W1!WHUU%UN(@&C";VWQ0K9CD2N[XM7:JL^$>[0^D)K[D&N;/). M'[-PD-#M%9,-R/XC*'JVHX+936(FTAC0166,#W(@KGI("=`:72$3R=8=SU^< MAO@ZRU2,-5!XGT%;G0JI;7Y\B8'1==)OI;,]0_]"<0%%W1!K.ZV6G9H--N3" M(=2VKPRUVQ:MMR6[Y521BX$2-6BX"N/M>J8"/Y.ECDI-+B%M44;5%#]2\(Y) M%7>L"9,=QF\<_XYLF%M],]FX9RD7L( ME)XQT0!CA=:&`MH[$5*Y/N/+I3H;.K\7%E8VV?4_Y0TGL@1."?M@N2G:(H'1 M]-REB8F=41#_%_Q&+/WT\WTAL9=V.XR9`CO0^HCV0_JP,FP##G+-\J^6:9D/ MSPL3K<`.-XZZF]7`[W4%'OH.4R$O?$3,.^`[Y4;9(/%0I)&!!9/F/;$(I.K( M82L9K)TC;#/I*[+&IT):*1!,$1R(=T8T!2RKK`%HN)ZB.8RS&31*# MZR,0>`6Y\AT0EN+T:JM]&7%WAI%41MPG&.T8IT%>([S0(TI<)C"#HO2ELN>4 MESS56B@4+"XM>`UF;%?)C'-8&0#X7X&'R+YFC]'#,/D1PB,:$E`FR!URZI%Y MK0"S0;7G!81?*;2"=2K!.*#KM/!33*_1O,3X-B/Y$MO=XDRIB*)T5R&X.K#%VY#X1;07&QUG]*2BIG+^#@<_@%)%W1I?; MOD(C_$#6^B-J#:3FW)OEI(S[3:(U"?0RQ1Z8@29I>P#KG[YRRR_T4#GDKZQ! M!0WM.AX$X)1;M*$R)\ID*QD7MBLJ;KIC4Q^-)R%BJO2+R@BU.!F!47)*-#NZ M$D[N*;3CBGQUJCD&=[!F4N=:N2`5T_`:(4OW=^=W%ZQ$4D+ZIGJ[0U&IKA.1]%L;@K=VI$??R`I9ZLTG4@"95P0J6! M!0WKTM@=%9K.<8+'LN>JC@^ZH6-0;$T>B).&O<1Q;1\_"=4F9Q@])![1S41 MQZHA]-K#;J]K;XHS6,N`,X+=?)!`/AWGJ%!2UWA4+F_&`Z)F3"=E)*<4#(BHJS%$#A(QXDP)"4D619AA^JRBR M<@`^.S&81GZW:$81S&%=C9L@7EP+D*M%76L\.:,KG-^.ER`Z.K,"PA>G,YUC MV.*Y)!U4 M,"=>/%-&O\%32M(ADM94)@T!<]?5GBT.^P2B]LRD(3@B[O5?DC%Y,3-UYCM5 MH..Z?H714V[$H#+TU00%UI`\*D#>9B-!?AY)RDK13]6$15V^PU/@U0+2@HW< M!4O@UK6]UM8Q`GP=NQ!=Z13W5+,H8,R'IK8O)#I%:H0S4%%FMD(9']'#\@1_ MQ9B)]4^(J#P01;.<9`VOLE<4`\[Q"MEU$94FXMV(V/`Y`2JT0>P8MA2M#K*, M?T$MEY\]R`RK)WB9!?C,BR9:,267*L)$QV_WQPGN3?>T.55SC=JLBL(F]<], M[$`KQ3"%&D_I8SD,Z_41\0\[X8[T!\&Y93@6H=H4.]?D&NL8J=.<06L6NN48 M2%I!N375LRY!],!;+!P2UKFPC>K[2"8^,G$,8&V2I#6@GSL1>-%](X..3`0I M`@X*C@I;2L!7;1=6.+KZ2*"J-`Z7"JB2R>KF-OSQ7V%PAX8Y$(!CA$O"V:XC M'B5>\!D5O?E*OND9#1%OIXKB6^>S:H*[J?U4IS4#V#*VUJ!&,=#)T,F6Q9V> MSTYM1E1P6A=E'B$:?D";G!]9WUCAX34W48$Q?+U0B&N+,@Y_C_6Y"LQ'C@0V M42HT_5"2'V1A?Q&A5(&)@D>1J\F@2I5!E$->HRA%FSZ< MFCQ]=SG58'%YGB26^%B[0-5N8ZJ6%=UQ0L3FMZ[H1`*+!PH'CM_F\@`V>4_< M9JB6&PTN-_\]-,!OS\^,TLMV",7(T.ONT[5AZ4QLP?ENMJU[;U1U3$/X$=# M-/LAU(H?%C'8U.W\R@OMZ(76/WRL&X",&9<#KCTL6_/RUR M?ARL$Z[=O&(AV[.%8@E:A7+H]'IN7!H#"X:U7[R>N.J`A9>L,)MAK*K:GJ\:L=(J3A"8ZW9?G)HB$\T=_M M.<6&'+-L4?7Z^0T+3BRDGF@CQHC!!.E]_58&E2QC'-\M]0L9&51IU&`$]!@)V[1+,U03<+8G&]4N MK3T`#%2.P!'J("S.ZX[`PI9/F=?#$L(FT&4:]D0[8:$`GZYE4DB9>AK=G!KE M)WH0,.28J.N@-^7)B(A2R+I0VKLF\W/+ULMU[H;:R&']N@M`]QW;UV1AK;SM M$=T,#E$+6YR5197`]Z02ZD7>P;JEG^/5WB$-_TV\`[:?G\QU$>(9/H40A;XL M7AR5!%GN.RH(V%5)K,R)R%Y&-W!?\50?@GQZI0])XP_YD,->X+5R`O8IC?\M MO``R69&T4TYB$,"[\E.\7'8-K]Y?MI-I_"'7<*(:8!TD=)&P(N-D-7U/>8?E MZCDICK=^FJ*9H6ZYJTUH,W$8P_M2N1&$PM6>3BC=6[:]XCX'K^=**VAP4,B- M>-=#,)"=B,M\$.>SY?AGR&B+UH1!L:G*J[\'K637AIL)K[:2:?AO8B75^/]* M/(K&"&$:]_)?O=0X(GM>:1S3^-<;Q]>*!QC'-/ZSC:-"\2@U)=A->-6+-WW+ M9.HEN4VVFZ_>>K:;:?SGVJS9\'=[A=TK-3NN! M#9]H\`LU(@+`7%55<%8SN*FJ7<@#,T#*`X60X%`3AKHI>6!ZH_JE4J=F*`GX MI`PE@9Z8H9PT;\Y0$NR!#"7;_,A-O31]*!'I>!O-_WT(N`O&AX"G9U;CDF"C MRAP#33@`Z#0*GF:$KR=:4*6CP!$'`MY#-:^6"M`S+?OR$`GH?=Y(,* M;-+B+97I)I%%NMM\MP[/6G*GUT2WF<,;3)9=F^/=H$5RQS`4UZD;:C>!.>F" M-H0@TPU]*X;,L?Y,18WR+[C.1/V"1^\S%0+E(>3U:(EI,J=::B4@?JB"!VB<_%B%ULCBPAIENH*!@X093T]=&AJ%#Y8,#MVY% M!R1)[MXF2U7*;G4H%J2F@]^YH,!']HP7OU4BVE&Q)/()`_@MEFH`)]%*V8OV M9.Q<3,URPF[Y5)&0(_4B-(L#/N\8"+[HPFD5>Q']NPV54Y>RJN_ ME57C4I?9-]FEEZ5.E5)G#:UQ"1QXS@M(H\;OP>Q0U?8T!N[G6-/#'0''+A*Q MWU?9SS+JV52\(_\@?*23S\4>!G9:RJ[J)GZXMT'-7U'QHJ=5#=RM+(3PBH4UR"0S"F# M1L.+0;3=L1%">`>W9\1H&")HOJ3MF](V;>H-(!-*^^`8;.:HBJW.J@W)<+J( M?_!VU0GZX51QP>&J4+M.[/1%VJ(J;6E;-AMH2R.[B9K]E8G.=&P052_WJAG:/2$7:Y1EKK50D&%(O%.=:UM>3]*(_?'7,L(TD(3V>8JJQ M_MV<2UI@!8X66_8WZ#=R^R]O3X\71_9ED6I4L4K2Y^K+T+TNB52]^&5*UEDE M?]IA6V8^E^Q\3?&H.6]LXHK$4Z&IK(_15FV,))(08]`/88CC.).N]-ZS\K/L M#VU8K$,"5\3U^2<$*'U'C$E+*-CAX=L&4SIV[%=TJ6=#,/F[!+SL3;W'&.@K M^+$V$!=*!C_)W9=-O?F6DV+'U`=/:((`LT/JAM="\4I8\7,!G:B7!E("]086=E#0HO4&%R96YT M(#,@,"!2#0HO365D:6%";WA;,"`P(#4Y-2`X-#)=#0HO4F5S;W5R8V5S/#P- M"B]0;,\82>!XG9&R&\#.@RR-1N,=26.UY''V MUR\/R7-CL;I;/4Z`P'"/NG@[/->/AZ?ZYY,77YZ?M*?PW\/;DQ?AG_-+^/AX M^I]?FU/3-=Z?GE^?F-@C/+#^='#N]/3\]N3[U9_7FW[UQ=JNOHW_&Q._G+_Z MZ@]KO_I\O;%N6OUQW:6FKT+3?\&`U_#MN_7&=.&["U]M'K8>5R_7?S__$ZW6 M=9-8[0L8!RN]A)F[U5F8^:_AZY=GX0.6>1G_S52\7F^&^/3569RSW)EI_"!W M-K2G0S?FI;Y=`VW#ZCQ0N7H%'V>*,&.LZ`V]#.S-NC90U,7A7T3J-K"E+M"Q ML6*RN($^<"2M\BUT.UN;^.6;.%D<\#)/,QOX=6!;[($+P;]?X3KPX!OH&"G/;[%!;[%WGK:X^L%:OS[_B1M]+_;_PVJ=-G,/XKT+&WD,#]Z% M.=OX[2G\_R:(Y"K\^\-Z+HW`RV:T4AAV#36M/L/`^Z;GQ=#"F+CVYJZFG M?BLK=S1-8H+?:V&W7K01W_]['10X<]!D%L*JKZ,(^;N4HDA@_P%ST,]&D#ES`$%GR";U>XG=CV5KL)9P7_ M/D06@7>)B]PFMKBTJW>X;IPF[VECO=?;1]8^T)XND)JMMI)@!+QTH]MZ2=8Y M&/E-DJCUX`Y17+>1DQ]H%6#?/T*GKDT/HQ#N42'>)6X@3S4YP0S\,.05\V21 MYYG\,`KV$"?[N.ZI2^9V)NTZ+1C9"*K"O3)9VS119&6<29F+;XF(U4;:F/&= M(.]VOJTLV["H32T/B:#X]X^AUQ;%]SXQ0$K+=E[,(FS'H>D@+]_1X#A?`RP: M4N18MKLX6!B>,6P)D0RED;T3.ST#ZJ)>LF4EH?\85S*@:&KX.(GA'0QJ=8=) M"OKSM`$;)M/=>B,9;N;S]-;-%88L^F70D$CL9226Z`YD(P.SAD0231A)I,2E M2GJLQLR3"FH%F M#Q'LL*#I_&%!$_L%2>N@R1/,@R:W4=!,D"8C2, M&OM_U.,J;?8B>=9'"D^_IJWRAN[HKPP!8F^(J1)O7!"M18#^=1TB2O*J-0B2 MK!,"CQE7GQ&#FJ!(4^DFG%7!!2BAF)=6H-#?).925,Y0*3ITBHSYNY9`8$:B M/L=?EVSW?=YV`;,BGV_63@31MQA>Y/3WB=O,@3MB./6_)=GDP.0!F%NO? M-DWFD&\1+%91H,G`1<+`T!OL+T.%F6^_)0?\*X()"`2EMAATQ>SN+[5M98OC M>/>($>*-E`5L31M(4.F?(IE/`CCD,,5[N*0I-2Z5G)AM+FM47$WNR)I);$EJ M&HQ"IF6&>>51?EE+A,@B?A1V8R*'LD=(4/@]$OT1K&B.)35"VM+.[HG3[\12 MTI5Z8+(9T)<$`FX2E^,H/IH\\M$$90B]KM!BKME0'S)<,47$8W;!)7,YUJG0[O,[E5/`&(("L\&DDG\"EO]Q?I.3P%,[20\O1R)S,BB)RY68Y*=X*/ MM^BU=H3F#1V1C(S-&ZMBL]%P=J/AK`[.Y!D=.D9);J$%?4!,20OJL7K#L3JZ MBN>&Y72@`[7Y#%%#BH=\D$^QS^?P^0[!+3F`9#2+FS-8= MA];RL%#5S]_>(]%Q(7DD/TAJ2QT;#(D7)P)5UUJ]&78GJ&3H*I4Z*I96X$YI ML-<*[,UNU%4++P@N\WQYFA*M4_`7!O^PQG.8"BJ"?-0$N-)U2GQ M-C%KAFET]F80$KE`!U;!U]XO.(6:YF>8-RR&[%U.0R,'G<@,Q^R^GRB/Z11V M?!Y]!ZTOTC-.6&U$@333G4H:YNTEYM,%QICWOOG0- ME!QXDZ3BE(O=E-`\;"-YP&NI41*VL1Y<2;X9.F+`')RP8U-Y(M;'XT8<(Q'2 M0FCC!:37IE0#(B#I?`D"W=..=KHB9N(UF95<4;HJAN@$<_]8F-S/KXQ!_13[P4AQ` M!S9IB-1&##1T(U)[/28(+%(NFSV)EVR1Y%)E^A5,&[H*%`& M`9%UZ:1K.S+MHK"0]*)>0!3*NY@C\RXQA>%4WB6K9+#*66J20VS.$N946*DB MQOV[9UY,<83_+5(LKKBM^]=D6%!O_TTR+'W;?TJ&I:SBX.G^26D7M>#HQ()/ MJ'3_VEP,9P(H%Z/`:3L)&G-^?",0[YZH$[CP2_:U<[HP!7Q!^]1P+X75:C*H M?H5#![`^VX\9!%34L&^CCV"%7G4!Y5:N:U7(UO>>,640/;899A>?RS@P$'1# M?NAM1--&H$MY>T58T"?7=R/5#0X'\/`^WD`().B'_4@P)R=Z>R#J\\RL]V<1]5`U5)U-5"OM!<(PSE:(Q"NE.3X!&6T(5LLK*3(D M,^F05*E+V@SUPB0)C%Q%H>CPDUC.FZKI8T7@&#_WJNT#8 M*VAX#9OK8PGE'T(?*'6$*KQ7!]80=!8MYDMR65L.9Y>)XZ_0(3^@_DFQNR*Q M:UPOYDTE(=^LLY"W:UW9P?C`B$'?Q3B48\+9#041Z76*5*ZUCB8``U?5&M9. M8O97X!Q2%:XN_`R<57,HV5C7RFVM$W&7Y*O?D\922+JH:53"'@0'Z1!,JEU) MQOF!KR%KR;B<#$#<]!8359Q;U4&_;\5&5:%:WTI.R3@J,QD"^J=$_Q,9Z2Q_ M*VU;94Q*]T!UICG]*MN#XG+[PGV2LC!'_9.W+XR,YMKBN5DA2YG7CAS?$L>5 M'E)0B-)Y(I:+<,_XJW26\2QA9CYI5^)#^G84-I62YHS+2]`%JO_@Q)($-� MWYTI#3:DP1NEP>1F2Z>(E;!"@X.$?T17H14X5Z15]%<77G="-(HP,RU05DTS M]T+^WW.`*("GR)(7F+@SK#[*/$!/V_99UC$L&@>6=UZC($S*^R;((N_^4MI0 MICE5'0Z?@^6%(FD<51(S#!#8>*;ZIJKZ,@+(`]'/J&4\,;M#D3PJRX<[9P0K M$NV\X;D@A$I_POME:B68!AJZ&I> M%UU,-$Q7S9NA%Q-JQVV&2;3M+K32N351`I&O5'>50A?5#3,48DJD[B8BR8'JH.9=^<&+@ ME@Q8.1=*?LE:Z!T5<[8_N&*N..'@R-H)AV<]^(0C7Q:*O?]7N/0GL-#H+WYB M)X+9;U7*C3O_H!)J\IJ)KO)U.K/SG)'%3!/=P;&?RV_>/)Y MQMF=#CZ$JY9>S(O:UQ?%?OH5N:GLH*)T-PO3]%9@3J3H`X]<3J7Z]%M(5G3+ MK]@90]D>4\D#VZZ3QJMO-#VWKSZ3*CATW*!T"$`0.XJB\J90%Z<225)@*_G`.%G'YF M1)12*U_/D1W!:*BC])NRTRAGVY^7VM23;_*8X^;QQD"9HQEF98Z5*-)7PH@O MH@BF$2*Z!ZCS$^G/<@QQ`BC-2A468@@"^U^!^'H0V8@@8JI!)/M\ONB0:52. M(FMQ,)V%DHT1%RKR#F:^#7K_<9;"R#BYU"7SC`24X$$.&RQ^4G]*]E,@EM@E MOGG6)>76>?Y!T#*D7AJ'MZ+#!T$GN*I%U:5"B)G'1BE47+:I58Z3DFB?;41! MTSOTAN\HC_/$_AP]MCYARFTW<[A.;;,*@@ORG[4L3G31?"13%9-P$:2/L%ZJ M+M53:!W/Q3CWM2Q'QV\:F$I*$;H7>@FB MP5X^&=$/-LQJQ73,#P]F"F3TM?ABNHPT^=7YR8N_G+SX^>2%`76-/P-S%[[8 MMIG\J7>^">?<6_&@:\;N]/W)BZ[MFLKWWC:32=_[9K*5!VG*\.#FY,7__,?I M764],W;P+>R^,=/IPYO8]WHWH9$.,]HFQ.\0?V"IG0,[8YN.5VR"VAZRGM[% MT/3]87Y^5U0W_NP[J)^MZLWP0W`?5]X6)R772=&!;?K9\=R M(SJ`+=GXEM:LWV!%/[.>%Y%:+^AC MF/,@$2FRC&F<.4SE)2VW_!TWTWO7`,=F#V@WO1^:MJ\\J.]/KA5W.8<"CP'=YYOJ:PKG_C:",O3<79O_B1'Q;L MPLYS`#EVZR)`AO$420X?;WO)^6,C>T_ M@7O6HR<*XYT%13^>?.>%WN37XKJ4S;<,ZO?NB2/V<7L:IL:12$,X&)XYGH/1 M<>LSP.@YKCQC@CXX`RM4LGLN_9XU&OX\7J#P"TG/TD<1ZH[B71^LV9/LO6G: M\7CRX^^*D3YB,7%2RA'^@)N*Z2"=%$'EN'UQQ.\I/ASGX"<&]BW,\VPW&288 M04'KP[5/FR*@ZMR.SNQ!0N=V;U_J&D*EV44$6W&<%SBVV'=L!0W!^LSS>*-. M!!E`+JXED>G8M#NZ"F7>NX6^=8#0SDUYJ0`E.CQGM,01+3%^)./._^.M_.4?#F1/Y-LUS M`-RQ[$7/E,8?#>!P^6,!7!Z_"\#MAF!'[S\[T#3^DR%8)[0K5DQW:#?ZZ"_[ M1:@VT;7]H0#MZ!UGUY[&[P)H!VQXF&@C^<](8X_# M=VGX#GRW&Z$=NWL,:GGY3T1H?;NHKEVZ*1B"6AYV;D",=O3.<@A-XW=AM`,V MYH=2+8L42^WLYR:)M67PQ)8<"9UBT4@P5@+W^F005GFR3H55N^0&A)ML(T,. MQ(2I\T&8,'7=APF3YJ>^AV$O).$0[)7Z[L)>F1%!Y=TXQI.`70;BLO/4=-/> MSM:!SF+GJ+][^XY\'MG%X<"*W#<$F)W;P\Z1B'V=PW;RM&,$1;L[QBEW=P37 M.!W(`^I[``]`Q)9X$$2\1QTLL6"I[_\#MI8'P0T*96YD7!E M("]086=E#0HO4&%R96YT(#,@,"!2#0HO365D:6%";WA;,"`P(#4Y-2`X-#)= M#0HO4F5S;W5R8V5S/#P-"B]0T?H/^C!&U%GH^ML,IG,B]_Z&CO><;O7TH8?W/N@2^EBJTJ: M*FDT\^^7)$`"()E,\E3W.B:F6HG#3`(?01``;W]Y\LWWSY\,3]W_[M\^^<;^ MY_DK]^?KT__QLWJJ]'F>GSY_\T3Y$I8PSD\78YX^?7[[Y-^O_OET/5U]=QJO M?O'_5\H_//_IA_]YFJ^^/5V/9KOZTTG#3S_8G_[%O?"O[NG7T[72]MG8QQ%? M.ZU7/Y[^[_-_BK5IO;':OG/ON9I^=%_65\_LE_^/??S^F?WCJOG1_Q>Y^-?3 M]>*I/SWSWTPE4^=YX9(MP]-%KUC5+R?'VW+UW')Y]9/[\TPPIM3(2KM2RLDV MFL%RI/WKWWGNKIU(VO)Q/;*/>0$FBPC4\HLK]NRD_,.?_!5]N[)-V8]K[;\>%;JZ6UX5-MY M,T\_V**K/H]3@3!LYT$#83K/:X$`G[2$=T^^^;?__O0NJTV-YKRN3ZTNGX?E MZ?V-+_FFPB0PH<;I/$WVM>&\J?IK:C5GAS;6=]9C4VU2@L%5VO;:?-YFAF4@ M1/",'IS$.2&"9_1X'O/G(I:R/CT9US`]C`(;>M+G;=S#TUJXI/=G^N8E&E#A M?G:]Z*/3NGMICH:1E?KLE/W=26U6MT4I-N;FS_>ZU+73S6I9:.:_/7(%/)[4"US>V:\Y0W4OWBQ1S M&GD%FGH?%5AB`6OFK5W8ZY?:G,WYS,"*7)N!.`G9@34UL2D9^("(X#U!2"/:I,21"-P_!KTK8AE)`3PM%G. MRY@3"#QMMK.:K@.@RG)?Y$69@=@JQH.:/N>:/7L8E#DQ; M?5S2L[5G:W>S2:CFLVI\;9[/O-7"'S\7M-4U#WEZYN3+4:%=;@[GJ;"Z!4C1739;`06W+!W,U6VW6PCIEA,6R M:+BYR@CPR9*YPI^BN=HLK8%'X(%9JX.W)".W1%C7\XR6U9NSG,"$\?TZ)Q2E MDS7:UEA:I)-L-;M(HYZ=T@8P`92&RCC_TP;*5<*RP4P-7C-0[?]LPR;O-#QX MA_NA9I`"%U9R$[G(%?68!67[Z[PL%``X7\5Y+5_L_[UC`3Z&=WI>..X^NU`$ MG"J,`79X''4<2D!]`B%JRS@E^A0(45O&R5O-G%!4'UGC>M9;2XM*MCRN3>JS M38R35O61_$_KY;IC5J8[SB]T'J9OH?L;Y_=6]2>P@?JS7J8\]BN)\DS@PMXY M#]7JR*A`A][;H/$NL,<4R"G5@1)MWI0S)4)"U!GKS/O!+R-$G='#Y/I'3B@K MD:AQ=<-;2[L*MI96#YFY6Z!$NJ4RR;_1YSUS?MR$6AFF1K\ZQ4FB"#UR17LX MS4+1:DX3<@DZ!EQ>HF5:K4S+?,6W)P,:Y*P4Q%@U1LB%!1T*!%(9\.]R`JF, M=W>RYZ(&R?J61LL@F8K.XI$&36H\#]VCF&#?!NN/,$1Z5>5!;*Z;(&0!+1"P M<)%ZS&MFA&@`,TZ=5;0\]K=6RS-9\`T?O@(A*LED<5[F`B%JR32J\Y@_%[5& MUK>XK&9#0TJFK$.CV[1FWL[=9D=P_PB-F;1^Q-"%7#QNY+(?^:-'KLG&L//$ M]0<)I"[+ZKMN1B!]63;?NAFAK$&BQK4Q-I!LH;5JR>W$F-.KD!_P&BKC_!L% M0=:%:K1N!T.7&48Q=#FWFE3-I_'J+0C,X@`&S%ZD;=N8CV`A1=@TA%%`CU$F M/$?-P8@W)T3-,3;:$5Y1()3#3%[?U&B+!%-]Z3Y,582(=G"C06ML:M^#2+'X ME@S9;%DS[%>!T<`:TXFV5.7#HUZ#'[:ZKE/[+/G]\-F#LI'=:?4!R6Y9\E;] M=QWHM;);Y`'"H[VRS,6$[U9X<&6I+6[8&P[-;QL&Q+G MJ0V224W$P%@I%X>^P]9S10D-UWRU^LED'_.Z*&H[4V.6C&S#1S>6.C2CM^/' M;2<2C&`?6OIL3'U9HZ#"2-.68,.70O*J^%IJB<>GVWG>N"5V0;/%&PSQ]VXX M?^%F3!_<'+.;Y]RN7MEQ9-JN?K*>XZ_/W&__6,_#Q'R7%ZDOGX^O->?SQV$( M_F4/@"P'YU[3Y[8ICI`?ZZQM'$;T>>U;>G)_FUZ;."3HDK8P"0$TO!:3-X>O M8?*F5S9*1]G7IC8<63ZB2[(MCN#VM:5YSF'4E]3&[A9$F*$GK/,PRLQ9HERVF"NQ;6ZM&ACB^4R/ULO*^UJ:1 M+$[MJ2O$F@'&L0T/C#4[4:30N;VGL?BI2RXG[AL[9E!U>FB>UM)&*'_7'%JHK6\.#4*3_A@`WFN+`;`.6)ZRZRC'(1N8=M` MT]0&CRN[Q0]K[6U&>V@`KS6%!MBPJA[5+&LCW]:23/W-&D*/P+>I1$TB-^A: MM0D99JM,R/$IC5 M>0WFUD8#EM3V/M@8?)O"B*$LH2]L@[=E>[JXX/2712DQW$B;(KI]3](91S'*:PJ.R5X\T)[]8V"/QSD_A&!#QM?OCR?<0CK4(%!8&/]4Y9M(+B7?V#7/U3KEV(=AN?"1L,<#,"@8/1948HPB7J M<^Z3ZD-+\$>1\T5HC=;61[1^N^)KOD>7\PH_*?G+1K]\*WX9%>OUH^NNB^V\ M:U-'E:"QA2`$_)3TW$`@X-$)R@CEEA`U0J:SJR4$@[0DY**6T`MKB5.3X@K9 M;HE`^&#^(B,0/NC^980R8*)&]#&[$!,<3H_HYW8H3%5M=G^^/>FKR?UCLXJ7 MKM;<84J(S!:/1-A";B8C1-B":YP1RCB*&L'I[H)1,$C+2%I'",G<+1%(0,P/ M9002$',S&:$HL:QQ[#1YDCU*.UVD.9J;KZ810DIV2P1"QR2F*A`('8Q5,D(9 M+E&C#8A6W8F8X#!FSBX#3/.NYF;!E5MWNUR=Y0H@%PG%8H/M?J:I^TD@V+H; M`A/S>1F!P(3H+GTN8ROJ6[IMF&2/5N!JV^$"TN^V;88#HR(Q`XRYH^ ME8'B-6'(W`44YVQ[U.BH%]7;9Q?N\_NGB$A(HF:$"$K(86:$,E!4E_/GQDZ8 MB#?*S5Z&TKKL>7-Z&UCGW,)(Z<=-UU67IJXJ46"+G1B2FXPL`H&0A(1&^EP$ M5M8'BYUZH)7LT;*G2\"UW^KMJD*TV_A,V$#*.WTF:#"+DQ'*8/':,%/4!1;G M[C&NV32-===LM@HWM2F<$)BMCB+,,)F?$1AH6]*7D5!&4=0(F;,N%`6#2R5_ MM/?^EG0Q))"`.*&0$:*`(9F?$78DYC7VNF:2/9JGN$QSMJG3S$O);HD0T0D3 M(AF!T-$RUX'/1;!D?5IUFR3)'TVT7(2744/JF>F2:V9$7*Y=@3;?3$!!"\H8 MEDFD%`@,S#E%&PAE>'E]4S^XG#W].&CUN&_NB^M50,*8<;:5-TQFX4N_PWJ5 M,2Q@_,GE@-]X57!_(6'Z*J25Y]GG4]^XQ.MZ]=K^DU+(7^S39USCLO@!\.=3ZY75^[P#!/+'H^T4P^2Q1G!-N:X\&1Q1HA]HI0] MAA]C]OA(G21?M:1Q<=$/DP\(49R0&LX(41Q,2*;/.]+Q^BA7?"P>9ZN6(BZM M,HK2X3/)@JG1B@#)&J,*==#@`1?M4QK<2$6R8<$$@<3HAF!Q,%<6T8HRR=J MI`SIH8""L4$(R0Z,T*$(^3F,D(9'U%CS'P>PB/XJB4\ MB\O5HGR!0.)@6C,CD#B825Q)!X22!J3].=`(&DP MFY41RN*)&BDO>2BA8.R1Z4B79VQ4<"D,RRT2()A*S`@$"*2QTN'8A%+C\S836[K4:,N2SE8\HUAL4E7+1`("\CQI,]% M:&1],?EV!([DJI9S*RWD).'@F42!W%CZ3))@WB4CE&7CM5&N[%`VSM2C4F0N M[]_:[D(0E@,C+##EE1$8&%O2*=*D6"D'%@9IS($=HB/XJJ6^BBM=F7Q;HM>8 MX,H(49R05"5)IT*."?M^,SRM:TIRF(UKFG M"5[KWM/4":1,O:C>/4V=M8E$2/^>IEA;WYXF>*U[3U.O;"+,[]S3U"N9"+F[ M]S1UUB8#V/X]3;W5B7BR>T]39W>3X5WWGJ9>V7BHU+VGJ5,C6>S2OZ>ILRX9 M5/3N:>I$43CIG7N:>N427G/WGJ;NVK@7VK^GJ5/WI5/8OZ>IMSKNI-7V-`TN MZT5_$E?!,AWWB4$&N>U]\!GP;;9Q(3]7(10V;DW%I;L6S+K]%^Q:V!7<\.T: MET\FF67]@[(E[[B2=V4$C*K853`+>QGE# M=`HC&G=L9C#*9.*,FL>G5:+@"H+.TMR:66B;A?/B89K!TAN?<^9XYFVTA`]'-S0A00G,ST>4]>7A_.MO4)S/F+_G-!X/QX MF]+.##//.XL[2K4+T>+L'<,&W/2<0."`CYP1RG")^G#VK@DYP8"`0_Q0T;8:0E1(TP3 M=K6$8+!V6&=#2^B%M42V\*]8O9"-YAT9/A"%Y03"!X*@C+`#F*@1YQV[$!,< M3H_HYVYG1J)J+3LSBDP)D6E^DF##"#,G1-@PO,L(.SB*&F%^L@M&P6#M@,_R M^Y(YFK%D`D*4FQ-(0(@P,T)98EGCV&GR)'MLZO(2S='JV^$"U.QS)L(*F2$PB<94V>=H#B M->%T;!=0G+/M4:.CVYG1V6<7[O-[D2,BF`K*"1$4S,1DA!V@J"Z]ZGS3NES&5A9'TP.]T`K MV:L=2'L,KMN9T=E5A6AQMIEAXQ-WV3-!`WFSC+`#%J\-9YN[P.+6=&D2WNS*!R.SLSBMQJF1M!J!B62:04 M"`S,.44;9LW+\/+ZIGYP.7NU0W\;H-7COKG'G-7HM%6[$V:5P8-Q"Q/\O#!L M1PB%]T[Q4N=IC86KYTW%LL`%EBTSX?)&VQC*6E=C&QL*>R9BX;U#P6OVS@?X#]8]X;M;.9T-AW/92/61+VVXR-NI9+-N@9^ZXLD7H M68WC4#CJ687C:1R8MA\H6BS;,'_S(2[^\9,U7]W,VWN5?#G,-=[YJZO^?M*# M6Y0ZAZJ\\]O7)UO:"(P[KD+ M^\_N`-[/$4B$ZP5"Z+>R[<>Z6YOP\Z2TU^%ULYEN8T&6SG@X?+]P;^/08V:)O?7XE+,:>;5&R,J#@(BO/1OOJ_A.E1^K`O^`&D#4PQ M)7\31;T'C6)J*JXL5+P=[Z2&)T4U+WI+\[)QC9^QI2%FJ!N\"7D,,0;XPS>T,5"FC.DFSJV7U296_, MAKTQP`R#*+!,K,#9M82Y^OFCNX5;-DL&]CAL[,V[L%FVT"SCR$MBLX@"DTH^ M%8T)*LL-D]4$LR@^L9KCUE*R]\G;AP?16@;`^C;)%7.PQCA50WG1J=Z`>M:L M`&K"BVB$'?]+4!Z"U8%QASD'L:IOV=W$2?5GY/^0?Q=R4O,IS%MHF@S M/L0N!YU)?''A[SV$D578B-0N6X^!O1.MGU>UN:1IKB,.847-!8-7,E@6;!O: MAVQG-"[ZL-W*Z\U_D#*]PN9PIB2\6]U+39;GJ^M<-Z>2%75-_HJ:U]E3;IT\ MMV_BFT$D9[[3S>IJX:J?+U\&P%_%\>H#B.XWL!NV_`@]BIFO7_%21!\EAL@$2)L8[@^+A?/L'P$%9%O?++C1+E<$8S:@=LWT^49]I6EIL) M/_C-+?C#*'Y@;YSY#\M`/VSB!T,_:/[#.L8?_AV$*9B>;6&%"@,\O,.-Q4/0 MN]A=`D)%EXL\KBFX7%X'^;>PT;@+"2HEU\//XO@#Y0<,RQ4-&'%]6FG$8#C% MD7PNCAC;Q$KR#BMOEU>L5'0?XI!Q+8:,;'S7AK\NAHRE87S7&Y=&ARD)UTXZ M3E%D(\`T3CM*--E1DK[W;6:XZ;>^`2-XMV'$L.P-=G`P:;)M8-IM.&-F6-+& M2,>&N=0\KN>M2T&OR?*I:*/C,``*5(P!PGK#3[%[^.;E)E\G8XTR"V.B,!!, MP3Q')_=SD"8.!.$7[SS[]9B[`X%_U;W`Q@$Y>N(X$/J@'`>F;6<<8([/%#Q[ M/A!X:%S/+W7:ZW032QK+588!M85Q8.;M3*,9&P?FHV%@)TI*E6:9>7O));,8 MPD;%C^-"P(\KTC](75`+^[8&]\C-[82E7N1F\X*?6/_W:.5>CB83K75BHDF5 M50@^\3MHI*^ED5;Q*)JOIXF^-7.-#XV1QG:D;3&V4]%&IVD/GH

1K",D^6 M3V1%A!%<-@:5!,2UP'WV_=="'2=V*`U+55#7OXO%,[MAA/_U+JC)E^A$Q#'M M-9!,8E6=KL6;K&2_NXDF%NN`U,5'4#O7>GPT1[4HCMQ5J)&M\^&10)-19P77 M%OK':8/UO'Y9?/*D5YRBP!6Y.0$^EDYBL'K"!2+E:8@">Q,[%']P^<"#G6=^ MI7*HK/6F9\E^\R7UN$Z7(`P$@`TGUI*GB!E,SF3/10AE37J"-<4=+%H>]*3] MK$49QH8+Q5?;(W7PAW]V3@U>MRKZ[:!9*7^I[[N3']*D@V58J3N_/U(M_A]) M03VR@O%J:;B3\QHNIWU(G*^5O7%S9PWQ:TS1S:F?M@ZLJ+OK]N:3+?[9QWLW MMR=GJ*;TWE*7-:*7M+^--O7$YE@"U@/O[L'UDX.]VBH4I>\J3]2VV-LM`YL2 M73PEV+ZWBBZ>$:("YWT>?F)]OFD++C+!MEM8G6KJ]EA?YZY8?*UY5VSH4Q'+ M2`C@X6K'G!#!PT5S.:&(IJQ1+:/CL8M50'3QNQIV$&VP``[CD2UDF1/-'[V, MH8`Z;=F*X]+NRMYFDU"U[Z[TR^^HU<)S:*-HH%-";"/L>.ESL,U#M_WQ:P6>`*\8/ MSIT$+MPRR*J\V=,L07(EF/PCDM[D)Q?[TX^"/^GO/T^OKZU?6XR8;4 M)Q"BMN`NH)P0M06WG>2$HOK(&F%;T'&+2K9Z#TKH5!_)OU^L>:'NF)7ICG,) MZ4YZG\>KZD]@`_5GO4QY[%<2Y9G`A;T[*:_+HP(=>G\:O5*E"N24ZD")8,,, M4R(D1)W!'3TY(>H,;D+)"64E$C7"%I^&=A5LM9])8;C&XA$`AY5)_HT^[YGS MXR;T\4U4HU^=XB1AA!ZYHCWXA#LI6LUI0BY!QX#+2[1,NSAF8`F6F<(K9Z4@ MQ*HQ0BXLZ%`@D,J@?Y<12&7`W4F?BQHDZUL:+8-DJME9Q!T0G69(L.\6]EUN MB/2JRH/87#=!R`):(&#A(O68U\P(T0!FG#JK:'FNIV;+@UL02&L"(2H)[I#( M"5%+8&5^]ES4&ED?;)DX;DC)5.?)(YUF1W#_"(V9M'[$T(5/:&!M(MIK/>&$QIU+-"%%SMTQWJF- MA0>W2K=2=@U^F+]_J/99\OOALP=E([O36M]S0-ZJ_ZZNW,_MRFZ1A[5^QS6Y MF/#=ZFI_WA9FVL=LSRV+%ZW5K^<.D"PNR[2_'%OI8`8/(9G41`Q4-DK0T'?8 M>JXHH>&:KU8_F>QC7A=%;6=JS)*1;?CHQE*'9O1VO/42[B#C_B7<29^-J2^E M.D^[#"\]_K1+O855\-^[X9R.-X(YXUK7B3USO[6<VN#4V[PK>Y3+JFVKE,N\;7NY$VO;)2.4JKSE,MNR;8X@BO5 M?ZSWELKLZ..4B:$GG*9>]W2V,-$%)^DZY[)8MI@J4ZC[ELE(-0.,?;%F)XH4.K?W-!8_= M+&:[FQ6S86N-\V1KE74Y!X)G=S54L?$($/+81]X^(JF\A=S?6&L<"TWPN+); M_+#6WF:TAP;P6E-H@`VKZE'-LC;R;2W)U-^L(?0(?)O:SE6>&\13/QIJ(%ME M0H[G*`Z@5JULT75V8FYL5;Z< MG[%.L?`3RWLVWN?,T?KN4A` MC!!S0A00QK;L>4=>7E_U-L8ZP\!.+?(\UCMW/FQ0O+;+?X5H\7Q8A@T$N#F! MP('H,B<4X1+U56]WK/(+[%0CYX9K_IS[%=#*SX>-/RWI^;#QE^Q\6.KUJ^NN M2_,MW1(T6@C"@)^2GAL(!#PX03FAW!*BQMHUDG6.@9]:5J&A)?3"6J+I8G@I M&YT/R_"!_$5.('S`_LL`T/[\5H#7O/"5*UP")G(6>TMM M/D17`$%+2@A,S-CDA`@F.LPYH8RNJ+%VJV6=8^"GE@HJOR^9HU-CF8"0-&DO%=/'0YB*K`@A:CQ%?75[MRL\QO&@OWD80.T9NL="X1H<3$XPP:2E#F!P%G6]*D,%*^I>HEG ME5-@I);W;,!I4;U]=N&1@'^*B&!J-2=$4#"SF1/*0%%=U4M!*YR2C_>(D5*O M8]91_9$7\9188WLE4EJZII2:ECQQY#897P0"(>?3&MES$4A97^T*T3J_H6ON M)Z0;KMQ4NK=K"M'B*;$,&Y_XSIX)&LCEY(0R6+RVZIVD56X?[Z"Y@U*J#IH[ M)79L4S@A,*V18IA!2C\G,-"VI.\BH8RBJ+%V=VF=X^"*[2?]]][?DBZ&!!(0 MIA5R0A004_HY84=B7F.O*R;9J\Y6-&C.-G6:=2D9G1)+Z."T2$X@=+3,>.!S M$2Q97_5VU#K#:.!KTRT-.40UI`8^GA*K;;!C_]$6@0N1X_(QCED2`04"`VU. M405"&49>7^T.U2J[B.'C(-3COEDOK4Y!"6-^>9P:IJ["2RRM?-&UN/9+)BP3 M]&=4P)Y[>8)-.!P!#OKQ&^_3HX_XF1OA@+M9L0,5\7P+<;10/-H&#ZPR]:4O M(+C!TTT??;6:.U@L+`A6[$@$>1K5[ME2^:5BI:E";">6*S:T+P]2PQEA&L]: M\=1P1HA]HI0KAA]CKOA(G21?M,&_;5<:EP$49R0",X(41Q,/Z;/.]+Q^B@S M?"P>9XLN##N:R^2L4":79,'$;48@83"CEQ&*XHGZ*)-[))U@BUWP=8DM&$?J M$T=79$M96(*5$@2=0\$P@,3>!FA#)"H,298#P$2?-&]6VV;YIA\2"!Q,/V9 M$4@5I&)MU60289(0=^7B-C8.TY(I=>W2T>$UPPC)1 M49J0>,H()(V6$5::F2IEHM"HJ=9^*]EBUQ1=E)`85;-^"V$HQ\302'S20&!P MS"E>2=*ID&/"OM\,#^=*5\`IYH:`L[Z=2^&EWV'GDOT,I$A^].?0'1QQ&@^Z M;MG!%$7KV\&$K_7N8.H%4J9>>GS&R._9=7MQK#^ M7<>%OT(TFL,C;-!93PD,'/"4,T(9+E$?SN'UH"7XZ]J-D:/E=F-$M/+=&/&G M;#=&_"7;C1%^J>[&*,HE0&.3A03\E/1<)##@(8K("#LM(6J$R<*NEA`,]NS& M*+2$7EA+-%T&+V5CLX^$#\9B*8'A`Z%01M@!3-2(LX]=B`D.VQ?[%?":%Z9J M3;LQI#8?HBN`8'.7$8NN\`5#-9W8Y3>E\RQV4P2 M$"/@E,`$A.@S(Y0EEC7V7A0OV>O:C9'KD^9&K6G'4;Q=,Q%O7;HP"2NN8 M==3FW1@EUJ34;**8(;?)^`()##F?@TJ?RT#*^F"BN`=*R5[/;HP<3+<;H[-K M"M%HYIFP@21>\LR@@1Q:1M@!B]>&,\]=8''N'N.@N=T850>MO!NCR),0F,U0 M$V:8GDP)'+0MZ;N8+"RC*&J$&>HN%`6#]=T8Y?>WI(LA@03$%&E*(`$Q/9D1 M]B3F-?:Z8I*]KMT8!]\TZ9JA&IY7C>=8NQ54[^C86UGBD5_6%E8<%177=BV08]

2+4+/JDRLK"D."D_CP+3]0'EBX19-<\[!VJAIH6R+ MIKDA>!O;,(YE&S!VQYIITK2ARD0L#!A7"N=F4?F13,["C0L=%J:O_N7D;JNU M$<1/\I[T*9:3%U1O&_O`/\JK?(>9_?;,S6^Y+RM?QP_N`N;_)\_\IW[@/VH9=1R^R/,&_Z`$ORS.Y/_5W?(O?_5">:*?F?_ZX7[D_TS M^I*_>!8.)KHVJT53F-)+[_+]`>]FP(NM/[';;_T%V?[.;S_SA=O>KOG5\O%. MX0^G:ZU\<;6R*X[Q.F"Z^IE?:_N*;H=.]]OAPBR^CTVD2^QH292WZO\K=P4_)7?RF'H3.QW4RH?P>N M9%9*3`>[#WV*L'X$&)1H_G%VJ/>HP25K3%>1Q&J_>!@DFC^4-,8KWA,_R0OFWX4+N%TRC M:-Z<*8,1%ZM_#.#MWY,N+HB^B5UA1VQ_]$R"T1;>;Y=E7=P M4993L_AMNDJ<%HTBTI_][5Z\-QB^M!0)I&=,![!C%N]9+]K!=#]O4?=MZ[X- MK7W'N56`Y`?48NR%UK+$Y0RAH6"K=++0P7'EJ_SJS,5'QLQ]IAHJ;$RF!B4< M4<(")`*19^]`T[OZ`]JJ&>$\VU_?('UBE4R6!:Z7\;QS$=*K\P(V@20_,:6GR&=GU; MZUW^)P(6.=[K+'ZPP$'G?1RPZ4[[8.5@;/LK61_D$?>4[YCHV?-,CD!N2H9P MOT3H8TX#(UK!@/]-&,=7T>8],-AQ2(5E5F$M@F:4;+X..J*65&F6,,*2;69>Y@M`*%0:/*4X`BBO`$ZNMB&@U/QO8CN& MBI>I9O1$T&+CKGB(R9_8./*SO^SM932H7V*M@`>J\!AMV6#K7L-X.)FH=*:L M"9-0A>`@H2[HH._?Q]8G*5Z';H_--+O01H4K8@C"5SB:+\&^'OC%A@:AU\GT MK6(@99Z##Z2BY;R+4E'K!1<]8O.GJ#ND[??1>'^4%VOKB=5.HRO?5"(OXIY9 M^:Q]''3//I_,;MCC^H)9$XUH,M&_TE)35"*8:!,FP9:SC:P=?0QL>?Y6Z$7N M(W;4BGC:PI/[]V\G]S>/@):`K@C=U,R$0)50/$"[9_TT1=#RR-[&*M]$[;TG MAY6OY13*['4O';RGMB[>7@94A3)G_:GCS4ZSRMQ/D6=*A MXW5HZ./FX>;N#3/FOKM_#?D.;JCV8RM29^E/8`O=87#O')!E8QT1/1+J0#$@ MM)\AQY4,%1?R=U&T+X'W9!7^AZ@.Y.R_9>/W%]%%/TLC&@_.REYC=E+$I*FI M&4,`QY6;!9KD4L5!3`SOJ9HJ&Q&&CR;I5[6PZIB>0D:#L1<7$EG)ZQAU=:%G[-@\4"XH8 M1I0TLHJCU8,8J$!OX;/NX4UT03_$/V?PI40^PS9@T>/Y-0/K*\3\UZJ@-DH$ MB9^@+:YE`M50)X+\:>PK#8ZO(;,Q9-92*)PS;9&=AR!JT@EY4L)G90V%&M'^ MHDX(1\=MO8I?9VZ:](9F5BCWV:STWYTF\GW)$_H`ZO(,;_6E3++:S21?4R8E M!(;1Q;Z)@QFY2*AU*N9R_)3'0^A$SB0+WUAQ69[Y$(>RN^3R"%?$60D-8HMO MB:9!QWX\F;38:E@Q5?C.-N7?R9(\#'>3+.MV&CN,=-.RA=CY02]R\[7PDF0H MI(OFV(F%O-SC"7-6P4%2"T1Z:Y(RXY_O3"NRH<],?!O;=6$;FPG)$:&GX\"J ME^ZZ3TBI18;R)EC(E]'TP(F.X;4TG7,=LPD%^SOG+L62C)-LCHI'V$8$V-<\ MP+;6A,P9>C!$4-`&!D-Z7*SQ_P"K4_>/#0IE;F1S=')E86T-"F5N9&]B:@T* M-#,@,"!O8FH@,3$Y.34@96YD;V)J#0HT-"`P(&]B:@T*/#P-"B]4>7!E("]0 M86=E#0HO4&%R96YT(#,@,"!2#0HO365D:6%";WA;,"`P(#4Y-2`X-#)=#0HO M4F5S;W5R8V5S/#P-"B]0)R]/=F.Y<9U[P+F'_I! M#WT#W1M6D54DC2"`+$T0&XZD>"8P`CL//;W-Q+V,NJ?Q?_-R9^>?OZFW\_^/.O#D?K^O/? M'6I\]4UX]3UT^"-\^^%P-'7X[L)72]T.W?FWA_]Y^WN9K:Y[-=O7T`]F^A9& MKL_?A)'_*WS][9OP`=-\&_\E*/YX.+;QZ>LW<_\5:?WC[O^FE;Q3^?SD_(#*/P-Z'@,BG\.!#&+.*WU["_]>! M)5?AW[\@OV]C8XP&^QX\7^+@``MZ%U]Z?OWD?WL<'3U%X MKX%H[Z'58QCY+HC\%06WU[#&)]"^P\1KCC;;7A;5P!I MBV->8Z]OH.TC/+B'KA\%J-#+5N=_PVX`P#MX]0G?AY8?!)$XW150PN&K.,C' MT"6"^9BK7.L4#7\Z4)<[).2-(,<@`34!E468:1`&.0",9(DTLKY%4KT7V)^0 M2F/RXAS,@&=DVXW`\Y2AXKHSWQO"1`!@(MS+')%(P#K]R.6R\XA3Y>Q)@F1( MFCJ$081X%_"]TMASH60\#;IUT?D M!O/EEF6-*0]2$JQ&5(-(4<>R$P2C'JNZ&ZEZ8XQ"\W4.UP48U(=;^"2`OH>_ MHZ#<").?2DQ*TWHU3X"N@:[!BH7/$Q"E#6.#V<@DKZI5I]\'N*(QN8,/TE@3 M=<'GW6J-TUXJ>J7-E\,_P-LV;D3.7!6;3!Q_WB5=M&X?$:QOU%\)Z0KQ\0A#8# M",`'JU(B9B`Q,I\6,]MTYS\'"6,R:NOX3GR`Z?`)HX((A5(W8PA.W*I-,^P>XR*]!4J$H[N MM7N]1"9ZMN]&7$:2C"NT7$E@`;AG=.'H.#[EH@3C/:.9_9EXF*@*4A+EZ)T0 MD:RF-M_7%!>T&9CL(\AA3(BTF[:76E&$7D_(_"BRK,4OY)B\C[IT@TU&>G:? MT>(Z"@7[W2!9MFW8!_B!"P@PHY*2+=%*ZIAJVN-&`&X2QT!6F:#PZA&##=/R M>)G0V&HH-3C-4+)`"^7(G(&;*P%Y#0]6F!WF^N$I\F/&,P;N"=0?A0-)YZ\2D\AL0MCZPH/% M/]B_`Z_`0]3*0Y#O%H\B?1M]T((3$&TG#_#)+`@4X4 MVJ0S6H+?0`B5=.M%B/"!]?F#J$MN$1Q/]3J/F(*8);PFO8S37!I@&KT*SOD< M)=1)=$0.+*`A(8W*-K8XG;95(+YYC5ES@?>H>ZS6""K1<"+-(_H.3&:5^CM\$[N6A3*/&ON!LQ3429IAFD$!, M!$0!!#5*BM(&XEXJ(F'Z,05AC#C_RUUT]_#=-E%WOR\2G\JI0?,8EVB3>UO? MYCG?;(!-\A>=#/1Z#=I?D#_<4!"2/#"EL+Y=L2"B="Q=J;>;E:ZAB!H[P?77 MH?,O;`[C_.\X&B*!I]CI(E$/#8))D0Y&I5_#M(F^02+PN4SGVR1D*2--^>_5 M..3?(4L!S80J,=`,&1A38,W`B4@8;/4M0E`@;K9KU;R9N-5C7^2ZGEIBR?"% M/29%>-I\IPBL51E[+A?(QDS1?:-F69),[;Q-2:)^2YH1_GS'5C!+O)9BNHE( MF`-3,NS)4Z1&@\J2MA`7XKPOI:V`H$."=\I::V$>:*5K.4Y<"D)238P+8%OJ M%FAW'I%/VG=*BSQ@>V#MS^-Q`8;)4,Q]&2(RO1%?]=7!N'-W@/^/4F92>=)' MYO>%(OA1#(ARS-YS2.YT%NX0%XAKQBKH?"K!MU'@P-%8$"L,]\#=H$=`0@5[ M$'.UZX.M,?B_D[#A$IY=HW7C)@^4'^"81A*&D-82?*;%1GEJ8*M>0<<07,"0 MG_*&UDG#(.JZ7E9;-01%0<:P$XTZ%1]<*$`]@GUUD.KK`R;A&(L;*E>\(,1( M>`,11_CP%'$$2;58.'3XHLH+L4X3'M$*4/S$99#:,T24_4?#;%J%PB7FDEFR M7[5JU.<#U@T`4,_(RCA MJ5`S0'P+\D+4C#+)7)Z(G$#E&XYI7R*)#8=95(/O^Z'4V6@<#=5DN\&BC5Q">#BH_89(/PTW`&Y"B4#'3<YXI55[6:(S'K(491AHAV M!QTEV*XNJ_&7>L\M>]F8!S]XOH-+W M\T1H*CLF_&KE4DMCM"B?#K7AA;*8)T8S;CI*LL]DT+=M-,N_1,(X0C<9FZ'5-VRO`?B>`7"K_-.5!?5JQ%-<3==]A MU[^BG@[-@T_6(?,E']G48:"8O$7R[L]L$;#0&EGM$9Q;'&[,Q'&TD*8DH^B8 M^@Z=!LW[2A+ M-BV0&EDD#BU?DD"3VT0?%066''>*C6)`/&'LH\LQ$K>153-(O2DW!UDQ%G`(T$9N[LI$2=: MF5;)8.C[-^!5K?*:.=936A(+'$ M:ONLW!(CY>@M$)2A[%1I,3)09,@\,96L#Z,DKFG3NL6.FG[*7-,ZVY.4HJB& M,+VO($_8K$`RV+<0XH@$XSL!@E=II%QPR18LK6A+A>Q9NBTO,*?=%]*+B)'T MGW*#?#^:AO'3(5OOP">2?4OF,.!!-ON&FU\7^&8H[%Q%$=V>9;9Q>L%GR.R&\Y2" MPFP45PHEZEF!#:UJ)0UU`JF:EE6C-K`=6X7[L+RI;4MBE.RYR#F5;VM\.#C% M3K(XRV;%R:KHL1WP29D5-\.FH^3!FAB:3QM,2.8@FD9Q;<*TI"KZJFT)>+3P M`%8K+,)A<-6U1Z4>2DMMM6/:L0-%S*@JEY>9%H;.`;O$M,0UQ573DE:<9$^1 M+'*7&I;C]%8#7-A:V"ZIC$LS:UMP]21?K7A@@_V@@,HW!V5FQ>4KVMH-!BJE M/1G$'`Y_)FQ+X(FR+4,9L)PK)#FN6&)V[F0L\X0.UL]XMRYY0I`(`L$H`[-7 M.//(VT(L)NA2;IALRHV$2[S-!RBGMUV3C1JN#Z[MXCUF*SRRBU>\QY!28H-2 MU',EDS\)@%/2=AR%7V+?AP%8LL3K=M),+`@T!K.@((IY$8]?_+E4/I/O,\.M M(;(U*M\]%3V*W^QN?+!"=3W8^";+IKD8>Z/%V"AP+3XW2 MT2CC39OMOSPXEIQ:MG@.#UN);.[Z(7RI MW*D)C''F%."^3P^:_E359W?PP)]Z._&@[DZ6'H2_FHD'.&AX\/[5%W_ZI[.' MB1GM*1B#(+^GJCU[NHXM;Q8!13#,*9`O!`BG;KE77?S/Q8)*8^7QM?3+])C@1C-8@%Z;( M"8U=&%!`:OS)^;,.8(*V?P)(?OMV>-)]>+8:-I;!P7J.M\#0->=/H'&DS:!Y MT:%!H!)/P#:Q#1J1&?%M;'-2[&WJ(NQSD@:T79D,-M:I?O?I0>)FYR*I1@\2 M.SL?Y7CT8)*_^8P^,*@0PPPPUY_FM`7:UH&&`I$)'3=S-PRAN/O=`2Q>C&P; M*MPF]L&$`1N9+S"PM=LG=$9->'^P%>X)V"(Z7:>%``U*`64S=MF3V6:^ZO;4 M.FUG:W>J7696AP\"A9S39G7T``>=L;/X4NQL,!!E@$8PMMI9G$SL[/ID&@%E M9]FR"-<`15"S-,$[3` MB#9]`->G*J8/(4D?XLV>0I,94:^[YE3[Q!TRDZN@9_3HP$@4=0LF3TLZ?V=& ML,<;?!/9CFBY[-MFP@2X&,0%@_:Q\+F-*;*:;`_WV!Z]K(DYP6R76M M]B.'(%R1!\*&8-'L^'OB@K,#MM"#2;;D\]DRK:O,YKUZ(%S@^&'X(+&!'-+HP31?LAE#GS#J)DB1-18\TV[6 MA,1DE\:0QQ:5*;/`.3UL*6_$$6*8$OUG!4_*/!KVJFV,R"?[:><06Y-3F6W, MYC@VCJT6VSK/;7OXF&]+IK!DV$#*%"H&:PO2LTZ4/*<)8C0[@5@`FF"A)6M< M`=A-2&",3=18A"`(NBT=-[1M;6)VC%X*R!&H*+RIYV>H3KX[2Q\B81(6AJ!S MR4+-]7=L+V+_>2V:[L^AWO[Y)8H-_9=COJ$M&1S8B43ZPP8J9_WRA&[B`E MVG&>?CX_*2!DYS;*00KB]]&N#[`GH^07K$H!]'T[*0:N2`PH+M^+BH/]2 M@+Z.21-Z;>2#1.W[H"?_2^KH/@]ZT";A@Y.EN*:,#QB([W4S*EV)ZC`?]14@ MXOQ6-J0H?1\?*-PF/E"XO1?\5IO%YD!7\[1E;*"@>Z]54ND)8++`A]5PQ;FE M,'PUVH#NA?$XMNY/K5EHFSQ7:+L2-X>V*7<.:M7,Q?FKKF4=+G$#+A8(JB6X MDME=QZ'W[!YAX/8T&YVO&D;H7Y`$$+4V3I.5*8(JK(?Z-$\SG\W,B[809"&. M'R2(&+X'SM2]6I%:[89JP-VX6EU8E]T\&VH-=M/K7^OY_G2,;M5>F^D8'6\] MI07N7P[IDHX45:=S570?%]['1F=9G]4."5D,'MP9)?>!->E*K_>X3GPYL8U\ M+0\XRB5B/(;/VI6UIR7>N'\>S6VZQ:+ZAAHP=2M"2ZDQ M4*.LN)KT*)*BJ&K/D2!-M!`)3A5RL=?>0JX-<757)T-AMR5&TIVTJ+0[18;[ M9X]J0=U5A#@>H#!`[/QZ@/@@P=6GOU?QUNVHW28>U-MX@#:"NDN$LH>$4+EE M$FZJW.Z6'[14+``2$>X"WE>*_T8*19OJMKN9@+9SG0F+5=O=9(PV6";W<[W+ M:K;;)`"#S]UT0S_`W?V\!2FKV`X$0)W\**O8[L6#'!-WE\AT#QY0K]W(@QC? M[H8='20KH?LLV$&'A`?I`&MAF3`&O7N]"3EM40/S&6@XOY4%&$+OY@&&TLP# M":5W`=]J0P@'&YJI['BQ4KO7$E%XS7C,\V`E'&G3MN[@W<;;(E?B">R>PNSQ M`-IQQM82[TZW94<5VTJ-<[:M3U!(G;84"_$E)7"1Y6]I#W*U!!?;VA(1Z+QXJABF4_=ZGGASDMG" MOE';!;+@CIY^J?H>PFJ("+N@`;'.T2SMO.'&<>BUQDT?99X:SR\AZ+8(Q7+; M(/,@6]@VL'1Q@80;(S%6&H-A[10M%G<645LFQ6$N0MD2)Y;9H M`:EM&TW@:F,$8J'Q?/#5VP(D5KJOX377O8DJ1=T-5%1V]4?H%_I3?*9179)& M:5L@N8U%2T>2Z^=7I'1CE-R%QO.!6A$2*]W7\)KK7BM4N_F-9BO=(_`+W:.U M-=$PEVB7M"W0+K#B?>)6O;C741J3T9UOO!Y4]76\*I#O$I?SA?J$;>&E./%^ MD=E;M8ZCZQMZIZ:>OBNG^)CG1+6"?P!*CH_S?8+Y->UR*O1)+8%-+W?I$@@O MG05H]>U;)5?:-7VZ"'_JKH.XAO?"U):[9>K!Z5']LT^.#XK&&DY^$:955(YW M#\!RX&^62M"N@ZPK^*^JA6W7\:OI.W!GU%#9KH)5YF,PM56S7GE.H-RG!U7%1V&:-F8\PP<: MG0X,QNC!-'[YC%A"*<`OA\N#PD]G''G1M?)J,K2D19-I!%P;8W.@9KUJ4J9. M,P;JF?1S5>DTHQW<5`:_;)I:[CCAR'`'APLG^1#N#H*P'6![%Z_/2(?O$9*K MN!Q.!_9N2Z`)R5Y`BJ!9WY,T34'3\X4.W\)O]<:?SKF^#R"\@W.#T=Y"#;#' MW^+]J@`N$X*RSX0K^`[3==N/C5"6($I'#Y(-@;PJ*,;X@>@8!%5^]'U:Y?+Y M6O@HT8(<*A?7;@I,2@;)??H>A#2Q_BMB\%/_FT:+SV3@5RO M[,1V!I$)_\3EB`J^;1>"IL:KCE`(_AN$\X+O(6C\^?7#H2:=L:0RP5/!+V<; M3UIU&4U!/)]X)T(XSQ4Y\8/ M$F6"M7!^_&"&5GJ^&!04D4I#U:),%VA=!LA]`C4ATQO(.\TNZLW-+D@O"WZ8-!4[V$_"6T+LL2N^,:IY^8"\[*A;RV!>Y]$I?3&_4!:I\ MYU([N'+)M]E6!6,F]XF.MBK0#ROPE6R3&7>\<:ULLP(E>3OY(SEO["_I6GE_ M7T&?SYB?# MRH_,<4R]4S4X68G=V^VL]HVBU@YJ#YNO4FRTLVB M#ZU;N.OD\V2E]4.STFTXUD=Q]UYL*9\A5IE9%S`38YC+ZG=1SIBXR*@6PVU8)01LORBQA/P5Y,0WA4OB6#199W5V"WIE-(KJ& M'1#MEW9CL'>.C5=V6'BK5@.:9NM>%W&-L3_6[F;W/NB:X#*^XC0*4&ALK6@# M&UWJ;2CH\E(W3P!M7;GMW.8-;V'2=A&[K'= MPVX2SJYVHY1K\VQH.:F;9%JK-RU1BL33%5[0Q+87NTEFM//N!Z]D$](=OUQH MK]74Y==]D07';I+<@PHS""^;(BY"E^+P+69JZ5=R( M>UF7;_BB1&*C`)$WPEYM,5DI;=A*(/)G6V>C,'\K:N01A1WS]QL6L`/J7,(. MNWKPEF+UK2#W]J3H8\IL!T?F&[G!KIFZ5<7ND"+IC;A%Y_ZKJ(8#KA(O@HTJ M.;!#CC_8]*K>75_%WK]&?;7I%^NK=&#+9>>U7OA"\V*'O59`+3GKM5@_+3_K MA9Y[+_G9A6/__>73_?.C4Z?^OT+YM.EWE$\9_+WE4^R_6CZ-FSU-$\@<`W:P MO-O+IUX)>3\12BQ73O6RL4)9H8!GKU90Y(/=]U=.=U.;8J'U^0LKI]MDA4*JW<2C MV$ID9;YR6E@5;;)+3?+?3FLZI0M-&7[]Z3,L)L5AS)N]I=*]LL&1&?7_%4JE MFX2#`[R]U(N17H$5*2R5,NQ>_^J94[;CW!5AQ3$YY MO`"W='#Y=*9Q\LZA,=>]YMNV,K"43XN14/ZQ[J5\.CU7\F6K^"K/L8H"ET\] MWR^#Y=-R%,1L1[!F"9";6&SK%MHF@Q91J)?&I?*IH##+WC7K(O<=S4VE+$'= MI_+I3&/2NU4>HX%V\?:1!O8U+9R>H\9XD':EL47!E("]086=E#0HO4&%R96YT(#,@,"!2#0HO365D M:6%";WA;,"`P(#4Y-2`X-#)=#0HO4F5S;W5R8V5S/#P-"B]0)R]7%MS M&S>6?G>5_H,>9JO(JK26:#30Y.Z3$SD33SGVQ%)V:VNR#[*HBS,RI9"6G?WW MB\NY`FB*2K:V4I'))AJW\YW[`7X[>O'M^='B./ZWO3EZ$?XYOXQ_OA[_Z_?F MV-@3[X_/KX],:A$>]/YX=.[X^/S3T3]F/\Z[8?9RWL_>IO^-25_.7WWWP]S/ MOIEWO5O-7L]M_NF[\-.[^,+[^.WO\\[8\-V%KSV\-E_.3N?_??XW&LW:E1CM M97POCG0:>[:SL]#SS^'KMV?A3QSF-/T+LW@_[\;T]-59ZK- M[1*&>CN/79,,\NEYT MEA8PA!W)H[R-S<[F)GUYDSI++YQ"-]6+WX=M2RUPH/CO=SA.?/`F-DR=&IB> M[BA0SO3YXUO\02]Q<)Z6./NE[_W\_%?^T0]B_;_,YGDQ]Y&\F["0S^'!Q]#G M(GU[#/]?!9*LP[^_S&MJA+T\6?:2&/W*'H\]=&_FG9_U!Q'1+8]'8R:(&#?$ MA^__AO`QLQ_"UY=Q]]]'H,1V/\P[BW3H,PG2\]@@[$(?%G86?AE\>FQF/X6F M/RL*_U=K@:L3OY(3#>OS2P\3?3>/N];U?HR3ZL->A6X>(GX_AT^K_/U3).6' M^#!]W<9)+,/>N+"F\#!QVQBVRW>5.?1Y=C1,1_C)LR4UHNZ5?81,Z,Q2M0_\!@)VIEQCH96MBN(H8 M@UD*:KQ.J]A$0GRA@7=SV$(U@]`DSL#[+)MN8H,M;=15?/8I_H[M^R&T/P`= M;K$2$PK+&.+[@742S;\FYO*PW;>*:P,#^!$%YFEH^$C$NXQ]P/88(,!.O;SR MXN4(R@2*].<^T<(8U&NG)\XB(L8L@FL*FP,_ASUI@,VYLEL_PX$WH(.L! M>'"1Z1;G?97V^8Y0&1=]H>#76Q]^]TG.K#)[\&P(G@$=#&VQ@@T"<4MHO$WK MR2N."`ZH,B6JO#D857:P8CM?IRWY$J6$!E3>V0-`84=)'@D*,SO1:G,I49!W M^#%C$PG_.'>"VX'I(CL"]U:\])H:?YF;D7@X[&3)Q`XP+B$9U`7J\$/Y>IR4 M7'(JKMK-S(*13RZ%A,N<:#)]/V>8C$J(X>N$&-BQT.(ROGY+*-H1#P%LX^BI M]8?PX5?&WR7@)W;)LC%\N:2%;T%PA=\N,H(SY\09\1[1\K:T!N@;X1]1M,D< MG4B9.D,.C)W!9CA\2*P[I@_WQ+$[L?6/R`UY`2.BXR]9PX"J^2:HOP5^:3Z) M[Z<1KC-E)$E+J#@+4/DN+F%"0?6+(&^"M$D:.9,D:D])<4`5K2S.6\,DM?XG MJ$@'#[\(N1"G>I&9_J&>;+^P8K9;HE[3_P(2[;Q)Y^W(J,]$\.1&'=( MNVL"!BZEMR,U`SX(PN^:P+`5(,F,#`]M!L(:)5NB\$V>Q1HW=$!M?YW>2(/> MY3\`C*_11,I:GM_G>8-@3"R1)G5-R+TD$?I1[>Z&V&\G4$L8L5ZOMP3)8&C; M<:0;7...]C3]>*%G0'`(*^"6W(C$D11G:7+54.$]`E1:.W-GL4]:@6S).-AE M$H1/=^)W1(W/-&7!HUZ,4WI`40YBJFN(*99P'X!O$JVK6>V7JFD(8@0:DB3? M1;%94IK6R)T>*VGRI]%-+^=P'ME1:L0+1*7>HAM4\I\% MG3>DV])&?Y#HE>@+,FM'&+D@>`.QE"`:P:>]FX(::#5-^1"2#E MM+)PC.PE2J8=\2/C,:KC.[%-::U@IS[''W+X$EM,P%*5H5!SH)Q)-@PB!Y2\ M."WJPDK9+ZF8!JP9,GN\2@I2V=J88"<[(Z1:46L`,B/_M@M`6S#@0"@_9KDBHX<"#-\0TUH#&/0 MYW1@O\2UX+?\FM+5<3706<$X;HD.T`6Q)MN'6]"+$BR78H>$CYU8)GL(7FDQ MX6G"RDRY72`IT.1G*[LPP-DP<6P+*5+W7JRH84:##C>3.GR?B]:O>M%["HCM M8W+AHQ6.Y[`0_2A6'5;$A6;V.QE0:<]0&\4E7-!.WA,#H4C1M@3B@,P-29M] MT2T6O&`OEL@9T5N5B_5,+]0I^WS'VA(J$<3R5X?%P*4FD6Z]\@KK53"J``9M MX;9&2^XKA!L=Z(G[N1.>)'$!CKMKF?MA\AHARLX@[TD:`SFRT*\V<<6,?^J]3W8!>Q%%<>7P%1[*7EN+V=#YGIST[G6<7_I,7# MZ,0Z_SH?:(^['/-(J[K+>/\Q_",C=?]$8@$'HY.IY885`TQ9*U:_,R[TYBN' MK_9X$P]':GD[Q6A/A5:R0T/AC6TA#4IK' M!T4((L04%Q1JH/`#[[1KZA9B_+LL9#^P..9H*0C@"_%Y-8_I*Q=$OS:Q99?3 M5$\)`(;O\+2L#X`'`(*L#W*X(>S!`+P"K)BH[$Q.$!3I!53(3>3JF+Q<$U&G M`4@!C_\(D_C/>;?*TOGO&2.]=-$/=&/-A-(I<=2CL[DWDII"9UW#16?P9\@1 MFC8I-E';0&&E3J,INC1B%D8$K3F@E89[9+.%[-W887S&5%B3J;D_]OD@31>< M=EH;&/`?D,(WBN,W+4$C5'9I\C$D#]8;.B@=!`^8*]*X`ARH!+Z5!-5Z@^2T MUWJC:^D-5ZH-4*5D8M6^E\'2`&%@HDI@N:OEV-*+][XE=7--T$-CDSQ8+?Z- M$=*@EO]%"H)XPL'6_J[W^#*CP-=AU(>D%E`21&UH[70(IW=6+.M)[M1>F7PU M!S7E?M:.SX'),:K"(.'DY4A*04"LK#`_!&O?)(U3.&C@"U'>`*;I:M=$(59- M@^/B=X7ZS&F9P@MZT"N4CK5K('0Q:O4B?_?R]TG*+JUHQ:!0D2LGFOS[G&/V M6W)POR!0*XN=),>THWMH&4>VU5C>)0L/MPMZ+JL*7--B'"SV;L8*KDNU(4UR M)&R8$N7% M^ZU"ED[GGGDB,K9UQSMZ)5R5C@*5+;7[D0;@3)...Q38'E:>/2DC9GDE.$HA MV8AWF(&S;2.DK<-L(]OT+,&8S,G&*/(7PR"&4/D+H^1Z4>(1GB@Z>Z^28)SH M,]*&*K/:%%.;TG[$=J@D-F@FL,,(9CSZ,55'3*UJN!)N%/#+(@2!JJV1438L<,FV MUV3%1"T,O6\4]D@3XQ$-&<04N3F/J!`+D*YZ,4FJ8O$MN>WVQB>EX]5I9;@!`^PS.ES<]15%@8D1/E.H2T)=ABU9_6C9,)B5 MV)1F%,,([&$L47%WQK^;#$D"$U5*>ACM'S(C^3VTAD@"KS.#.-H58>BG0=B> M*^VJ1FB=)3_%C,CDNX*`VL:4>X557"B=F]Z_ M$=[_L&K4&5A:8T3'QZRG)X)1TVD'",3F#I/;R<4+GQ5-43]F;'=/I*AY-HT< MM9XZ2VNN.;F6<0XC\TIW(DY0HM'WTD`&7O$%+<91-"PL-["K*GM.Y^=\+G:\ M1]KE,1(]R5'A:)RT&(MEE4Z5C; MBJ8PZZ2!:@+F>'+I_1Q"^C5]A'S+W@#J6?R752>K/=)J5V)/7X4F&8DZ([T0 MT[@56^$H1>--#F>AJ18EI`A_Q++"&!9,RQ]0)+O2FNXH'RD*'7H8.+6:J$KBL7&)[3X)*0QRPAE$"C;[BM/,6)K6$C7IL@KYTY$Y6KE!9`] M6;MLL@92+$%#R],,=%E#@A;-K2IK*-U`LQRX(U758%8+T9%D.UU6.8A6CS4; M]D8VN*/=H$+"LN:NJ!F'H([,TN<@$%0OVKI\D=,W%-;>6PW8+CQT++8R+;M1 M-*(4^S`KBVY2Z,AAE:I19*#XF MW,U&T+BLHBV4CO6E"W#!PT*#O;)J3V5:UR@?&A;L>NK\R+YP6;NX\)#J"&I\ MK:2IV@5#F]..")D<>I6F3!7B*`P+$DJR)&I(Q*]*HJI2ML.*2;JZWDR6IH+_ M@6:^](VD5^)9L>RMI0!EU(W%R%Q)@@'Q`I-VY;28<4(]?$(BH54K8P=[RH6O M>4`JS.Z'$ML0S!<,R::4C&5KS].(*8.N81W':HCR"V9LHLG*^)WT61W7]:,J M94_3+HJXP`X84=IUY.&(;#,DF@UL%J=]A95^1.L`" M3$C!,V`>P0"_Q1%\48/,D5XI/<"CT9&*D=:E?9``8K%B&9SK)-3-4HIN`D0C MB9KF;<86$\OJ..7S.[618W5JI27$[3BK+`P*3&@6MKZQ,.V\6J2S3BNR+E.Y MD'P&".3R6F.MG?L-(WU3`Z>B\H7,F"+YRF&'PO>J,3M1 MZM@0.46I.??VO#/`,OM24;,20I/6.I3C:#%DE!@"V0X^1'N60RT9?6V76G&% MP/^?78HU.'>8W89HH3@B2$&YSC`'`:RE4>8F;#(HM`^LSK-A%8:VI*%8=7$. MRQ?L(7-HTF9-8WJ12*WXJH(6]38=MP]%_[#>6(AD;LZO+QITYE5?CD M%.G-G"M"2_FJC[>W2^]9.@N[F\0SZQ%9SV<0GY-DY2,Z%QN2!Y/'^VK M7*^)>)"8.-H^I7E#SK?S!)D$`D, MF6S"%HE]F5X59T08/4^&.:@:]VOV)D2<6FQT=19GZ<3>G+V:&ZC\KR1MK*71 MQ^'I!&,W-HXP%MFQBE=T(-GRV0]99I1-MZQ_NH.,8%]XG?\G1G`9:[1F*?9C M7=-G0`+FD/`#C@E=F_(>$HC:TCTDP1XN[R$I3.F\GSES;EA-1@#\H1"KC&84 MO-,O>TJ,=<^OE8H2Z4]>!&%Z.8NF/P1R?9L7)X]C4-AP279(*KI* MR]QMU[J%I+BUY(#CJ?$4&L];'4^U[V/@, M.HH^G[%')H1BTRP7Y>??W\\',E&R5-#86_&:=#1G6(UBM3;+ZER$_/U'@>H2 M8`/?H0P:H7O25XQ*,BJ:QA#!_B_RD_S($X!Z$Y MBE])5TW`X@9"9970(U)-W7S3.L7NZ!![^II/LL?=VG=[!Q>_)IYN5#H,K5*' MAN1J9(6\+Z/J&.8&B$LA2F<>JYS7BOQY^5$7N;P:QF??!MAH%.AF:9TC`2VR2I9"'@"6:@K*YP8 M%5[8"&3N59,Z-O?D*=,IJ#&8A;AD$8\1/+P*H+B30T;5Y<499M(+$W>2E19. MB8S>'Q`W^9.1LT9F.5X"590:\F5;74[(<$KA?ZQ",,7<=NBXG\Z>W>M!&M/%.)3Z,J\*]+=Y<4/4KC^!44D:&,C+Y01 M)V2/G[XM-IXW1'-%W1:K"#=0NV!U2`ME)3J`:V7C_;WB-MCTZ:_IFEDKGKR+ MU\R^/21Z$"L,, MA[=G/TPBU/`AP'>V)BQ,.>!(>F M6YPL[?'VZNC%[=&+:WSKVW.]Y*&YY!YQ_6.^^)..6V;TJ0W@PF9@7A9HZ2

!Y]6&@D(7Z1F M0=/IW':OL\='?7,CHV?3GB$AK$7)%SA2NY9WK,XRCO69`+&CBI=S2'YG_ MM2Q[35>UO);MMN6(?BW47AUK5M$?5;MV*A@891W\V/VI?D`.,U)OL%M6`S^[ MD7)AHCG5;F'$SLOXU8AWSN7C?R6-WK5\YK*O\V>2<9S)YO$9E_A2[8`8.##* MVSUI!F\M-Y)7([\O(C'3H$CJ\-GKUZOF(XF9>GYS?\2HY#4S,'?>.`(/EI0] MEUQO%=>O7,O[*`>2,])S^+53BI'F"1.-2S=>FTB_F,^1]IS2=CI%W^=J]JXNWC6C0=;$-_M:-K]C&&[OUZS3ERH?UD9QFP&WNFJ:):;1BB M`_,0>5^;F>ROD9[EJOE<0LX=]AN*(P[\*]IWS&?W21.?3P?G1<=\U^O1+BW[ M#JQ\+K^1'SLT9APBZQG_%K?7I'S]"E7\^:V2KPWDR,1G0BOD'L<,Y/Y$?L"- MW%0BT3#Z\XP:P%/A9C`,6G700NZ(Y*E),"G>(5#HJ!27# MC8(`F?W?RW7_>69T],4-D5Y_/BQJ:3+-,%:9N.U<48V)([_?:H6F@3]HS375 M5<5RHXU6X]\0Q9')N,F-=+HN!CX28KG,NCIN$ODY;`LWR60Q MF>>:JLD/"5NX<:9YW*3&>F/#)-/,YCJCV;%`VI!NCN]/*S&9+631Q%B=CHOL M_^5LS1#Z@62T"WIHQX3)A45#:+=Q169CM:G>:)[--<[XRWUR9M/,6HO59#95 M<[4-G!5(BR=S$XQ6+IPK*N3&SY@1RQD;JCE3G<4TKP;(8OMG*NK_(>N!329N MM-DXC_R4,HPEOZ0<0WY&FL;P&NI]16FT"1S1:[G50V-LZV4(;JC3.-\VL;3!:[ M59A-X`%6J#3:+;2ZL:K9OD5";*RS-%*RZEI+4YVQQ=Y8/==DMM:2O<8._&5W M7I#TA]UKK/5U,MU*5`?V:"8>&4LZ_\6!\TQUQ!+ID''CB\;D MC,G*+!HS?APW/H9.RD[NS![7)&KLZLS]9U^AR%X#;4"4!U( M#(SY!BY+=U4+6P9I$?-K:6PF(ZL:Y])08#=9,@_HJ9YZF)&K`V$U`+EQIMED M(@*+Y."YGJJ46:#=Y4-(,$,LUOD#:UL:9 M)KN1$LWVCP,E6,VU8"(P-;#)>^<``^:9`B_I%T7_8,"-W%QC73,-*4:+Q60= M.#J6*P:/!$]I<>P"]L1'0C!"(V=I,E75@HEP2V8`$K>/DU'9.-&7FN9]QX M6LIR_X`JB&^5)L=$L([1FD8(BB=G0E*)'):4JN%2XX?%Z))T.B>GXGQHU,7' M)R7!9VIB*I>:DJQ/UKLZ_XG7_:4SDEHQ!@/_LB^\S-+U9N?K%R\XN5FU^LH)M? MK-S\8N7F%RLWOUBY^<7*S2]6;GZQD"_(%8R`3_V@%4@,_K-9 MQE&?(;''OOL:W(XWLXCZ1290F6G.(SS]^0PWQL?P=WMR'R$Q@=0*H)8+9SO' MK84\79@-V&CJ%;G\73P/\&PJ,V()$_A[M]UNR=U[$LV29*W8_K_4_B>O%U&1 MK8O]:D]V=H*A$TIM+"T[(C4)^TE'AZ]_PLOL5\PSD(R"H.%DAYP) MU`[`(`/[V9[0\(2-!]EWH/]M]BW8/1GV5H>K(@$F/,R^@)0HB'V>W!3@%R=72EW5`F0%EO+T%<"SN"U51' M"_=X^R1L`I$N!-$O!,DM!,DM1`+H6N"@66"GB6$7`,T"H%D`-`M`*CK6`NM9 MR+^7@$\Y``?`@MPM('?2W@Z?70#_J[+KC6WB/./O>V>?[3@7FS0PMR&<[HYO]]S[_/\ MWN=Y[_S>G?/!?J]S__?!<\`":XG?PGGLQ*A.B<];'0HFV='*=B,2O20>P:DV MQ".5Q]LBLP]:K@8V$6&;ZM;#M),\.EEQ-3+O9.6)MIJ%ZANQ)C%/O@,(I`7< M#GP9B`,V,6^U=RL7Q;WD12.?>"VW1?=5]WVTWIJG1=6I-N27:_U",94DK*2=/2<6E.6I!<<]*<0\BY MI]W'W:+7[7?WN`UWRFU7''0A=E*<8-^7`'N!:6`.L.$<9^'WB\\`6;P;69R* M9]@/-X,)6E[@.O;78.UH>:#S0.>!UP.O!UX"9I$4D`.FZU'I?N1>'Z:_Q2(` M^]W[)GC9-Q36P+?8'C"$EHR6C)8,U77A,XS0"_8#*4#DOC4`LP9\+]93C^<` MB<=O<TD8Z115M4C6K1CNBBK5OMUKH[NA=MBJIH2H>R:)L=7AV^,GQM MV)8=GAHN#8M];)DC*]03X3:H,?N>]?@3D3Y/;*>PBL/)@N>!#P"1*.!N(`I, M`39A%:P(*_"NP+M"1H`L8$>/%79[`2OU&///\QC;8W'AH;B(`S]K[>@=B0WA MEIL%Y@$1N<\B?I:K:WNKW&^"U[A_I*Y?X'X%?*^/B!O<&+_-C>'R&R-1(`M, M`W9R33Q$/@"0&:P`T\`J8!/'\#HD'A)6\#HKG!7#AKQUO4(V;,"#HWF=TQOS M"HV8`S)]E_/KG$]QCG)N-YJ&Y#M#\F^&Y!\,R5NP(W3@J2G3GW(.&.Z8?"XF MC\3DSIB,;%\B`2(+ZSE+C.G?.>_E'#9:`O(G`?EV0/XH(+\=D(\%Y*\$6+^- MN'9EH86SFS%]C?,0Y\V&6Y%_K\B'%+E/D6,R/4-1G?1SWL2YE3']^)PG[B&N M2_1C/'!E@5IZIU(5"#?TKJ7'8/YKZ7M@_F/I9V`^M?33RF7Z">6/-'K':K^I MQ-;3?])!&VO?KMN/Z"!9AKT%>Q1VB>A4@_V5I9]@^G?0_TVT?TF"3J;_!4GQ M?O-TD/O?KO?[N16>0-6WK/"W4?5-$N95?V:%;\)[V@J?@OF)%7X!9M;2V`"? MM_0GE=@Z>I2T"TR;)YK`1C)!G'=Q#-O])!:UGYTP5VNBSE6KA*M?/*']5+RN_:J_2@I5P-5YT( M7`E7!?J>4L9)-J$5Z'EE-7Q465%Y=%%%%&_UO-ZEO*6.*6]H:%O*B?!E-@SR M(H[X(,*9\"YE6%]6=FM5BK"AHYC1H.Q0OZELAWM;E0Y6EI6M[54VE![D6#ZO M/(F*FU4^E*_U712>(@Y:-,*.&<>$XZ!CGV.GH]?1Y?`[VAP;'2W.9J?7V>1L M=#8XG4[):7,*3N)LJ=Y=,T+LRWDM$E_U3+(QMO%]K\!8X-_=(P)U"KAVS,?$ MI)`<[:=F1L*3;62BLJ9!$M:8I-RG05#6^GAX^4%8U6K#R1"-U]%HAM>A](&FHZ;! M+*AK!"XOC^$DRR\Q&HE6:TDJ[5D+/%:R?W] M-)E*EYVDGZUFRVU%<#?@>LBU!C+]&[S3N_C%L3/@>Z7UHHW@L>4.9VIAWRO[`RT7J3OUD->N->I_21$?(GGXO?_"H7"#$.Q M&`+/%'W<-X.+-C":-'?O&TN;NJDG3",7S_"53XOU;2!M>*_HUW1A2B_IL_J\ MOJK;B\4,W,U7@M>"0C8X%2P%9X/SP=6@Q`)/I\\;^GSP'T&QB-E$9[`EXKQF M$19_K#E3++"-H$`!J)4+%4,#Z5B0Y/%IE^*3>1=Y#%"!7F`4L)/?@O\,?`C< M!FSD>^#3P#M`A7G$+K$KX7LNSBIF0NRFXQ,CE9ZG(MNJL.-':G9TK&83>VM6 MCT5\L%:TMR'FP0=O2BZ"_P#\!?@;\"E@%R-BA"F>*81"I,"7D85CADE#].%Y3V@!_V47"-X0&(BXM\"Z%9F]O_T/ M=]P1"`UE;F1S=')E86T-96YD;V)J#3$U-B`P(&]B:@TR,30S,0UE;F1O8FH- M-C`@,"!O8FH-/#P-+U1Y<&4@+T9O;G0-+U-U8G1Y<&4@+U1Y<&4P#2].86UE M("]&-PTO0F%S949O;G0@+T=-6%%#2BLC-3,C-SDC-D0C-C(C-D8C-D,C-$8C M-$8C-#4C-D4C-C,-+T5N8V]D:6YG("])9&5N=&ET>2U(#2]4;U5N:6-O9&4@ M,34W(#`@4@TO1&5S8V5N9&%N=$9O;G1S(%LQ-3@@,"!270T^/@UE;F1O8FH- M,34X(#`@;V)J#3P\#2]4>7!E("]&;VYT#2]3=6)T>7!E("]#241&;VYT5'EP M93(-+T)A7-T96U) M;F9O#3P\#2]296=I2`H6F5O;BD-+T]R9&5R:6YG("A)9&5N=&ET>2D- M+U-U<'!L96UE;G0@,`T^/@TO1%<),3`P,`T^/@UE;F1O8FH-,34Y(#`@;V)J M#3P\#2]4>7!E("]&;VYT1&5S8W)I<'1O<@TO1F]N=$YA;64@+T=-6%%#2BLC M-3,C-SDC-D0C-C(C-D8C-D,C-$8C-$8C-#4C-D4C-C,-+T9L86=S(#8-+T9O M;G1"0F]X(%LM,C4P("TR,C`@,3$Q,R`Q,#`P70TO4W1E;58@.#4-+TET86QI M8T%N9VQE(#`-+T-A<$AE:6=H="`Q,#`U#2]!%=I9'1H(#$Q,3,-+TUI$@_W%:A]-*U4F']J@?QUJ;3&K!)2--#_[U) M=EG!DT,R\#+O3=X,JYI#(X4%]F(4;]'"*.1@<%&KX0@]3D*2.(%!<'M&(?.Y MTX0Y<;LM%N=&C@I(41#VYJJ+-1OL'HX?K]7C-=VG-+^CV8%F""B.XZFDQ.2(G)10E&[*`G*X4\].:GZD7]U)K!3QQZC)"H] MRF\#ZO.@/;-\%[^JBW&^&N-F"OL,MKPA(?&R,ZB\ M4P88$'G*`(%:,0P;F!QF<&9`R4>(:8II5*9EFF8>3:W38%KH*;,Z)WMH>;*L MS%.IV>MDQ],Q2Q/F?FO-'EYJI___WOO_G=^]LUE[?>M;WWM]:ZV]]P(8`/"% M5N"@.$N?FW/US\O4B#D-$!Q+\S`'P(MA/J$;&, MBQZ"[3QLWU+?X%B079T7CFTK`'O-;#4:`D<,Q2[57`"FK<&PH'&GG".D%_#& M6PP-0O'9O\P!B/!%F[YOM-H=I!<@^0KI;[0)C5L/#LD!2!D.P,U#'$,O4D-0 M-];!E!R"?E*W!?U3YC5QQ?05/_LRQA[%$LL%!J_;]M?V;G7]^>L M?#OL;7WY@VK?7EL9"9JT]`E-F'JTC"N3*(-"RP6;26^JL_"EMB:[@R\4'/.M MMKF:H>H00N`=-,1#$,WG6HRQFFCU1'>'JH_3U"#P>H>AH=%DJ>/U@JW99!3X M$JO5H9FLCG=31Q46\?FYVHS<_-S22EZ;F:DK+M5E1?,3C)')B?Q`'>HQ0WV3 M$]53-/'J1#7^9F$S61,_22,V__,=6+JE?\P9*7!+UV#<5[%+E\*)6/YB_:+H MF-BEHSIE>W=ZOQC@>]LI_<=-Y]Z:-''O!Y>]9D_^U[<=/5X^QS\=.>O`L:\O MK^SDEW3'5`Q=)1;\];]^'8BK@/ MCP9+[TTXN&[WOH(9W_Z0.O;9\L>6A&\RKS@\(V?#7?MV)'QXS2OFQ+[DQUD. MDWI02G!H5TK`IN72J>]_V_KKP@]W77JFY9KTVB.WSE/MBIKP^?U!PJJ>Z/N8 M!V9MK'X[8&?KI1O\JYN\Q+`EL"+P5]U1WR#3'WG6M?##[H]R4==]^()NV M^=EM"V9]?^6:45?4Y6U1_V-;PIX8K\__:1V_QW=FE71*T3WOEA8=?S$ZXV/O MXVNZ[G"]T'K\W/I]]XS-S?`WGWC4R90_]?I[L5M2+MWS=,6.C\8*Y^_?LV#3 M2Y_D9-3/CEGSKPNTY M?_CK;=D?))7_%'[L]7&I,1'Q[SY^]I7TG.\^;LAI/G]8_91?Z[OW?)RZ9.N5 M1R9JHD*NOAE\X6_.;\NTC=DQT4O4;5X[L/AMY5B&9?U;:M=;ECF/O\`$6C8? MWB?,ZV\QBPEMN$'4;SY"D]0:]X!/[,V(3&M#@V`SF@QF7F^M=8334&A\EJ MX9OC-=YJ+\(O"V++])H@=0!I*(*4MQGL]3CU'%:+QE\]Q!T*>8E0TV"UU&C& MJ$<1#!<$4$7PM_AUR;?7;U,^I9JQ+62S<]LSE__ M45IAQ:UM"W_PFE*^O_YPAFY;JN:I7S]^Y->R(]%//_5Z9-&[EQZ^R(4M_&=( MRJY?=AE=M^B7 M^UI6/5.KW#WS:KN./-Y0WYH<_=*L>) M_%2;]&_J-NDG='1&!TE8-:B]">@GD7"L=*MZZ4K28B1+6]5+6OT7KO_RKYG= M]8_^*^FH)?5'[[8GC?\#$ZE-RN[#IT)U.+%$PC`NR5!UL)H\^?4]V85RK+P5 M<+211"F1J=%X6;JZ39+0CT9)6-LD*D2';8UL'5_O<#3:4^+B_LW$>+*-ZUK: MQNTKK3?9>:-@=;[(C MF9VW.VPFH\/4F M87XT#B&?/%D]>9*R3*]%NL86FZFNWD$V24URS\K59^9KF_K2DMS,TOQ*7E^6,4.7 M6<6%?+%)=K,TMQ,'?*A@`)=82F:353DZO5EJ(_7 MEI5.+RI!6Y0>(_4>#_C<@N+\7-%F745QB4ZOY_N\PB`49N:791$I?5@EVEV@ M*\F;G\X5% MI(YUIQ;EOP2&SU@[.Q3J3'9<%H8:W6"TDK6I-0HW> M/1&T#IP9U4TX@93"`N2GR=UL,#<)O+W>@'E@L3KX:H$W6K&KA@HQV'F#T=AD M<\_`6JNM@J52]]CJPD MO&3I3G6KNE7F7;5B.K/B%QTC9QA$3)`I<%612G$%#1UU4_D8)'5U+R6K+E>' MA`Y:#]7XL,*,N-6#'&^GD37U[<2]:PIO-AFJ8WFS`^?"P*=+]UNR.K3?2C=2 MHE#+<+7#OT'//>1)[9'\;2UEIQQS5D>\MH._:.YZ?F'VPB>VW'UPGFQZ2*!P M]/;(7V:FKIK7>2DX:<&I!_[HW9K0O#:O]I4FC;)6%R#QZ#KZJ;_@?WC!@^#`U[RMRY]1CV\-TI> MG*;_QB+!9XR^EK=FT+:C#NMCE&@")?[2^^SQ1PN<7>]\=_D9RQ'?%]3%_:BAV>2P-0F.ED8A M;M`CC:2-@5E'@H[<]?7F588O#HZYT.%4[M\TQ6[^8L7SOW<.?^^>F9[BKE867"EZ*Z'A[Y8 MX'OLR_;J-7.?]=\\ME[^>?#PEE6W5%X8?V^U:OB")E:2M"4O?<0K'^G*ITXH M'"8?;1QOF37QD6_G7%VX>9]MS.)=.R_K`Q[_Z:O[VTZLVO)J^-U^9[_[S%11 M-6EC'GMH^NY'MZ]<\4WJ9SU%C[__]:DC9\T3/WBYZD]OU'^P<;QAPIN+3QB^ M?+#\O1!S8&[5ETQ#KCWHL=PXN/#_IXZ@)3[8QQ_&I[FC?6,@T;EC_//7N^RC&8)KV]D@U?N350Z/&=PVU9LJDR;.N2]/O'NSP_6"; MLG/)PZZ?@Q[QRQN<5$M;=0N7-,QNF)*QL/F3\Q\W7@D)R'NP\N31Q:^ZZHJF MVG]:=+IVBGRNH`L>,A+N<5U]>>.NR$W-7^UO_%7YO_-+@5]\[S]][ZKOXE;-;SGSL&KEKW8-3V]IG1SSTMZ=^4@=F/+ED M;-&]7M.O'4QX//6EW2<*O[I_CYTL:HSD&-,!4@#I1NDD;$:X:VXKU+*!/IQ4 MRK",7,9*Y3#H5V"U6"'](G_1);V_)YN9I/!F7FL5^Z2W@T::#V%81G'K8"2` MZXQ8ONRI=%V0S@55SUVNT^/]D'B?6-P_`T3`'1`),^`UN`B'F(E0#(==Q\$( M%>Q\B$'\`_`B'(;/(`MJ@(41S"+@79O@?A@'RV`K)$M&N/9#/GRC\(-0N`52 M&"O((`3JX`GF-.1"'LI(A1Q8!3:\ST3\STP2]C"@A-M1^SIX'`[!N_`Y#$>) ML7`2!_YGUY\@$]<3(RR$`_"9-$.Z&H+@0=@)N^!5.,_$,MN9[[@?7/M=1UU_ M1ZY(T$`"S,:UIQH>@B>1;B>\PZJXIUPC7`M=3[O>A%%H_1[T^E7X"^JZS/!, M.6-D=W`M/5==%M<>C(,/VHS6XZ5%;PK!`7]`RI/P*^.%5QO+L]-88T^`:RC( M(0S7MRBTKPS7NR6P$M:@%QMA"SP'WS#3F'KF&/,#Z\NVLJ](B^6%\D*O5[H_ M=.6X+J,.'PA':V^#N;``.1^"AV$]RG[*_<$,Z/B^8JN2IN$7>6NZ*0=A?U;.@Y[BIV+:#?F&48SPB,6A:4 MPAQH!#O,AT70BM:MQ:L#H[<'+R?&\Q6\7H>_P3F\OH)OX'O,."GZJ&0FXJ7& M*Y5)9V8P9V:YPKU57M6N/JP.L;C/$8]&8P3:SB]@U M[`;VY@]B2/AXF0X$L.X'"Z/NXV;S=W!.;CUW*/<8]P3W!:NBSO,O2%A M)2F28HE-LDS2(=DF>4YR1')"Y)ID[S'C,<12&-` MNA;WVA_1PM',^VPBT]`;!+6LE6,:/8[4Q^][+NC[G'75N8X>Q9@.Z`;BV; MB1E7YMK-'H)_P(:>*Y(OX!#[*93AJF&D,^='G'OS<:4IAVNL+\XG/:XCC>G3 MIDV]-2TU)3DI<01 ME3V0QLE743)^(&4Z4M8.HDQW4Z;W4C+^?!JDQ43S.A7O/):EXKN863,K$%Z3 MI:KDG1#AR\+IA]5F\DZGB=<[LYOIV7546RNOT5F:J,@5E M3#1T*KT1]$;(.535V,D,G&+5CE'J+)TSN&J+&*"DXO0&6J< MQ3,K=%DCP\,K8Z*=3*915>T$58;3+XJ20"95XY1E.N54#6\B[L!JOC/ZD'7%_`"!W?7EJA"G=. M&ZFJ-&2-Z@R&]I*6YX>G\\,']L1$=_H'N`/;.<1/!'Q\^P-";Q^%*#F!\DIZ M(\L0BU2YF!%.WLBC)14J]"F)W(0D:#Q6E6C/X\5A@^*,;:&RI0X#']X.!G@U5WI4(T-9^O,"G>;A^J1 M>R$]+JK2R5:1GL.>GI`RTM/JZ>EEKU)A)N^C9Z0A3L6XWC\__]`@77V*DPG] MC6[!W9^G5^7-G%7!Z]JKQ-CFE0YHN?N3>OM$R!F46<&-9$6('A>4$^RGW1_"&\`/`,?O2AWC)882O;+B/[S_" MB8*HPB_]OX)I!1RG)S<\>O+DHQM.LEIW?9)*8UMA MC/'MTW?ZI?VD&*V@2IZ:_E(JJ??F?W#&Y>J9BINF-S:]*3VU0>'=,Q7OY3U[ MKL4J'"*^[W=(<@P?(\CO*BH@2G;#E])]8)``1$AJ8*9L-^3(DF$ZMPQ2L*\4 M2PSV/8A]$4AO$>L'V627"_$SL%S$$HU%CX7'4HVE$DL^ED589K+)\`R6U<`!7BQJ'^25(?*$0X0KH8 M@N6C"8_K&VSGRR*0Y@>TP0[C)"]!$O*F2I=#*-J>@WU)TDC(D,U!?><@%.7L ME'W-W(7U#&D6XL#U#PEPIU!V*=K1@B6;NP0ZY,V51$$.-P/].P$Q[#;(Q%J' M_2%8-))-Z%,43$"8V)^(<"76)J0I1-XH[,_!>&K1UF+N1YB-=1S*G8 MC;`=ZY-(/UER&8*8JU1O&H.CA3P)&"N0R>"`3,:HL?X9RV5%.43*ST,>RK_= M4W.3H);$#A]I3&),6Y"_%O5H,?_N$F-,RBU$%^;.5Y(3;+("7&O0=UZV'L=\ M,<1@;.Z0GV?:,%:%M*P'`]8%I*"\)"R)6%+%DB+=QRBQ>&._'MLS9"5@)$4> M!O'(&XNZ2DEN8)\:[:1%M#]?M)_6:&<!3"[0]3`7R-[NKD&%\%):(R^S'5^!`.+I ME?C_S77'?]A%UJ/#N`))Z1K$@C_$03I"%Z1^X@HUD>GI7;7N$==5H*]W]X@P MBZOY'YD_A>7$(]DH"GLA58\L M6H09\)%/%&$6AL@31)B#$GF6"$N09KT(2V&8?)L(R\!??E"$%3!._K8(>T&& M_*((*]ET1;P(>T.-TB;"/E"K/"G"OK)]WFDB/`3F!+AYE<3^P'P*>Q/[`RLH M[$/Q]13V)S8'.B@XF-O=!ZE;VFHMII+A+HFL\'FD9OBQO(I?:=T"6I^ M0N_9=*2[O[Q?KQM34-IK&IIBK;,9&NM;^J,$/LMFF$^^-!;5UI(/C9KDI&1Z M'EEKM3C(Z0@Y;;/3KY)VOE"8SY=8&PP6/LG'BXQ=0)%L&&F,8FC+!=X(M-O+'>0$XST>E8GB]#7*W5 MQML%AX.X,T`,$6`WF@0+/0GER3=9BB,G/JB^H=%LHD>A#BL]W['3V)$0-)'3 M5@MO=R"UP59#@V*/[?\E78PE_9!>[V@PQS4XR#\HQC78[W2+B278W\DQ7S`C M5J`LA47]C@6+LOG\W$Q=H5[':W-*=/1@T%?IJZ0CY?!D+('1_$:;M5&P.5I( M-&\P_`..D*M;^!9K$^$T6IOI*1BZC$-#Y&!D&^BIFX$W8VI8D-Q0A^-.0A7+ M5R);O:%9X*W5)$60TS'`&+OGQ$0PT<&N,=D$OAJ3 M73S"HP=O5HO0WZ%C=H]1@CVV-Q2]S"8RLN2XCYYB&^R8%OVY8_DRBUFPVZGS MU`O!XCY)-%DP"0R\O5$PTERYSG,>HVBA*49X#34U)I*YF&3TZ-D>3=`V&EMZ M7CG(*$PT$W$(E5`ZDHJ8733Y2?I2I'4^KA[ND[48-SVBC8+*('-M%N2FROMS:9:WB;T&S"F4YR MX'KW"1V.I&#"Q'Q$L^BB873TC3%QS"!:77MCL=3D7@8CKC#NLUDB MB!S-.E((`3GEC^$G)$U.C.03-4DQZLEJM9=761XBU1K-Y,EX3YR4R"9-;]YF2D!V&B>70>@@6L8(,&,(`9].#`V@(U>+?AO11:H!$$J,6V$6L> M=F$IA7H*%]##-RORN*EXR*2R&NG=@'@3I>`18T;^6(2R*-[PORDIKM/O3%&`$KH^:.RI6M)1$K1$]:[DIE4!'@]#-1TT6Y.&A"*VII=8)8NR2 ML)!1,M$(B<>M"!E%R$!Y[52J":T3*%R(]7P:42O-+.)%#NH2\)I+N8EU)LIO MIASNK..Q945.XC^A(:,13?6::/1MHGP/=36E(?:2S&BBH^[`NG_&.&@\R+^J MUU.Y//67M'B:AT8:3_+/[,9^7&1<>&J[FZ]!E&FD%O-4:YWHN<<:HL5"=;AI M&JG%C72<23R+D8?HJZWQF.!'3$F M:@7IK14C,Y_*F]N/SB#:[?:^@>?)@B91DHE&RSYH MW>C+%.);/?6B$6=%'%[SZ16+$@?F9:QH2QRE;T!=<7AW((V!6D9:=KAS@#6Q MO;3_9W60##2+M$(_+84X0TIQ=\RE>AQ@]WLDZDX-S M0(=7`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`Z6_<1]:?_F\9[N>%&]&>`3-=30?V M&>CJ5T-MOXF&<`5L)<.>AH5^O?R-GS8$`MGQ>(UCQX&5"04&[J3W(GJ?1N]Q MY,[&[8T+"^MB8_=N)57TWM&16-V2[GUF1)AF?&!8VGC2'IJ>:HX,^V+W\+`S M6/:,CP];F18?M@Q+')9F;!.Z\;LCPZSCK0W6%=;[)(D0&HJ6!`8HTKN8R5V=#&OI"?+.UZ6=SPO[ZB3=]3(.VZ3=V3+.Q+D';'RCBAY1X2\XQ9Y ML")0X:\8HO!1*!4*A4PA4;`*4`1WN;Y(CR(?=(-E_O2[KH3<)13V9\F==7_U M91D%"S/`&<3EL7GZ#&=25%Z7W%7B3(S*<\J+9U=T,LS:2L0ZV95=#)16=#$N M@EH^DARJ'P"&<2U?,U*L*RN9/.=A(^15\\[+>E47HYPYRRE593#.P#S(*\T8 M!J'-TX9-"YP:D)R==8-;E7B/ZOL-B^K_RRMN>0G"F";ROU&,XWEYV,-R@M4C MMH-B.PBV@V*'C7:NS]-7.'>/KG3&$\`UNI)Y7KL_?2$YIJ]2Z00L5<[5S?7# MG*W5/-^9OE\\OQ]756VL)[5!<.Y7"5G.=%46WZE=>(/NA:1;J\KJA(6ZTHK. MA>E"UEYMNE:G,F15'H!"IKISXMH!ZE9YU!V`B4SU]1*[F&HBE`#S-'A'53I]5!E.7RRD*T8;HR5=F#"D:PCYCPRQ:]B2U/"1 M!YFGQ2Y_1`>H,B"J*6K0STY^,$QGRB(%+3G@.LRV[@T,BX^J_%_QOU0R#65N M9'-T7!E("]&;VYT#2]3=6)T>7!E("]4>7!E,`TO3F%M92`O1C@-+T)A M"!;+3(U,"`M,C$V(#(U-C@@,3`P,%T-+U-T96U6 M(#/0Z-[@R0JB+9>^B.WLVP>CZV;?MX2XL-+1]HN:-E M0;=W=+-/R986C):'A.>TW-\`R5Z=1*=T#ZM/-#J/T&FR]AL'U![6I*Y!8A?& M'KE]X0-"=MV,/_7';!%8JO/?LX21.%HNT''=(ZG6(6JH#B%J@EK^ZR^J^ MN(OL>Q'8+&#XYA>XX-96YD M6AY3>=#K*#_/L( MF7Q04%98HN57CT-(,@\A<7!A<55!YJZ2"H1\]B+$?%NDD.@/RO,)YWL2I/?O(!U*!AKI#W+Y$_4_:6 M+8;QYU)>I%66;7P]C()^/D'5/ M*,/T(BER>A92>\J.G#2R&B>5V,QW3M*9JYC-X,Q[]AJG4"O'*@M+^71UN4;+CU)H*U7J M*<&]90Z$P:)G#R.#/Y](`LQ>\\G_`POO,8LKZ] MK<+#9*'!(3+ZFM#;2C9`%BP+"^D?&AX:/N&__P1FK>VH!_*VBZ?X!@;-MK4:_]78L^67C_;W;?C\GME3`^Y<6]QJ9GGJ MG/.$O<>_OS>O?G7S7.E/SV7::"8_F'@OJ5;=XT09/88^>^1ENQFV-B]Y?/QY8T^_IWZ(OV+QS)HW9]S9 M9*+N^VW6S8]?N/SBTA'G1LEO-KYY/W%(V@"+M67C[KWD.[/WB:MY!ZN4)II` MW:O>M;]>W[KETTG'S3^R,5MTHG&G][)#53XOO'Q>OZ\P-FGC8ILK!^6_KQI[ M]95/-%&_MZQ.?6%[QBFTDHFJW%=2]QUJB?O& MWG'U_T0G!I\-"1G4V8D'MCEQG5$^\X?D$V9F\=B9#9:%&QA"TA7J$@VO*N#+ M-0I>KN6+M-HR34104&5E96`%--9`X\`\54F0NDQ.!)4%!_>324ECMF??OYZ] MK`9[=/7C&FR-H-R;9)>XGKNDOC[KU8.>KF4UY M`=^]=,_'\7C92VG_NKYL?_2Y`](?8C/.W)M]6_S]_!4NP7=8Z\]'K/+T/>_L MO*CFCN[FII&7[3==6G3F2-'[\LPMZL]_ER6E?AFDRN._?/&CFF??3WG'^_"L MHN^_JXG>GAA1]T?4P.,C]J?'3IBF>+;UA2M'AJ5OWSODY^HC3K\=ZC]KUE'? M5^_/?#IB[F+[6[(5MR#L3BK:E;G]HF-6DVS6;EFTV!0BNDAD`NX)#B.3 M&?,R/,>3&`5LHLK3E'4V"BD)TFCEVG*-S`R,XMH3%@&2Q1.2YX;(B)TM+G]E;5E/THN4LY29&YNPIC(+4FC-<2PC;GY$%`BX MDYJ7X^_XU:^>UF,:+7]J?*=P]ON2ZXL2K4XZC3QP9_HT7A;B6#3_Y?TA*VZ] MTC380=SOV:&,&+WI_O(+/4I])T1EW M-HQ=_>'`B'"%J4;S9LBG.[6V:;[G_K?+DEQGSR M,H@"=K"+_6F(`M;H/30_,G*>[2=#[^7]?#&Z:Q`H"_:3^1@6@D>SV)`'Q,N;9(I59JJX2M*3A8)@L35G6(+#BD?["0_2^0Z$F+=`OS[GMEWPV^ M/^UKSSPM^W']EH72[-];7QWQQMNMJ]?S0Z>/7O_Z^D4Y(5,^BW7;OE^B9_C=T.6Y]GG9(H4:UW#QLS];=/-IG&3V>-&W]S MS^"G>\VJY+ZZ=^"MZE=;=<=GGMGDI)X8^=$[MTS?\)`UBF0K>\Z^*"S2 MS;)9&V2SUA/OQ]RLE;)9KU7;/'6J[*92O48R>H9]P\B7],?6J?__VZ_F"3[. M$AN^^H-%\\([KSF&7F_"GF],S`E9N\;BV%#1DGF+CD9\YW[[UOA7_'?7 M#?LP]^:#+SX>/'C"EH'IRE;/DJBC'V^]()K^=?#"(6MMRB;O;[5+=50V/S@5 M=]EV`I_Z8^ZS.[?V^=`O3!IP0+'.KE9JG??&;^DN?[@?/>-P9\SVTK@0DY:: MWK]?+2RV&GWOW5_&''GW^T.R!WRPV3S75WV<1IYV93;\4GV)W?74W?JO/QQ_ M0Y%\9$SZGEVLMYU^\9E;IHMF-+UV>%N8_Y5I5S977JZH0ZEBE?NV^?H%GYU.CTH\[I*QL>R<7<3< M5\K7;OJT#J+"43@;U`MG@\D6*U*;T86MMI^?C5ZY^@QX51_A_/Z=H&=+PB0C[WRZX&K+SI;#S``WSR-7 MUYU/_WD&HQVV[5Q(9B_[T3Z#?IG1L&M!Q+#=X:-*T]\/MHPHN7_\^+&T56MC1MB.H)SCU?+8=G-FD&.T9LW35W@6Z>;F2JVRC;W?VK+UI%Y*OB MCPQX=_@KK[^ST?4/D614CL^BCWUOO[!RQ8[-Y\S+GCTS(&;QAK<+CDQT=GVC M?X_7TUFGJ.6+FS[^?@BGC7-9]%OX=XW;DZ9-\>V1B^7A%:4M0Y>;I-C_@A-; M'-"E85^E7A%=J98RF'VC!GN#/CP?M;^R_S-"C(W83'C\=,!P$L"(GC==>W"] M.'N?B7N=]QSO?V/_FJSG?KOZ4>`AJP'>LCYM#>P9SK*O.1J+RN%1-0[%=#A0 MX$29-3W#8*SG1#(6DD<%LX3,;U?&S'RP^F!29>5;"[[\KL_A\;NGSV>7/)O%D.\=GYS^^ M=)U+Q-":=VYLF+O`94%*5?;NY#^?#E%&N*7O*!]Y,?][6>2Y_.3X^_"W88>P07^Z@7I-T?GZ_N`=Y/]SPG/O4@8&?_!#\ M:\B73U^LFK9/METY9_C]!;8'G1>F9\EJ1-80S'XS!#-SN8EM''U+84!'99&W M#?['!`T2_4)DH2&A,EEHZ(!!)/KUA^`7"H\[)"N;M>[_]T1"'K>,V,=T]L1C MU-85[X9O=NQWUV^(Q8BHZ96!FX[M_F2!U?L1VB]>V7VI+B4JZ^D3":DKJWQ^ M2?[8:=B-C/=-A]KQOV?#1B*IJ5RMR3HW/$@\,A2VQY0I'WXPFK^U*^BSNCUOS7S: MJZ%I[A@?V:PMI%["S5H'#_/5CXP[Z[1O_E?$RXWW@*O:GFF$N[N_: M'_N^,-KL2*\E3,:)N-A=QYTGZ>Z$<$/LKKIN,MFTZ(T9"1D5SLM>7:*\]?6@ M.TDOWBR+?OO<[HSJ9O90X![O\^8U/8[$79Z6-*E)_.++T<6EA\__OO*FQ0%W M\P5!$;NO;SHQ=6Z1Y)O&*X[/-0W#&_P.91YK>+$XN^4S_T.J)DF#E3[RMFV" M]K:9>(7CUZKF.=C1SM6OU\YQ-Q7]U_U8..IN2LVV:];G\9\7#0*TDI(QR`5E,E1*=")0)FZ!>=;SEJ_/D+C%_A%Q_*+5IXD[8P\^F.[CGC^(MW[YUPU9-VOF52G" MG0M[6(8W3I1L6.ER;%SK[K0[37T/[7`?DK`]Y?8:]G=FZ/5#$;V_:_A]VHL3 MOZW%28/-]VNFS&E-6G!I\.[D3MWW,QKNO'6I8IIIT2O?1E8 MH_]RY4_.I6=D'#-P+5-KC;U)Y)??^[.AILZA^=]UY=,9?DMK[W^V]&*DDNK M+RT1K[JY(WWMV=*I8Q=_KC]\9L[YENFC[FI]KF]ND`]\XXO#,[Q^^VQ=#3-" M5L,DM5M.'%S#A$-1*/7TQO_V[V(^XGW8SGZ>)7/LZ-`6[9^(8/#GMAI1L#4Y M(P3+@@>%!`>'A?2?\)`_OW9^V/%S[S7D#'^_HMISO^>J1_A34H3/=PYWOVW\ M,WO_@9.'M$&C?;R_;OUB^/M[/U!.C,-CWOWLUZAKV5MN+KE?F[ODYV]RQ@U, M_$$ENGG./26WYNJ<[>6VT6^6QP0]]!J5'CQQW`WUBG MKIKPU'LQI_?+E]WZ$-T_4G=A[A$QQWF!\[^[ONRO8> MU8OSSUI/G#0K?O4REU=,M\W_YO:?,E_3NBE.K1.WI'T;]K5#Z^`]([TC/']2 M!?%U'VR[?_/=+TXOF&2_NFG%R+6R`0=7-S3M/#CHPL:$9S.GSOV^5+?KF-+. M=Z9/:))Y^=;G-XPJC[AF<_JC[*EC,M&C*E-R&ZDJ5:%HQ.L? MB!:T)N+^)NYX?S3">KT>^GH),`*Y`5S8I<@9(?TW@"N`'UJ'0XLI2-(Z67^) M)9^'[1"`D!0M0VN1)[J%@]'[J!D-1QM1#$I#2]$P=!+M1#U0%3Z&."1!\6@S MDF(WQ$"TZ0VV7(&^1!,AUEQ%EY`W2D$7L!WTDX#*4"\4KK\&]Q0T3[\7N,SA M$>,MM`\7X[$H".@DQA_[P?A=QJ=!5[ZNM1$E#?(5O4#\U$ M2Y`=FHP^TI-/`SWA4643GHZO(7>4@^9S`[A:_10T&.U&IW$*4"-1E>BLV6Y4 M#*W>P+UQL_ZB_GMT@,,0$6>B&C0/)&Y`S4P@&R>J@\CHA89`+)5#[;/H2]P3 M![/1^G[Z6/T**-V$;C-^S`>L"H.V>B,?E`%UB]`&&+\1G<(I.`LW MX_?8#2)9:Y3>7N^@_QXLZ(LR0<*U\)1W!=W%,N"!$5@/5LOUY;2BD)99,,-\ MM`J=0I^`'!=`[[^BW[$O7-\P,YB9^O'ZS?JKU%/ZP:)KHEOYET*T7B@794X%[+/0]'ZS4@)K@.@.SM,4\S&(0 M'H7'X$*\""_#3?A+_"4C9MR9J:[&1U&1[$#]L(!,*,ST/X>,YB)A^L-YB1S@9W-+N(>B.:T7FK]J?6^ MOA:9@)<-`SV4HZV@A9NX%\C@@R=C#;X,DB]F=K$]6!M6PH:R,6PZF\7.8Y>R M'[(G.#6WC?M*E"R2B[:9R%M+6S_1I^A?H)_WBD&N?L@?#4!AX#\%X$U30+XR MN-1H.IJ%:M%+X"\OHSJT#>9]$!U%I]'7Z&>P`,+N(+,21B\!KYN-7X)K!=Z. MW\.'\5'\#;Y'+L8#+F]F(!/%Q#&)3"$S&ZZES"GF#/,#Z\+FL3/9:KC6L'O8 M+SG$<9Q>%`)7DFB^:)/XF(FW29))KNG'#ZZW^+9DM5QH1:U.K4^U+FM]K_5[ M_3A]%<@O10&P@T]'"#&^#:"IZX!WV`/D9?4%EO8P:+P.,=L02\P1^L M%H6'X62X1N+1<&7`-1Y/@$N.R*]BWV/?9S]D_.(;SYX*X2&X<5\@]SYWD/N'.A]L;-X@#A#/%F\7+Q3_(/X@8G8),TDUV2ZR>E,I1*LC,._= MJ.,K2'P2:T3VW#/,15@7CFR9:"[.`(V)F72VF'V)_514@&^Q//X*U[)*=HK^ M#3:1^9U5X7',0>S!NHDBV`*T`.GQ-N8;YB[S/>>`TYEKV)M;@M]F5&P<(R:# MB#[C'+CGR?]>8+Y`$9W`#1?:0$O6\1/0/Z'LK,P[[LY]P:=)65,'?P+;P,HL9Q/)SS M9)YFPO$VB+@MN"^ZCJ>B,OPJBL;[\=>X"6&\F=V$1S"68"T=8X7#,$+'67?\ M.6N.LHB,V(MQP&G,+2:#?4=\"G87#%'B4S0-LU@&OF-\M<*)L``M9?I!3$N` M:/(9#D&.Z#6(]W=;WR$16W16-!_\;!WK#Z=+&9K$'$,1L#:NPI6)YJ`0M`]\ MX/Q+B)X.:\&04A"T@6O8&V6;"?M&+\8!8F`VC_@[Q_R.( M^BGX!JK$/*RL9N3-D9H%7`)$IAR(O_/ARD>3(+<*O2S>+?H,I>+>"'%\ZQKP M\O/H:=AS+L/X3B@2Y)N`UG'^(#4/D7DJM%C5F@2[8C1(>`PSZ#F0>2BL\S0N M"2+O,OUDF*$2]J@1L"<>14K]:R@.;#=&_[Q^/LK6K]-/1(5HK'XSQ-\*?0,: MB.:*LIAQ(C]N`,38H_@0[$?G\'R(VTGH*XA'4NR(?H3K+9!_J&@_JN6^@-@9 MI5^@/XT<0!\>H*%T`4FC8S/2HZ.&#HD<'!$^*&Q@Z(#^<-P*"@SP]_/U M\>[G)?64>+CS;GU=79R=^CCV[F7?T\[6QKJ'E:6%N9FIB5A$WP;T3Y`DYO`Z MKQP=YR5)2@H@>8D<"N0="G)T/!0E=N;1\3F4C>_,&0VX.#?@$QZ)X7H=S M^`1=8D51;4)./'17;V$>)XE3F`?XHWIS"R`M@-+UEI35X]Y#,268W@D1]0PR MM0*A=$Z2^`1='TD\D4#'2A/D^;JTT9D)\<[N[ED!_CH1<:P]8-QXW6] MIUUQ;,]"YW9QF7,[UCJSM0F.2IYD:VOG\KJZT9D=:]W)/2L+^M`QTL2`&H,&4L#V,QL[,R=7@V#,B3>9`Y&6:GD"20DIS)O,Y,$BLIJIV<`X9QJM6A M,57N#4Y.T7OUEY!3`E^;GBEQUT4Y2[+D\2[U]JAV3%5CGVB^3^>:`/]Z&UN# M6NM[6`N$I55'0M%61RG*3JB4,6UZQ40B23*X@X[/XT&23`G,:1"Y*0:AVKQ! MP`:O+`RM=/E@#Z7.+"ZGUB8"RFU(>YU(:B/A:W]%8'_)]9\[E\B%$K'4YE=$ M2.(E;8X&]49:Y^>G\_4E#F(2!Q8%&8?2?&B`?T43HY.4V?"0@/I0&NA6GA41 M!,IW=R?FG=\4C7(AHZL>G6G(\RC7N0%%!_EEZ9@<4M-LK''((#75QIJVYCD2 M\.-=]'^8.>A,O=K^6=OTZIE0%*'#O?ZB6F&H3QDK21D](9-/J,T1=)N2WBEG MJ!_45B=0V%`!"M=Q4M!4L@1<;\R$3%(`_T321$F",B<)EAK(J.L9E\DZ,UD& MBG%F:5?@OQ/;>B:93$O2%R<54__/;S(Q!0>F)9A/U-GD)!GN6>;N[G^S49/^ M%FE%D_9FPIQT$7Z=\X,[Y3N)9UG+@L"<%Y.2/J&VUKQ372($J]K:1`F?6)M3 M*V_25^=*>!M)[5XVD\VL+4O(,9J_2;]OOK,N<4$63*((1X!K,RBV7H+GC:Z/ MQO/&3LC<:X,0/R\]LX'!3%Q.;%:])]1E[N41BJ:E#"DEA23#DPSL;K`J&AA3 MRN^\-QJA:EK+T0*:SVO"B):9&LLPRFMB#&4VQC(&RCA#630M(R\2*>+2,SOZ M`%U860&(P2YP2'&!ITD6CL\CZQF\GSD`QUX3YF`#$G%-S(%=+#(W(<1NC/J8 MBD4'H9Y!+/9!9G@*?AHY^MGZV[K92N&$7 M#CW@V>8'T2)T'PX[S="^+R,UV0T/F[U1+-X0G;@@"$\*S'74.&KZE`=,"YSC M^$)`;>"*P$T!FP,MXP*2`[/ZL.&!\8X)3FR(XT"G,']6Y.CFY=;/)M1FH*>C MEY-?H"E_*-:Y"9OM\AAR*#:6$!+W0[%22O@=BO6B5;)#L0-I2>2AV#`@HJ,\ M;`_%6BWT,#T4:[E08M\G,(!W["-SXOW[]![H']23\5PN[;=%65J)34SL['JN0"S3Q`YMP+UZ0Q(=@!QC798[.\(;(5*!)'-C&^T7:F['*F MU_+>`Q$S$,\U]45S;?7N%9N[UVVNV]R;=#VR M9=+U40F*^.\B;83++CQH)!2"_DGV.OR#I)7^:Z$,0?5BX@0-UE8831%YK4T[VWQ,M+(K&U[]7;P3UTX,!06XF'V$0B MQ=C=H0?C()0/94)MX4$"WF89^2E>,>VUL9(1F2G M67MP!?"@:(9[#Y+:>26WJ@?[]&P]SK=^;"OMY]EZ8E`_.UOO0:(11Y,26MY- M#V`]/<5^8YCXJ%%'6PXQD5)L[Y_8ZI_ARWEZXEZ^,?CGEE+FQ=:^\3Z]/#WM M?1/PIR.\':3T/^V2=UV=M_ZQ.]LZ\E?3/O2]$+3^LNO[)-U[>K?W?6W+`AMD MV@.R9NW_U=?$O34!C;=!][6M7C:&?CJ\Q+7B<+)VX&!O!#QTLO%H-H>0%%`L MWHJ2Q.&PM*>BT5"7#@B$\B7<\T@*_*60'POI$B80 M"1@!F`X8#;PZP$ND#R/8A6BBR=-(+CJ";$3CD`=@.-`2[C+RY33('>@DDH?Q M^K.NR!=H#ZCS,7$%WB/ZJZ0>^#PHWSAHIT'54#\4\A8`.Y.%R!E2:T!/*'>" M?C83F2%-8=\C<]7?!+H"Y$@&^CZDB2!K/*0CH#P5Z"$`*V@3R83K\X"V!7H( MZ,86:$M``K3[@[0!?BN0,1_J[2'/$%X8UPI29$+??JP7V!GO!(>,[Y`]5PZ MLH?Z'A0P;S)GXYR(_$2FQR"1R-<1!ODHB*Q,NVP/@>D"!=N?VFJ6,-=5S'%4 MQM;I;P,M$=NC!`*3+R#J;44_`\*Y?-3'Q%7_`\B8+-J%0B%O"G"D('VN0G/8 MNR@:ZOS$R\!O\M%0)A@J0O5_,L\B5[$4#8/Y@KY1/Y`]B_@>^((G\(VE[?-1 M7^XJ<@(ZF@!\_KLV/8%NP/8ID,:!WF^8(OUUZ"..`/K9"W@/VO>&\8.(#HC= M\;C6;HJ`1KPD3Z`WE`_G_HPM"'M89P8,H;!#LB&^B"`^!X@Q`C!/D98 M&$'UOY6B%Z`W(`Q`QET&V`\8!5A*>*#?7L#?%^2807R&^";Q#^(;U/_!GZC/ M$CMJ0#?$QPQK9@-3@.8![`'^$P^1X`O\-+U0NQ(9"9K@?1-?(OXC#&%>B^# MW^.;9)[$ISJD$I$_'9NN0>);'5(?XOLD9:/I''R89C20^*Q!U\:4RI!`UB-9 M$\;4*`]9GW2-0,I.03V)[HC=C:E1%VUI'9)"W0C1EV@8%XS&LX?!_R<"G09I M&.AG#5V#-[E7T15F-F),FI$_V)*LW15=TN4$)J?Q9.BO&73IQ1U'*VAZFO'@ M3F.1:)O^FF@;,\,`(]TQ[0K<;*@C*4''NG]:_N^`.2/:A@J`_E%T6J_G3J.7 MR1YA\A.6`7AC"N4-@&J`KZD?7FXZ!3>99"`;\)N[`!47C2)$T2@,SC=1G`-= M=U(HSX"^@[@I:#"T8W$S>I'-0.O%V]``]C38$<9BSJ#G"4C_D):U^5%7GWO8 MEVAJ]-='I&0-6!E3NJ;"]1?HN@K77Z1K,ES?:DA1.-D;2'RF^P.BL=G6Z*]M M?KD:>;&_=O#/+G[:P3\'0SN;KG[9(>U!4F%OL3*N4VC3B^PU9/XT/HZCZXG& M.:AK,/)W3=O:;T5-S%;].1J'CZ,)QG4-"`9(H?Y?0AR!.`SV)GOF0OU$<:5^ M(CM_D_.#I6R+\*!!=8E M*0;&6,R\3VXC^1%:"?Z`;$HW'`LY7.54KC^'+D M2?1`VY;#O@)]F?@A.XY!?@*/E+8I@?,"U0?$P`ZZ$/;FH:1/\1CJL]:T37_] MGZ9V*)Q`M!$-A/&E=*PD%&$:CKQ$X_0WZ+G"#HUBCR`9FX3<@':B?C\7]B@? MV"^38'\$L)";-H8\W:MIJO^#[OR)YJL!QV:DS6(,>C;1=@'[2#/0+JH`Q8+92Z&%+LS7Z)QM"X= M76(.,#N9`_HIY!S(?H6RV3?!?CN1.SL!]N_#L#<.ACU\..CJ%,ID3P#M`>5K M`!5P]M,B:\X:Y;/?`E\(U)5!N^/0QWJH)Y@#;J8KX!W)*K" MF_7[\"J4B*\"5@G8@9)H6@\8#6LL%$\'!'*AZ&W`+*#](3T`V&G(HY6`=&\`08"_X,*92M`2P''#/6=009ZU'E'2%RUN_KE-\->PT`WX4Y MW.U<1\>`.Y(?I]!.PUV$,`XIG(WJ0"V;/]H+POM.N2%SE#G-N-/)\D MSY.`3R(9U:$!T7]GCG\79.V2_?D_U=_?!=AW)F`2E>$&Q&/J0Z@'/J,_#^DX M?`;V[7*(I0#(!T"^IU&?1CM!^2NTO(O]P%?@(57_6]?RKOFN=GU2GFE$V1UA M](,V?W@9#27@HH`?T#5O>A0-)1`?AKK##^>Y34_`!#BCK"0R@0_V>S@O3D7] M"!A/D-6)M($U!VC+GX2X"B"\M+T5[)<`NG8!S"[8BP%M]:$0\P$=]#J0Z)5= M::@WVL=HEZ[V`?FBN1.`"7">/8%DD(Z%-,:8MOFW$"\Z^?QH@[^WY4DLN=J% MIWU-M*\-6"N/Z_-_$V#M?`0X`OC@__58&(&O`FP`](PZ&)[!0^'L.8Z\5=/R M,4(/["'M"?L"K+P'EX#^'.A<@!_0;T/9`[]CZ:/>_[X MNZGPG!%I3!]ZAO@GZ>"_E79ZYC#:_TFI\5GB$2G5@R"_N(,\CWO&Z92"_YAU M!)RE)>1,2<[1Y"Q+SL_D_-B6DN>V))KV%/HQIM9D#R1G9W)^%?6G[S>29R"_ M#L^#"<9]HV-LQ7?1&H`-P%E(IP#/'_"LP'N*%#.`*L`.\#&4S3!^@$-,=*`3RNP%[H.PZI/FD#M*U>"$$ MMWOZ%LC70-Z&.TYY,P7D/\F?N_HM.9_3\R'HC,;!Q41^%`08#+`#U`-*C+8F MSYXP]O?,.PB1YUQN@OY7[@2@RQGPB6DHF@K8`7EKR%L+'QA5=*,;?Q_,M]WH M1C>ZT8UN=*,;W>A&-[K1C6YTHQO=Z$8WNM&-;G3C?PDP^A?)K$4:NPKT!SJ MBU<)M`@YXGT"+48>^%.!-D%G\5V!-D5>S,<";8;F,+<%VEPTCGU&H"V0VO2$ M0%NB`K-H@;82[S+;*-`]T$2;"!MD3]'<8)M!4[P>%%@>Z!`ATO@R28(UJW[&-+:1&Q2!]72HMI>0"EJ:7Z MA%/:E-+)E#8C-NJ3)=!@(Z?Q`@TV1`@TV9TI:TW"!##TJ'4=J&S,4WCM(]@;;S'4UI>\J31VD'VH^* MTKUH^4Q*]Z%MYU/:F?(89'.E/%LH[4;IW93VI/SO4=J7TB"F,74+L2"4D[!?2JH;(7";T%/D(F@P^I M8%PB4QGP5CV62T%]E_!54JD*V\95"BLC@/JBELI`?J:F2M"#FLZ*].I/OTR0 M\&MI.8]&4/T131J^:I#X:'_P4:)');6`NH.6Y2B7]LRW2=>^+HD<:JH]GLZ% MU,J[Z-'8NS%OM%9'BQOL.(+*FR_8J)1J4@-]RFF_:CJ3`F$.E536/+B3?K6T M1$[[RJ=]DA562N4@%B)KD_`4"3P:^GW)Q%93@3+HH9CJ+A=R>=3O%%2N4B$M MZ.`1E52&8NB;]%5"UX=6Z#6/:D8#5P%=97P'F^91S<@[Q`R#;$:-&*Q62/4D MIVWS.]E>0\!9/[9-/J7*J-075RU_[0C]!0TK:1UZ'%9%+N?_:3PPKX&'[ M==2P04>E@J2E;64DBI33J,<+D4B!GJ&KKI1:JX+VJ136H4%'AK(RVM:H58,7 M5=#H6]&V)HBNU<+8ZC8+36GSN:[KRZ"'O[?&#+.+I9YC\&M5F_P&OS3HH52( MYYTU;O"Y?&I]@W>74PT;>BJG,F4;[*J,_-55.]RIC7$FCT;J4ZL2PGI6= MO-D0(ZNH9,6TA8;.M%CPNB)J1[DPKEJ(=V1V&FKY\D[KATA+5IQ11N(-//5* M@SW(O/-HK"MNLW"Q$$=S`<54NBIAQN4TUAIZJJ0U1;0W%5R&F)DGV*8$VAAT M/1[X\ND(58*..L:37-IVBB"K04-$`X6`:92'>$K'6$%\W;`':(4:5:<8FD_] MJ[R3%8T]RVE,5W7H+9_JKXS:I*H39S[5D)KJUFC70+K/:X$_`LX/0:`#<@72 MJ-'1(P.%J!-$^4N@]R"X:VDD('*1G`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`*^SECUK'1HO)N^BZX!])VZ[EAT?( M$\YON4*NHT0*82?4PMYC[($\/Y&O>"1/*MYH$/T"5Q^@P^#)8!"4RJ"$/".2 M=TTR4(K`*8/:8*@9(-!A\`P11EL-1*'P1$%`>O]G>]V_OS,:ZX*Z:*]M/TRO M*E,4R/,4_!8^O4C!DV]XUD)1QZ^\Y\N*\P+Y>+E6_@2F(-(9/U957$Y*-/2[ MO\G/*\@"X!82R,<4%_-CR!?F:_@Q"HU"7:'()U\UKN%'*2KY,:H2>>D816%Y ML5QM'""B2S4OU$>,4Z@U9-#^@3(9[]WVW?H^7?@[LM$JJ*$5:6-'IG?AW@KY(<2_FB>O5A0J-5J%6I'/*TMY+;!FC.73Y%K>BT\?R:<6%`3R M\M)\7E&L4506`5M@6T_I;5]UW[%(P<>KY97DR]:A+?FN]0#R]>NEQ8HJD$&M MU*A*_?EQRCRM2LV/D*OS%:5:4&O_D/0BI09D(2++(PQQ&JTGR84:FB4E,F+U.H_?D"&*&R2)E7Q"NU?*53Y9RQ=!B:8\5Z.86@XR%%?QN8H\58F"5Y4J2']$$94J=7&^AB]1 M@0":\KP\A4934%Y,1>/SU`JJ0PWT1@2!J14J2^7%?+YA]AJ^$I3%EX`9^/+2 M?(6ZJQ;Z@4!*M2*/&B*WJJM.P`!M\S,(#!*50J>EA%*KR@N+P"Z\XAFMHE2C MK%#`)!7$JD"5J55$5%!1A:JX@EBBH%P-K=5D0E.(YHSV`AD>83$8+E:N`5VK M2/^@2Y"A%/Q<$!PTE\_G@;K+\[3`5*ZAO_V@4)MBB\D\U`\DZ";*H2JI`ZO'*?`48LEQC\)-< ME6J*A@I4(B^43U.6*C0&KU`K8`5H(:,R>&B^*J_<,$7"+"_6J"A;OE)35BRO M,A3F5RC46B69:V#'WWX0%$E_^J%(6U(<5*(E/ZD<5*+)UA+3@3^JR8H,))5_ MLV&EHIAX(FTR*C4].3$Y+B8].744GYK(CTB.2Q@U-H&/&38F(6%DPJAT*W,K M<[IVVA8,H8NH%X#I0&/@S(]8LG162I@R^954<+\J53EIF:>JH*'`X+*D'ZWQ MYU3E?#$HJY3\J&JA6J$@"@ODLZ!9D1R,IQ"PE]W';N_^ M8*7[@Y7N#U:Z/UA!W1^L='^PTOW!2O<'*]T?K'1_L-+]P4KW!RO='ZQT?[#2 M_<%*]PZ\L%QR*Z+F*`2TWW/"+3XWMX-)TL/-N3 MYQ$2$TAN!.2&P=G.^-1"WEV8`E0\717#A&?Q)*`3J,Z()Z0)S]T&OR7/WF/H M+DG&"FS[3^V/>>U#Z?IF]IO&A(20Z"9(_0)IVN#M$[*75#0XN82\RW[#;(?- MR`T*+C;T@;$'(QQIR]@&X"&/8">Q&Y#]&.H_8H_"[$FSHPU6MB'0X1'V M;62'W-@][&ZA9G=C#]L0%*-A%R*,FN%^"G`)<`O`(16["T'8!NQ0Y0#J? M?86F;T+J!.EZ*.\+Z3K(DW2MD'\=4E*_4BA?`?E>D"X7TM>@W!G29?2'8=W8 M5X5\!5M.VVF%M([5-/1ULXGI"_4\0`9@@5H*U%)0W5)B8+AC]GFVF(Y4#VD( MI"6&%-3U7(.[A-KHN<;>?4+J0*7/@>J?`\T]!YI[#G%0-=W(,]W`$\!.!Y[I MP#,=>*:#5F2L!L;3D+^7@+L-@`>PH'<-Z)V4Z^#>##A%RU^`^V)`'/-9&;1 M9FEF(A4[DUW$LFYL$!O%IK+9K*A)W]Q@$M$?DNAAXHC^BRWJ+'06S1:G+$0Z M<;/XE/B2^)98Q(MEXFAQFCA'7":N%B\6UXG-%HL7FS`Y%F46U1:LC05O(;.( MMDBS$+F9X+J8V6PN^7L)N-L`R@"+`1SH.!O*>?9I0#98(QM4\33YXF:X(\C9 M`$X!?0E2$>2L@<\:^*RAU!I*K(&[FU!'RM?2.D*1 M>J93/0L3W]X0T3\U9CB$W&S`6@`+?6^'^NV4VT#MI.4ZN%^BY:D"?QTM=X.[ ML0T+`6X"#7,38/E-0%&`;$`90(1.LN/110#T#'2N_NT18Q5KMBK%)CK'QBK*"WWL@=63$.]"XF=_P3 MO8^B=_]H>W>K/]RM[KA;_>)NM=K=:JJ[U1!WTLX%UJX58T_O%N2.E]'[<'KW MBK9PL_K`S6J\FU68FU6,%5Z#87042^]]Z=V9W/'M7=;QULAL/[X-&ZX5@QLB M?=R:&$03K&^(C(&DM2%R&"0M#9%K(/FS(?(5MW?P'YAN:?A>@^<5MQ@'?!V3O41=#6XG_9NP=(_;"37A< M@UNS?Y,I5!ST;V+P;K=Z4+(.>!F\QVVG?Z';#@FMW2"!6C#UVL@`M]Y)4J;,%1'1\)@T>9N$1*U6S@4#VK" MR8W;W((]FX@H,NACVQXW7QC12T)%R0C;QX0B$UP>[6^B-Q-7$Q<3>U,[4QK2'J:6IN:FIJ=B4,V5,D:E]D_Y2M!_YXSQ[,?W5,S%' M[ARE;1AR9^C?[B$&FS*P=G0]V10F96PLUMFEH)3T6%V87TJ3B7Z,;I!?BLXT M[:G,>HQ?RH*23I^],"L+I^B:\U!* M+J^[-Q;F83YZ@DXDB75$O2JB'*/LAMJ&)\8_XI8CW/W:7XY^'5^.KKIE*6,S M=5M=LW0AA-"[9J7HAI&?3-W+3&54"?%[F3*29&7NQ=.8J0EC2#F>%I_5QH8\ MF#)@0Y$D(6R-R(.P(0_<2-E&4#9P4X^$^'H/#P/3^SB9,('[O$^9"@U]><(0 MT%<:28"-Z8L\:5^>3%_"!OY@Z,RZ8V>6"%O3SJPM$>W,A3#52Z7`XB\E+/5A M4F"HEX;1ZFWMU1*I09PL)*7C2'$6'0?C=AYO`P]X@<##F`*/WW_RI8C]!\RX M47X^/X_\<&V.)$$!R-'-KRARU%7G\GQ]_GGA%VV]0GIF?5ZT(KY!'BU/D,CCLQHWSHQ+Z336BVUCQLV%XV94/IXACL[CC#>1^'8-NR\,O264IB=58`4A40$Q!#JF!U MDJH>Y*>)A2K'&8/=G??AS4*5#13;2F*1'W),4,:W_=-H-%J"\G(_N&O+'6F9 M%A:M^]@472+Y(=5(762"+CHG/@L37#:Q7`R#T`]`1)`?\!8@`C]"^Z? M`2X#[@`X]#S<7P&\`6@D)6P`&Y#@J(PG(V;YD:#CR(8TRD)#!C5!*B\PI&,G M&-*$488T,B;$$=*&J/[F,=9P\,9H']P_`GP%^!'P)T#$AK`AM/-R@]=F:9#& M#X/X"#):,K6(#`(),!$2S6D M63E)VU[_!P??88H-96YDF4@,38Y M#0HO26YF;R`Q(#`@4@T*+U)O;W0@,B`P(%(-"B])1%L\,CAD93=E9C`X-C)E M9#')E9@T*,S4X.3 EX-10.4 3 exhibit_10-4.htm FORM OF INDEMNIFICATION AGREEMENT exhibit_10-4.htm

~~~~~~Exhibit 10.4~~~~~~

FORM OF INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) dated the ___ day of ____, 20___ by and between Mannatech, Incorporated, a Texas corporation (the “Company”), and _______, an individual (“Indemnitee”). RECITALS A. Competent and experienced persons are reluctant to serve or to continue to serve as directors and officers of corporations or in other capacities unless they are provided with adequate protection through insurance or indemnification (or both) against claims against them arising out of their service and activities on behalf of the corporation. B. The current uncertainties relating to the availability of adequate insurance have increased the difficulty for corporations of attracting and retaining competent and experienced persons to serve in such capacity. C. The Board of Directors of the Company (the “Board of Directors”) has determined that the continuation of present trends in litigation will make it more difficult to attract and retain competent and experienced persons to serve as directors and officers of the Company, that this situation is detrimental to the best interests of the Company’s shareholders and that the Company should act to assure such persons that there will be increased certainty of adequate protection in the future. D. As a supplement to and in the furtherance of the Company’s Articles of Incorporation, as amended (the “Articles”), and Bylaws, as amended (the “Bylaws”), it is reasonable, prudent, desirable and necessary for the Company contractually to obligate itself to indemnify, and to pay in advance expenses on behalf of, officers and directors to the fullest extent permitted by law so that they will serve or continue to serve the Company free from concern that they will not be so indemnified and that their expenses will not be so paid in advance. E. This Agreement is not a substitute for, nor does it diminish or abrogate any rights of Indemnitee under, the Articles and the Bylaws or any resolutions adopted pursuant thereto (including any contractual rights of Indemnitee that may exist). F. Indemnitee is a director of the Company and his or her willingness to continue to serve in such capacity is predicated, in substantial part, upon the Company’s willingness to indemnify him or her to the fullest extent permitted by the laws of the State of Texas and upon the other undertakings set forth in this Agreement. AGREEMENT NOW, THEREFORE, in consideration of the premises and covenants contained herein, and effective as of Indemnitee’s initial appointment as a director of the Company (the “Effective Date”), the Company and Indemnitee hereby agree as follows:              ARTICLE I                    CERTAIN DEFINITIONS Capitalized terms used but not otherwise defined in this Agreement have the meanings set forth below: “Controlled Affiliate” means any corporation, limited liability company, partnership, joint venture, trust or other Enterprise, whether or not for profit, that is directly or indirectly controlled by the Company.  For purposes of this definition, the term “control” means the possession, directly or indirectly, of the power to direct, or cause the direction of, the management or policies of an Enterprise, whether through the ownership of voting securities, through other voting rights, by contract or otherwise; provided, however, that dir ect or indirect beneficial ownership of capital stock or other interests in an Enterprise entitling the holder to cast 30% or more of the total number of votes generally entitled to be cast in the election of directors (or persons performing comparable functions) of such Enterprise will be deemed to constitute “control” for purposes of this definition. “Corporate Status” means the status of a person who is or was a director, officer, employee, partner, member, manager, venturer, proprietor, trustee, fiduciary or agent of the Company or of any other Enterprise which such person is or was serving at the request of the Company.  In addition to any service at the actual request of the Company, Indemnitee will be deemed, for purposes of this Agreement, to be serving or to have served at the request of the Company as a director, officer, employee, partner, member, manager, venturer, proprietor, trustee, fiduciary or agent of another Enterprise if Indemnitee is or was serving as a director, officer, employee, partner, member, manager, venturer, proprietor, trustee, fiduciary or agent of such E nterprise and: (a) such Enterprise is or at the time of such service was a Controlled Affiliate; (b) such Enterprise is or at the time of such service was an employee benefit plan (or related trust) sponsored on maintained by the Company or a Controlled Affiliate; or (c) the Company or a Controlled Affiliate directly or indirectly caused Indemnitee to be nominated, elected, appointed, designated, employed, engaged or selected to serve in such capacity “Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee. “Enterprise” means the Company and any other corporation, partnership, limited liability company, joint venture, employee benefit plan, trust, other entity or other enterprise of which Indemnitee is or was serving at the request of the Company in a Corporate Status. “Exchange Act” means the Securities Exchange Act of 1934, as amended. “Expenses” means all attorney’s fees, disbursements and retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, fax transmission charges, secretarial services, delivery service fees and all other disbursements or expenses paid or incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding, or in connection with seeking indemnification under this Agreement.  Expenses will also include Expenses paid or incurred in connection with any appeal resulting from any Proceeding, including the premium, security for and other costs relating to any appeal bond or its equivalent.  Expenses, however, will not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee. “Incumbent Directors” means individuals who, as of the date of this Agreement, constitute the Board of Directors. “Independent Counsel” means an attorney or firm of attorneys that is experienced in matters of corporation law and neither currently is, nor in the past five (5) years has been, retained to represent: (a) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement and/or the indemnification provisions of the Articles or Bylaws, or of other indemnitees under similar indemnification agreements); or (b) any other party to the Proceeding giving rise to a claim for indemnification hereunder.  Notwithstanding the foregoing, the term “Independent Counsel” does not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. “Losses” means any loss, liability, judgments, damages, amounts paid in settlement, fines (including excise taxes and penalties assessed with respect to employee benefit plans), penalties (whether civil, criminal or otherwise) and all interest, assessments and other charges paid or payable in connection with or in respect of any of the foregoing. “Proceeding” means any threatened, pending or completed action, suit, claim, demand, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, including any and all appeals, whether brought by or in the right of the Company or otherwise, whether civil, criminal, administrative, arbitrative or investigative, whether formal or informal, and in each case whether or not commenced prior to the date of this Agreement, in which Indemnitee was, is or will be involved as a party or otherwise, by reason of or relating to Indemnitee’s Corporate Status and by reason of or relating to either (i) any action or alleged action taken by Indemnitee (or failure or alleged failure to act) or of any action or alleged action (or failure or alleged failure to act)  on Indemnitee’s part, while acting in his or her Corporate Status or (ii) the fact that Indemnitee is or was serving at the request of the Company as director, officer, employee, partner, member, manager, trustee, fiduciary or agent of another Enterprise, in each case whether or not serving in such capacity at the time any Loss or Expense is paid or incurred for which indemnification or advancement of Expenses can be provided under this Agreement, except one initiated by Indemnitee to enforce his or her rights under this Agreement.  For purposes of this definition, the term “threatened” will be deemed to include Indemnitee’s good faith belief that a claim or other assertion may lead to institution of a Proceeding. References to “serving at the request of the Company” include any service as a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to any employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he or she reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan will be deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to under applicable law or in this Agreement.        ARTICLE II          SERVICES TO THE COMPANY 2.1 Services to the Company.   Indemnitee agrees to serve as a director of the Company.  Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation imposed by operation of law), in which event the Company will have no obligation under this Agreement to continue Indemnitee in such position.  This Agreement will not be construed as giving Indemnitee any right to be retained in the employ of the Company (or any other Enterprise). ARTICLE III INDEMNIFICATION 3.1 Indemnification of Indemnitee.  Except as otherwise set forth in this ‎Article III, the Company hereby agrees to hold harmless and indemnify Indemnitee against any and all Expenses and Losses and causes of action of every kind, regardless of the sole, joint or concurrent negligence, negligence per se, gross negligence, statutory fault, or strict liability of Indemnitee to the fullest extent permitted by law and the Articles and Bylaws, as the same exists or may hereafter be amended interpreted or replaced (but in the case of any such amendment, interpretation or replacement, only to the extent that such amendment, interpretation or replacement permits the Company to provide broader indemnification rights than were permitted prior thereto).  For purposes of this Agreement, the meaning of the phrase “to the fullest extent permitted by law” will include to the fullest extent permitted by Chapter 8 of Title I of the Texas Corporation Law (the “TCL”) or any chapter that replaces or succeeds Chapter 8 of the TCL with respect to such matters. In furtherance of the foregoing indemnification, and without limiting the generality thereof:

(a) Indemnitee shall be entitled to the rights of indemnification provided in this Section ‎3.1 ‎(a) if, by reason of his Corporate Status, the Indemnitee was, is or becomes a party to, or was or is threatened to be made a party to, or was or is otherwise involved in, any Proceeding (as hereinafter defined) other than a Proceeding covered by Section ‎3.1‎(b), which shall be governed by the terms contained therein. Pursuant to this Section ‎3.1 ‎(a), Indemnitee shall be indemnified against all Expenses and Losses (including any excise taxes or similar taxes), together with any federal, state, local or foreign taxes imposed as a result of the actual or deemed receipt of any payments under this Agreement, that are reasonably and actually incurred by Indemnitee, or on his behalf, in connection with such Proceeding if the Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interest of the Company, with respect to any criminal Proceeding, had no reasonable cause to believe Indemnitee’s conduct was unlawful, and the amount of Expenses incurred (whether actually or deemed) are reasonable.  Notwithstanding the foregoing, the Company sh all indemnify Indemnitee against all reasonable Expenses actually incurred by Indemnitee in connection with a Proceeding in which Indemnitee is a respondent because the person is or was a director of the Company if Indemnitee is wholly successful, on the merits or otherwise, in the defense of such Proceeding.

(b) Indemnitee shall be entitled to the rights of indemnification provided in this Section ‎3.1 ‎(b) if, by reason of his Corporate Status, the Indemnitee was, is or becomes a party to, or was or is threatened to be made a party to, or was or is otherwise involved in, any Proceeding brought by or in the right of the Company where, as a result of such Proceeding, Indemnitee is found liable to the Company or alternatively, to have received an improper personal benefit. Pursuant to this Section ‎3.1 ‎(b), Indemnitee shall be indemnified against all reasonable Expenses (excluding any excise taxes or similar taxes) that are actually incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding, together with any federal, state, local or foreign taxes imposed as a result of the actual receipt of any payments under this Agreement; provided, however, no indemnification against such Expenses shall be made in respect of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been adjudged liable for: willful or intentional misconduct in the performance of Indemnitee’s duty to the Company, breach of Indemnitee’s duty of loyalty owed to the Company or commission by Indemnitee of an act or omission by Indemnitee not committed in good faith that constitutes a breach of a duty owed by Indemnitee to the Company.

3.2 Indemnification for Expenses of a Witness.  Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is, by reason of his Corporate Status, a witness in any Proceeding to which Indemnitee is not a party, the Company will indemnify Indemnitee against all Expenses actually and reasonably paid or incurred by Indemnitee on his or her behalf in connection therewith.

3.3 Exclusions.  Notwithstanding any other provision of this Agreement, the Company will not be obligated under this Agreement to provide indemnification in connection with the following:

(a) any Proceeding (or part of any Proceeding) initiated or brought voluntarily by Indemnitee against the Company or its directors, officers, employees or other indemnities, unless a majority of Disinterested Directors, even though less than a quorum of the Board of Directors, has authorized or consented to the initiation of the Proceeding (or such part of any Proceeding); provided, however, that nothing in this Section ‎3.3 ‎(a) shall limit the right of Indemnitee to be indemnified under Section ‎8.4; or

(b) for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act or any similar successor statute.

     ARTICLE IV

ADVANCEMENT OF EXPENSES

4.1 Expense Advances. Except as set forth in Section ‎4.2, the Company will, if requested by Indemnitee, advance, to the fullest extent permitted by law, to Indemnitee (hereina fter an “Expense Advance”) any and all Expenses actually and reasonably paid or incurred by Indemnitee in connection with any Proceeding (whether prior to or after its final disposition).  Indemnitee’s right to each Expense Advance will be made without regard to Indemnitee’s ultimate entitlement to indemnification under the other provisions of this Agreement, or under provisions of the Articles or Bylaws or otherwise.  Each Expense Advance will be unsecured and interest free and will be made by the Company without regard to Indemnitee’s ability to repay the Expense Advance; provided, however, that an Expense Advance will be made only upon delivery to the Company of a written affirmation by Indemnitee of such Indemnitee’s good faith belief that Indemnitee has met the standard of conduct necessary for indemnification under the TCL and a written undertaking (hereinafter an “Undertaking”), by or on behalf of Indemnitee, to repay such Expense Advance if it is ultimately determined, by final decision by a court or arbitrator, as applicable, from which there is no further right to appeal, that Indemnitee has not met the standard of conduct necessary for indemnification under the TCL or is not entitled to be indemnified for such Expenses under the Articles, Bylaws, the TCL this Agreement or otherwise.  An Expense eligible for an Expense Advance will include any and all reasonable Expenses incurred pursuing an action to enforce the right of advancement provided for in this ‎ Article IV, including Expenses incurred preparing and forwarding statements to the Company to support the Expense Advances claimed.

4.2 Exclusions.  Indemnitee will not be entitled to any Expense Advance in connection with any of the matters for which indemnity is excluded pursuant to Section ‎3.3.

4.3 Timing.  An Expense Advance pursuant to Section ‎4.1 will be made within ten business days after the receipt by the Company of a written statement or statements f rom Indemnitee requesting such Expense Advance (which statement or statements will include, if requested by the Company, reasonable detail underlying the Expenses for which the Expense Advance is requested), whether such request is made prior to or after final disposition of such Proceeding.  Such request must be accompanied by all information required by Section ‎4.1, including but not limited to, the Undertaking.

ARTICLE V

CONTRIBUTION IN THE EVENT OF JOINT LIABILITY

5.1 Contribution by Company.  To the fullest extent permitted by law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, will contribute to the amount of Expenses and Losses actually and reasonably incurred or paid by Indemnitee in connection with any Proceeding in proportion to the relative benefits received by the Company and all officers, directors and employees of the Company other than Indemnitee who are jointly liable wi th Indemnitee (or would be if joined in such Proceeding), on the one hand, and Indemnitee, on the other hand, from the transaction from which such Proceeding arose; provided, however, that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted by reference to the relative fault of the Company and all officers, directors and employees of the Company other than Indemnitee who are jointly liable with Indemnitee (or would be if joined in such Proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the events that resulted in such Expenses and Losses, as well as any other equitable considerations which applicable law may require to be considered.  The relative fault of the Company and all officers, directors and employees of the Company other than Indemnitee who are jointly liable with Indemnitee (or would be if joined in such Proceeding), on the one hand, and Indemnitee, on the other hand, will be determined by reference to, among other things, the degree to which their actions were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary, and the degree to which their conduct was active or passive.

5.2 Indemnification for Contribution Claims by Others.  To the fullest extent permitted by law, the Company will fully indemnify and hold Indemnitee harmless from any claims of contribution which may be brought by other officers, directors or employees of the Company who may be jointly liable with Indemnitee for any Loss or Expense arising from a Proceeding.

         ARTICLE VI

PROCEDURES AND PRESUMPTIONS FOR THE

DETERMINATION OF ENTITLEMENT TO INDEMNIFICATION

6.1 Notification of Claims; Request for Indemnification.  Indemnitee agrees to notify promptly the Company in writing of any claim made against Indemnitee for which indemnification will or could be sought under this Agreement; provided, however, that a delay in giving such notice will not deprive Indemnitee of any right to be indemnified under this Agreement unless, and then only to the extent that, the Company did not otherwise learn of the Proc eeding and such delay is materially prejudicial to the Company’s ability to defend such Proceeding; and, provided, further, that notice will be deemed to have been given without any action on the part of Indemnitee in the event the Company is a party to the same Proceeding.  The omission to notify the Company will not relieve the Company from any liability for indemnification that it may have to Indemnitee otherwise than under this Agreement.  Indemnitee may deliver to the Company a written request to have the Company indemnify and hold harmless Indemnitee in accordance with this Agreement.  Following such a written request for indemnification, Indemnitee’s entitlement to indemnification shall be determined according to Section ‎6.1.  The Secretary of the Company will, promptly upon receipt of such a request for indemnification, advise the Board of Directors in writing that Indemnitee has requested indemnification. The Company will be entitled to participate in any Proceeding at its own expense.

6.2 Determination of Right to Indemnification.  Upon written request by Indemnitee for indemnification pursuant to Section ‎6.1 hereof with respect to any Proceeding , a determination, if, but only if, required by applicable law, with respect to Indemnitee’s entitlement thereto will be made by one of the following, at the election of Indemnitee:  (a) so long as there are Disinterested Directors with respect to such Proceeding, a majority vote of the Disinterested Directors, even though less than a quorum of the Board of Directors; (b) so long as there are Disinterested Directors with respect to such Proceeding, a committee of such Disinterested Directors designated by a majority vote of such Disinterested Directors, even though less than a quorum of the Board of Directors; (c) Independent Counsel in a written opinion delivered to the Board of Directors, a copy of which will also be delivered to Indemnitee; (d) the Company’s shareholders, which shall exclude any shareholder who is not disinterested and independent with respect to the matters underlying the Proceeding; or (e) the unanimous vote of the Company’s shareholders.  The elect ion by Indemnitee to use a particular person, persons or entity to make such determination is to be included in the written request for indemnification submitted by Indemnitee (and if no election is made in the request it will be assumed that Indemnitee has elected the Independent Counsel to make such determination).  The person, persons or entity chosen to make a determination under this Agreement of the Indemnitee’s entitlement to indemnification will act reasonably and in good faith in making such determination.

6.3 Selection of Independent Counsel.  If the determination of entitlement to indemnification pursuant to Section ‎6.2 will be made by an Independent Counsel, the In dependent Counsel will be selected by: (a) so long as there are Disinterested Directors with respect to such Proceeding, a majority vote of the Disinterested Directors, even though less than a quorum of the Board of Directors; or (b) so long as there are Disinterested Directors with respect to such Proceeding, a committee of such Disinterested Directors designated by a majority vote of such Disinterested Directors, even though less than a quorum of the Board of Directors.

6.4 Burden of Proof.  In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination will presume that Indemnitee is entitled to indemnification under this Agreement.  Anyone seeking to overcome this presumption will have the burden of proof and the burden of persuasion, by clear and convincing evidence. In making a determination with respect to entitlement to indemnification hereunder which under this Agreement, the Articles, Bylaws or applicable law requires a determination of Indemnitee’s good faith and/or whether Indemnitee acted in a manner which he or she reasonably believed to be in or not opposed to the best interests of the Company and in the case of a criminal Proceeding, Indemnitee did not have any reasonable cause to believe Indemnitee’s conduct was unlawful. The person, persons or entity making such determination will presume that Indemnitee has at all times acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company or, if applicable in the case of a criminal Proceeding, Indemnitee did not have any reasonable cause to believe Indemnitee’s conduct was unlawful. Anyone seeking to overcome this presumption will have the burden of proof and the burden of persuasion, by clear and convincing evidence. Indemnitee will be deemed to have acted in good faith if Indemnitee’s action with respect to a particular Enterprise is based on the records or books of a ccount of such Enterprise, including financial statements, or on information supplied to Indemnitee by the officers of such Enterprise in the course of their duties, or on the advice of legal counsel for such Enterprise or on information or records given or reports made to such Enterprise by an independent certified public accountant or by an appraiser or other expert selected by such Enterprise; provided, however this sentence will not be deemed to  limit in any way the other circumstances in which Indemnitee may be deemed to have met such standard of conduct.  In addition, the knowledge and/or actions, or failure to act, of any other director, officer, agent or employee of such Enterprise will not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.

6.5 No Presumption in Absence of a Determination or As Result of an Adverse Determination; Presumption Regarding Success.  Neither the failure of any person, persons or entity chosen to make a determination as to whether Indemnitee has met any particular standard of conduct or had any particular belief to make such determination, nor an actual determination by such person, persons or entity that Indemnitee has not met such standard of conduct or did not have such belief, prior to or after the commencement of legal proceedings by Ind emnitee to secure a judicial determination that Indemnitee should be indemnified under this Agreement under applicable law, will be a defense to Indemnitee’s claim or create a presumption that Indemnitee has not met any particular standard of conduct or did not have any particular belief.  In addition, the termination of any Proceeding by judgment, order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere, or its equivalent, will not create a presumption that Indemnitee did not meet any particular standard of conduct or have any particular belief or that a court has determined that indemnification is not permitted by this Agreement or applicable law.  In the event that any Proceeding to which Indemnitee is a party is resolved in any manner other than by final adv erse judgment (as to which all rights of appeal therefrom have been exhausted or lapsed) against Indemnitee (including, without limitation, settlement of such Proceeding with or without payment of money or other consideration) it will be presumed that Indemnitee has been successful on the merits or otherwise in such Proceeding.  Anyone seeking to overcome this presumption will have the burden of proof and the burden of persuasion, by clear and convincing evidence.

6.6 Timing of Determination.  The Company will use its reasonable best efforts to cause any determination required to be made pursuant to Section ‎6.2 to be made as p romptly as practicable after Indemnitee has submitted a written request for indemnification pursuant to Section ‎6.1.  If the person, persons or entity chosen to make a determination does not make such determination within thirty (30) days after the later of the date (a) the Company receives Indemnitee’s request for indemnification pursuant to Section ‎< font color="black" style="DISPLAY: inline; FONT-SIZE: 10pt; TEXT-DECORATION: underline">6.1 and (b) on which an Independent Counsel is selected pursuant to Section ‎6.3, if applicable, the requisite determination of entitlement to indemnification will be deemed to have been made and Indemnitee will be entitled to such indemnification, so long as (i) Indemnitee has fulfilled his or her obligations pursuant to Section ‎6.8 and (ii) such indemnification is not prohibited under applicable law; provided, however, that such 30 day period may be extended for a reasonable time, not to exceed an additional fifteen (15) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining of or evaluating of documentation and/or information relating thereto.

6.7 Timing of Payments.  All payments of Expenses, including any Expense Advance, and other amounts by the Company to the Indemnitee pursuant to this Agreement will be made as soon as practicable after a written request or demand therefor by Indemnitee is presented to the Company, but in no event later than thirty (30) days after (i) such demand is presented or (ii) such later date as a determination of entitlement to indemnification is made in accordance with  Section ‎6.6, if applicable; provided, however, that an Expense Advance will be made within the time provided in Section ‎4.3 hereof.

6.8 Cooperation.  Indemnitee will cooperate with the person, persons or entity making a determination with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity, upon reasonable advance request, any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination.  Any Expenses  incurred by Indemnitee in so cooperating with the pers on, persons or entity making such determination will be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company will indemnify Indemnitee therefor and will hold Indemnitee harmless therefrom.

6.9 Time for Submission of Request.  Indemnitee will be required to submit any request for indemnification pursuant to this ‎Article VI within a reasonable time, not to exceed two years, after any judgment, order, settlement, dismissal, arbitration award, convic tion, acceptance of a plea of nolo contendere (or its equivalent) or other full or partial final determination or disposition of the Proceeding (with the latest date of the occurrence of any such event to be considered the commencement of the two-year period).

ARTICLE VII

LIABILITY INSURANCE

7.1 Company Insurance.  Subject to Section ‎7.3, the Company will obtain and maintain a policy or policies of insurance with one or more reputable insurance companies   providing Indemnitee with coverage in such amount as will be determined by the Board of Directors for Losses and Expenses paid or incurred by Indemnitee as a result of acts or omissions of Indemnitee in his or her Corporate Status, and to ensure the Company’s performance of its indemnification obligations under this Agreement; provided, however, in all policies of director and officer liability insurance obtained by the Company, Indemnitee will be named as an insured party in such manner as to provide Indemnitee with the same rights and benefits as are afforded to the most favorably insured directors or officers, as applicable, of the Company under such policies; provided, however, the Company may obtain additional insurance coverage for “independent directors” (within the meaning of the corporate governan ce rules of the Nasdaq National Market) without providing Indemnitee with the same rights and benefits afforded to the independent directors under such policy unless, at the time the policy is obtained, Indemnitee is insurable as an independent director.  Any reductions to the amount of director and officer liability insurance coverage maintained by the Company as of the date hereof will be subject to the approval of a majority of the Incumbent Directors.

7.2 Notice to Insurers.  If, at the time of receipt by the Company of a notice from any source of a Proceeding as to which Indemnitee is a party or participant, the Company will give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies, and the Company will provide Indemnitee with a copy of such notice and copies of all subsequent correspondence between the Company and such insurers related thereto.  The Company will thereafter take all necessary or desirab le actions to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies.

7.3 Insurance Not Required.  Notwithstanding Section ‎7.1, the Company will have no obligation to obtain or maintain the insurance contemplated by Section ‎7.1 if a majority of the Incumbent Directors determines in good faith that such insurance is not reasonably available, if the premium costs for such insurance are disproportionately high compared to the amount of coverage provided, or if the coverage provided by such insurance is limited by exclusions so as to provide an insufficient benefit.  The Company will promptly notify Indemnitee of any such determination not to provide insurance coverage.

          ARTICLE VIII

REMEDIES OF INDEMNITEE

8.1 Action by Indemnitee.  In the event that (i) a determination is made pursuant to ‎Article VI of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) an Expense Advance is not timely made pursuant to Section ‎4.3 of this Agreement, (iii) no determination  of entitlement to indemnification is made within the applicable time periods specified in Section ‎6.6 or (iv) payment of indemnified amounts is not made within the applicable time periods specified in Section ‎6.7, Indemnitee will be entitled to an adjudication in an appropriate court of the State of Texas, or in any other court of competent jurisdiction, of his or her entitlement to such indemnification or payment of an Expense Advance.  Alternatively, Indemnitee, at Indemnitee’s option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association.  The provisions of Texas law (without regard to its conflict of laws rules) will apply to any such arbitration.  The Company will not oppose Indemnitee’s right to seek any such adjudicati on or award in arbitration.

8.2 De Novo Review if Prior Adverse Determination.  In the event that a determination is made pursuant to ‎Article VI that Indemnitee is not entitled to in demnification, any judicial proceeding or arbitration commenced pursuant to this ‎Article VIII will be conducted in all respects as a de novo trial or arbitration, as applicable, on the merits and Indemnitee will not be prejudiced by reason of that adverse determination.  In any judicial proceeding or arbitration commenced pursuant to this ‎Article VIII, Indemnitee will be presumed to be entitled to indemnification under this Agreement, the Company will have the burden of proving Indemnitee is not entitled to indemnification and the Company may not refer to or introduce evidence of any determination pursuant to ‎Article VI adverse to Indemnitee for any purpose.  If Indemnitee commences a judicial proceeding or arbitration pursuant to this ‎Article VIII,  Indemnitee will not be required to reimburse the Company f or any Expense Advance made pursuant to ‎Article IV until a final determination is made with respect to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).

8.3 Company Bound by Favorable Determination by Reviewing Party.  If a determination is made that Indemnitee is entitled to indemnification pursuant to ‎Article VI, the Company will be bound by such determination in any judicial proceeding or arbitration commenc ed pursuant to this ‎Article VIII, absent (i) a misstatement by Indemnitee of a material fact or an omission of a material fact necessary to make Indemnitee’s statements in connection with the request for indemnification not materially misleading or (ii) a prohibition of such indemnification under law.

8.4 Company Bears Expenses if Indemnitee Seeks Adjudication.  In the event that Indemnitee, pursuant to this ‎Article VIII, seeks a judicial adjudication or arbitration of his or her rights under, or to recover damages for breach of, this Agreement, any other a greement for indemnification, the indemnification or advancement of expenses provisions in the Articles or Bylaws, payment of Expenses in advance or contribution hereunder or to recover under any director and officer liability insurance policies maintained by the Company, the Company will, to the fullest extent permitted by law, indemnify and hold harmless Indemnitee against any and all Expenses which are paid or incurred by Indemnitee in connection with such judicial adjudication or arbitration, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, payment of Expenses in advance or contribution or insurance recovery.  In addition, if requested by Indemnitee, the Company will (within ten days after receipt by the Company of the written request therefor), pay as an Expense Advance such Expenses, to the fullest extent permitted by law.

8.5 Company Bound by Provisions of this Agreement.  The Company will be precluded from asserting in any judicial or arbitration proceeding commenced pursuant to this ‎Article VIII that the procedures and presumptions of this Agreement are not valid, binding and enforceable and will stipulate in any such judicial or arbitration proceeding that the Company is bound by all the provisions of this Agreement.

ARTICLE IX

NON-EXCLUSIVITY, SUBROGATION; NO DUPLICATIVE PAYMENTS;

MORE FAVORABLE TERMS

9.1 Non-Exclusivity.  The rights of indemnification and to receive Expense Advances as provided by this Agreement will not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Articles, the Bylaws, any agreement, a vote of shareholders, a resolution of the directors or otherwise.  To the extent Indemnitee otherwise would have any greater right to indemnification or payment of any advancement of Expenses under any other provisions under applicable law, the Article s, Bylaws, any agreement, vote of shareholders, a resolution of directors or otherwise, Indemnitee will be entitled under this Agreement to such greater right.  No amendment, alteration or repeal of this Agreement or of any provision hereof limits or restricts any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee prior to such amendment, alteration or repeal.  To the extent that a change in the TCL, whether by statute or judicial decision, permits greater indemnification than would be afforded currently under the Articles, Bylaws and this Agreement, it is the intent of the parties hereto that Indemnitee enjoy by this Agreement the greater benefits so afforded by such change.  No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy will be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equi ty or otherwise.  The assertion or employment of any right or remedy hereunder, or otherwise, will not prevent the concurrent assertion or employment of any other right or remedy.

9.2 Subrogation.  In the event of any payment by the Company under this Agreement, the Company will be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee with respect thereto and Indemnitee will execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights (it being understood that all of Indemnitee’s reasonable Expenses related thereto will be borne by the Co mpany).

9.3 No Duplicative Payments.  The Company will not be liable under this Agreement to make any payment of amounts otherwise indemnifiable (or any Expense for which advancement is provided) hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.  The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee in respect of Proceedings relating to Indemnitee’s service at the request of the Company as a director, officer, employee, partner, member, manager, venturer, proprietor, trustee, fiduciary or agent of any other Enterprise will be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such other Enterprise.

9.4 More Favorable Terms.  In the event the Company enters into an indemnification agreement with another officer or director, as the case may be, containing terms more favorable to the indemnitee thereof than the terms contained herein (and absent special circumstances justifying such more favorable terms), Indemnitee will be afforded the benefit of such more favorable terms and such more favorable terms will be deemed incorporated by reference herein as if set forth in full herein.  As promptly as practicable following t he execution thereof, the Company will (a) send a copy of the agreement containing more favorable terms to Indemnitee, and (b) prepare, execute and deliver to Indemnitee an amendment to this Agreement containing such more favorable terms.

         ARTICLE X

DEFENSE OF PROCEEDINGS

10.1 Company Assuming the Defense.  Subject to Section ‎10.3 below, in the event the Company is obligated to pay in advance the Expenses of any Proceeding pursuant to ‎Article IV, the Company will be entitled, by written notice to Indemnitee, to assume the defense of such Proceeding, with counsel approved by Indemnitee, which approval will not be unreasonably withheld.  The Company will identify the counsel it proposes to employ in connection with such defense as part of the written notice sent to Indemnitee notifying Indemnitee of the Company’s election to assume such defense, and Indemnitee will be required, within ten days following Indemnitee’s receipt of such notice, to inform the Company of its approval of such counsel or, if it has objections, the reasons therefor.  If such objections cannot be resolved by the parties, the Company will identify alternative couns el, which counsel will also be subject to approval by Indemnitee in accordance with the procedure described in the prior sentence.

10.2 Right of Indemnitee to Employ Counsel.  Following approval of counsel by Indemnitee pursuant to Section ‎10.1 and retention of such counsel by the Company, the C ompany will not be liable to Indemnitee under this Agreement for any fees and expenses of counsel subsequently incurred by Indemnitee with respect to the same Proceeding; provided, however, that (a) Indemnitee has the right to employ counsel in any such Proceeding at Indemnitee’s expense and (b) the Company will be required to pay the  fees and expenses of Indemnitee’s counsel if (i) the employment of counsel by Indemnitee has been previously authorized by the Company, (ii) Indemnitee reasonably concludes that there is an actual or potential conflict between the Company (or any other person or persons included in a joint defense) and Indemnitee in the conduct of such defense or representation by such counsel retained by the Company or (iii) the Company does not continue to retain the counsel approved by Indemnitee.

10.3 Company Not Entitled to Assume Defense.  Notwithstanding Section ‎10.1, th e Company will not be entitled to assume the defense of any Proceeding brought by or on behalf of the Company or any Proceeding as to which Indemnitee has reasonably made the conclusion provided for in Section ‎10.2(b)(ii).

ARTICLE XI

SETTLEMENT

11.1 Company’s Prior Consent Required.  Notwithstanding anything in this Agreement to the contrary, the Company will have no obligation to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any Proceeding effected without the Company’s prior written consent.

11.2 When Indemnitee’s Prior Consent Required.  The Company will not, without the prior written consent of Indemnitee, consent to the entry of any judgment against Indemnitee or enter into any settlement or compromise which (i) includes an admission of fault of Indemnitee, any non-monetary remedy imposed on Indemnitee or a Loss for which Indemnitee is not wholly indemnified hereunder or (ii) with respect to any Proceeding with respect to which Indemnitee may be or is made a party or a participant or may be or is otherwise enti tled to seek indemnification hereunder, does not include, as an unconditional term thereof, the full release of Indemnitee from all liability in respect of such Proceeding, which release will be in form and substance reasonably satisfactory to Indemnitee.  Neither the Company nor Indemnitee will unreasonably withhold its consent to any proposed settlement; provided, however, Indemnitee may withhold consent to any settlement that does not provide a full and unconditional release of Indemnitee from all liability in respect of such Proceeding.

          ARTICLE XII

DURATION OF AGREEMENT

12.1 Duration of Agreement.  This Agreement will continue until and terminate upon the latest of (a) the statute of limitations applicable to any claim that could be asserted against an Indemnitee with respect to which Indemnitee may be entitled to indemnification and/or an Expense Advance under this Agreement, (b) ten years after the date that Indemnitee has ceased to serve as a director or officer of the Company or as a director, officer, employee, partner, member, manager, fiduciary or agent of any other Enterprise which Indemnit ee served at the request of the Company, or (c) if, at the later of the dates referred to in (a) and (b) above, there is pending a Proceeding in respect of which Indemnitee is granted rights of indemnification or the right to an Expense Advance under this Agreement or a Proceeding commenced by Indemnitee pursuant to ‎Article VIII of this Agreement, one year after the final termination of such Proceeding, including any and all appeals.

ARTICLE XIII

MISCELLANEOUS

13.1 Entire Agreement.  This Agreement constitutes the entire agreement and understanding of the parties in respect of the subject matter hereof and supersedes all prior understandings, agreements or representations by or among the parties, written or oral, to the extent they relate in any way to the subject matter hereof; provided, however, it is agreed that the provisions contained in this Agreement are a supplement to, and not a substitute for , any provisions regarding the same subject matter contained in the Articles, the Bylaws and any employment or similar agreement between the parties.

13.2 Assignment; Binding Effect; Third Party Beneficiaries. No party may assign either this Agreement or any of its rights, interests or obligations hereunder without the prior written approval of the other party and any such assignment by a party without prior written approval of the other parties will be deemed null and void, have no effect and not binding on such other parties; provided, however, that the Company may assign all (but not less than all) of its rights, obligations and interests hereunder to any direct or indirect successor to all or substantially all of the business or assets of the Company by purchase, merger, consolidation or otherwise and will cause such successor to be bound by and expressly assume the terms and provisions hereof.  All of the terms, agreements, covenants, representations, warranties and conditions of this Agreement are binding upon, and inure to the benefit of and are enforceable by, the parties and their respective successors, permitted assigns, heirs, executors and personal and legal representatives.  There are no third party beneficiaries having rights under or with respect to this Agreement.

13.3 Notices.  All notices, requests and other communications provided for or permitted to be given under this Agreement must be in writing and be given by personal delivery, by certified or registered United States mail (postage prepaid, return receipt requested), by a nationally recognized overnight delivery service for next day delivery, or by facsimile transmission, as follows (or to such other address as any party may give in a notice given in accordance with the provisions hereof):

If to the Company:

Mannatech, Incorporated

600 S. Royal Lane, Suite 200

Coppell, Texas 75019

Attention:  Chief Legal Officer

Facsimile:  (972) 471-7387

If to Indemnitee:

___________________

___________________

___________________

Facsimile: __________

All notices, requests or other communications will be effective and deemed given only as follows:  (i) if given by personal delivery, upon such personal delivery, (ii) if sent by certified or registered mail, on the fifth business day after being deposited in the United States mail, (iii) if sent for next day delivery by overnight delivery service, on the date of delivery as confirmed by written confirmation of delivery, (iv) if sent by facsimile, upon the transmitter’s confirmation of receipt of such facsimile transmission, except that if such confirmation is received after 5:00 p.m. (in the recipient’s time zone) on a business day, or is received on a day that is not a business day, then such notice, request or communication will not be deemed effective or given until the next succeeding business d ay.  Notices, requests and other communications sent in any other manner, including by electronic mail, will not be effective.

13.4 Specific Performance; Remedies.  Each party acknowledges and agrees that the other party would be damaged irreparably if any provision of this Agreement were not performed in accordance with its specific terms or were otherwise breached.  Accordingly, the parties will be entitled to an injunction or injunctions to prevent breaches of the provisions of this Agreement and to enforce specifically this Agreement and its provisions, in a ddition to any other remedy to which they may be entitled, at law or in equity.  Except as expressly provided herein, the rights, obligations and remedies created by this Agreement are cumulative and in addition to any other rights, obligations or remedies otherwise available at law or in equity.  Except as expressly provided herein, nothing herein will be considered an election of remedies.

13.5 Submission to Jurisdiction. Any Proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement may only be brought in a federal or state court sitting in Dallas County, Texas, which will be the exclusive and only proper forum for adjudicating such Proceeding, and each party consents to the exclusive jurisdiction and venue of such court (and of the appropriate appellate courts therefrom) in any such Proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such  Proceeding in any such court or that any such Proceeding brought in any such court has been brought in an inconvenient forum.  Process in any such action, suit or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court.

13.6 Headings.  The article and section headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation of this Agreement.

13.7 Governing Law.  This Agreement will be governed by and construed in accordance with the laws of the State of Texas, without giving effect to any choice of law principles.

13.8 Amendment.  This Agreement may not be amended or modified except by a writing signed by all of the parties.

13.9 Extensions; Waivers.  Any party may, for itself only, (i) extend the time for the performance of any of the obligations of any other party under this Agreement, (ii) waive any inaccuracies in the representations and warranties of any other party contained herein or in any document delivered pursuant hereto and (iii) waive compliance with any of the agreements or conditions for the benefit of such party contained herein.  Any such ex tension or waiver will be valid only if set forth in a writing signed by the party to be bound thereby.  No waiver by any party of any default, misrepresentation or breach of warranty or covenant hereunder, whether intentional or not, may be deemed to extend to any prior or subsequent default, misrepresentation or breach of warranty or covenant hereunder or affect in any way any rights arising because of any prior or subsequent such occurrence. Neither the failure nor any delay on the part of any party to exercise any right or remedy under this Agreement will operate as a waiver thereof, nor will any single or partial exercise of any right or remedy preclude any other or further exercise of the same or of any other right or remedy.

13.10 Severability.  The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied to any party or to any circumstance, is judicially determined not to be enforceable in accordance with its terms, the parties agree that the court judicially making such determination may modify the provision in a manner consistent with its objectives such that i t is enforceable, and/or to delete specific words or phrases, and in its modified form, such provision will then be enforceable and will be enforced.

13.11 Counterparts; Effectiveness.  This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute one and the same instrument.  This Agreement will become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties, which delivery may be made by exchange of copies of the signature page by facsimile trans mission.  For purposes of determining whether a party has signed this Agreement or any document contemplated hereby or any amendment or waiver hereof, only a handwritten signature on a paper document or a facsimile transmission of a handwritten original signature will constitute a signature, notwithstanding any law relating to or enabling the creation, execution or delivery of any contract or signature by electronic means.

13.12 Construction.  This Agreement has been freely and fairly negotiated among the parties.  If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties and no presumption or burden of proof will arise favoring or disfavoring any party because of the authorship of any provision of this Agreement.  Any reference to any law will be deemed also to refer to such law as amended and all rules and regulations promulgated thereunder, unless the context requires otherwise.  The words “include,” “includes,” and “including” will be deemed to be followed by “without limitation.”  Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires.  The words “this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited.  The parties intend that each representation, warranty, and covenant contained herein will have independent significance.  If any party has breached any representation, warranty, or covenant contained herein in any resp ect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which the party has not breached will not detract from or mitigate the fact that the party is in breach of the first representation, warranty, or covenant.  Time is of the essence in the performance of this Agreement.

[Signature page follows]

- -

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.

MANNATECH, INCORPORATED

By:

Name:

Title:

INDEMNITEE

Name:

Signature Page to Indemnification Agreement

EX-31.1 4 exhibit_31-1.htm CERTIFICATION PURSUANT TO SECTION 302 exhibit_31-1.htm

Exhibit 31.1

CERTIFICATION

PURSUANT TO 17 CFR 240.13a-14

PROMULGATED UNDER

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert A. Sinnott, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Mannatech, Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 4, 2010

/s/ Robert A. Sinnott

Robert A. Sinnott

Co-Chief Executive Officer and

Chief Science Officer

EX-31.2 5 exhibit_31-2.htm CERTIFICATION PURSUANT TO SECTION 302 exhibit_31-2.htm
Exhibit 31.2

CERTIFICATION

PURSUANT TO 17 CFR 240.13a-14

PROMULGATED UNDER

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Stephen D. Fenstermacher, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Mannatech, Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 4, 2010

/s/ Stephen D. Fenstermacher

Stephen D. Fenstermacher

Co-Chief Executive Officer and

Chief Financial Officer

EX-32.1 6 exhibit_32-1.htm CERTIFICATION PURSUANT TO SECTION 906 exhibit_32-1.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Mannatech, Incorporated (the “Company”) on Form 10-Q for the period ending September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert A. Sinnott, Co-Chief Executive Officer and Chief Science Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 4, 2010

/s/ Robert A. Sinnott

Robert A. Sinnott

Co-Chief Executive Officer and

Chief Science Officer

A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN PROVIDED TO MANNATECH, INCORPORATED AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.

EX-32.2 7 exhibit_32-2.htm CERTIFICATION PURSUANT TO SECTION 906 exhibit_32-2.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Mannatech, Incorporated (the “Company”) on Form 10-Q for the period ending September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen D. Fenstermacher, Co-Chief Executive Officer and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 4, 2010

/s/ Stephen D. Fenstermacher

Stephen D. Fenstermacher

Co-Chief Executive Officer and

Chief Financial Officer

A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN PROVIDED TO MANNATECH, INCORPORATED AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.

EX-101.SCH 8 mtex-20100930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 001000 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 001010 - Statement - PARENTHETICAL DATA TO THE CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED link:presentationLink link:calculationLink link:definitionLink 003000 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE INCOME (LOSS) - UNAUDITED link:presentationLink link:calculationLink link:definitionLink 004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED link:presentationLink link:calculationLink link:definitionLink 020010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 006020 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 006030 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 006040 - Disclosure - LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 006050 - Disclosure - STOCK BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 006080 - Disclosure - FAIR VALUE link:presentationLink link:calculationLink link:definitionLink 006090 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 020020 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 006070 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 006010 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 003010 - Statement - PARENTHETICAL DATA TO CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE INCOME (LOSS) - UNAUDITED link:presentationLink link:calculationLink link:definitionLink 020030 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 020040 - Disclosure - CAPITAL LEASE OBLIGATIONS link:presentationLink link:calculationLink link:definitionLink 020050 - Disclosure - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 020060 - Disclosure - TRANSACTIONS WITH RELATED PARTIES AND AFFILIATES link:presentationLink link:calculationLink link:definitionLink 020070 - Disclosure - EMPLOYEE BENEFIT PLANS link:presentationLink link:calculationLink link:definitionLink 020080 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 006060 - Disclosure - LITIGATION link:presentationLink link:calculationLink link:definitionLink 006055 - Disclosure - SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 021010 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS link:presentationLink link:calculationLink link:definitionLink EX-101.INS 9 mtex-20100930.xml XBRL INSTANCE DOCUMENT 0001056358 2009-01-01 2009-09-30 0001056358 2009-01-01 2009-12-31 0001056358 2008-12-31 0001056358 2009-12-31 0001056358 us-gaap:CommonStockMember 2009-12-31 0001056358 us-gaap:AdditionalPaidInCapitalMember 2009-12-31 0001056358 us-gaap:RetainedEarningsMember 2009-12-31 0001056358 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-12-31 0001056358 us-gaap:TreasuryStockMember 2009-12-31 0001056358 2009-09-30 0001056358 2010-01-01 2010-09-30 0001056358 us-gaap:AdditionalPaidInCapitalMember 2010-01-01 2010-09-30 0001056358 us-gaap:CommonStockMember 2010-01-01 2010-09-30 0001056358 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-01-01 2010-09-30 0001056358 us-gaap:RetainedEarningsMember 2010-01-01 2010-09-30 0001056358 2010-09-30 0001056358 us-gaap:CommonStockMember 2010-09-30 0001056358 us-gaap:AdditionalPaidInCapitalMember 2010-09-30 0001056358 us-gaap:RetainedEarningsMember 2010-09-30 0001056358 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-09-30 0001056358 us-gaap:TreasuryStockMember 2010-09-30 0001056358 2010-07-01 2010-09-30 0001056358 2009-07-01 2009-09-30 0001056358 2010-11-01 0001056358 2010-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 2: INVENTORIES</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories consist of raw materials and finished goods, including promotional materials. The Company provides an allowance for any slow-moving or obsolete inventories. Inventories at September 30, 2010 and December 31, 2009, consisted of the following <font style="DISPLAY: inline; FONT-STYLE: italic">(in thousands)</font>:</font></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" c ellspacing="0" cellpadding="0" width="65%"><tr><td valign="bottom" width="31%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 30, 2010</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0 pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="31%"><div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Raw materials</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FON T-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,223</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: b lock; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,819</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="31%"><div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Finished goods</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align= "right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,156</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,844</font></div></td><td valign="bottom" width ="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="31%"><div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventory reserves for obsolescence</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><f ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,990</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,37 3</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="white"><td valign="bottom" width="31%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: blac k 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,389</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right " width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31,290</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div> Yes Q3 4313000 -8368000 28000 66000 464000 437000 61000 94000 0 0 26490000 26464000 26487000 26462000 23109000 35268000 74617000 115413000 1197000 847000 false -7738000 9000 592000 -2635000 7079000 517000 -0.05 -0.35 -0.30 -0.74 31033000 47191000 99257000 151357000 7924000 11923000 24640000 35944000 19963000 27144000 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mannatech, Incorporated (together with its subsidiaries, the “Company”), headquartered in Coppell, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the NASDAQ Global Select Market under the symbol “MTEX”. The Company develops, markets, and sells high-quality, proprietary nutriti onal supplements, topical and skin care products, and weight-management products that are primarily sold to independent associates and members located in the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, Singapore, Austria, the Netherlands, Norway, and Sweden.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Independent associates purchase the Company’s products at published wholesale prices to either sell to retail customers or consume personally. Members purchase the Company’s products at a discount from published retail prices primarily for personal consumption. The Company cannot distinguish its personal consumption sales from its other sales because it has no in volvement in its products after delivery, other than usual and customary product warranties and returns. Only independent associates are eligible to earn commissions and incentives.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the Company’s consolidated financial statements and footnotes contained herein do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) to be consi dered “complete financial statements”. However, in the opinion of the Company’s management, the accompanying unaudited consolidated financial statements and footnotes contain all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company’s consolidated financial information as of, and for, the periods presented. The Company cautions that its consolidated results of operations for an interim period are not necessarily indicative of its consolidated results of operations to be expected for its fiscal year. The December 31, 2009 consolidated balance sheet was included in the audited consolidated financial statements in the Company’s annual report on Form 10-K for the year ended December 31, 2009 and filed with the United States Securities and Exchange Commission on March 11, 2010 (the “2009 Annual Report”), which includes all disclosures required by GAAP. Therefore, these unaudited consoli dated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2009 Annual Report.</font></div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mannatech, Incorporated (together with its subsidiaries, the “Company”), headquartered in Coppell, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the NASDAQ Global Select Market under the symbol “MTEX”. The Company develops, markets, and sells high-quality, proprietary nutritional supplements, top ical and skin care products, and weight-management products that are primarily sold to independent associates and members located in the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, Singapore, Austria, the Netherlands, Norway, and Sweden.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Independent associates purchase the Company’s products at published wholesale prices to either sell to retail customers or consume personally. Members purchase the Company’s products at a discount from published retail prices primarily for personal consumption. The Company cannot distinguish its personal consumption sales from its other sales because it has no involvement in its prod ucts after delivery, other than usual and customary product warranties and returns. Only independent associates are eligible to earn commissions and incentives.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the Company’s consolidated financial statements and footnotes contained herein do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) to be considered “comp lete financial statements”. However, in the opinion of the Company’s management, the accompanying unaudited consolidated financial statements and footnotes contain all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company’s consolidated financial information as of, and for, the periods presented. The Company cautions that its consolidated results of operations for an interim period are not necessarily indicative of its consolidated results of operations to be expected for its fiscal year. The December 31, 2009 consolidated balance sheet was included in the audited consolidated financial statements in the Company’s annual report on Form 10-K for the year ended December 31, 2009 and filed with the United States Securities and Exchange Commission on March 11, 2010 (the “2009 Annual Report”), which includes all disclosures required by GAAP. Therefore, these unaudited consolidated financial state ments should be read in conjunction with the consolidated financial statements of the Company included in the 2009 Annual Report.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Principles of Consolidation</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been el iminated in consolidation.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Use of Estimates</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The preparation of the Company’s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The C ompany continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. Actual results may differ from these estimates under different assumptions or conditions.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered to be the most significant are described in this note to the consolidated financial statements, <font style="DISPLAY: inline; FONT-STYLE: italic">Organization and Summary of Significant Accounting Policies</font>.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Cash and Cash Equivalents</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash p roceeds from credit card receivables are generally received within 24 to 72 hours. As of September 30, 2010 and December 31, 2009, credit card receivables were $3.6 million and $2.8 million, respectively. Additionally, as of September 30, 2010 and December 31, 2009, cash and cash equivalents held in bank accounts in foreign countries totaled $10.5 million and $10.2 million, respectively.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"></font> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Restricted Cash</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company is required to restrict cash for (i) direct selling insurance premiums and credit card sales in the Republic of Korea, (ii) a reserve on credit card sales in the United States and Canada, and (iii) collateral for its Australia building lease. As of September 30, 2010 and December 31, 2009, our total restricted cash was $6.9 million and $8.5 million, respectively. The decrease in restricted cash was primarily related to the partial refund of direct selling insurance premiums in Korea.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10p t; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Accounts Receivable</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. Receivables consist primarily of amounts due from members and independent associates. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time they are past due, and writes-off receivables when they become uncollectible. At September 30, 2010 and December 31, 2009, the Company held an allowan ce for doubtful accounts of less than $0.1 million.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Inventories</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories consist of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. The Company periodically reviews inventories for obsolescence and any inventories identifi ed as obsolete are reserved or written off.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Assets</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of September 30, 2010 and December 31, 2009, other assets of $2.2 million and $2.5 million primarily consisted of deposits for building leases in various locations and certain intangible assets.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><b r /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Commissions and Incentives</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Independent associates earn commissions and incentives based on their direct and indirect commissionable net sales over 13 business periods. Each business period equals 28 days. The Company accrues commissions and incentives when earned by independent associates and pays commissions on product sales three weeks following the business period end and pays commissions on its pack sales five weeks following the business period end.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Long-Term Liabilities</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In August 2003, the Company entered into a Long-Term Post-Employment Royalty Agreement with Dr. Bill McAnalley, the Company’s former Chief Science Officer, pursuant to which the Company is required to pay Dr. McAnalley, or his he irs, royalties for ten years beginning September 2005 and continuing through August 2015. Quarterly payments related to this Long-Term Post-Employment Royalty Agreement are based on certain applicable annual global product sales by the Company in excess of $105.4 million. At the time the Company entered into this royalty agreement, it was considered a post-employment benefit and the Company was required to measure and accrue the present value of the estimated future royalty payments related to this benefit, and recognize it over the life of Dr. McAnalley’s employment agreement, which was two years. As of September 30, 2010, the Company’s liability related to this royalty agreement was $1.3 million, of which $0.3 million was currently due and included in accrued expenses.  As of December 31, 2009, the Company’s long-term liability related to this royalty agreement was $1.6 million, of which $0.3 million was currently due and included in accrued expenses.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain operating leases for the Company’s regional office facilities contain a restoration clause that requires the Company to restore the premises to its original condition. As of September 30, 2010 and December 31, 2009, accrued restoration costs related to these leases amounted to $0.4 million. At September 30, 2010 and December 31, 2009, the Company also recorded a long-term liability for an estimated deferred benefit obligation related to a deferred benefit plan for its Japan operations of $1.1 million and $0.8 million, respectively.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MAR GIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Comprehensive Income (loss) and Accumulated Other Comprehensive Income (loss</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">)</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company’s comprehensive income (loss) consists of the Company’s net income (loss), foreign currency translation adjustments from its Japan, Republic of Korea, Taiwan, Norway, and Sweden operations, and changes in the pension obligation for its Japanese employees.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Revenue Recognition</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company’s revenue is derived from sale s of individual products, sales of its starter and renewal packs, and shipping fees. Substantially all of the Company’s product and pack sales are made to independent associates at published wholesale prices and to members at discounted published retail prices. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company recognizes revenue from shipped packs and products upon receipt by the customer. Corporate-sponsored event revenue is recognized when the event is held. The Company defers certain components of its revenue. At September 30, 2010 and December 31, 2009, the Company’s deferred revenue was $2.9 million and $2. 8 million, respectively, and consisted primarily of revenue received from: (i) sales of packs and products shipped but not received by the customers by period end; and (ii) prepaid registration fees from customers planning to attend a future corporate-sponsored event.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six- month period. If actual results differ from our estimated sales return reserve due to various factors, the amount of revenue recorded each period could be materially affected. Historically, our sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days aft er the original sale. Sales returns have averaged 1.5% or less of our gross sales. For the nine months ended September 30, 2010 our sales return reserve was composed of the following <font style="DISPLAY: inline; FONT-STYLE: italic">(in thousands)</font>:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="65%"><tr><td valign="bottom" width="51%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 30, 2010</font></div></td>& lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales reserve as of January 1, 2010</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10 pt; FONT-FAMILY: times new roman">595</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision related to sales made in current period</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,591</font></div></ td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision related to sales made in prior periods</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">112</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inl ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Actual returns or credits related to current period</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,128</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT : 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Actual returns or credits related to prior periods</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(710</font></div></td>&l t;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales reserve as of September 30, 2010</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px doubl e" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">460</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Shipping and Handling Costs</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div st yle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company records freight and shipping fees collected from its customers as revenue. The Company records inbound freight as cost of sales and records shipping and handling costs associated with shipping products to customers as selling and administrative expenses. Total shipping and handling costs included in selling and administrative expenses were approximately $2.7 million and $3.6 million for the three months ended September 30, 2010 and 2009, respectively, and $8.8 million and $10.6 million for the nine months ended September 30, 2010 and 2009, respectively.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT - -STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Reclassifications</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain reclassifications have been made to the financial statements for prior periods to conform to the current period presentation.</font></div> No 69000 29000 1529000 2500000 428000 -1022000 4411000 1265000 10-Q 31365883 17367000 30945000 21680000 22577000 27697560 27687882 0.01 0.01 26490000 26464000 26487000 26462000 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 7: LITIGATION</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Patent Infringement Litigation</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY : inline; FONT-STYLE: italic">Mannatech, Inc. v. Country Life, LLC, et al.</font>, No. 3:10-cv-00533-O, United States District Court, Northern District of Texas, Dallas Division</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On March 16, 2010, Mannatech, Inc. filed a patent infringement lawsuit against Country Life, LLC; Country Life Manufacturing, LLC; EvenBetterNow, LLC; Micro Health Solutions, LLC; New Sun, Inc.; Oasis Advanced Wellness, LLC; Roex, Inc.; VDF FutureCeuticals, Inc.; and John Does 1-20, alleging the defendants infringe United States Patent Nos. 6,929,807, 7,157,431, 7,196,064, 7,199,104, and 7,202,220, all entitled “Compositions of Plant Carbohydrates as Dietary Supplements” (“Patents-in-Suit”), and seeking t o stop their manufacture, offer, and sale of infringing glyconutritional dietary supplement products. On May 14, 2010, Mannatech amended its complaint to add patent infringement claims against Angel Care USA, Inc.; Florida Nutri Labs, LLC; and Wy’s Enterprises of Springfield, Inc.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Agreed Judgments have been entered against seven of the eleven defendants: EvenBetterNow, Oasis Advanced Wellness, Micro Health Solutions, Wy's Enterprises of Springfield, Florida Nutri Labs, Angel Care, USA, and New Sun.  In each of the Agreed Judgments, the defendant is enjoined, for the term of the Patents-in-Suit, from making, using, offering to sell, or otherwise distributing the accused infringing products or colorable imitations thereof (the “Enjoined Products”); inducing infringement of the patents by encouraging or assisting others in selling the Enjoined Products; or supplying or causing to be supplied all or a substantial portion of the components of the Enjoined Products.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On June 25, 2010, Mannatech filed an unopposed motion to drop defendant Country Life Manufacturing, LLC because Mannatech discovered that Country Life Manufacturing was no longer active or associated with Country Life, LLC. On June 29, Mannatech’s motion was granted and Country Life Manufacturing, LLC was dismissed from the lawsuit without prejudice.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The lawsuit is now proceeding against the remaining three defendants: Country Life, Roex, and VDF FutureCeuticals. All three have filed answers, and two of the defendants, Roex and VDF FutureCeuticals, have filed counterclaims challenging the validity of Mannatech’s patents and seeking recovery of their attorneys’ fees. In addition, on June 25, 2010, Roex filed a motion to sever and motion to transfer venue to its home district of the Central District of California. On July 16, Mannatech filed its response in opposition, after which VDF FutureCeuticals filed a motion to join Roex’s motion to transfer. &# 160;On July 21, Mannatech filed a motion to strike VDF’s improper joinder. On July 26, 2010, the Court denied Roex’s motion.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On July 16, 2010, the court entered a Scheduling Order, setting trial for November 1, 2011. In order to permit the parties to engage in direct settlement discussions, the parties have twice filed joint motions seeking extensions of the Scheduling Order deadlines. The court granted both motions and the current Second Amended Scheduling Order, issued on October 12, 2010, reset the trial date for December 5, 2011.  Mannatech intends to vigorously prosecute this matter in the event settlement cannot be reached, as this la wsuit continues Mannatech’s enforcement of its patent rights. Based on the previous successful patent infringement lawsuits against Glycobiotics International, Inc., Techmedica Health, Inc., IonX Holdings, Inc., Boston Mountain Laboratories, Inc., Green Life, LLC, and Xiong Lo, Mannatech believes it could  obtain permanent injunctions against the manufacture and sale of any infringing products for the duration of Mannatech’s Patents-in-Suit.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Business Arbitration and Litigation</font></font></div><div style="DISPLAY: blo ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Marinova Pty. Limited v. Mannatech, Incorporated & Mannatech (International) Limited</font>, Case No. 50-122-T-00635-09, International Centre for Dispute Resolution, a division of the American Arbitration Association</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On December 10, 2009, Marinova Pty. Limited (“Marinova”), a company duly organized and operating under the laws of Australia, filed a Notice of A rbitration and Statement of Claim with the International Centre for Dispute Resolution, which is a division of the American Arbitration Association, against Mannatech Incorporated and Mannatech (International) Limited (collectively, “Mannatech”). Marinova’s claims stem from the parties’ April 27, 2007 Purchase Agreement, which was entered into between Marinova and Mannatech (International) Limited and executed by Marinova and Mannatech, Incorporated. Through the Purchase Agreement, Marinova agreed to sell and Mannatech agreed to buy set quantities of glyconutrient powder that Mannatech uses in the manufacturing of some its products. Marinova claims that Mannatech breached the Purchase Agreement by not buying certain quantities of Marinova’s product. Marinova alternatively claims that Mannatech, Incorporated tortiously interfered with the Purchase Agreement. Finally, Marinova claims that Mannatech, Incorporated made fraudulent representations to Marinova upon which Marinova claims it relied in executing the Purchase Agreement. Marinova claims that Mannatech’s actions have caused them over $5,000,000 in damages, as well as attorneys’ fees and costs.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On January 15, 2010, Mannatech filed its Answering Statement and Counterclaims, through which Mannatech asserted affirmative defenses in response to Marinova’s claims, including that Marinova’s ow n actions or omissions contributed to or caused Marinova’s alleged injury. Mannatech also filed a counterclaim for breach of contract, through which Mannatech alleges that Marinova sold Mannatech non-conforming powder and then refused to reimburse Mannatech the amount it paid for the non-conforming powder, thereby breaching the Purchase Agreement. Mannatech further alleges that Marinova separately breached the Purchase Agreement by marketing its powder to one or more of Mannatech’s competitors in violation of an amendment to the Purchase Agreement’s exclusivity clause. Finally, Mannatech requested declaratory judgments from the arbitration panel, including a judgment that Mannatech is not obligated to purchase any additional product from Marinova because Marinova breached the Purchase Agreement. Mannatech is seeking damages in the amount it paid for the non-conforming product, as well as damages from Marinova’s breach of the parties& amp;#8217; exclusivity agreement, attorneys’ fees, and costs.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On August 25, 2010, the panel of three arbitrators held their preliminary hearing, during which Mannatech requested the opportunity to brief a motion to strike certain portions of Marinova’s Statement of Claims that Mannatech thought were brought solely for the purposes of prejudicing the panel against Mannatech. Those portions of Marinova’s Statement of Claims related to lawsuit s filed against Mannatech several years ago, all of which have now settled and bear no relation to Marinova’s claims. The panel granted Mannatech leave to file a motion to strike.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In response, Marinova sought leave and was granted the opportunity to re-plead its Statement of Claims. On August 31, 2010, Marinova filed its Amended Statement of Claims, in which it claims that, in addition to its other claims against Mannatech, Mannatech breached the Purchase Agre ement because Mannatech allegedly falsely warranted that it was not the subject of any lawsuits or investigations. Accordingly, on September 15, 2010, Mannatech filed its Motion to Dismiss and Strike, through which it seeks to strike Marinova’s newly-added claim because (a) Marinova never raised the claim prior to its re-pleading; (b) Marinova accepted millions of dollars from Mannatech after it became aware of Mannatech’s alleged breach; and (c) Marinova is asserting its claim solely in an attempt to prejudice the panel. Marinova subsequently filed a response and Mannatech filed a reply in support of its Motion to Dismiss and Strike on October 12, 2010.  The panel has not yet ruled on the Motion to Dismiss and Strike.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPL AY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mannatech intends to vigorously defend against Marinova’s claims and prosecute its counterclaim.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORAT ION: underline">Litigation in General</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company has several pending claims incurred in the normal course of business. In the Company’s opinion, such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company maintains certain liability insurance; however, certain costs of defending lawsuits, such as those below the insurance deduct ible amount, are not covered by or only partially covered by its insurance policies. Additionally, insurance carriers could refuse to cover certain of these claims in whole or in part. The Company accrues costs to defend itself from litigation as incurred or as they become determinable.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The outcome of litigation may not be assured, and despite management’s views of the merits of any litigation, or the reasonableness of the Company’s estimates and reserves, the Company’s financial statements could nonetheless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from the above legal matters where an outcome was deemed to be proba ble, and the loss amount could be reasonably estimated. While it is not possible to predict with certainty what liability or damages the Company might incur in connection with any of the above-described lawsuits, based on the advice of counsel and a management review of the existing facts and circumstances related to these lawsuits, and related legal fees, the Company has accrued $0.5 million as of September 30, 2010 for these matters, which is included in accrued expenses in its Consolidated Balance Sheet.</font></div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Principles of Consolidation</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MA RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Use of Estimates</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The preparation of the Company’s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have no t varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. Actual results may differ from these estimates under different assumptions or conditions.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered to be the most significant are described in this note to the consolidated financial statements, <font style="DISPLAY: inline; FONT-STYLE: italic">Organization and Summary of Significant Accounting Policies</font>.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div>&l t;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Cash and Cash Equivalents</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivables are generally received within 24 to 72 hours. As of September 30, 2010 and December 31, 2009, credit card receivables were $3.6 million and $2.8 million, respectively. Additionally, as of September 30, 2010 and December 31, 2009, cash and cash equivalents held in bank accounts in foreign countries totaled $10.5 million and $10.2 million, respectively.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"></font> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Restricted Cash</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align ="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company is required to restrict cash for (i) direct selling insurance premiums and credit card sales in the Republic of Korea, (ii) a reserve on credit card sales in the United States and Canada, and (iii) collateral for its Australia building lease. As of September 30, 2010 and December 31, 2009, our total restricted cash was $6.9 million and $8.5 million, respectively. The decrease in restricted cash was primarily related to the partial refund of direct selling insurance premiums in Korea.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Accounts Receivable</font></fon t></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. Receivables consist primarily of amounts due from members and independent associates. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time they are past due, and writes-off receivables when they become uncollectible. At September 30, 2010 and December 31, 2009, the Company held an allowance for doubtful accounts of less than $0.1 million.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Inventories</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories consist of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Assets</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of September 30, 2010 and December 31, 2009, other assets of $2.2 million and $2.5 million primarily consisted of deposits for building leases in various locations and certain intangible assets.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-W EIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Commissions and Incentives</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Independent associates earn commissions and incentives based on their direct and indirect commissionable net sales over 13 business periods. Each business period equals 28 days. The Company accrues commissions and incentives when earned by independent associates and pays commissions on product sales three weeks following the business period end and pays commissions on its pack sales five weeks following the business period end.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DIS PLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Long-Term Liabilities</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In August 2003, the Company entered into a Long-Term Post-Employment Royalty Agreement with Dr. Bill McAnalley, the Company’s former Chief Science Officer, pursuant to which the Company is required to pay Dr. McAnalley, or his heirs, royalties for ten years beginning September 2005 and continuing through August 2015. Quarterly payments related to this Long-Term Post-Employment Royalty A greement are based on certain applicable annual global product sales by the Company in excess of $105.4 million. At the time the Company entered into this royalty agreement, it was considered a post-employment benefit and the Company was required to measure and accrue the present value of the estimated future royalty payments related to this benefit, and recognize it over the life of Dr. McAnalley’s employment agreement, which was two years. As of September 30, 2010, the Company’s liability related to this royalty agreement was $1.3 million, of which $0.3 million was currently due and included in accrued expenses.  As of December 31, 2009, the Company’s long-term liability related to this royalty agreement was $1.6 million, of which $0.3 million was currently due and included in accrued expenses.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain operating leases for the Company’s regional office facilities contain a restoration clause that requires the Company to restore the premises to its original condition. As of September 30, 2010 and December 31, 2009, accrued restoration costs related to these leases amounted to $0.4 million. At September 30, 2010 and December 31, 2009, the Company also recorded a long-term liability for an estimated deferred benefit obligation related to a deferred benefit plan for its Japan operations of $1.1 million and $0.8 million, respectively.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><fo nt style="DISPLAY: inline; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Comprehensive Income (loss) and Accumulated Other Comprehensive Income (loss</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">)</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company’s comprehensive income (loss) consists of the Company’s net income (loss), foreign currency translation adjustments from its Japan, Republic of Korea, T aiwan, Norway, and Sweden operations, and changes in the pension obligation for its Japanese employees.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Revenue Recognition</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company’s revenue is derived from sales of individual products, sales of its starter and renewal packs, and shipping fees. Substantially all of the Company’s product and pack sales are mad e to independent associates at published wholesale prices and to members at discounted published retail prices. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company recognizes revenue from shipped packs and products upon receipt by the customer. Corporate-sponsored event revenue is recognized when the event is held. The Company defers certain components of its revenue. At September 30, 2010 and December 31, 2009, the Company’s deferred revenue was $2.9 million and $2.8 million, respectively, and consisted primarily of revenue received from: (i) sales of packs and products shipped but not received by the customers by period e nd; and (ii) prepaid registration fees from customers planning to attend a future corporate-sponsored event.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six- month period. If actual results differ from our estimated sales return reserve due to various factors, the amount of revenue recorded each period could be materially affected. Historically, our sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days after the original sale. Sales returns have averaged 1.5% or less of our gross sales. For the nine months ended September 30, 2010 our sales return reserve was com posed of the following <font style="DISPLAY: inline; FONT-STYLE: italic">(in thousands)</font>:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="65%"><tr><td valign="bottom" width="51%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 30, 2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&a mp;#160; </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales reserve as of January 1, 2010</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">595</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10p t; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision related to sales made in current period</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,591</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td> ;</tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision related to sales made in prior periods</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">112</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="lef t" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Actual returns or credits related to current period</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,128</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Actual returns or credits related to prior periods</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(710</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MAR GIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales reserve as of September 30, 2010</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><fo nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">460</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Shipping and Handling Costs</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Time s New Roman">The Company records freight and shipping fees collected from its customers as revenue. The Company records inbound freight as cost of sales and records shipping and handling costs associated with shipping products to customers as selling and administrative expenses. Total shipping and handling costs included in selling and administrative expenses were approximately $2.7 million and $3.6 million for the three months ended September 30, 2010 and 2009, respectively, and $8.8 million and $10.6 million for the nine months ended September 30, 2010 and 2009, respectively.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Reclassifications</font></font>< /div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain reclassifications have been made to the financial statements for prior periods to conform to the current period presentation.</font></div> No 0001056358 7228000 2721000 158000 -2111000 1000000 1000000 423000 274000 3265000 2577000 13271000 14231000 2823000 2662000 --12-31 MANNATECH INC 28000 28000 400000 859000 -175000 822000 -3661000 -8571000 -8682000 -25308000 15811000 17748000 47579000 53403000 41770000 51018000 2881000 2807000 5309000 11319000 917000 273000 -2024000 -1556000 26490466 26480788 14000 17000 23833000 24104000 73880000 68283000 44038000 51284000 3000 3000 41442000 41934000 25743000 17869000 -1113000 -977000 -14791000 -14791000 0 1058000 4937000 -4708000 28000 -7000 5189000 3348000 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 8: RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In October 2009, the FASB issued Accounting Standards Update No. 2009-13, “<font style="DISPLAY: inline; FONT-STYLE: italic">Revenue Recognition—Multiple Deliverable Revenue Arrangements”</font> (“<a id="keyword" name="keyword"></a>ASU 2009-13”). ASU 2009-13 updates the ex isting multiple-element revenue arrangements guidance currently included in FASB ASC 605-25. The revised guidance provides for two significant changes to the existing multiple element revenue arrangements guidance. The first change relates to the determination of when the individual deliverables included in a multiple-element arrangement may be treated as separate units of accounting. The second change modifies the manner in which the transaction consideration is allocated across the separately identified deliverables. The revised guidance also expands the disclosures required for multiple-element revenue arrangements. The revised multiple-element revenue arrangements guidance will be effective for the first annual reporting period beginning on or after June 15, 2010. The adoption of ASU <a id="lastkeyword" name="lastkeyword"></a>2009-13 is not expected to have a material impact on the Company’s financial position or results of operations.</font> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In January 2009, the Securities and Exchange Commission issued Release No. 33-9002, <font style="DISPLAY: inline; FONT-STYLE: italic">“Interactive Data to Improve Financial Reporting.”</font> The final rule requires companies to provide their financial statements and financial statement schedules to the Securities and Exchange Commission in interactive data format using the eXtensible Business Reporting Language (“XBRL”). The rule was adopted by the Securities and Exchange Commission to improve the ability of financial statement users to access and analyze financial data. The Securities and Exchange Commission adopted a phase-in schedule indicating when registrants must furnish interactive data. Under this schedule, the Company will be required to submit filings with financial statement information using XBRL commencing with our June 30, 2011 quarterly report on Form 10-Q. We began furnishing financial information in XBRL format starting with our quarterly report on Form 10-Q for the period ended September 30, 2009. As an early XBRL adopter, the Company may choose to discontinue furnishing XBRL data in the future until the required compliance date of June 30, 2011.</font></div> 55851000 64485000 163000 664000 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 4: LOSS PER SHARE</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Basic Earnings (Loss) Per Share (“EPS”) calculations are based on the weighted-average number of the Company’s common shares outstanding during the period. Diluted EPS calculations are based on the calculated weighted-average number of common shares and dilutive common share equivalents outstanding during each period.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div>< ;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following data shows the amounts used in computing the Company’s EPS and their effect on the Company’s weighted-average number of common shares and dilutive common share equivalents for the three months ended September 30, 2010 and 2009. For the three months ended September 30, 2010, approximately 1.6 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average closing price of $2.41 per share, as their effect was antidilutive. For the three months ended September 30, 2009, approximately 1.6 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average close price of $3.73 per share, as their effect was antidilutive. The amounts below are rounded to the nearest thousands, except for per share amounts.</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="58%" colspan="15"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For the three months ended September 30,</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" colspan="7"><div style="DISPLAY: block; MARG IN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss</font></div>&l t;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(numerator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(denominator)</font></div></td><td valign="bottom" width="1%"><font sty le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Per share</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">amount</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="cent er"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(numerator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman">(denominator)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Per share</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">amount</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic EPS:</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">& #160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: i nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt ; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss available to</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">common shareholders</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline ; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,278</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,490</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.05</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="righ t"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9,207</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,464</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.35</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of dilutive securities:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TE XT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock options</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN- LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE : 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted EPS:</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bott om" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro man">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font styl e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss available to</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">common shareholders plus</font></div><div style="DISP LAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">assumed conversions</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"& gt;(1,278</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,490</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDEN T: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.05</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9,207</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,464</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.35</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width ="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following data shows the amounts used in computing the Company’s EPS and their effect on the Company’s weighted-average number of common shares and dilutive common share equivalents for the nine months ended September 30, 2010 and 2009. For the nine months ended September 30, 2010, approximately 1.6 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average close price of $2.93 per share, as their effect was antidilutive. For the nine months ended September 30, 2009, approximately 1.5 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average close price of $3.48 per share, as their effect was antidilutive. The amounts below are rounded to the nearest thousands, except for per share amounts.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="58%" colspan="15">&l t;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For the nine months ended September 30,</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 1 0pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&am p;#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(numerator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY : times new roman">Shares</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(denominator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Per share</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">amount</font></d iv></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(numerator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(denominator)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Per share</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align= "center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">amount</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic EPS:</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="b ottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss available to</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">common shareholders</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TE XT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7,874</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,487</font></div></td><td valign="bottom " width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.30</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="2%"><div style= "DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(19,519</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,462</font></d iv></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.74</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor=" #cceeff"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of dilutive securities:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock options</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style=" DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><fo nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right" ><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TE XT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted EPS:</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: in line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td>&l t;td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: in line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss available to</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">common shareholders plus</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">assumed conversions</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT- FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7,874</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,48 7</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.30</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt ; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(19,519</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><f ont style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,462</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double " valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.74</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr></table></div> 478000 12000 -0.05 -0.35 -0.30 -0.74 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 10: SEGMENT INFORMATION</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company conducts its business as a single operating segment, consolidating all of its business units into a single reportable entity, as a seller of proprietary nutritional supplements, topical and skin care products, and weight-management products through its network marketing distribution channels operating in sixteen countries. Each of the Company’s business units sells similar packs and products and possesses simila r economic characteristics, such as selling prices and gross margins. In each country, the Company markets its products and pays commissions and incentives in similar market environments. The Company’s management reviews its financial performance by country and analyzes consolidated revenues by packs and product sales. The Company sells its products through its independent associates and distributes its products through similar distribution channels in each country. No single independent associate has ever accounted for more than 10% of the Company’s consolidated net sales.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company operates in nine physical locations and sells products in sixteen different countries around the world. The nine physical lo cations are the United States, Canada, Switzerland, Australia, the United Kingdom, Japan, the Republic of Korea (South Korea), Taiwan, and South Africa. Each of the Company’s physical locations services different geographic areas. The United States, Canada, Australia, United Kingdom, Japan, and South Africa offices provide administrative support to their respective local markets and serve as meeting locations for independent associates. The United States location processes orders for the United States, Canada, and South Africa. The Australian location processes orders for Australia, New Zealand, and Singapore. The United Kingdom location processes orders for the United Kingdom, Denmark, Germany, Austria, the Netherlands, Norway, and Sweden. The Japan, Republic of Korea, and Taiwan locations process orders for their local markets only. The Switzerland office was created to manage certain day-to-day business needs of our international markets.</font></div><div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Consolidated net sales shipped to customers in these locations, along with pack and product information for the three and nine months ended September 30, 2010 and 2009 are as follows <font style="DISPLAY: inline; FONT-STYLE: italic">(in millions, except percentages)</font>:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="94%"><tr><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font>< ;/td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="36%" colspan="10"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="39%" colspan="10"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nine months</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Country</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspa n="4"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="4"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="6"><div style="DISPLAY: block; MAR GIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43.5</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34.0</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">47.7</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" alig n="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">77.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline ; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" align="right" width="3%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">109.7</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM ILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">49.9</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISP LAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Japan</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom an">16.2</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13.9</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><t d valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31.4</font></div></td><td valign="bottom" width="2%"&g t;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td v align="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Republic of Korea</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.1</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">&l t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6 %"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.7</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; F ONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.4</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19.2 </font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.8</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM ILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canada</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.4</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.8</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font> ;</td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.1</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.0</font></div></td><td valign="bottom" width="1 %"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.1</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inlin e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.0</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"> ;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Australia</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.7</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.6</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.7</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.0</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.8</ font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.6</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARG IN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16.7</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.6</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr>&l t;tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">South Africa</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.0</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160 ; </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.5</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.9</font></div></td><td valign="bot tom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.5</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inli ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.2</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div s tyle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.2</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n ew roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Taiwan</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FO NT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.6</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> 1.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.0</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-R IGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td>< ;td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.8</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.2</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font styl e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">New Zealand</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valig n="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY : inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.5</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style=" DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.4</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY : times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.3</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.5</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div&g t;</td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Germany</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom an">0.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; M ARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.3</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td v align="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2">< ;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font styl e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><d iv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.8</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div> </td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" al ign="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Denmark</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDE NT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td&g t;<td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><f ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; F ONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Singapore</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM ILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.6</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></di v></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="le ft"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Austria<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="bottom" width="3%"><font style="D ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; F ONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&a mp;#8212;</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Norway<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n ew roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td ><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font& gt;</td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left "><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td v align="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The Netherlands<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></ td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%">& lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width ="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT - -SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font styl e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sweden<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g t;  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="le ft"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style ="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px soli d" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="botto m" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Totals</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54.9</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div s tyle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71.3</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-F AMILY: times new roman">100</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">173.1</font> ;</div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MA RGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">219.6</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100</font></div>< /td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 4px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">________________________</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERT ICAL-ALIGN: text-top">(1) </font>Austria, Norway, the Netherlands, and Sweden began operations in September 2009, and had a combined total net sales of $0.1 million for the period ended September 30, 2009.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font> </div></td><td valign="bottom" width="54%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px s olid" valign="bottom" width="21%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="20%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nine months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="2%"><font s tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="54%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMI LY: times new roman">2009</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><t d valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="54%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated product sales</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDE NT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">52.3</font></div></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"& gt;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">140.8</font></div></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">159.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: in line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="54%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated pack sales</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.0</font></div></td><td valign= "bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25.1</font></div></td><td valign=" bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="54%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 1 0pt; FONT-FAMILY: times new roman">Consolidated other, including freight</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" va lign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.5</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="rig ht" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="54%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated total net sales</font></div></td><td style="PADDING-BOTT OM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54.9</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inli ne; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71.3</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FON T-SIZE: 10pt; FONT-FAMILY: times new roman">173.1</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">219.6</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"> <br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>Long-lived assets, which include property and equipment and construction in progress for the Company and its subsidiaries, reside in the following countries <font style="DISPLAY: inline; FONT-STYLE: italic">(in millions)</font>:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Country</font> </div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 30,</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT- FAMILY: times new roman">December 31,</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Australia</font></div></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0 pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18p t; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canada</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Japan</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom an">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Republic of Korea</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style ="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.6</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inli ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Switzerland</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Taiwan</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom " width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">South Africa</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT : 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> ;0.1</font></div></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25.5</font></div></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Totals</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21.5</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"& gt;$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27.5</font></div></td></tr></table></div><br /> 2010-09-30 464000 464000 107000 -284000 -1687000 -389000 27494000 32675000 82562000 93591000 41934000 41442000 3000 3000 1402000 1068000 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 5: STOCK-BASED COMPENSATION</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company currently has one active stock-based compensation plan, which was approved by shareholders. The Company generally grants stock options to employees, consultants, and board members at the fair market value of its common stock, on the date of grant, with a term no greater than ten years. The stock options generally vest over two or three years. Shareholders who own 10% or more of the Company& amp;#8217;s outstanding stock are granted incentive stock options at an exercise price that may not be less than 110% of the fair market value of the Company’s common stock on the date of grant and have a term no greater than five years.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In February 2008, the Company’s Board of Directors approved the Mannatech, Incorporated 2008 Stock Incentive Plan (the “2008 Plan”), which reserved, for issuance of stock options and restricted stock to employees, board members, and consultants, up to 1,000,000 shares of common stock plus any shares reserved under the Company’s then-existing, unexpired stock plan for which options had not yet been issued plus any shares underlying outstanding op tions under the then-existing stock option plan that terminate without having been exercised in full. The 2008 Plan was approved by the Company’s shareholders at the 2008 Annual Shareholders’ Meeting. As of September 30, 2010, the 2008 Plan had 321,088 stock options available for grant before the plan expires on February 20, 2018.</font></div><div> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At the 2010 Annual Shareholders’ Meeting the Company obtained approval from the Company’s shareholders for an amendment to the 2008 Plan to permit a one-time stock option exchange program (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Exchange Offer</font>”). On July 16, 2010, the Company commenced the option exchange program (the “< ;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Exchange Program</font>”) whereby employees (including officers), directors and consultants were able to elect to exchange their “out of the money” stock options for fewer options at a lower exercise price. The Exchange Program expired on August 13, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company filed with the Securities and Exchange Commission (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">SEC</font>”) the Tender Offer Statement on Schedule TO on<font style="DISPLAY: inline; FONT-WEIGHT: bold"> </font>July 16, 2010, (as amended, the “<font style="DISPLAY: i nline; FONT-WEIGHT: bold; FONT-STYLE: italic">Schedule TO</font>”), and the Offer to Exchange filed with the Schedule TO as Exhibit (a)(1)(A), (as amended, the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Offer to Exchange</font>”).</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to the Exchange Program, an aggregate of 784,930 eligible options were tendered and accepted by the Company in exchange for the grant of an aggregate of 440,558 replacement options.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All of the replacement options that were granted on August 16, 2010 have an exercise price of $2.46 and were granted under the 2008 Plan, as amended. Each replacement option vests annually in ⅓ installments starting one year from the grant date and has a term of 10 years. Incremental stock option expense resulting from the exchange was minimal because the fair value of the replacement options was approximately equal to the fair value of the surrendered options they replaced. The foregoing description of the Exchange Program is qualified in its entirety by reference to the Schedule TO and the Offer to Exchange.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: Times New Roman">The Company records stock-based compensation expense related to granting stock options as selling and administrative expenses. During the three months ended September 30, 2010, the Company granted 465,558 stock options, of which 440,558 were a result of the Exchange Program. During the three months ended September 30, 2009, the Company granted 30,000 stock options. During the nine months ended September 30, 2010, the Company granted 772,194 stock options, of which 440,558 were a result of the Exchange Program. During the nine months ended September 30, 2009, the Company granted 305,000 stock options. The fair value of stock options granted during the three months ended September 30, 2010 ranged from $1.26 to $1.40 per share. The fair value of stock options granted during the three months ended September 30, 2009 was $2.01 per share. The fair value of stock options granted during the nine months ended September 30, 2010 ranged from $1.18 to $2.03 per share. The fair v alues of stock options granted during the nine months ended September 30, 2009 ranged from $1.24 to $2.01 per share. The Company recognized compensation expense as follows for the periods ended September 30 <font style="DISPLAY: inline; FONT-STYLE: italic">(in thousands)</font>:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="61%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="18%" colspan="5"><div style="DISPLAY: block; MA RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nine months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160 ; </font></td><td valign="bottom" width="61%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bot tom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total gross compensation expense</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline ; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">123</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">125</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro man">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">514</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">437</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></ td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total tax benefit associated with compensation expense</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman">10</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">67</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">97</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inl ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total net compensation expense</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">113</font></div&g t;</td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">101</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inli ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">447</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">340</font></div></t d><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of September 30, 2010, the Company expects to record compensation expense in the future as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="61%" rowspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%" rowspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2" rowspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ending</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT - -WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="2%" rowspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="8"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Year ending December 31,</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" ali gn="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2013</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total gross unrecognized compensation expense</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: bl ock; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">112</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">375</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> ;  </font></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">184</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td v align="top" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></div></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tax benefit associated with unrecognized compensation expense</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font>< ;/td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">49</font></div></td><td style="PADDIN G-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td& gt;<td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></div></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total net unrecognized compensation expense</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0 pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">96</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">326</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">164< /font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">65</font></div></td></tr></table></div> 26481000 26490000 1207000 1207000 -889000 -1265000 -3697000 2505000 54866000 71295000 173137000 219640000 693000 652000 2162000 2503000 1507000 317000 999000 8075000 <div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 3: INCOME TAXES</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For the three  months ended September 30, 2010, the Company  recognized a tax benefit of approximately $1.9 million. This was the result of changes to management’s estimates for 2010 annual operating results, including the mix of income between tax jurisdictions, the change in the valuation allowances associated with certain deferred tax assets, and the change in reserves related to uncertain income tax positions. For the nine months ended September 30, 2010 the Company recognized a $0.9 million tax benefit. For the three and nine months ended September 30, 2009, the Company’s effective tax rate was (20.0)% and 19.7%, respectively. For the three and nine months ended September 30, 2010 and 2009, the Company’s effective income tax rate was determined based on the estimated annual effective income tax rate.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The effective tax rate for the nine months ended September 30, 2010 was lower than what would have been expected if the federal statutory rate were applied to income before taxes. Items reducing the effective income tax rate included reductions due to changes to management’s estimates for 2010 annual operating results, including the mix of income between tax jur isdictions, the change in the valuation allowances associated with certain deferred tax assets, and the change in reserves related to uncertain income tax positions. The effective tax rate for the three months ended September 30, 2010 was higher than what would have been expected if the federal statutory rate were applied to income before taxes due to changes in management’s estimates during the quarter for 2010 annual operating results, including the mix of income between tax jurisdictions.</font></div> 2010 -6062000 1630000 99000000 99000000 0.0001 0.0001 20000 39000 1000 182000 14791000 14791000 17869000 25743000 1282000 1288000 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 6: SHAREHOLDER’S EQUITY</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>On September 16, 2010, the Company entered into an Investment Agreement (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Investment Agreement</font>”) with Dutchess Opportunity Fund, II, LP, a Delaware limited partnership (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic"> Investor</font>”). Pursuant to the Investment Agreement, the Investor committed to purchase, subject to certain restrictions and conditions, up to $10,000,000 of the Company’s common stock, over a period of 36 months from the first trading day following the effectiveness of the registration statement registering the resale of shares purchased by the Investor pursuant to the Investment Agreement (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Equity Line</font>”). The aggregate number of shares of common stock issuable by the Company and purchasable by the Investor under the Investment Agreement is 5,000,000.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company may draw on the Equity L ine from time to time, as and when it determines appropriate in accordance with the terms and conditions of the Investment Agreement. The maximum amount that the Company is entitled to put to the Investor in any one draw down notice is the greater of (i) 200% of the average lowest daily volume of the Company’s common stock traded on the NASDAQ Global Market for the 3 trading days prior to the date of delivery of the applicable draw down notice, multiplied by the average of the closing prices for such trading days or (ii) $500,000. The purchase price shall be set at 96% of the lowest daily volume weighted average price (VWAP) of the Company’s common stock during the 5 consecutive trading day period beginning on the date of delivery of the applicable draw down notice. Before the closing of an exercised put, the Company (not the Investor) has the right to withdraw all or any portion of the put; provided that the Company may not withdraw any portion of a put that the Investor has already comm itted to resell to a third party. There are put restrictions applied on days between the draw down notice date and the closing date with respect to that particular put. During such time, the Company shall not be entitled to deliver another draw down notice. In addition, the Investor will not be entitled to purchase shares if the Investor’s total number of shares beneficially held at that time would exceed 4.99% of the number of shares of the Company’s common stock as determined in accordance with Rule 13d-1(j) of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the Equity Line unless there is an effective registration statement (as further explained below) to cover the resale of the shares.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"& gt;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>The Investment Agreement further provides that the Company and the Investor are each entitled to customary indemnification from the other for, among other things, any losses or liabilities they may suffer as a result of any breach by the other party of any provisions of the Investment Agreement or Registration Rights Agreement (as defined below), or as a result of any lawsuit brought by a third-party arising out of or resulting from the other party’s execution, delivery, performance or enforcement of the Investment Agreement or the Registration Rights Agreement.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT - -FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>The Investment Agreement also contains customary representations and warranties of each of the parties. Investors should read the Investment Agreement together with the other information concerning the Company that the Company publicly files in reports and statements with the SEC.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>Pursuant to the terms of a Registration Rights Agreement dated September 16, 2010 between the Company and the Investor (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Registration Rights Agreement</font>”), the Comp any is obligated to file one or more registration statements with the SEC to register the resale by Investor of the shares of common stock issued or issuable under the Investment Agreement. On October 28, 2010, the SEC declared effective the Company’s Registration Statement on Form S-3 (File No. 333-169774), which registers up to 5,000,000 shares of common stock that may be resold by the Investor pursuant to the Investment Agreement.  As of November 3, 2010, no shares of common stock have been issued pursuant to the Investment Agreement.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>In connection with the preparation of the Investment Agreement a nd the Registration Rights Agreement, the Company paid the Investor a document preparation fee in the amount of $15,000.</font></div> 1207094 1207094 0 0 -1278000 -9207000 -7874000 -19519000 -7874000 -3241000 -7673000 -8856000 -24304000 699000 774000 1538000 821000 8911000 11842000 26292000 30831000 7097000 10624000 85808000 102302000 72000 399000 2772000 3085000 8691000 9357000 85808000 102302000 5632000 7201000 3515000 3139000 25389000 31290000 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 9: FAIR VALUE</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fair Value Measurements and Disclosure Topic of the FASB ASC establishes a fair value hierarchy that requires the use of observable market data, when available, and prioritizes the inputs to valuation techniques used to measure fair value in the following categories:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; M ARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Symbol, serif">·</font>      Level 1 – Quoted unadjusted prices for identical instruments in active markets.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Symbol, serif">·</font>      Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which all observable inputs and significant v alue drivers are observable in active markets.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Symbol, serif">·</font>      Level 3 – Model-derived valuations in which one or more significant inputs or significant value drivers are unobservable, including assumptions developed by the Company.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The primary objective of the Company’s investment activities is to preserve principal while maximizing yields without significantly increasing risk. The investment instruments held by the Company are money market funds and interest bearing deposits for which quoted market prices are readily available. The Company considers these highly liquid investments to be cash equivalents. These investments are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The table below presents the recorded amount of financial assets measured at fair value <font style="DISPLAY: inline; FONT-STYLE: italic">(in thousands) </font>on a recurring basis as of September 30, 2010. The Company does not have any material financial liabilities that were required to be measured at fair value on a recurring basis at September 30, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div styl e="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="55%"><tr><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Asset</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style=" DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 1</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="14%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; F ONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 3</font></div></td><td valign="bottom" width="5%" colspan="3"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Money Market Funds – Fidelity, US</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,029</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$& lt;/font></div></td><td valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,0 29</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest bearing deposits – various banks, Korea</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDEN T: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,969</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inli ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="7%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne w roman">4,969</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,998</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign ="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I NDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,998</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amounts included in:</font></div></td><td valign="bottom" width="5%">& lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160 ; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="7%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cc eeff"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,345</font></div></td><td v align="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font sty le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font styl e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,345</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long-term restricted cash</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISP LAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,653</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" wid th="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="7%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline ; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,653</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: b lack 4px double" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,998</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font>< /div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,998</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div> 26490466 Accelerated Filer 136000 136000 53000 2220000 -1963000 1534000 -982000 -4785000 -977000 -1113000 1736000 3923000 33443000 42679000 EX-101.CAL 10 mtex-20100930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.LAB 11 mtex-20100930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Statement Of Financial Position [Abstract] Statement [Table] Statement [Line Items] ASSETS Cash And Cash Equivalents At Carrying Value Cash and cash equivalents Cash and cash equivalents at the beginning of period Cash and cash equivalents at the end of period Restricted cash Restricted Cash And Cash Equivalents At Carrying Value Accounts Receivable Net Current Accounts receivable, net of allowance of $14 and $17 in 2010 and 2009, respectively Income Taxes Receivable Income tax receivable Inventory Net Inventories, net Other Assets Current Prepaid expenses and other current assets Deferred tax assets Total current assets Total current assets Property and equipment, net Construction in progress Other assets Other Assets Noncurrent Long-term deferred tax assets Total assets Total assets LIABILITIES AND SHAREHOLDERS' EQUITY Current portion of capital leases Accounts payable Accounts Payable Current Accrued expenses Taxes payable Taxes Payable Current Current deferred tax liability Commissions And Incentives Payable Commissions and incentives payable Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales commissions and incentives earned. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Deferred revenue Deferred Revenue Current Total current liabilities Total current liabilities Long-term deferred tax liabilities Other long-term liabilities Total liabilities Total liabilities Commitments and contingencies Shareholders' equity Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding Common stock, $0.0001 par value, 99,000,000 shares authorized, 27,697,560 shares issued and 26,490,466 shares outstanding in 2010 and 27,687,882 shares issued and 26,480,788 shares outstanding in 2009 Additional paid-in capital Retained earnings Accumulated other comprehensive loss Accumulated Other Comprehensive Income Loss Net Of Tax Less treasury stock, at cost, 1,207,094 shares in 2009 and 2008 Less treasury stock, at cost, 1,207,094 shares in 2010 and 2009 Total shareholders' equity Balance - beginning of period Balance - end of period Total liabilities and shareholders' equity Preferred stock, par value Income Statement [Abstract] Net sales Net sales Cost of sales Commissions and Incentives Commissions and incentives Primarily represents commissions and incentives earned by eligible independent associates based on their direct and indirect commissionable net sales. Total cost of sales Total Cost of Sales Gross profit Gross profit Operating expenses: Selling and administrative expenses Depreciation and amortization Other operating costs Total operating expenses Total operating expenses Loss from operations Loss from operations Other income (expense), net Other income (expense), net Loss before income taxes Loss before income taxes Benefit for income taxes (Provision) benefit for income taxes Net Loss Net loss Net Income Loss Net loss per share: Basic Earnings Per Share Basic Diluted Earnings Per Share Diluted Basic Weighted Average Number Of Shares Outstanding Basic Diluted Diluted Statement of Stockholders' Equity [Abstract] Statement, Equity Components [Axis] Equity Component [Domain] Par value - balance Common stock, par value Par value Par Value Charge related to stock based compensation Declared dividends of $0.36, $0.22, $0.04 in 2007, 2008, 2009, respectively, per common share Foreign currency translations Shares issued Balance - beginning of period (in shares) Balance - end of period (in shares) Tax benefit (shortfall) from expiration of stock options Additional paid in capital Retained Earnings Accumulated other comprehensive loss Accumulated Other Comprehensive Income Treasury stock Statement of Cash Flows CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash provided by (used in) operating ativities: Provision for doubtful accounts Provision for inventory losses Loss on disposal of assets Accounting charge related to stock-based compensation expense Deferred income taxes Changes in operating assets and liabilities: Accounts receivable Income tax receivable Inventories Increase Decrease In Inventories Prepaid expenses and other current assets The net change during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods and in other operating assets not otherwise defined in the taxonomy. Other assets Increase Decrease In Other Operating Assets Accounts payable Accounts payable Accrued expenses Increase Decrease In Accrued Liabilities Taxes payable Taxes payable Increase Decrease In Commissions And Incentives Payable The net change during the reporting period in the aggregate amount of commissions and incentives incurred but not yet paid. Commissions and incentives payable Deferred revenue Increase Decrease In Deferred Revenue Net cash used in operating activities Net cash provided by (used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment Purchases of property and equipment Sale of investments Purchase of investments Purchase of investments Change in restricted cash Change in restricted cash Net cash provided by (used in) investing activities Net cash provided by (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Payment of cash dividends Repayment of capital lease obligations Net cash used in financing activities Net cash used in financing activities Effect of currency exchange rate changes on cash and cash equivalents Net decrease in cash and cash equivalents Net increase (decrease) in cash and cash equivalents Interest paid on capital leases The amount of cash paid during the current period for interest on leasing arrangements meeting the criteria for capitalization. Income taxes received, net Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Treasury stock, shares Total comprehensive loss Common Stock Outstanding Organization Summary of Significant Accounting Policies Inventories Inventory Disclosure [Text Block] Income Taxes Loss Per Share Stock-Based Compensation COMMITMENTS AND CONTINGENCIES Segment Information Subsequent Events Recent Accounting Pronouncements Organization And Summary Of Significant Accounting Policies [Text Block] Organization And Summary Of Significant Accounting Policies Allowance for Doubtful Accounts Receivable Long-term restricted cash Capital leases, excluding current portion Notes To Financial Statements [Abstract] ProceedsFromStockOptionsExercised Proceeds from stock options exercised Proceeds from stock options exercised Proceeds from stock options exercised (in shares) Declared dividends per share Declared dividends per common share Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Type Amendment Flag Amendment Description Document Period End Date Cumulative impact of a change in accounting for income tax uncertainties pursuant to FIN 48 Pension obligations, net of tax $8, $26, $12 in 2007, 2008 and 2009 respectively Unrealized gain from investments classified as available-for-sale, net of tax Pension obligations, net of tax Proceeds from sale of assets Tax benefit from exercise of stock options Repurchase of common stock Summary of non-cash investing and financing activities: Unrealized gains from investments Entity [Text Block] Document Information [Text Block] Fair Value PROPERTY AND EQUIPMENT Capital Lease Obligations Accrued Expenses TRANSACTIONS WITH RELATED PARTIES AND AFFILIATES EMPLOYEE BENEFIT PLANS Disclosure of Litigation [Text Block] Disclosure of Litigation Litigation SHAREHOLDERS' EQUITY Schedule to Financial Statements [Abstract] SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS Fair Value Of Assets Acquired Assets Acquired through Capital Leases Weighted-average common shares outstanding: SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Components of comprehensive loss: Document Fiscal Year Focus Document Fiscal Period Focus Interest income Depreciation and amortization EX-101.PRE 12 mtex-20100930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.DEF 13 mtex-20100930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT XML 14 R11.xml IDEA: SHAREHOLDERS' EQUITY 2.2.0.7 false SHAREHOLDERS' EQUITY 006055 - Disclosure - SHAREHOLDERS' EQUITY true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 SHAREHOLDERS' EQUITY 1 us-gaap_StockholdersEquityNoteDisclosureTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 6: SHAREHOLDER’S EQUITY</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>On September 16, 2010, the Company entered into an Investment Agreement (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Investment Agreement</font>”) with Dutchess Opportunity Fund, II, LP, a Delaware limited partnership (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Investor</font>”). Pursuant to the Investment Agreement, the Investor committed to purchase, subject to certain restrictions and conditions, up to $10,000,000 of the Company’s common stock, over a period of 36 months from the first trading day following the effectiveness of the registration statement registering the resale of shares purchased by the Investor pursuant to the Investment Agreement (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Equity Line</font>”). The aggregate number of shares of common stock issuable by the Company and purchasable by the Investor under the Investment Agreement is 5,000,000.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company may draw on the Equity Line from time to time, as and when it determin es appropriate in accordance with the terms and conditions of the Investment Agreement. The maximum amount that the Company is entitled to put to the Investor in any one draw down notice is the greater of (i) 200% of the average lowest daily volume of the Company’s common stock traded on the NASDAQ Global Market for the 3 trading days prior to the date of delivery of the applicable draw down notice, multiplied by the average of the closing prices for such trading days or (ii) $500,000. The purchase price shall be set at 96% of the lowest daily volume weighted average price (VWAP) of the Company’s common stock during the 5 consecutive trading day period beginning on the date of delivery of the applicable draw down notice. Before the closing of an exercised put, the Company (not the Investor) has the right to withdraw all or any portion of the put; provided that the Company may not withdraw any portion of a put that the Investor has already committed to resell to a third party. There are pu t restrictions applied on days between the draw down notice date and the closing date with respect to that particular put. During such time, the Company shall not be entitled to deliver another draw down notice. In addition, the Investor will not be entitled to purchase shares if the Investor’s total number of shares beneficially held at that time would exceed 4.99% of the number of shares of the Company’s common stock as determined in accordance with Rule 13d-1(j) of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the Equity Line unless there is an effective registration statement (as further explained below) to cover the resale of the shares.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>The Investment Agreement further provides that the Company and the Investor are each entitled to customary indemnification from the other for, among other things, any losses or liabilities they may suffer as a result of any breach by the other party of any provisions of the Investment Agreement or Registration Rights Agreement (as defined below), or as a result of any lawsuit brought by a third-party arising out of or resulting from the other party’s execution, delivery, performance or enforcement of the Investment Agreement or the Registration Rights Agreement.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="M ARGIN-LEFT: 36pt"></font>The Investment Agreement also contains customary representations and warranties of each of the parties. Investors should read the Investment Agreement together with the other information concerning the Company that the Company publicly files in reports and statements with the SEC.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>Pursuant to the terms of a Registration Rights Agreement dated September 16, 2010 between the Company and the Investor (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Registration Rights Agreement</font>”), the Company is obligated to file one or more registrat ion statements with the SEC to register the resale by Investor of the shares of common stock issued or issuable under the Investment Agreement. On October 28, 2010, the SEC declared effective the Company’s Registration Statement on Form S-3 (File No. 333-169774), which registers up to 5,000,000 shares of common stock that may be resold by the Investor pursuant to the Investment Agreement.  As of November 3, 2010, no shares of common stock have been issued pursuant to the Investment Agreement.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>In connection with the preparation of the Investment Agreement and the Registration Rights Agreement, the Comp any paid the Investor a document preparation fee in the amount of $15,000.</font></div> NOTE 6: SHAREHOLDER’S EQUITYOn September 16, 2010, the Company entered into an Investment Agreement (the “Investment Agreement”) with false false false us-types:textBlockItemType textblock Disclosures related to accounts comprising shareholders' equity, including other comprehensive income. Includes: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in ar rears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables; effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 15 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph d -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section C, E Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 1 -Section B -Paragraph 7, 11A Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Article 4 false 1 2 false UnKnown UnKnown UnKnown false true XML 15 R10.xml IDEA: STOCK BASED COMPENSATION 2.2.0.7 false STOCK BASED COMPENSATION 006050 - Disclosure - STOCK BASED COMPENSATION true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Stock-Based Compensation 1 us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 5: STOCK-BASED COMPENSATION</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company currently has one active stock-based compensation plan, which was approved by shareholders. The Company generally grants stock options to employees, consultants, and board members at the fair market value of its common stock, on the date of grant, with a term no greater than ten years. The stock options generally vest over two or three years. Shareholders who own 10% or more of the Company’s outstanding stock are granted incentive stock options at an exercise price that may not be less than 110% of the fair market value of the Company’s common stock on the date of grant and have a term no greater than five years.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In February 2008, the Company’s Board of Directors approved the Mannatech, Incorporated 2008 Stock Incentive Plan (the “2008 Plan”), which reserved, for issuance of stock options and restricted stock to employees, board members, and consultants, up to 1,000,000 shares of common stock plus any shares reserved under the Company’s then-existing, unexpired stock plan for which options had not yet been issued plus any shares underlying outstanding options under the then-existing stock option plan that terminate witho ut having been exercised in full. The 2008 Plan was approved by the Company’s shareholders at the 2008 Annual Shareholders’ Meeting. As of September 30, 2010, the 2008 Plan had 321,088 stock options available for grant before the plan expires on February 20, 2018.</font></div><div> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At the 2010 Annual Shareholders’ Meeting the Company obtained approval from the Company’s shareholders for an amendment to the 2008 Plan to permit a one-time stock option exchange program (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Exchange Offer</font>”). On July 16, 2010, the Company commenced the option exchange program (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic" >Exchange Program</font>”) whereby employees (including officers), directors and consultants were able to elect to exchange their “out of the money” stock options for fewer options at a lower exercise price. The Exchange Program expired on August 13, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company filed with the Securities and Exchange Commission (the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">SEC</font>”) the Tender Offer Statement on Schedule TO on<font style="DISPLAY: inline; FONT-WEIGHT: bold"> </font>July 16, 2010, (as amended, the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Schedule TO</fon t>”), and the Offer to Exchange filed with the Schedule TO as Exhibit (a)(1)(A), (as amended, the “<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Offer to Exchange</font>”).</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to the Exchange Program, an aggregate of 784,930 eligible options were tendered and accepted by the Company in exchange for the grant of an aggregate of 440,558 replacement options.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; F ONT-FAMILY: Times New Roman">All of the replacement options that were granted on August 16, 2010 have an exercise price of $2.46 and were granted under the 2008 Plan, as amended. Each replacement option vests annually in ⅓ installments starting one year from the grant date and has a term of 10 years. Incremental stock option expense resulting from the exchange was minimal because the fair value of the replacement options was approximately equal to the fair value of the surrendered options they replaced. The foregoing description of the Exchange Program is qualified in its entirety by reference to the Schedule TO and the Offer to Exchange.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company records stock- based compensation expense related to granting stock options as selling and administrative expenses. During the three months ended September 30, 2010, the Company granted 465,558 stock options, of which 440,558 were a result of the Exchange Program. During the three months ended September 30, 2009, the Company granted 30,000 stock options. During the nine months ended September 30, 2010, the Company granted 772,194 stock options, of which 440,558 were a result of the Exchange Program. During the nine months ended September 30, 2009, the Company granted 305,000 stock options. The fair value of stock options granted during the three months ended September 30, 2010 ranged from $1.26 to $1.40 per share. The fair value of stock options granted during the three months ended September 30, 2009 was $2.01 per share. The fair value of stock options granted during the nine months ended September 30, 2010 ranged from $1.18 to $2.03 per share. The fair values of stock options granted during the nine months ended Septembe r 30, 2009 ranged from $1.24 to $2.01 per share. The Company recognized compensation expense as follows for the periods ended September 30 <font style="DISPLAY: inline; FONT-STYLE: italic">(in thousands)</font>:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="61%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="18%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"& gt;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nine months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="61%">< font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td> </tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total gross compensation expense</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">123</font> </div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">125</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">514</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">437</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td style="PADDING-BOT TOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total tax benefit associated with compensation expense</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></div></td><td style=" PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt " align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">67</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">97</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  &l t;/font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total net compensation expense</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">113</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" widt h="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">101</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">447</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">340</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&g t;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of September 30, 2010, the Company expects to record compensation expense in the future as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="61%" rowspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FO NT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%" rowspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2" rowspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ending</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec ember 31,</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="2%" rowspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="8"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Year ending December 31,</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; F ONT-SIZE: 10pt; FONT-FAMILY: times new roman">2013</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total gross unrecognized compensation expense</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="r ight"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">112</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">375</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="ri ght" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">184</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="top" align="right" width="6%"><div style="DISPLAY: bloc k; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></div></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tax benefit associated with unrecognized compensation expense</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom " align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">49</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY : inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align= "right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></div></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total net unrecognized compensation expense</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inl ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">96</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-L EFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">326</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">164</font></div></td><td style="PADDING-BOTTOM: 4px" v align="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">65</font></div></td></tr></table></div> NOTE 5: STOCK-BASED COMPENSATIONThe Company currently has one active stock-based compensation plan, which was approved by shareholders. The Company generally false false false us-types:textBlockItemType textblock Disclosure of compensation-related costs for share-based compensation which may include disclosure of policies, compensation plan details, allocation of stock compensation, incentive distributions, share-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph 64, 65, A240 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 93-6 -Paragraph 53 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 false 1 2 false UnKnown UnKnown UnKnown false true XML 16 R8.xml IDEA: INCOME TAXES 2.2.0.7 false INCOME TAXES 006030 - Disclosure - INCOME TAXES true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Income Taxes 1 us-gaap_IncomeTaxDisclosureTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 3: INCOME TAXES</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For the three  months ended September 30, 2010, the Company  recognized a tax benefit of approximately $1.9 million. This was the result of changes to management’s estimates for 2010 annual operating results, including the mix of income between tax jurisdictions, the change in the valuation allowances associated with certain deferred tax assets, and the change in reserves related to uncertain income tax positions. For the nine months ended September 30, 2010 the Company recognized a $0.9 million tax be nefit. For the three and nine months ended September 30, 2009, the Company’s effective tax rate was (20.0)% and 19.7%, respectively. For the three and nine months ended September 30, 2010 and 2009, the Company’s effective income tax rate was determined based on the estimated annual effective income tax rate.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The effective tax rate for the nine months ended September 30, 2010 was lower than what would have been expected if the federal statutory rate were applied to income before taxes. Items reducing the effective income tax rate included reductions due to changes to management’s estimates for 2010 annual operating results, including the mix of income between tax jurisdictions, the change in the val uation allowances associated with certain deferred tax assets, and the change in reserves related to uncertain income tax positions. The effective tax rate for the three months ended September 30, 2010 was higher than what would have been expected if the federal statutory rate were applied to income before taxes due to changes in management’s estimates during the quarter for 2010 annual operating results, including the mix of income between tax jurisdictions.</font></div> NOTE 3: INCOME TAXESFor the three  months ended September 30, 2010, the Company  recognized a tax benefit of approximately $1.9 million. This was the false false false us-types:textBlockItemType textblock Description containing the entire income tax disclosure. Examples include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 136, 172 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 43, 44, 45, 46, 47, 48, 49 false 1 2 false UnKnown UnKnown UnKnown false true XML 17 R12.xml IDEA: LITIGATION 2.2.0.7 false LITIGATION 006060 - Disclosure - LITIGATION true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Litigation 1 mtex_DisclosureOfLitigationTextBlock mtex false na duration Disclosure of Litigation false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 7: LITIGATION</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Patent Infringement Litigation</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic"> Mannatech, Inc. v. Country Life, LLC, et al.</font>, No. 3:10-cv-00533-O, United States District Court, Northern District of Texas, Dallas Division</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On March 16, 2010, Mannatech, Inc. filed a patent infringement lawsuit against Country Life, LLC; Country Life Manufacturing, LLC; EvenBetterNow, LLC; Micro Health Solutions, LLC; New Sun, Inc.; Oasis Advanced Wellness, LLC; Roex, Inc.; VDF FutureCeuticals, Inc.; and John Does 1-20, alleging the defendants infringe United States Patent Nos. 6,929,807, 7,157,431, 7,196,064, 7,199,104, and 7,202,220, all entitled “Compositions of Plant Carbohydrates as Dietary Supplements” (“Patents-in-Suit”), and seeking to stop their manufacture, offer, and sale of infringing glyconutritional dietary supplement products. On May 14, 2010, Mannatech amended its complaint to add patent infringement claims against Angel Care USA, Inc.; Florida Nutri Labs, LLC; and Wy’s Enterprises of Springfield, Inc.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Agreed Judgments have been entered against seven of the eleven defendants: EvenBetterNow, Oasis Advanced Wellness, Micro Health Solutions, Wy's Enterprises of Springfield, Florida Nutri Labs, Angel Care, USA, and New Sun.  In each of the Agreed Judgments, the defendant is enjoined, for the term of the Patents-in-Suit, from making, using, offering to sell, or otherwise distributing the acc used infringing products or colorable imitations thereof (the “Enjoined Products”); inducing infringement of the patents by encouraging or assisting others in selling the Enjoined Products; or supplying or causing to be supplied all or a substantial portion of the components of the Enjoined Products.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On June 25, 2010, Mannatech filed an unopposed motion to drop defendant Country Life Manufacturing, LLC because Mannatech discovered that Country Life Manufacturing was no longer active or associated with Country Life, LLC. On June 29, Mannatech’s motion was granted and Country Life Manufacturing, LLC was dismissed from the lawsuit without prejudice.&l t;/font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The lawsuit is now proceeding against the remaining three defendants: Country Life, Roex, and VDF FutureCeuticals. All three have filed answers, and two of the defendants, Roex and VDF FutureCeuticals, have filed counterclaims challenging the validity of Mannatech’s patents and seeking recovery of their attorneys’ fees. In addition, on June 25, 2010, Roex filed a motion to sever and motion to transfer venue to its home district of the Central District of California. On July 16, Mannatech filed its response in opposition, after which VDF FutureCeuticals filed a motion to join Roex’s motion to transfer.  On July 21, Mannatech filed a motion to strike VDF’s improper joinder. On July 26, 2010, the Court denied Roex’s motion.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On July 16, 2010, the court entered a Scheduling Order, setting trial for November 1, 2011. In order to permit the parties to engage in direct settlement discussions, the parties have twice filed joint motions seeking extensions of the Scheduling Order deadlines. The court granted both motions and the current Second Amended Scheduling Order, issued on October 12, 2010, reset the trial date for December 5, 2011.  Mannatech intends to vigorously prosecute this matter in the event settlement cannot be reached, as this lawsuit continues Mannatech&#82 17;s enforcement of its patent rights. Based on the previous successful patent infringement lawsuits against Glycobiotics International, Inc., Techmedica Health, Inc., IonX Holdings, Inc., Boston Mountain Laboratories, Inc., Green Life, LLC, and Xiong Lo, Mannatech believes it could  obtain permanent injunctions against the manufacture and sale of any infringing products for the duration of Mannatech’s Patents-in-Suit.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Business Arbitration and Litigation</font></font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT : 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Marinova Pty. Limited v. Mannatech, Incorporated & Mannatech (International) Limited</font>, Case No. 50-122-T-00635-09, International Centre for Dispute Resolution, a division of the American Arbitration Association</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On December 10, 2009, Marinova Pty. Limited (“Marinova”), a company duly organized and operating under the laws of Australia, filed a Notice of Arbitration and Statement of Claim with the International Centre for Dispute Resolution, which is a division of the American Arbitration Association, against Mannatech Incorporated and Mannatech (International) Limited (collectively, “Mannatech”). Marinova’s claims stem from the parties’ April 27, 2007 Purchase Agreement, which was entered into between Marinova and Mannatech (International) Limited and executed by Marinova and Mannatech, Incorporated. Through the Purchase Agreement, Marinova agreed to sell and Mannatech agreed to buy set quantities of glyconutrient powder that Mannatech uses in the manufacturing of some its products. Marinova claims that Mannatech breached the Purchase Agreement by not buying certain quantities of Marinova’s product. Marinova alternatively claims that Mannatech, Incorporated tortiously interfered with the Purchase Agreement. Finally, Marinova claims that Mannatech, Incorporated made fraudulent representations to Ma rinova upon which Marinova claims it relied in executing the Purchase Agreement. Marinova claims that Mannatech’s actions have caused them over $5,000,000 in damages, as well as attorneys’ fees and costs.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On January 15, 2010, Mannatech filed its Answering Statement and Counterclaims, through which Mannatech asserted affirmative defenses in response to Marinova’s claims, including that Marinova’s own actions or omissions contribute d to or caused Marinova’s alleged injury. Mannatech also filed a counterclaim for breach of contract, through which Mannatech alleges that Marinova sold Mannatech non-conforming powder and then refused to reimburse Mannatech the amount it paid for the non-conforming powder, thereby breaching the Purchase Agreement. Mannatech further alleges that Marinova separately breached the Purchase Agreement by marketing its powder to one or more of Mannatech’s competitors in violation of an amendment to the Purchase Agreement’s exclusivity clause. Finally, Mannatech requested declaratory judgments from the arbitration panel, including a judgment that Mannatech is not obligated to purchase any additional product from Marinova because Marinova breached the Purchase Agreement. Mannatech is seeking damages in the amount it paid for the non-conforming product, as well as damages from Marinova’s breach of the parties’ exclusivity agreement, attorneys’ fees, and costs.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On August 25, 2010, the panel of three arbitrators held their preliminary hearing, during which Mannatech requested the opportunity to brief a motion to strike certain portions of Marinova’s Statement of Claims that Mannatech thought were brought solely for the purposes of prejudicing the panel against Mannatech. Those portions of Marinova’s Statement of Claims related to lawsuits filed against Mannatech several years ago, all of which have now settled and bear no relation to Marinova’s claims. The panel granted Mannatech leave to file a motion to strike.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In response, Marinova sought leave and was granted the opportunity to re-plead its Statement of Claims. On August 31, 2010, Marinova filed its Amended Statement of Claims, in which it claims that, in addition to its other claims against Mannatech, Mannatech breached the Purchase Agreement because Mannatech allegedly falsely warranted that it was not the subject of any lawsuits or investigations. Accordingly, on September 15, 2010, Mannatech filed its Motion to Dismiss and Strike, through which it seeks to strike Marinova’s newly-added claim because (a) Marinova never raised the claim prior to its re-pleading; (b) Marinova accepted millions of dollars from Mannatech after it became aware of Mannatech’s alleged breach; and (c) Marinova is asserting its claim solely in an attempt to prejudice the panel. Marinova subsequently filed a response and Mannatech filed a reply in support of its Motion to Dismiss and Strike on October 12, 2010.  The panel has not yet ruled on the Motion to Dismiss and Strike.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT - -INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mannatech intends to vigorously defend against Marinova’s claims and prosecute its counterclaim.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Litigation in General</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company has several pending claims incurred in the normal course of business. In the Company’s opinion, such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company maintains certain liability insurance; however, certain costs of defending lawsuits, such as those below the insurance deductible amount, are not covered by o r only partially covered by its insurance policies. Additionally, insurance carriers could refuse to cover certain of these claims in whole or in part. The Company accrues costs to defend itself from litigation as incurred or as they become determinable.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The outcome of litigation may not be assured, and despite management’s views of the merits of any litigation, or the reasonableness of the Company’s estimates and reserves, the Company’s financial statements could nonetheless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from the above legal matters where an outcome was deemed to be probable, and the loss amount could be reasonably estimated. While it is not possible to predict with certainty what liability or damages the Company might incur in connection with any of the above-described lawsuits, based on the advice of counsel and a management review of the existing facts and circumstances related to these lawsuits, and related legal fees, the Company has accrued $0.5 million as of September 30, 2010 for these matters, which is included in accrued expenses in its Consolidated Balance Sheet.</font></div> NOTE 7: LITIGATIONPatent Infringement LitigationMannatech, Inc. v. Country Life, LLC, et al., No. 3:10-cv-00533-O, United States District Court, Northern false false false us-types:textBlockItemType textblock Disclosure of Litigation No authoritative reference available. false 1 2 false UnKnown UnKnown UnKnown false true XML 18 R3.xml IDEA: CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED 2.2.0.7 false CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED (USD $) 002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED true false In Thousands, except Per Share data false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 3 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 4 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Income Statement [Abstract] 0 us-gaap_IncomeStatementAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false 4 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Net sales 1 us-gaap_SalesRevenueGoodsNet us-gaap true credit duration No definition available. false false false false false false false false false false false totallabel false 1 true true false false 54866000 54866 false false false 2 true true false false 71295000 71295 false false false 3 true true false false 173137000 173137 false false false 4 true true false false 219640000 219640 false false false xbrli:monetaryItemType monetary Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 true 4 Cost of sales 1 us-gaap_CostOfRevenue us-gaap true debit duration No definition available. false false false false false false false false false false false false 1 false true false false 7924000 7924 false false false 2 false true false false 11923000 11923 false false false 3 false true false false 24640000 24640 false false false 4 false true false false 35944000 35944 false false false xbrli:monetaryItemType monetary The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 false 5 Commissions and incentives 1 mtex_CommissionsAndIncentives mtex false na duration Primarily represents commissions and incentives earned by eligible independent associates based on their direct and indirect... false false false false false false false false false false false terselabel false 1 false true false false 23109000 23109 false false false 2 false true false false 35268000 35268 false false false 3 false true false false 74617000 74617 false false false 4 false true false false 115413000 115413 false false false xbrli:monetaryItemType monetary Primarily represents commissions and incentives earned by eligible independent associates based on their direct and indirect commissionable net sales. No authoritative reference available. false 6 Total Cost of Sales 1 us-gaap_CostOfGoodsSold us-gaap true debit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 31033000 31033 false false false 2 false true false false 47191000 47191 false false false 3 false true false false 99257000 99257 false false false 4 false true false false 151357000 151357 false false false xbrli:monetaryItemType monetary Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 true 7 Gross profit 1 us-gaap_GrossProfit us-gaap true credit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 23833000 23833 false false false 2 false true false false 24104000 24104 false false false 3 false true false false 73880000 73880 false false false 4 false true false false 68283000 68283 false false false xbrli:monetaryItemType monetary Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. No authoritative reference available. true 8 Operating expenses: 1 us-gaap_OperatingExpensesAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false 4 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 9 Selling and administrative expenses 2 us-gaap_GeneralAndAdministrativeExpense us-gaap true debit duration No definition available. false false false false false false false false false false false false 1 false true false false 15811000 15811 false false false 2 false true false false 17748000 17748 false false false 3 false true false false 47579000 47579 false false false 4 false true false false 53403000 53403 false false false xbrli:monetaryItemType monetary The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. No authoritative reference available. false 10 Depreciation and amortization 2 us-gaap_DepreciationDepletionAndAmortization us-gaap true debit duration No definition available. false false false false false false false false false false false false 1 false true false false 2772000 2772 false false false 2 false true false false 3085000 3085 false false false 3 false true false false 8691000 8691 false false false 4 false true false false 9357000 9357 false false false xbrli:monetaryItemType monetary The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. No authoritative reference available. false 11 Other operating costs 2 us-gaap_OtherCostAndExpenseOperating us-gaap true debit duration No definition available. false false false false false false false false false false false false 1 false true false false 8911000 8911 false false false 2 false true false false 11842000 11842 false false false 3 false true false false 26292000 26292 false false false 4 false true false false 30831000 30831 false false false xbrli:monetaryItemType monetary The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 3 -Article 5 false 12 Total operating expenses 2 us-gaap_OperatingExpenses us-gaap true debit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 27494000 27494 false false false 2 false true false false 32675000 32675 false false false 3 false true false false 82562000 82562 false false false 4 false true false false 93591000 93591 false false false xbrli:monetaryItemType monetary Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No authoritative reference available. true 13 Loss from operations 1 us-gaap_OperatingIncomeLoss us-gaap true credit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false -3661000 -3661 false false false 2 false true false false -8571000 -8571 false false false 3 false true false false -8682000 -8682 false false false 4 false true false false -25308000 -25308 false false false xbrli:monetaryItemType monetary The net result for the period of deducting operating expenses from operating revenues. No authoritative reference available. true 14 Interest income 1 us-gaap_InterestIncomeExpenseNet us-gaap true credit duration No definition available. false false false false false false false false false false false label false 1 false true false false 20000 20 false false false 2 false true false false 39000 39 false false false 3 false true false false 1000 1 false false false 4 false true false false 182000 182 false false false xbrli:monetaryItemType monetary Amount of net interest income or expense derived from banking operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 10 -Article 9 false 15 Other income (expense), net 1 us-gaap_OtherNonoperatingIncomeExpense us-gaap true credit duration No definition available. false false false false false false false false false false false label false 1 false true false false 400000 400 false false false 2 false true false false 859000 859 false false false 3 false true false false -175000 -175 false false false 4 false true false false 822000 822 false false false xbrli:monetaryItemType monetary The net amount of other nonoperating income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 false 16 Loss before income taxes 1 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments us-gaap true credit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false -3241000 -3241 false false false 2 false true false false -7673000 -7673 false false false 3 false true false false -8856000 -8856 false false false 4 false true false false -24304000 -24304 false false false xbrli:monetaryItemType monetary Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Subparagraph 1(i) -Article 4 true 17 (Provision) benefit for income taxes 1 us-gaap_IncomeTaxExpenseBenefit us-gaap true debit duration No definition available. false false false false false false false false false false true negated false 1 false true false false 1963000 1963 false false false 2 false true false false -1534000 -1534 false false false 3 false true false false 982000 982 false false false 4 false true false false 4785000 4785 false false false xbrli:monetaryItemType monetary The sum of the current income tax expense (benefit) and the deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph a, b false 18 Net loss 1 us-gaap_NetIncomeLoss us-gaap true credit duration No definition available. false false false false false false false false false false false totallabel false 1 true true false false -1278000 -1278 false false false 2 true true false false -9207000 -9207 false false false 3 true true false false -7874000 -7874 false false false 4 true true false false -19519000 -19519 false false false xbrli:monetaryItemType monetary The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 true 19 Net loss per share: 1 us-gaap_EarningsPerShareAbstract us-gaap true na duration No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false 4 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 20 Basic 2 us-gaap_EarningsPerShareBasic us-gaap true na duration No definition available. false false false false false false false false false false false terselabel true 1 true true false false -0.05 -0.05 false false false 2 true true false false -0.35 -0.35 false false false 3 true true false false -0.30 -0.30 false false false 4 true true false false -0.74 -0.74 false false false us-types:perShareItemType decimal The amount of net income or loss for the period per each share of common stock outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 36, 37, 38 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 false 21 Diluted 2 us-gaap_EarningsPerShareDiluted us-gaap true na duration No definition available. false false false false false false false false false false false terselabel true 1 true true false false -0.05 -0.05 false false false 2 true true false false -0.35 -0.35 false false false 3 true true false false -0.30 -0.30 false false false 4 true true false false -0.74 -0.74 false false false us-types:perShareItemType decimal The amount of net income or loss for the period per each share of common stock and dilutive common stock equivalents outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 11, 12, 36 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false 22 Weighted-average common shares outstanding: 1 us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false 4 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 23 Basic 2 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 26490000 26490 false false false 2 false true false false 26464000 26464 false false false 3 false true false false 26487000 26487 false false false 4 false true false false 26462000 26462 false false false xbrli:sharesItemType shares Number of [basic] shares, after adjustment for contingently issuable shares and other shares not deemed outstanding, determined by relating the portion of time within a reporting period that common shares have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 171 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8 false 24 Diluted 2 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 26490000 26490 false false false 2 false true false false 26464000 26464 false false false 3 false true false false 26487000 26487 false false false 4 false true false false 26462000 26462 false false false xbrli:sharesItemType shares The average number of shares issued and outstanding that are used in calculating diluted EPS, determined based on the timing of issuance of shares in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8 false 4 23 false Thousands Thousands NoRounding false true XML 19 R14.xml IDEA: FAIR VALUE 2.2.0.7 false FAIR VALUE 006080 - Disclosure - FAIR VALUE true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Fair Value 1 us-gaap_FairValueMeasurementInputsDisclosureTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 9: FAIR VALUE</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fair Value Measurements and Disclosure Topic of the FASB ASC establishes a fair value hierarchy that requires the use of observable market data, when available, and prioritizes the inputs to valuation techniques used to measure fair value in the following categories:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style=" DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Symbol, serif">·</font>      Level 1 – Quoted unadjusted prices for identical instruments in active markets.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Symbol, serif">·</font>      Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which all observable inputs and significant value drivers are observable in active markets.< /font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Symbol, serif">·</font>      Level 3 – Model-derived valuations in which one or more significant inputs or significant value drivers are unobservable, including assumptions developed by the Company.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The primary objective of the Company’s investment activities is to preserve principal while maximizing yields without significantly increasing risk. The investment instruments held by the Company are money market funds and interest bearing deposits for which quoted market prices are readily available. The Company considers these highly liquid investments to be cash equivalents. These investments are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The table below presents the recorded amount of financial assets measured at fair value <font style="DISPLAY: inline; FONT-STYLE: italic">(in thousands) </font>on a recurring basis as of September 30, 2010. The Company does not have any material financial liabilities that were required to be measured at fair value on a recurring basis at September 30, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /&g t;</div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="55%"><tr><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Asset</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10p t; FONT-FAMILY: times new roman">Level 1</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="14%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">L evel 3</font></div></td><td valign="bottom" width="5%" colspan="3"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGH T: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Money Market Funds – Fidelity, US</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,029</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign=" bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,029</font></div></td><td valig n="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest bearing deposits – various banks, Korea</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><fo nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,969</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" >  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="7%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,969</font></div></td& gt;<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="12%"><div style="DISPL AY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,998</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: i nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">< ;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,998</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amounts included in:</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; F ONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" w idth="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="7%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width ="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,345</font></div></td><td valign="bottom" width="5%"><font style="DISPL AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,345</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long-term restricted cash</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MA RGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,653</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-S IZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="7%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g t;4,653</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="34%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" wid th="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,998</font></div></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1 %"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="7%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN - -RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,998</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div> NOTE 9: FAIR VALUEFair Value Measurements and Disclosure Topic of the FASB ASC establishes a fair value hierarchy that requires the use of observable market false false false us-types:textBlockItemType textblock This element represents the disclosure related to the fair value measurement of assets and liabilities which includes [financial] instruments measured at fair value that are classified in stockholders' equity. Such assets and liabilities may be measured on a recurring or nonrecurring basis. The disclosures which may be required or desired include: (1) for assets and liabilities measured on a recurring basis, disclosure may include: (a) the fair value measurements at the reporting date; (b) the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3); (c) for fair value measurements using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period a ttributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (ii) purchases, sales, issuances, and settlements (net); (iii) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs); (d) the amount of the total gains or losses for the period in subparagraph (c) (i) above included in earnings (or changes in net assets) that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date and a description of where those unrealized gains or losses are reported in the statement of income (or activities); (e) the valuation technique(s) used to measure fair value and a discussion of changes in valuation techni ques, if any, during the period and (2) for assets and liabilities that are measured at fair value on a nonrecurring basis (for example, impaired assets) disclosure may include, in addition to (a) above: (a) the reasons for the fair value measurements recorded; (b) the same as (b) above; (c) for fair value measurements using significant unobservable inputs (Level 3), a description of the inputs and the information used to develop the inputs; and (d) the valuation technique(s) used to measure fair value and a discussion of changes, if any, in the valuation technique(s) used to measure similar assets and/or liabilities in prior periods. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 32 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 33 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 6 -Footnote 4 false 1 2 false UnKnown UnKnown UnKnown false true XML 20 R15.xml IDEA: SEGMENT INFORMATION 2.2.0.7 false SEGMENT INFORMATION 006090 - Disclosure - SEGMENT INFORMATION true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Segment Information 1 us-gaap_SegmentReportingDisclosureTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 10: SEGMENT INFORMATION</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company conducts its business as a single operating segment, consolidating all of its business units into a single reportable entity, as a seller of proprietary nutritional supplements, topical and skin care products, and weight-management products through its network marketing distribution channels operating in sixteen countries. Each of the Company’s business units sells similar packs and products and possesses similar economic characteristics, such as sell ing prices and gross margins. In each country, the Company markets its products and pays commissions and incentives in similar market environments. The Company’s management reviews its financial performance by country and analyzes consolidated revenues by packs and product sales. The Company sells its products through its independent associates and distributes its products through similar distribution channels in each country. No single independent associate has ever accounted for more than 10% of the Company’s consolidated net sales.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company operates in nine physical locations and sells products in sixteen different countries around the world. The nine physical locations are the United States, Canada, S witzerland, Australia, the United Kingdom, Japan, the Republic of Korea (South Korea), Taiwan, and South Africa. Each of the Company’s physical locations services different geographic areas. The United States, Canada, Australia, United Kingdom, Japan, and South Africa offices provide administrative support to their respective local markets and serve as meeting locations for independent associates. The United States location processes orders for the United States, Canada, and South Africa. The Australian location processes orders for Australia, New Zealand, and Singapore. The United Kingdom location processes orders for the United Kingdom, Denmark, Germany, Austria, the Netherlands, Norway, and Sweden. The Japan, Republic of Korea, and Taiwan locations process orders for their local markets only. The Switzerland office was created to manage certain day-to-day business needs of our international markets.</font></div><div> </div><div style="DISPLAY: block; MARGIN-LE FT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Consolidated net sales shipped to customers in these locations, along with pack and product information for the three and nine months ended September 30, 2010 and 2009 are as follows <font style="DISPLAY: inline; FONT-STYLE: italic">(in millions, except percentages)</font>:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="94%"><tr><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: bla ck 2px solid" valign="bottom" width="36%" colspan="10"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="39%" colspan="10"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nine months</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="1%">< ;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Country</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspan="4"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="4"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="6"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN- RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt ; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43.5</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" ali gn="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34.0</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">47.7</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inl ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">77.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne w roman">44.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" align="right" width="3%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">109.7</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  < /font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">49.9</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDEN T: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Japan</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16.2</font></div>< /td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">< font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13.9</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7 %"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT- SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"& gt;<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Republic of Korea</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.1</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE : 10pt; FONT-FAMILY: times new roman">9.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MAR GIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.7</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#16 0; </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.4</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19.2</font></div></td>< td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.8</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  < /font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canada</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" al ign="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.4</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.8</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align ="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.1</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; F ONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.1</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n ew roman">17.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.0</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-S IZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Australia</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.7</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: bl ock; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.6</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.7</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">& amp;#160; </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.0</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.8</font></div></td><td va lign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.6</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16.7</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.6</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="b ottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">South Africa</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.0</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign= "bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.5</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.9</font></div></td><td valign="bottom" width="2%"><font style="DISPL AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.5</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.2</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.2</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font>< ;/td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Taiwan</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro man">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.6</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.4</font></div></td>& lt;td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.0</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font sty le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width= "8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.8</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.2</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FON T-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">New Zealand</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valign="bottom" width="2%"><font style= "DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.5</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I NDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.4</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </fo nt></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.3</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.5</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width=" 1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Germany</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.6</font></div></ td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><f ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.3</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"& gt;<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</ font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FON T-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0 pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.8</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font ></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width= "3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: i nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Denmark</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right "><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" w idth="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 1 0pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</fo nt></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MAR GIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Singapore</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LE FT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  < /font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.6</font></div></td><td valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" w idth="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" align="left" width="2%"><div styl e="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Austria<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA MILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></d iv></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#16 0; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt " align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></t d><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Norway<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font>< ;/td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"> ;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" wid th="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.7</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FO NT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font st yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The Netherlands<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="righ t" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td><td valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline ; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roma n">%</font></div></td><td valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FON T-FAMILY: times new roman">  </font></td><td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sweden<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td>< ;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT - -FAMILY: times new roman">—</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width=" 7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font ></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY : inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Totals</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman">54.9</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71.3</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100</font& gt;</div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">173.1</font></div></td><td style="PA DDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><fo nt style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">219.6</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100</font></div></td><td style="PADDING-BOTTOM: 4px " valign="bottom" align="left" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div></td><td style="PADDING-BOTTOM: 4px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">________________________</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1) </font&g t;Austria, Norway, the Netherlands, and Sweden began operations in September 2009, and had a combined total net sales of $0.1 million for the period ended September 30, 2009.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font> </div></td><td valign="bottom" width="54%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="21%" colspa n="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="20%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nine months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="54%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> ;</div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="54%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated product sales</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right "><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">52.3</font></div></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT - -SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">140.8</font></div></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">159.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="left" width="54%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated pack sales</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.0</font></div></td><td valign="bottom" width="3%"><font style="D ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25.1</font></div></td><td valign="bottom" width="4%"><font style="DI SPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="54%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Co nsolidated other, including freight</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"&g t;<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.5</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY : block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="54%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated total net sales</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" wi dth="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54.9</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt ; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71.3</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new rom an">173.1</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">219.6</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="MARGIN-LEFT: 36pt"></font>Long-lived assets, which include property and equipment and construction in progress for the Company and its subsidiaries, reside in the following countries <font style="DISPLAY: inline; FONT-STYLE: italic">(in millions)</font>:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Country</font></div></td><td style="BOR DER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 30,</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, </font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Australia</font></div></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left">&l t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canada</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">< ;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Japan</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td&g t;<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.3</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Republic of Korea</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT - -INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.6</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Switzerland</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti mes new roman">0.5</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Taiwan</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">South Africa</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style=" DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div></td ><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></div></td> </tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font ></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25.5</font></div></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="71%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Totals</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0p t; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21.5</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27.5</font></div></td></tr></table></div><br /> NOTE 10: SEGMENT INFORMATIONThe Company conducts its business as a single operating segment, consolidating all of its business units into a single reportable false false false us-types:textBlockItemType textblock This element may be used to capture the complete disclosure of reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10% or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 false 1 2 false UnKnown UnKnown UnKnown false true XML 21 R4.xml IDEA: CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE INCOME (LOSS) - UNAUDITED 2.2.0.7 true CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE INCOME (LOSS) - UNAUDITED (USD $) 003000 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE INCOME (LOSS) - UNAUDITED true false In Thousands false false 1 USD true false false false us-gaap_CommonStockMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi us-gaap_CommonStockMember us-gaap_StatementEquityComponentsAxis explicitMember u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ false 2 USD true false false false us-gaap_AdditionalPaidInCapitalMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi us-gaap_AdditionalPaidInCapitalMember us-gaap_StatementEquityComponentsAxis explicitMember u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ false 3 USD true false false false us-gaap_RetainedEarningsMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi us-gaap_RetainedEarningsMember us-gaap_StatementEquityComponentsAxis explicitMember u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ false 4 USD true false false false us-gaap_AccumulatedOtherComprehensiveIncomeMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi us-gaap_AccumulatedOtherComprehensiveIncomeMember us-gaap_StatementEquityComponentsAxis explicitMember u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ false 5 USD true false false false us-gaap_TreasuryStockMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi us-gaap_TreasuryStockMember us-gaap_StatementEquityComponentsAxis explicitMember u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ false 6 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 5 Balance - beginning of period at Dec. 31, 2009 3 us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap true credit instant No definition available. false false false true false false false false true false false periodstartlabel instant 2010-01-01T00:00:00 0001-01-01T00:00:00 false 1 true true false false 3000 3 true false false 2 true true false false 41442000 41442 true false false 3 true true false false 25743000 25743 true false false 4 true true false false -1113000 -1113 true false false 5 true true false false -14791000 -14791 true false false 6 true true false false 51284000 51284 false false false xbrli:monetaryItemType monetary Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 25 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 26 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A false 6 Balance - beginning of period (in shares) at Dec. 31, 2009 3 us-gaap_SharesIssued us-gaap true na instant No definition available. false false false true false false false false true false false periodstartlabel instant 2010-01-01T00:00:00 0001-01-01T00:00:00 false 1 false true false false 26481000 26481 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false true false false 1207000 1207 true false false 6 false false false false 0 0 false false false xbrli:sharesItemType shares Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. No authoritative reference available. false 7 Proceeds from stock options exercised 3 us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised us-gaap true credit duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false true false false 28000 28 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false true false false 28000 28 false false false xbrli:monetaryItemType monetary Value stock issued during the period as a result of the exercise of stock options. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 false 8 Proceeds from stock options exercised (in shares) 4 us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false true false false 9000 9 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false xbrli:sharesItemType shares Number of shares issued during the period as a result of the exercise of stock options. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false 9 Charge related to stock based compensation 3 us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue us-gaap true credit duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false true false false 464000 464 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false true false false 464000 464 false false false xbrli:monetaryItemType monetary This element represents the amount of recognized share-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph 39 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph 64 -Subparagraph b Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A91 false 10 Components of comprehensive loss: 3 us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 11 Foreign currency translations 4 us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false true false false 136000 136 true false false 5 false false false false 0 0 true false false 6 false true false false 136000 136 false false false xbrli:monetaryItemType monetary Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity, net of tax. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 52 -Paragraph 13, 20, 31 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 24 -Subparagraph b Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 19, 26 false 12 Net Loss 4 us-gaap_NetIncomeLoss us-gaap true credit duration No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false true false false -7874000 -7874 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false true false false -7874000 -7874 false false false xbrli:monetaryItemType monetary The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 false 13 Total comprehensive loss 3 us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest us-gaap true credit duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false true false false -7738000 -7738 false false false xbrli:monetaryItemType monetary The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A5 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a false 14 Balance - end of period at Sep. 30, 2010 3 us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap true credit instant No definition available. false false false true false false false false false true false periodendlabel instant 2010-09-30T00:00:00 0001-01-01T00:00:00 false 1 true true false false 3000 3 true false false 2 true true false false 41934000 41934 true false false 3 true true false false 17869000 17869 true false false 4 true true false false -977000 -977 true false false 5 true true false false -14791000 -14791 true false false 6 true true false false 44038000 44038 false false false xbrli:monetaryItemType monetary Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 25 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 26 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A false 15 Balance - end of period (in shares) at Sep. 30, 2010 3 us-gaap_SharesIssued us-gaap true na instant No definition available. false false false true false false false false false true false periodendlabel instant 2010-09-30T00:00:00 0001-01-01T00:00:00 false 1 false true false false 26490000 26490 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false true false false 1207000 1207 true false false 6 false false false false 0 0 false false false xbrli:sharesItemType shares Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. No authoritative reference available. false 6 11 false Thousands Thousands UnKnown false true ZIP 22 0001056358-10-000128-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001056358-10-000128-xbrl.zip M4$L#!!0````(`-);9#V%^)QS[H(``.%I!@`1`!P`;71E>"TR,#$P,#DS,"YX M;6Q55`D``YO1TDR;T=),=7@+``$$)0X```0Y`0``[#UK=QI)KM_WG/L?:KV9 MOK1SI]3[L?+DY+Q[N_/OC\=^+ MQ;/3B\:5_*_P?SMBK.GI@'NV8(ZRPX'P`M83GO!Y(!S6&;-T;"&&S6JEO5*M M5"D6/Q[?=7R7P;J>_K#3#X+A4;D\&HU*^+BD_%ZY6JG4RC):8L>,/'*E]W7! M<`NNU^RU0!F6!7+JM2RP)UT?!;R?ME\&0^56NU6K8-%F)@1\810 M%WN<#_/`0UV.GN.<>K%B%6M6/&,0B+MD^#3BE7JM$@]UA)P"#,^R0#_^S]\8 M.\8-.-+$VBO19;0A1\%X*#[L:#D8NL@W>M;W1??##J)0C!`4>/0QIKIB'9?3I\E`X3F98?5B MK8*@GP"-C*X_$W="5M@P^BT$'%G(DC#,G7F3UCJX#D#V< M??97"/B=J,%0>?!1-^ZDWOD8#X/G`^5=!\K^:F`=EV"1_*@+NO8@_V-V0/KD3`I2><,^Y[X![J5\'\@PUA?L,& M1SMTT<-N!WWAXSA?]!':K6B"QSX0KV(_#C=D/VY\P77HCU_/45!?+Y\B\G?W]#?P5'^IS7K^X&1#7-^7VJ#G#[8VW$5XJ8W; ME*#RVSC6+[5+SQ^"+N]WI`0]PN_8E'CN&^8RGH3O&Q/*O4PNXTGV8%/"MV^= MRW@2YC]_!+?ACLK3[D?U^0/0#5/7EK[HF+_F6H/PI MKC>KZW0G!EMI&?_Y$4+\_.'+:EJYOZ)6AIXTU(396_ M3V!/A:<&TIL'>#X5*>1I$,?E#`59+#:]6]A7Y4NAB\6("9$IC[\:GTIM MNPJ7NH$-^]$%R\ZBW;O"@HHX@_I/-W@/*S$=C%T0L]/F]>6GQN]'K(,SWK// MC:N+9JOXZ>S\YHA5AL%[=G/VVTVQV3H]:\5/HC%7S8N?S*,=QEW9@W/(%=U@ MYY^]X#VNTH75IY:1G@MNV'MVWF[=%/]S9D!TE.M$CZZ;?YP=,8O6H0?GC<_- M3S#Q!DX[S5IBQ*[4@'NT2JM]<\:J1ZS9^A6P:U\USZYQX3*N'&.!;(W_7D#W M))4)%1V?E5>$=0\/:_M/RL25.):1))0.+77`5)?Y?,0&8*9]R5W-N.>PKO2D M[@N']91R=`&6M-T0B\38T%<#9<*9=$Z)W?0%0W^#>V,<@J*,D(`H5XVH=*RK M?(;?:GA0',`(``:/5$RL]@*1"#4OJ=SD).[I7 MWJ)-M8$:X2?;&O".*V(\%F]C0-OHP3;ZM(W,%JZKA]RFBKV*^3SDCA-_'DDG MZ'_8V=_[(5W.3_YRV&V$4D<%@1HDXVO6#T\A=9/H$D@^&+[_A[5?><^F^14X M]^.V#JA%:_[8OCH]NRK^V+ZY:7]&E>=@:*O#.P92+)V=N114?X"=4KAQ\&5M MY_%FY!Y3/"%P3VN,9W%R6D47ZL92^U[=L'VO;N"^3]G@QV_[BZM[.6,P?=;I MP08J_\/./VQ;B&YW9P$%V3-\EF5==M^K!U,;7[0.OXWC,(MQ5UD/80-V>/[6 M^;+7#V99H&=36;/B,_'CS2,V:R9'ZJ^=(_5"M5K;3!%>HV-S*5EZ@&%<+UEZ M`,,Z*L_C*W#@K6WOQ6F[S>O M\IT3XL\S MJNAEORHW]`+NC]FY=(6?%((Z0AZ9(?O6)(Z=TJRYFGT<$.,N MNZ2:8'8.CW,+Q^/,,#.*!LU<_)>:67ONK&3]E@BPXA!?4Q#LK2/,7^_@&;.Y M[E/M'_TA_@HE"`*^XC!9&7L"WS<\!_\[2T>9U9H1[-,(,L-R6\*52IL9K"@' MW-4?=HJUG9FT[-:L&OR9[N4JR[T2.K'(NWA8VS]\/*&7OK*%<#3K@CZ!3F)U MLAIB%:EFXD[XMM3"F:0LGG0.<^A5E;:9<19/6'W;JGE:[EUAK0C`_=C??R`! M#=M6H.M8!VOWN=\3S!?T1A8+E*&GB.T40=[48"@\S1$.D(9_BTG"KK&X_4<< M?I(=O;H6[>_FR)D-=WUIJ)`E.%B%AD]*:P;K.%(/E0;;JKJ,:RVF%?N"2T_C M<*';WC6HF6YWZ?6Y!@U?G=O[5@[1>^"_-,;(V_KN@S"^]$57^+YPC%`4F'D9 M@ZDPP'==L%)Z6E6C*:1%M(>ZG0[/H6YE4:_,X/7>SL>$P5TFN[O'AZ\6@HJAH+]ZI-0@,T5I-;D$*#;!FX=OHMWF[ZRA2UM MCS+#P(EJ)H-6LXVD`#6K4B?4%P)^(01!OFM[UM@W5%$*73 MLO9VHS!C20Q#L-@0M@V53\X,G-2V:3;!7/3'9P0/].TG_++=@8":G!4=PUF- MI7N(<3UO$!8OL!Z(X\EWN/L@O!L0QSHF4G9Y+QL:)]_@%S/%KPL("1,1YP8G MP&\4TF]GFR4P%YVQ(C-?D8/05ZX#L?O_4HP8C-F_V()YI@4,HS.=92UGD5UR MG_W*W5`L&+8`P,)ETPXH;,BE8^);L[W1E[.^6SAOX7IQMP\FHG8?V6=Q"Y`9 MC^ZA(FUCP12ZG0\?EA]%/BS+=<5@IBW&8H3B/@Y1/`I`!Q@?37\U]7E2FZ8; M\+MF_.+GI5'-1A#XLA-29NM&M92'HNTKUX4A37SU2.A5[0:F&0X. M:A-IAJ=%:;5`?K&F&"=@@99,1IHXH*EU*)S3T$>\*5EBP-R?%[C?%8/#MIZ/ M05=>,1MC^R%JCHF:9[QPGD_Q-+UHQB?).](%=7W(4;Q7SWMARZSR@BA39JRZ M7]M[.-*1?@?\COG"%O(6I?=^S,TT4`*AKY)I#W!]*@?U>W"?N=(:H(^\W[,. M'H7]G'`C/@9`6TA5HF$Y_*I9_*JS7?-BI5392[&;`_:;8%,E;&KK@0U9>L"F MLA;85`PV![O+8V/.XA-ENB90!FKZ*-5P2EW@*Q+7X)FM'M=!6%>;N%K(@_QV MV(#P[!Y8=6LML$'AJ=>K>P=K@0V%9WM6;4ET8D3T?$2NQ*WPPA6-(0K,0;VZ M.P.)"-[SHU"EL*\Z2V:_%0Z4C#+9M!?#`26BME??768OP`D="A^"-4PC8-PV MQ."OP#P1S+A#HJ&7+O<"B/K/XM%X=[AZ?%ZO[^[;D;M)63W^W79:L M(]:^NFBTFG\T;IKM%FNT3MGUE\^`Y.^L?MYGGSI-&Z88V3D_:7UDVS M=<$NVY^:)]NN3/=Q^'/\$VL%"OO]H3*_K/E=D?8G0@^H:6D<7@#V%*WIM7';H&!):F9+*AF;M1PRP_PWYD4,^WE'+`@KIJ".@."!+\ M@8MK[(7$^K+7+P*-$&*-"]A]:@CLH5H9+PS\.(.DP^'0-6H,G%-#B94M!.0K MY95\@5.=T(Z!C^@JH`B[Q'LT+_D>*.`!,S/`@OG2'6,].MU#2R`1XE!LS8?7 MI`H,2"!,PGA`W`-^*3O+Z"]@%>$361E8^@365-N[B2`SM)6O>]INC93 M(H:A;_>Q*"=(Y3R6?^O@O4ZE#62-]I3>OA[U\:TR<%Y0]FR``S(G)%D)U`;\ MZ&->TV4V["$$P2!PRJ>^:"%$['!X:E0'=UQBGR-Y7`D3CH4`5(=A4F@I9M&R M$5JI9N#+5QC,FRFH<=8?,0 M2)$!`Y*8APIYJ]Q;H\"@<00TH:<;8"==X&V;83'W/WRT"$3:2=>G:!&AL:),^<9F7^0C%L!DB(\V%$QY-'!B.!\AWH5 MTGG+TW(C$&8`,D0!,S]\"_J#WV//L]EV',UO`Y0/#"LI@,1$M!QD\)$>/!^8 MJB,Z;NB,]\#N@HB11."\^C$'A'\E>GB#@`"NB[^5\$X! M"`!\W7%AKB[?SQWJ_ZA4`.IHVD1&MR2@&@)(=11#134=(04V>(Q;+4Y2E`+Q M,6CPS8\%/QE;WV:B<&G5]=45DB*8U[QKE2B:'WMD=^`Q> MCY")SC!<%1Q]N\\L*^K2^G8B1*&E&@;5*T(U'ZV,^M+NQPS2).U.$G/G[0BJ M/&V`+[KDL\)25.*\/#MU7X7@M7>PD)2;ZV7E_1EZ9']3/MP/**\O4QL\3?7\ MXSU-=3QUIF)F>@30@AT.!^3?M+L0`_0\V05E@=,Z4V][J?!7`28J7;)P`$P$ MI=W-P$A!Q!"VB9-MXF2;.-DF3K:)DVWB9)LXV29.MHF3;>)DFSC9)DZVB9-M MXF2;.-DF3AZ<.%F?X_W;IR%R/UJTA!-P[\I$S^G92?N*TA9')@#%[VC^97K^ MP`[FDE/3^[/>F_72OMBJYUGL/L1'9#A#C<@CAL<8\KCCHAJA%Y+-@(#+X[K& M_D>';&QMS7(0/WN:1]Y4ZO2!&TZ_6B=BE4^W?:N7ZZ"77S2=TV<0"N*OM._32RFBBFH>Z+B3\<8'P20RN`A"L0MPCX?R83:=.88\*\B\C$RR)CQ MG5##=ND(=8"K!M(&5^M6^LJCS(-QE@"!GQ*,,4H#M(S79AQ0LE'HO"+VL&S\ M6T681<%LQ[R=S""$9B^;.%78`0H@VN:=3PRP@&HX]3"[RYG.7)1$#EV4)($] MBO(M.MN@9((#&'7F2!AP6%3"YOL)RCF.F12P&1&E2))E3)[*O"RYS8`LH>A3 MJBYBT*>N2A4]UX4YF3P-4CD MYCL')W%+,?HCT[QKZR6L9CPRQR"IL@FW\3(-#@E7`F-196]%E$(RQS\<73T9 M_6ANG`X@%\,7J/]>T".8#;9&!GA1YV1> MUM3,`9%2P:[P[VO:8`&#S#7`N+)Z`G]L'&`+ZD!;]Y8E=)>'G%X4IV# M^4,5="/L7TIX[G#[GECPF"/@2N#M-&5E\1#8&OZ'&7Z92:C2M;'AJC$&F#1^ M*]^!I^YC'(=WR^@824^'/D6#$&0.9#@PCF'6H)F+V"CU.:,@S:%OJB/P;P`$D&SE8G`"ACI)T2>E$^#02IFS97H":Y ME$EIR1S?S,5IQ!V3?QO?DU$KT'1$.5K#:V008.;*<+L[5 MB`QDE[8J[`3=T,W=/9B@!8M_WE1*5FS'M^9S'>C)+<,&MS-_2:NT5,(DPI.:K]^A`36UO0M,FB]NI1AI2DO$9$W^2"%A M;U(+Z2")9E-VZ:30T?#`G""1'TH6'(U3(/#2I+M5^W50>]-3T#3&WNK]"N[2 MJG$.\=E]) MS:LM?*ILDQ[8"U,>:_#8:N`Z:.!DN^"T7^]6'Q_]#L`]1>"I5VYBFRCFCZ(! M\R&=33&1)X(HA:+@>&56+;V;CDHP2^R,0W0R\1B3OWC`5P^9P\<3806G!I!Z M$:;DOR,YICAOP5LP$#SE(9%!,87U!G-SF3`2XBN:$O3;T8[D[MECI.FHGPV3 M"OWQEZFBMP7P1G1)F%O+LPZ6QYS]GY37*]X(?\`R_4>WIF<5T\,:82\$OQR. M^EH^.!9>_%I@H!C/\/H2?/+BV6#H*I/IN%)C[@9CUNB!:M(3N@T\]4OI#<:/ MX!VDGS[;#;R4$@M>1<`:&^P8W9<"?!7;U.ZTNUUI8\G],/1UB-?R@)HI"P[F MYZ[!`.21R2P/S@A6':`%Q2HCHB0.'-#9Q[)H?'&H)SULFYGQFH!A>\9',95" MQF10447*4VNOQ'XQ+UB"0Q2EAB9*9F#Y57B;*W&*_2,(G4#O3.++E!+WS"N6 M>>,)QC=?BLS$'5Z#DE=G5?9*NTEB`Y,J.#9.U\P6"\+>CW#D,8X%?,,*4]:9 M0A#.ADB:2$GK"$_\?WMOVMRXD20,?]^(_0]8;3NV.Y:4"?!NVQVAEM0>S71+ M&DD>[SQ?WH"`H@0;!#@XI.;\^C/%D@C1O#/Z8.OE$;W76)XZ,1:=&*="XHA9*[1'=>O@A,M5Q*U"2W4"Z>5`H)<27I!XDP`/6.)[Q2UJ>,1$E"!E>_WI.< MD8.+O%4S$8\"!=Q%SQ\`&^:%Z7H>:E"[?1)+@4U"M&R[B%2G5/;9LLN6%+%^ MTMXC"[LY^^+$-;WDII2RR+-)3W1*I,YO;ONWYL:?U&`G[8&B/#/-RS;[;`^. M]]ANXP,1=,FN'?3%#(4W4>E+6MU7FWEV*H9S-'%R5(03$S8VI>7*V+8D>%MT MT,'[Q-2X)95N$H``A2.29X=*@Y>':6=399!'N$<00_)%[H[E!,`UZ-2W9/*] MYWN4E1-HH1\',NLFE[TGXMXS4A?)OP0%%N:BT^" M=0*H78I,U>3/;W*9?-=)0.-(^K"E'HLC(SB3? MIN&)HFC'@AH=L^4U,M*9_SF#4IY9Z_'DR_0`R$EW"K\GG9750_79`X']8OP: MK\Q^PVT1E6^X=@Q;007E:"7A&%"\+F^/9(H,3W2:/CEVG!K-L*72IY@1')$A M+RQ%CSU3SR[K3UEOZ-&93$@ZX5[2;N-[E(<1S]#)5$)84$1%^"L3OR3:^F/3 M9HMJ!RVL_T*VM9^&BD1)@19X>TYUEKQ[E^N>*?Y0U%$$S%0Z9+$!36(]XZMI M^![*FB1'GK\NZJ&D+@S$;&E<21W$444X/75WH:`F MBK*!`U8XAF15H&,86)3\:H83S,)!(X'.^^Q&2F:UDQ`=\9+#@\2+=;I&R(32 M9X6'KN_)%'D>AD1#KV\NY?948MQ(B,EI8!2C,N?&SS>D=T]<8N:BL>282?`_ MHOLC!<4F,J,$Z9(>F$N%P6#)YP4"D$:3WCG\)$-:/_#T3<#@B4M61HCDX/*&V5$K%61%!"*.Y!!R$9\A`*@CZYGER2NV<2'M\3'H#R6+(O;W-_?-/=+[:K M1=9G\@6UN)3S+-Z@$6U0T,-@N^`&A9/%=4.0NH`>WO\=?I^8MBU_?W;LZ/&7 MHU[WAW2Z(/F)4M`)I'L_`M9*WN_J/VQ#GA3!I2$33[DVB_O(SL`FYOQ\=7-V M?M/\?'5W=_4-\8_*HC'YKE&B[-&\)>C&#]A]"+'C8:>XS:5P4Q\L%L,%NFZW M%FT9+F>WUD)VWBIZ=\T@/V;X.-#N'X#4?O#+T7];%F.CT=$"'L\>FF4,ORR' M<'98C46V=5*7C*G=^LKL,0=K`1:!3=!FO`W6^*2OA+9W MVT:*WMH#K'2'W0WP4G$A\?SH1.P01<1UX#\Y8>%2C&MBY'1QI/N7!+>4HT2=]6M)C75/^\W\/E60 M+6NN8(]%4/\M/']*3BG=YB5_XZMYI#O`EUBEPF5+;NQ#/L?@,13D]L6S9=ZJZMVCB;(K7$D/R MXJJ9`C3N%"/#^OE0L6SM59GNE"MN.S?&`S_GT6JS$6;O!FD$6E(9=7:BI6)) MRN>I0U37_HO!&V:YL!^HH#A%["OAMWK:85!$8J9UBXR4YE%>)1TKJ-EDUE%` MTL>G?@Y)S?F<^S'7^6Q10^LM-(M.>E>?P_-HJOT.8JOYI^<_>[#3S=#'?)Z+ M,(Q9(#M4V\SYR%_&=_^&K\HW^8NE_:#$0,81UCL%.2L&_YRU&P?E8+9&\(/ M`K$+!MXMH/#&)V-%0*]%1U4>(QQ@!D_$^QEA$A35F)3`RC;IUR)[_KXI*((EWZ8:,E766*7A5AO_!XI=XS4;'W MPJ.WKV1*-"])MCHI.L8@!_9R\^P,9$1U4V\9QB9`9XH0O@QSMF+AZMCMZ/H+ MD&;&?V,`$9>ZT>NN`>"9;\6T3^ZF$Y8]&N0#_'OYUF\U_\[/@NRKQ7/HFJ?A3>CA_Q:W9!1N=HT]MO=WK#@;M['F4&2\!Y'1N)P)18C*MSX+R MAY_<_ZN]^!GCU;+Y!T7BXM<@&?`_F3XB)]&I&038K_4?5'=D-2*W`>?]=J^? MH_)2$^T?+@R@?VO8Z2INWL"NC56WSSEMXC]=?.P:R_(,J(?/W>L-_M94$N'WE70*+L`2`' M_<'`6![(ZT`FT0DX)V;`*R[-Z'/R31KLV@RN`NK,8!-IKEE`X^=`-K(@&^5X M;1VW](P>M]0DU8`>$;X1])_-T+&*@/Y.#CEFG_!8ET(K3;@[V`V"O=>I(>RHB0'L@WX-86]QV'O&%F#_ MZD2B1D7.5C]+6GQ?C=)7$J])*3KKYHI_DF.Q!J[" M_??F7H/@AJ\OO!%6K.%5Z5+VK)MK=[OT6HF_EQQR)H_UF^EAFV[KL8$EJ8ZU M)RQ:@&WGID"'$6MH7[^>-C06P1KRCENLHW.LM3^"]6L]-5NM;KO=O&H4VDF= M.:+?%8P91%1Z![T87OH`E&(00F;8T,Y,US7Q$QZ27@-R[]*3?^5IW\S`>M3T MGBQX623ER'%YQ5"^QYSL'G/-YS#&JJ$/IN.%T2S-?\K]"<>.,<6="DN)%\Z? MF/>911$++OUG\;=OCA7XVE^8Z4:/VJWOQJ*H$CW$%=S&'@?O)^T*SJU0.[&? ML-R538YZK*,E7K[QV7?YYC_.OFA?J.;"*8,1+>JHP1^AT?57_Q$X"CL#Z4T# M$($%11]D[6FL7^'9)F^MR#%08%(A@R[]\%CK-8;&L#%H]1M:OZ%W^XT.5LB` M'X>]1JO7X3\.&WJKPV\=^PVC930,,2N6`',BQ+HLH6&TJ,88UNR7M?_(60H6 M8W#O/T[M0/:X/G-8A%F5M_%DXO*;EF00_2?M?69$#G#8=+SF+1`Q\]H'44.' ML3]%S0I0V2'&JZ9T93M3,,;]DI8MS0(0+[$;EADW;+F5,"][`AG>"+T_@[RXB M"XAV>R*)_L7U`\7\GJ]?/!9!.<:^0PU^:CK2MG M-CL*L'"9,YH6@G'V0S11D678E;']P"\,T[M%6?58DC?$\(FDZK!+OZ4;]F-1 MQ,R3&)EZPG/DS^_3_UG,"CF62L?CO)5R88.S(?*9D&:EA7PO/%[H0ZRLB)%& M7C)AG1_F_>%CK<%&&A*!Y4G%`(4=WQ"MR\P_21I3+R"QI>6V!]1066ZJ,?A, M)3R2A'%XOC8H!J]3#/`D7!)%A\NH0!H.D7G#C,AJ'@ES.S M_H1?D8R:BB$LDW=*XHV2Z1%U*,)"8E@B)DSKBVD3T$ZHS)]H1Y>KK%0ZGY(> MKZ'8_#7VF&9T9T\3H=%X8$3X$U[0A3?00O+:`9QTZ9YZ07W!'GA4'#D=G6JZ M/9%\HHK)\T>@FC*>3V6$\:Z0`H0$P^8"M6;4*CHL^?J&F97E3BRQ))SC(3"I MQARU97UA0?@^+`'[<\AP-2J[+C0]A,>/\=AF?\2VLT%A.,6[BV(+);X=Y)!G MV0J=`N?$H8=4"=@8?A'-#AC+'7IYIN%Z,#)`B19\K)V`(.-#T"DK=TCXS`+9 M-_+9E_(KG86/.V_81G8P7NHUQBZ;(MZ4N7L+,5[5C'%H$?8 M:5,!&"BG9A3Y@<>F8>9;40+R`BN]\O+C#8Q(*8@'6HBT=5)Q@*H%+S*9_HV* MQV*1+UZ42U0Y?\2"LW;&(*52>``S]CO.&JJGL%8XG3W'%-O8G9+Y5110/*F* M:L)1#C7)*@$_KY3%:^R78+YD(7CDT"++A$1F4:6*B`33T$OD:!9;L,@_&4*4 MF\49\S`4`L+&BH;)@+U\GP4P[X&]/#Q;Y\"JY,WKG)6""5-B6$2,1-76;JU' M9L>D-%UAK]P&[(V(:X%8-HX4SDO8CA0#RXOZZ+3K9&==O+8$%3#MDLT[!(`4 M,'DY[*11=A0)XQ#/TI@WBFKDOB/!$CU3^P+B0N2L2+!(F`@(]CWB-9<3W:NX M"N`V$T.59:55OFIY8-Z#PI@,*ENCR*#$6X;]#+0389O.XH??'Z*LN;(BG]!B M2`QC)*/HZ4+8L[&((:(PJ:G9%2@LVX_I'H15,X_'3CXY#W[@QR'VM@E`J['B MB/&6'6,L.1G(,M2\*&@&RQ:,YF,+&(#*Q%6(,G_PI3R&1%L=P'RY=&88MFDE M^CCOZ$5F.>71`'(_9QJDH?;P1/4.P]C"EC?8WW>!?RDUY']%C\*]`Q2Q0HWB M^SR3^Q:X&=[0[@"T,<,VI,)^DP\N?.__M+_XU.HPE'_\[(<1P/0-#R>,:`5# M#4MQ4DR/?.?7`&W.C!L3&>'_8-('[:N?E8?W#(R")^KBS(LREI'.OZ>)<"^8 M'E_P'[$GR[EGSO:,GR7G7^&]@F9M+6GPV;&H0SKW*"V8@7LJ4??_UN.S;!EP M$MP[LOHLLLJ6KSX.B,YEVSU>JUNTW,2LD-P%55<08YX00/CQL6 M"M]7`_O3B"N5Q!TU9EA7ULNQWXDP7=75RQ):5W+6ZRU9/[N<-;)N>_E&P5]/ M?B8J[(VJG,^3'X3-G[:'(@&2&/1(R9,8\Z]; MS14(P)N6<+LV!/2D3A.AK69MT9-)X+B:T2=Z]S49JY^V%,PVJ,MU][MGT3,J M(@F'++=.BOO_3LH@%38O_SPO;S*+O%T[@`7/KP/IZBZJG] M"QM&\J9C0/?THHBNA/QGSJ5FEL9QF'92&>?<:)@(B<8W:9V)2W6&7I)&A7'O MA=([9XF(,]*.8_(%RWKY>?A+64*`4@8)Z*6<5LA\Y7`53H"(G,JDW*/*'XR( M,9+--PMW9MHO6$D;F7PQ)@HS4@+7*#!C$"B\U4`V_8HLCF0\:E_`^;8XAX-? MDK.<&EPB(TJGST*@%\.:0[1LAD1&(;ECB9AC7K_]7;?1:K7P'[(QS3%8F[R0 M^3,Q:CC?:21Z#H3U]=!7)VIEWQTHLIKQW/L&E$XGY%&EUK7)29HXY:5SM)'4 MW9<[*A&C80CB!X7Z:.2`_4CW!>2-%;(Q<1=F-F?),=40&=E\(]*^*GD7@U0OX2/L3T%LMJ3X[N)GP&T-0K1H(E$[NXL"'F/ MT7?@P!!TOV@J&HR6GU@2#]AXE(6\H2:\3TZ:J?9'$AV0*%UF1FW$IFINEMO- MY(NB&D`7+4ES3E''3"Z!FG^*RX-,'V>:,Z%%>A4H_["8(J7D=E+GI3BJI,ZS M),]QT'+GFQPH!VZ.&.D6FZ.V9JF5Z:4\]^1LJ*.S0DNI]M$I^[-WL['UU+[X M/L#.]B5765+?%T$=\[7]6=-XQM+`FW,LX$+E3>X#_@N<32B]Y78&D8,1"2)W MF]^QRQ.#XV3&^LU9:]B:!FC'6@B@>0%.@J_CN%+EM3/F@;Q* MG!T,E1CI-8NR-C$]D+I)TG&=5,9"$&S&T%_!^S$3WR3T>919H+>C['HV@P1+ M)FDH/+")WV.%\?T?S$KZ5";"!3O?4M-@<561Q1<69@E08:.>95ZFN-)B^^I; M(@;.>`B3\%JB2"@:#4Y$FE:8$?:EXLACS^ZT"1C&(!8R2B1.WIL?4BIZ%"@2 MF([P/HAW>84;01;),;"PG[3W]YFO30M;*Z/7A1>:(MEM^ZZ+`E;H;0D!*/;# MX;09`ZL^FXOT=FE_<4J+YH569FXG%(:E-`PXY.)@0N[RJ&?A>!+QXKXB\BL] MD\K<-A@1B2>N%R&G"-LNL4_S[L'T\83/B`&6L-7D5?(BLI9=KV?@R9PBCX(I MIRS2@MA-;Z,7#:\.DITOI<('R4MQ&#Q2+B.!Y]\V@!URZW<=5RO+.[Y2-4UN1F%C<3I;DG\=URT/N"O<8#92S]IC_XSLE$CT\D[Y%3@AP\R MEM2Y!3-0:R>)!Q75^O0-"^P'AYJ14R=C[G_GU2!1IY8+X][) MD*7[!)L-NXQ;$@1*OH`N*-5!S$*!$KW52HF9FM1TD8.-T4 MM6R*[&:8205\#YA1;/PR&X-8(;P!U3(X'IOB-AVK\F,9"9M[BFTP#)R(+O;- MA]G+@B>'/2D)3-N64-9>H7$,[O M8E]:R)1SK>=[##ZC+M3EO;AQ:Z`I)<2KO(C(\VPVAA3/"-,&(XI?\`CP4M<_ M#\I]8!YN+]BE#J6HI1`8S=N:FTLI>0A])]T-:W16X;Z*#W MB+I&$N_L8B]MHYW2LD&X1,4C<35I6MN"U' M3Z)]-EV3Q[2-C"R*"1675%\K`)%5D1-%=6D!:=E=+Z^YJLO!N ML4S.S)L72P$CU'(F+K]D2+F@AI52=GW(S5&*,X<#;OV1[T<@#5FR M+67>-+)U\7RB+W![HF[C3IO^,V8*HS?-L1TSX(J4Z_(H,!GS><]WK\A1P4RN M7$P43YKG-V41%PI6ENQUT&?V?U_^QJV[XQ$-?%$4%/D:>)[IPHLR]K[UD9 M:F,5'S)9>:X>:N&P:CCU,,W.U,*,,L)AE$H16B7C"9>=,QI=,B&(X/P2T*ZQ M':RV`5/9HCQD.*6#]U: MT3)'-!@&XE4S54NETX*S=C(1#N;8O+8#64MDCV(SGBQ'X5Y-#1#RXG%[*&F( M\3)0>1?U.DE&V?X7_$)K:64\QX-UX,C]5PZ2TM#T0Z;LLM(2UG.ORJU,%^1P MHCX\NNA,`L3:(BZ!*P-T_,/1]8`AJ7@TQ4&2]I%K-P5BG)P_7#`4*WCGSV!A M!R2FN#6W\#?OKHLN4NKQQ>#!/5IN=LPRO<0R+U&ED##T@X8\IFE,44!$!!/, M&Q4EUP._V"&'$SX1UP0`J='!Q?4-[1&O(N`,G.>9P)4DN6T\X@5SV^;-2O%P MN7Y>U'C+2#MQ%3IH%3S)GZF!YE#?+P;LR>]D`UZY M`+8^X_W!NC,=PXPYD._F&KH+?":4A)U(\ M1&4>?DL)4OR]\R$M1<*KQ&5NLP(V=F(1KY$5:+P5H[BRO6$3WJ<%Y-+?0'28 M#1@5AC63GL38$FO>U_FZHOS0]TS;Y(YD&`A&PNQ5-)-$X16*'I29O*#0.BZ_ M^,-&-:L+:A#O7+XEV&%"6.)UP;O>\3`O\`:I!"Q*ZCNJ%\4[YH@,I9D!)P&H MUX%#)T[6XI*WBW0CR#M?O$P7F(,PKM36*LBL$WF&WB3GO9);*]1`E>A+U272 MT?B-N2W:PCA!>@.@4$Y"$#B.*)">N$)?$WG\%H8&'3'XWRFB_F&V:C#&(O0S\0W-$* M4CMWFXB*+%XVNZ[_3`)R1*2*[R.LM92]>^!&RR.\_*YUK$LYKL1G%<1GIL.< M$INKY'>DC?^DR`%.#\SGQ+<<8KD3SPDQ]>'!]VVQH\%,YJE$W-;GKPK7/FQJ M%V]N\Q1C^T$N\_=RVD+SDH-IT1G12A>#WB)T@23`+CH'"*J(#V M2&W[*FQ[WCN4]^94^WX%=6E5.R=*>[3BE^^,U'$C?5"I;R=56H1,8=PD810# MR[=DWO+BB?+B2@ZP9Z:%)&50(\9X>@]<6R,XU`ZLP@[$5GRRW`62Z\)#11!L M6K4?5SJ'RY1WC9D!>E+S&'82#.<"]9Q`VOS"&N"_I%^33>2Q2+A0*&)8;Z=W MTZ*Y_+%VCA4."G]&YR\>\,9`L\UI."]\>"ZDI+_C.R:OO&K]*08=X8WHDF,JR5,%R3Z>N#[W=-SX4].- MIIET:+H-/,L62?\,VD$F_=4ZP4LI-ET00^X'8Z#PZ2-6G+BU>.S.U6CD6)C% M,8F#$$O+H0N41_-&\WW7(`#RP&2F!V4$HPY0@F*4$:U$&@ZH[//:#6D?XE1K M`H1U1?D6BA02[04H=3K!J=X]UOX>FP%@DM)`IORV-.?`A>E7P6TNQ$GJ1R9V M6K&XX\O#J"7MP?7O,S5XN)P#X9O#$Y::LT3P_SN]U3WN)(X-=*I0W6WAKBEG M"X(^$#!F*MZ(Y/9,((B)4>Y1DZ5+NV<>&SG13%02?I@EWQAT1%G=F1\VLC@V MEME+X\8H_#QQ\(VHU'\"VUS4"RAD]+GE/V!!4%P`G9%DP&(/$)B@G(?RL5;I M\LRR4I78'H)8:OYMP_PMD8;_%Q&Q=?6FF=+T;:#NG?2]UN^44AZU/WI366UWN-Y:D38]&)<2K3S))BN<*& MD^DV940.0'Z2L\@G`8X1E^*P)NE)$HSNO'P1F,I+G7&W4"Z>5`H)<26)I=B$ M,!A3IS%9V4-&HB0A@ZM?[TG.R,%%WJK9'!:.`NZBYP^`#?/"=#T/-=7\0[$4 MV"1$R[8+8M[T,K+/EBW$I8@5Y=IP!1G8S=D7)Z[I)3>E?S4GII?)4N6G1.K\ MYK9_:V[\20UVTAXHRC/3O&RSPVYYQ(8?3XQJV<(!_QZSUSX004\L*Q['G$FX MECW_BQD*;Z+2?U"*^PIB.$<3)T=%!W,51]0Z3\:V)<';*$MY_R@S-6Y9TJI1 M5H4SI<'+P[2SJ3)4*9WX@CJDE.7XT4=8<1&S<@*L&!7(K)LDI`_#"47<>P:N MXO2HGF(]'P#DI#N%WY/.RNJA^NR!P'XQ?HWW2[OAMHC*-UP[ MAJV@@G*TDG`,*%Z7=I[PAX[(:?KDV'%J-&,AB.1IA%T+R)`7EJ+'GO%5T_I3 M;#T,$)F0=*)&>K=IKU/,JW'=10)$FNG<7YGX)='6IP+SJ-;.\9J"TH;R@JYH MJ=`#=4`":9XD.OIIJ`CO%2:TU/2[@($.[HJ/\NY=KGNF^$-1)VH*"(>L^3TI M#,!?3N1LZWYL\1_=K(5D_/,SCW/5#I<\&227V3DOHMQ2Q6A"@O^I-$ULS77&^U$P\Z`D.. MTB0_9VS^`8-RVP7'3#D=3CVY1GX5"G_%\6PR:'RP/V1J#HXS`JS_0@L]UK[(JO/`9C+Q2=2L MG15K100EA.(>]#%OO2V4A_1Z_V*X669_) M%Q%=8HAY%F_0B#8HZ&&P77"#PLGBNB%(74#/+TCX"UDO>[^@_;D"=%<&G(M`+K+.XC.P.;F//SUS6VLA.V\5O;MFD!\S?!QH]P]`:C_XY>B_+8NQT>AH`8]G#\TRAE^60S@[ MK,8BVSJI2[E!2%0N2GGN8])]:&7VF(,UZMJ;H,UX&ZSQ25\);>^VC12]M0=8 MZ0Z[&^"EXD+B^=&)V"&*B.O`%STU,Y=B7!,CIXOC)4W,N=Z[.0\8N^:!@]JV M>J,[U/=WXQ[PZ;[$UN4M)414H46?]6E)CW=-^,[]/%63+FBO88Q'4 M?PO/GY)32K=YR=_X:A[I#O`E5JEPV9(;^]!Y]+"67#,^[0^&9)@(3,^%^89:\CY*\/%,F"53D MU5'3=Y.(*++X,W#)FG64[6>/L?@,13D]L6S9=ZJZMVCB;(K7$D/RXJJ9`C3N M%"/#^OE0L6SM59GNE"MN.S?&`S_GT6JS$6;O!FD$6E(9=7:BI6))RN>I0U37 M_HO!&V:YL!^HH#A%["OAMWK:85!$8J9UBXR4YE%>)1TK<"OE'`6\>Q[UZ4-GB[]GW]\Z<,90.`5+):*)4F^:W]CTQ((^"OT!KQ0.C7]I]MK=P2"XC8AL8:5YL=\7?O,,7KTW'OF21AGWF:>X8)CW"(JH@O]WP MEZ-F^Z@4MKYA#.#'E&2S@^X`,GCCD]$W]&4APPEDQ?(GQ^81Q.^I'8GC?1"Y M473H)<48BR##$%@@^5H,\'GZ&WQ]X5W(3T^2+T^3"@=7:3+HRHC7NWF\;S9_ M73&!A&X:NJZ_!BZN`QGS#AJ5]6<#5"03,Z?-.'KT`PS4+RX]^>(6/[BEUT^2 MMW-+T[-+:Y70N`LTIA5F%K9X_&H`WFJO#[B4W$FR``NV=*9@ MC1QCM1T%V.X8[1S,"X??/-OIYR35W\+<&CW8Q[(A5P3O+;@-> M7'#!'N#5)E%N2\+XMJ[(U(C@)@+LTQFU5BTQ?P>>G$ MWTXN+T_NSD__HEU M<67,2*\.'+6/8+>S(/P?41?@K5??VN+J>0T-61U`",$/I48$O7KI>TEM'6X` MG/-O5EN#`13L%'2:Q>/O'&+CZ-.@.ZP1Q"2?]'ZW1B"C^3$PC'4@_HH);CS) M,+$\9D#-#T&?K,RVS7:OES_%2X9]8["`-YN#;K]B8!$##GH#HUI@<1NWVVX- MEH;K]F4??1',7WD'MA///LE]L+:XU+N#@EG^PA35@1[84^_W.X-:0H]``4V)KM[2!R_" M<%8HUC#/NA'5<3:PO@;Y+5X^\)O"10;7H-5?!:ZDY=$<+X1\OJE?!(1X?EN6 M#_RF<)&EK[?UE0"[8;(Q$W8BX485K]N8*8XUP_G)5^'5"(OT8HW>4_[Q5_SV M*OUT=9DWU/,D7V&RJBZ+7V.T-UY6LNVW+.%#N$EW0LO=OMK04O-F[`GF8Y9[L?1]26!T[3(NC\_8PK_"I]=^5+`J/7 M&;8ZO5X*]J+A=P\S=XB!##QIG1(/'9-3U:WG^O3T8M'8S/D>.>#%2Y+$[_]+W$"Q1X.F"BNF'Z]S]@<51XJ+<&)*:H(!;%L:@\YHH^&RZ)-W, M:+;NG-;4Q(%$DVK9PZ6I79N!1K[A!6_]KY89OR26;[D)%KRVUI,JT+9S]*FM MZ+IW=-5[NZ7K>C=O2]!SP<=KW_>M>A?XUGN4O$N=CJ'HN1?TU/M(SV%[E^?I M#58A]JC49("52\/,G\[%GY:@WLPP6LDX2_ZI`I1I]2@!7BBU4>WG*[O5,]1 M/%$IGM"'P!/#0D#GV[+$74!-]*8B^@JP1X6>PYDG+Y-[WE`SCU[\O0*D:0UP MNW;Z0UT1IW+$,5IO09SK[/U9^*A1%Q#FV3,JQG5RBW4F7UG=^YG-,)@=;P=` MH4]4;Q52+[F2V3A8=]'@NP>8R-!?'6"NY,PV@"SA*GHU M$V:#(G#M"!!]4!*36SKX+D'%"X%VNQ`!MP2H>/\'3T].JWR[N+RU^UZYNK2_CY]/P;/+A5Z>\O]6F_LB)?]!T7 M38^^G-Q^UAS*2R49K64!GFDE M4M:J3G9@,G[ZALT:@=M!YW4=;)V"C3WD)R=!@/N#=DL"B9ZO@J"]+\!H:H[] MR]&?;/KL!_:1YIECEOXJ,8]90%^N7=,2UY;-9L(&)I43O/U-$TC(3/SA6,L\ MT&+"'&\\P[X[/(%X+!;49"[O0BU[Y)B9Q6@/L6.3CI[VG:KU6 MMVET>?T5&(BR5))OA4(ANBH_^UJ8UA5(>CR*B@4S\&E+P<=GYMUP1']07D\Q M&=AF*+P=C_>8H@;;HLE7IE>>G1(W7W7%G,57!@YM;$ZQ@5`$5D?$&Y6&;&)B M3RJ2^U0_S4R8F@,;,FSG+*$=^S9@A,GN0)Y'^12B"SB59DG;EB:=Z/E:'.H_ MZEM\:HMB#2*:@(.`-,-&>SB^G5OB''I1FV;V?8(]=3CNG-!R?>Q;GVEFC\1< MBHGRLZS(=\^.ZR)J&35DNA=;FIR`$V;IW$AK7#WI'O4-<.HL$^S?UIVK\KM"/3"?E%)6RU@4-Z1 M*6DAI3GC"9`:09_7#RXM"3+Q0X?#'21-M+"-4Z+5UJ%@SHZ/(]%+)7^P\'/I MEH'HX]'B&)1__EUL6+R;AN.*;T`ZM6X8#U7-G5#M=A,43J.Q=H>KS*E!UK[) M=\&9&9G(.1=CE*YP?";\D!1%.9Y[%-V)FC*P;T#Y2WO26\1H#A>:0FJ++F2E M)6@0(24/M%"HE8GP70:)^/]T?3:N#TO9F*`ZA[B/Z73XOP@=HGCV?I;]GM,R M,U]AS-B$8;-'[?]]OOF:/QI)&N&ZL249[?JT9>$2@&+W4H%T:C(G^M;#EBM# M!=C/`:$!Q#]"2XD=@/GIO[-E?7"U'+`E`)`@F]KD$?BMB47!!,+I++.XF4[G M6Y"D]X8@>4%>CN+`<\#(+^+Z6/L-ZSO!DD`\R>%R[2@349R<`-BE(+X?.S"J MX](-&)5%*T.#XW%:(OR#,!!-R.D6Y)&*FH/UZ&-'<$`G];,EOP3++H0^IQTAV_[QSI>H M3KCTAX0FN(7!0,6CD]1E;!0%")5N57VILD];M0H+,7C2'B[/^^?I^.LG>'0' MW4+)A.R`;P4*FN^]3F?070*4Q.T2)+&[C:0O<1*2#+^\TSNBH%Y?0SY84")O M7IY*&AZ\2_#UPT>DV7203L=59?)J677H,H.<'YCGI M?-2^7MW>:M?G-]KM7TYNSI5BNA!IG\W0L=*0E/?(7!]2[LJI.>?7MUDM1[-, MU\+[9'*LX\M)NUX\+IZI$BJSFZ(+K.;%='HM:.INB825F4P5S:82$IE#\5@[ M<]P8512`Z@5(Y%.LJ3H?J/SD*`ULG`&5E^PC"NE^,EW>AGL6Q$S77V44O5R? M-VW/2[I'^.@_AYG&RJ$F+H=(Z8@CR01EW(.,@&3CQ@0WYA>9MUOFA?7JVZ:M MCY?ZKE$HN:MGZM[*;?/R_J*K;E"K_T`,@4HH:\M035_V7;BDJ.B!/6^7<0T; MM$^)/?3>D',D<,0I:QQW=-P*'#+9ESJE#=E&H-))W*Z$"SRH*XT+EL%$^[C? M7@T3=YDM<,]@BY!8"[#(-+>*J,(Q,RE((.E.W4"(`5&\<*N<3PXT*X_6D"?U MZEP]R'0B6*9SM5&%!C55[1&PH.'W(-LM&Q3X5R]O_>;-LI<532OTC*@JG7.= M:M2>V6TC>F.8W5K]/=Q9&W86WQ]*#_:?TJWA'E!:R<<*[9J<>#3V<-.@1V9= M1T+-EOH>+'"\4?:#I;OJ[3-K#U;OHE9]&O/2+X?"T#;S?`H(4BR==`;<;W%] M+;TN!\+BW+>D>)O$]7ZSMM)$#IBU]X_&2A-9GZ6K8-(JNU$I(ONHB,QI%/_? MEL78:+1JJWCCC3J9OV:K>!&DAERK,*]56*YUJPO:SK?!''7\^=&)V"$JXUC#A2J4F4^F MXU((7^1OQ<:LVDJSH;ZB?-)^VA_BUP#CHG7' MR'N]8?0'FZ,E)]/T-\#*:^[R3;RAI6SR%L[R5V43H]?H#/NXU562[G4EW1K:;+6X1.V;F7TS;!BMOMHX2D5X447H=397$:KHKE$J MPE(8Z=8=(Z`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`[$:EB-146JL:E:J1 M8M5`4PGDZX!6X03R"F.MP@GD:ANL`UH5E$5%T,.0:Q7FM0K+-5488V5U_&#K MU!UTZ8O]M#]J4]5!=4G:""/O^XU!?Y/V-S7)[U!=DC;""&;;#39IIE4W45?% MK#DEZC83=:WC]B91I4K2U;20@-HWF^T;?=CHZIM$Z:J=HHK]& MZ0BU38Y?54=0UI#JI+@MU*E.BOMH,%;X;GX_-=#]ZG)S,`KAWI.MPK=X2A#4 MF:-J8P(ICJHZ1ZFCI9:[K6Y'2^TM__T2!"I"1752K!IH*K!RSP(K*XRU*IZ; M:AOLF46D"+J?*K;(QJK+M52?%RK5O MJ*+#>N-"'JO&\&]ZR%0PHD7UYJD00ZZ<+7"HPKV*$81*N%=J+ZV:M:!D^S9D M^WYV4E1;NAI;>N6$"K6IE<+VV@K;2JD;:RAL5?"J*H6M6M*]BE$C6U#8E#%> ME6:*/_\8A\T'TYQ\/#<#S_$>PFL64)77._8]^HRX^?2?_Z%I/_]7LWEB6;R? M6L`LYCSA<,TF?RH'N?"L@)DA.V/\OQ>>_.@F^4:+/2>Z8:-?CN)6JW6DV//F5P7#)>75?6:B^]LEOV M,&9P,EQX(U1$,/^K"(YXY89-_`#;M9XY(7;"C#/2N)2'ZWJVE36VO;RZ.X=W M/VJWY[]^`_BTB\LO5S??3NXNKB[7O?8[H)[`HE4KLHD=6W#L.=@`%1NL,KPP MAO]KV&P5#C1_@M7ZL?%JR-FN@1]1!7#^9]-U,3,S-P!N#AC3B_QTH(#8E0Y) M&,6)I@TQ#W-=WA)X$OB3P&&1&4PU+XXPO=/W3%<+X\G$93AWV-`B?^)8\$?L MZAO^B5V+L?4J?$KK:-#?>=OA)BS8?*#ODN=:]!CX\<,C@>NQZ-D/_M3&9O`G MH[783@C3WL."N)J`QL_['R^9SCQS/]"P':`QX M)R$(4VGW4PDU30^?NM-_LS##C"#&81CFQ?!7>'L&L5IHNBP/CJ!%;L59#G$\ MFTVP%2F`:(:A#U!%3':K%JS"YGPO45+.4TZ>$L?:I2\W2NFDVB,0&%87:";7 M![%;,IQ:8Q^X/X)18??_L+@1/TY!D$2Q# MM*@FJ40\E?!#1F;8S@C.?:1K(CTTDYI-$]E`&+DVY\^YXQ.UF?8;2!+LCQLA M0`WM%+:#;3:TVV1OP&2V/VYH?S5A5?P1:!+Q MO0NB!?CG;\!0IO;^%M2A1_[+AX9V9SK/^#(NCS\Y&8&0,5^6?25K"%GP1`(J M1<<#\Q\"<_((()AH]G`DS%ED9EUSUE0$$P`XH0B M9\Q#W#6T7QD*\JD@GV3*2P;_)GZ%Y5WZP;,Y%7`\,\`@!T)0=89+^9N<-S-$ M$+`5(`.JYDGI>^Z4CY_9-8)3J%,\&N`1[P+/3RK-8J#`P'ZVS6DS\IOPG_1L M]QBS0P3-CY$'X'CV3*&_B!E?E+5Y)^Q^"-#3TF,'K"]G,N&XM8`?_#%2"C`+ MA`I92DN@L.O##@,"/=*!GCO/G=1$2O@/3E_&Z*T7NHEKV!R97L3>N2183606 MU_5!#UD2$W?__`JH<")`I,6]EK`&./9=#CS[;L&4J,:@K@0<%.9=R_9GTUNN[O=^\8=$="0&^]U>X0J@P.VY(\N'>D_PRE?9K M4#SR)]4A]XI-T'<.[ROF/U?)"UF&H5-NO6_IWG>))K_][$;N[N$^1JU,B>PB MI3M[2>G6)L5P]X?2P_VGM-K3LY3N[26EE]_3ZY`MJ;6W$7.WIU>D?;])ZJTS,O87RHL1PV^0NWMJL!_*-YABL[<7%A6L>+V?@K+@?+.UHE<>N]XDVZ@ZFRK MV_&P9VZWS52SNHF;VI-+W^SR3GE)ZRUN:N_^,KK'`T6O^M!+5^[*5Y`W;EVOL-V_KQ)EW/ZZ;KU-^TZARWE6EU$&Y#%59:.5:;R>=63L3ZB,[NL:Y. MNOJ0:Z@.N@,VZFOOE.HI'V*=R+59](1R(=9;VM3?);79C9NBUYN+FTV\+LJ# MJ#R(E6%E?;@-T5,;3:?V=M5@H\LF95?5QX&HX@XKQFB\&*;R&=9'6':.>^IL MJP^Y!EM7J^LN<@[)BJ^]$VHK<4"UD3:U)]=@HPLEY3.LM[2IO0]*WTHQ"$6O M^HH;Y3-4/L/=B)[^1N6;ZJ;I[(%=MRJ^O@,5=!AY5@MZ7VC'(?UD9@= M58VC3N0:;.3G50=7-M7IY7CL#[2IO:.*+VC\I7K1*_M M*S?*<:@J*&*.*P3N;I;+^.L'(?*<5C# MA/NZZ3FUMZHZJH#\@?@-557^4.HE+5<2W5N0RU*W8`5OQM7=" M'9:TJ3VY#!5M>,#29@^<4,IG6"-R&:HWBO(9[H?/<"MASK71<_;`JE(^P\/P M&:I8PXHQVB7\]O^8Z9J>K=R&]9&8+15,7R=RZ:HCR@$;\K7W0^D'U7]I#\BE M0@T/5]KL@1]J"Q7&%+GJ<:>DW(;*;5@95FYOI*;73<_9`ZM*)7`=AMM0A1I6 MCM5^90'\.%5.P_K(RY9JB5(G>0[K M(VWVP!6U!?M=D:L>UTK*Z&#M<,[[V7JC602G3>T"N;5]1**=A?:3-'GBA MMG`AJLA57]U&.0V5T["&2:]UTW/VP*I2H1B'X314X8858[1;QWLP)W[`E-.P M3O)2'6^U(M>V;^/K+G4.R8S?`R_4(<4U[P&YMMU]23D-ZR-M:N^%VHKIKLA5 M7]U&.0V5T["&(?IUTW/VP*I2A0T/PVFH(@TKQVHG<1@%CKG*R/W6#S]I_SB_ MN;LX/?G://EZ\>LEC,V^1TWD01STO?YA%K?*)5D3:;S)Y;$Z/-^<7*K7RN$Z M"6KOX^+X&!BZL85#HC921Y&MZF=[W03!@;N?%+EJ;[,K;Z'R%M;_+*N-"E)[ MPV=OR58'1YZ*_JO8Z7/I!\_F5'GQE'14@86U))<*+%1>O-JR[][J8HILM3[; MZR8(:N\6VJS?'J?Y;51@6IO>&SMV2K@Q=/A>-5[ORY>V3: M)8L>6>":GATJAYX2E"HLKY;D4F%YRJ%76_;=6[5,D:W69WO=!,$>>(A4Y;]: MD4M5_E,./>70JZT*4GO#9V_)5@>'WDQ8G@#L^N3L[.+RU^;GJ[N[JV\?-6/R M_:C*A_4J8.^E&_#VF=G,JXSW;PTVJH+U(.;\?'5S=GZ30'WOFM:?"+L6^JYC MS^6H/1/,J_4G68/B51#6BN)K&P,;R]R:B]Q5#(5Z'ZM;V1T'ZBM3Y4P[43:S4N/J;MX=(^85@ MU\%#71)R.F=IG7KH*TN!71_G?(A[W[77BE[U(],--]^-BY"8EV)O4=%^ M52DFL>CYP=ATU\'CN]516'HF`!XUVX_O75;C0V%3INQV5DJN7D,<5>B`4&PP M-S6QM4I1\(VE>W6%^_IB:0MVUO*27:\P#]90LE?1:[OIEN[KVW",'91DWT%O)7L$>2DJR'[)DKZ*S>^,MW6]O(URE)CX$Q0?5$.T5O`>IF6B?)OT8F;!7RM;X:K3\(PXC9S3= M!@[N"`>7@(.;!`?_WYS_+21H71>[RI!+I33D^49T,VMHO!YR0XOR]50:&OQ; MX]D5VCU[,#W-G[#`C!S?"P$&[99-(C:^9X%FM%I#_OJC:6LFJ#7C>X#0UB*\ MY`(^AC68+BS0'VGO6L>Z-G9<%X;11GY`T\*XCF]KS+/AHW3<=JM!8Q^O2]\B M-1.\W@?:CV\QEN`4BWD1"]*;7-R7GF9]+%7VR\%++S^69EGFT1^+I;XQ:LJ\?U")IK&=-CNX> M$OSN,6!,&\,\CZMR%&_O(<4O8:BM$;Q*RMN*0GOG.;_[)RZ' M;^R@>?.]8[3T+33_KK^4/`!"M[;0,:[^A'X+OV!-=W']Q?6>$G<;.[=:>LTZ M176KJ.F4^4N[%;P76PD=I[Y'V\R,F*U-`M^.+>&\V8`-RS#U%I$-KXFH52ZW M:GMIM1)&.MUM--*J@I:A^/<0^;=K;*,0[IM(X' MVT;,6V@.BE7>G%6ZPY6B\VJFP2_;W%;I[SO1W]%RWE1YKPH''HP>TC_>$Z^L MXJ0=LP,EK\,'.N5S5A"J<-RLU+5F#XE70'A2CUI]1VRNILO5F MU%U1O'*J5?_5:CM62%%61"]F..U]#=<->Y+4)(EO[:RS*FK:FT;RY)3O0E[, MYMR^-&HK>&VM$HTKE6#Z^C7@*J1IJ7VD]E']*F[5)M3DL%CR+33I*E<+JDU8 MBV++JK'E&U0WJ9+1MU9EAFTFLU?CDF*9J@FZSR!866& M(8O"A@:6M/4H+C<8QK%/6!!-J40!^U?L3,8,9L#?+##+HB"VL*H!%C6`5Q\" M%H9):8)3?SPQ/?ZI$X5:&-^'CNV8@<-@'GC5@0G@0WQWY+NN_XR7*98?>Q&^ MHBV)HKM_?@4<.6`6.A:M\#V,*3FA2G_K"F5OGEV5JS2R[JZJV9I5TN^!)/V>,4OPMGXXO+U\MN3Z*8G; M.F_6TO>5:\F/RR MKR?%J>F9]B;'1-WV_SYP^Q;"RJM(KPJ#IEA)*=E%Y/W5!(-S/W?BWK+[%K([ MJDBO"H.VMZRD5,XU47?#)O&]ZUA80OIO?L"4]EDOQM^3^H,U`FUO66GI.`&E M?#T[T;]Y??_]W(][R_2K9.G5B%X5!FUO66GI/#JE@Q:Z"YC.LS+>:\;M MRNVI6$FY/7\I*'"$#0S=^4AKH>BC\ MS7,P??AOCO=@^^/]W)A[ROU*D"I6JK(F.B>C:NGJ:'LD7F\C,]I&489#JC94 M_UVE#U^[[$R%:%Y3L!6KTI#&"G5]7Z/44(WD_\8=9;%2SRL7Z*E^K'F-$^8K MN=LW3Y??1C7$/:S1H[:2VDHK;J7^6F?I_`H.,IG^YQ_CL/E@FI./M^P!ZPW< ML(D?1([W<.:$ENN'<<#NV/?H,V+MTW_^AZ;]_%_-YIEOQ52;F(Z- M)1`L!WY*B??:$*Z'?5)+M!#G?03&9T'X/U38(II6',.M'6+X?#1B5H01I%8< M!,RSIAK[;CV:'J*=MA#]'&H^\FOXR`N$X`\X#XA(!+&(7S[HU>A\\:EI##J;+_R4KQ'$3\#"*'`LW%BX ML.)B+CPK8,!=9XS_]P)82WZ`@Z].N*;>&^1)]](#-<#F@LD++-C MXA$'#(:[E,VPS95\XUR\L!J0!DAHH]\9YIEC9M`W!\LX^M0V>OUNMO0#Y]_,;FA& MO]$;]AO=7O+4"<,8RV[!@6'T&IUAJ]'I]>1#/X[""!XA*P$Z4!GE;\(P@WYC M,##F##-H-?J#P=QA0*$MH)2OZQ:7M8Y2`@1OY_!8'$\A\$5F7!:!@ME=/$W" M!BHBHO\,UTTBC8PDWYN!D'_X%;^[N@=;D33`\-+WY(Z@W67`81J/F9+(RL8EV$.K58KT9Y!9R,E5,_C$)2T6FH:W/*M7EIW98> M3*_J17A%+W%9T<++J[MSK?M1N[V[.OU;\_/)[?F9=GKU[?K\\O;D[N+J!C M,+E'TTGT,9F\">+^'&`)A?6C+1RIX;/BT5B)P!\@:8' M^)T(#"\M8L%8\WSX*X/G6(+2A->9ITV9*9>0AS1=R!.HYAJL'+YZ]C6J7QDP M)K^\S:`"L`4O/'M`H!_PQ;$?$"R9@I=)M%;_I_P)PF>'L3CD#-T[6.DKH5$" MF8DE-D$TLL!R0JS""28Z+B@")$UAD9%VST""AB%?I4[`C.:C4,!Z;&A@9?H!')CD^,)1-3J8\.^"L:YACVOO\3,YA]'ZB=[$)\G? M])\^2$D`B@\+GE#IPDJNJ!^9,!K"4V!28(V,G?%H)5E15WF0^T; M8PC]L79"U,F5_R3MNI$.10`A%ML&4!:5Z3S;/)F.2T5P$?=`2^'@7^>#DN M02H!24Q03&VZ7X$=FZ$8@K:]LSI1_ MEGY.[6HT8D&>63+2[EB[\K2_QG#XZ[TL"R?:%`@@!G*/B]Q=KN.:SS5W)2"_ M6,!@TR>"5WN?-B?U1R-0'H(0Q+N='B=Y0:P]PP`:[4F4WR[ZO/$'"0$L$I2* MS#)1/@FU`J0TFV;`*>QVY)X1@_%SNHWF^OBGO(+#95IQV9H4VH#^D_@A!D5- M;W."*8UC>>-@Y+B`0U*5D6JW#*P%)\(RZ\@+"=+1^P#G'?+Z*[+V[?GI?&[& M:>\8G9ZT@WE0*4D>@.K6>F1V#(QZ=P6_K@[34*:BU$-5Z!61 MD:YH+E*XZH0P<)3`YDQ(5J1L!D&P@//OC\X]2.;WYH?W^H?W)Q_>;%TSD,X7 MQ>ONX\T\'7AWZHRF91Q1^ZU_'0>HMB>'=5&J-NA(?P!3[D&8>_U!IS%LMT#Z M.P\.G@127M/9$-&&%'Y2T[)0_RLJFJB;)D>&;`+!]3L8OSA?I]-J=+L#T.5! MX[/$_N93*KG^@C+HNO+T+<$>MR>(:M+-D#DZA703-OV,CP&&?6<<=WI$Y]P8 MJ3V3*'X-+94DQ]JY2;9C$1[RK>`I@TJK2TPB]GZW#=J"XX'EY+KD]004F13F M0\XK="JD:BKG(_)-<)=$*#T2`#*L1[AJZ-85!\,8C[P&2E=C:#J"TL.[MHNA M$YY%(PJ,,'0:@T5BF7'(4I=*SI=2AO;$!/L.`T0,ELK^A7JZV(&S@X3DK^/; M*J4=F\K1;:X0H67TX"/$-@NMP.'K$6/,:$M.J.&LSLCAQB(ZT=`3$+!HBOLU M8""54:^5<.7.BWF'C)+0KZJ<@5KN!W8XWU&;@_@DCD?LZ08^/'I%7;,SCF6/?)RY@(10ZO2X)\1P, M#61.[E.10I[;%V+SS>/=58%J#D&R]]?;[1D,?=EYAO2_# M-'^YW;+UWLW(G(+S6WQNK\@(6H!KL+GX?*)^*#"7;NJTI5O/FB]*L"V9N*; MQ.X@V^6H^_K1^V_>\NWD.*7Z9GSN8$W_D6SZ5G MU@#>O1:7@WWO";>=YG_UEY('0.CE.^'M.:'WD;AJ%U/)@?TD[C9V[L[/XO5+ M8%9E!4N6E>M5L-/TZA4NM(?`#\-2;\L&S%B&K[JC:^N=%-]"BKUNX21C"ZU` MJW`:*?8]3/9=I93*4C@QZHZ3K7/)6^CAKXJ1KKY)!P[%):\E2]8I(?:J2.FT M^_NKOB];-6Y1.<&=KVT+Q4[W1.F/S._:/?/8"(/>P]"W'(K+H"C,#4V!>C/& M5NI,UE\S6L7+M`;!JZ#S*SZM/Y\:JZAF]>;3K1"\]LIX;Q452Q%\+_3JX2O3 M?.=2?>-2_8O*N>Y\=5NH,+TG2K?'HE=2KI?&9-T1N;,*N+57E71]"ST.%@F: M"AV=:GNH[;&RQ;M*DZ8U^.R`//(J M;5XL59G_C7*NJSI6A=-(%]=CDFEA:"A9$=7FX[FFY=EA#J\`-XJC.,CFBJV= MM+46$6J3@85F-4SQ7`R&KDP83BIC*@7FAGDZ1CX$O6QI^Q/4NG26UOXLF5$A MO0-9[!FSA.#6&P>RY*T%X>^14#,Z6:$VV$-!]D\LY\*WMK8TTR^1[K=Q(L2^ MIS/I6^B>72'?I"+T7$(;FQ-ZY^:H(O02A%[Z)F+]7*)M72-6K5%Y-F_XN"U,-*K.T;:_4T2C!0#*P;>M00> M;)+[I'2(&C!PY$_VE7O[2WL.7B/I:6\MD`6I0]NT2.H8R5M[L+<2=+X'ED?O M=1FU"CJ=8M3ZGW"=50H&*3Y5?+JK/+U7SB>M$,%K"O:R?+K'YL+29_[KY&OM MK;V0Y#Z]@750Z5#5;81SUUZUWEDX=_VMDN$6K)(]S.!2&V0[&Z3V!WC;4!M$ M;1"U01:XM;90+T6I6%4G\VMND'VV_Y:^K'\QY^SG'^.P^6":DX]G3FBY?A@' M[&ITFC%Y;G@GO%,_C$+JA/X9N^9=FU/J)'G'OD>?$6&?_O,_-.WG_VHV/YNN MB5T/S2@7?:Q1GZTF]3W&[L+4MNLJCL+(Y*'*3=YG/5SPRO]JF<%+FH@M,?J" M=]9ZTN3KEDCDDUR$84R-/)WHAHU^.8I;+?U(LYF%#2_#7XZ:;8R<]"+`'3VW M6O"_SM$GH]<9Z/!C2I3L>`K#FV%8[Q&&AZV-,7P7,!,VRE3CS>>:O#]<.//@ M96S.&6GFR8N_;X\/!T>?=*/55TA:@"2CM2R2+K&2CAD^:G'(V\2.'`\62UU# MKE)\N6ICZU)8_C;U80%)F^" MF%U*Z\5=`4MI#@;#W%(V`Z`^BV_AXG6CUWV-U:-$<\*0-XOUX\`>=. MS"D>QG+I8P#J(S54AJ,5]A+]]\++#'#B`0#R\VO^]1IT;O>&G&?7F[&B2T,J M&MU6=QLK0Y8-37>6+6_QCS?LB7DQ^]7W[?"2_,0K@&GH1Y^ZG4&OEY<:)>.^ M"33&T:>^;@R[E8`&N5/OM_5VOQ+@$$?IPUZGM3PX7WU05JA/NHV=O['7.-8N M-L.013,@GHE7[LSO)_0"C'3I>Q8U*E\5=]VC3[UA.P?IXO%W#W.K#3!WC75@ MOHH>03TH!Y&>B8\WP*:A]_*@E8[[5A`AKD"\M5>`",ZE,`IBBZZLX-R=8!]L M%LY`EWWOPKL6;_TJ+2A$"T;?':2(S;:^.J!P9/AC1MLC`&W7> MNM3]J%Y>G5]_.M;N3_SN_7>BA4=5TOHB>Z-2*/N,R M?:%/?*[83N:SS'6]F6L9X(\TD1O/%S90/79C6S:D'SO?<0Z'[XU[%CTSYA'0?\2!$]H.R:&0+Y5#(NL%8=M[ M'H=@8KD@M)K#V:X(+(A,^*#D2&^0MIX?%Z!D`6KN`7?TX:)C3P[BI,)EXH<. M07:L2>IY:9_CN23+E4?*T>E=*R5%EFCI^,0=!//+,[6&)G`0)]A+`Y1!<`*7S5`G@YEL[1Z= MK9K/R2^9SI:\-G>88R5^%HJ?.\3F+%.,5N%KI!1L0H:?F)[V_&A&VK,?N[;V M:#[AQF:>*`>&SH\1+_C%;)`.+JS$C.+(#Z:"Z`RK@$TFKL/W7R(;`"`"C\&F MNP``<)?:L25%R7PVXB('1J/WN6O$CAD.KH3;8N'V`F]$F3I1BYGCT7EX?"/N M*-(6%O+XY*-,D2?3!1*,]\*\8E:5_@)0"0:MU\ M@3\FZJ7-G(_R+?X2OD.OE&J5N-R??USP53+WB67YL1?-N+@R"R@XG>07ZSOL M>JV")?KB)+L"%UTF>J_=6A-:M47@Y^S!N:/O&F`TPK8!\`3V#0K<&;;(#'5M!E?!;81R\Q_XZC4+ M:/092-XHXK'_B-`3../K6+/HPJ`$9^Y@K"1=)S4!3U+T#VE86@Q>6N.!MXB6KY M8=30](;1ZC=:PXX43J`3Y*R3XDKD92DQ.''U&C[`3G^8Q^_LJ%6%'[?\2O#? M,-0B08"#J@`6P\.,BTN^<"Z>P^$7CV-21,_`T+6<-7S3>G_0R^^LEV?9'<3< M=]WOM->'.(P"AY1DO$F>A5<^QAO;$X_^<_ZOV(%#`L.33J)3,PBF,,FZ#&T4 M=N6*,U9B(<39QF"PE87<_N7DYOPO5U_/SF]N_T<[__MO%W?_G+F!P\WRZ+M@ MSH0X9#2]]".V)4?OFS8UV8IKN/=1RV`M8X[="OS5P%NS7;2NA,/BD#E(T8N4 MO)7@\,K+&.5ZK[12.QVO&+L`=C-8Z!?>$^P(,BY/'L#$IY_>XQ>28$9K`Z:Y M^^=76+$3`;XL@K=LOCP?R&GUGSYPY\=9'%F/>&A>329^$*$,F&I?8L]N:!<7 M#>WK-1R?VAESS6=4=UUG[*"X`9TY\F`C/CJ3UU^/'\Q=P[%V'0=A;,)L@'$$ MI`P%C98$I8!HL1WA;8HG M^.H[X`&0,?@/>BWF.6>MG,GA/^'EKC9A@>/;^%F[)[T_H\`?<\>-$X""&`4F M.49L!Y0.>6%],>39>'UR\9`FA."&M"=X18 MK=R_2&*!BNSC!!FP+5@P'PU.J'4E,RAO^GYD'G!*>K,1\FNY2>!P;[5F6M@M@^)`2=:1JQ7>+>YEN7O* MB,IY:VQ^=\;Q6#/'Z&E"]VN48QP'W;:1$[E2J!3V"_`.P@-O^K`F6JOM/WN: MYT<.0.?PRT*8TXPXX[YW/J!!\H,$S02)83XPNAP`L6";CCO5GGPW'K-EQ0[) MDO3BY_+D]NSD[]JOKG]ONMHW,_@3#$SID&YG!0^(!Y!3@5R1C=B%.6WF@O0! M*TN"B-YDB_9-<8$-#53QR.'>9K&IY(K$UZC%X7PPE24N"<+8>LS#`7]\[P!F MWG7%)B/B2.'%O\4][[K:/?P`"P(Z#7L)%LNP]\PPK0+OOP1`?)3W__C]Y/K# MTKC-.+Z[R%DALV+NZ\\(<"'O[T$:>VBD2%*L@=%C[;-PU6=PAQ?3>`/``LM! M60YLF-=/WL/'.:[\H#W*BVK$`I(8=PK-AE@$A.-WJ!G@B2+@@G%_PJ@:"F6= MW0RXG7&B=*3\$";?'_*S9(<@**8+>\">YL]HO'$!8%"G@B^<@.L?4Z(^7F,$ M!%+AM!9W&S`EL4YRC_!8LO^(`,E-C\`F_9'DAKC`Y1L`H,;9'0N,2SP>04*< M<>)S?B41E44'YT=$"/!D5DH(?+7TR6"^R:&+:"W[:;^_H]D3]["%@LH9%H[_RZNYTXLBK70A^T./R?&=)M6 M@LF,Y$8T3G!VR6_SSJ+8<\F]1%SGA+39DDN].:K7>VS$%`=$8/9]XG)?R3T# M4?2!5$W2!?-*&?[&4;BV%K&9Y?5''$;.:%K(/3Q4P^]NGKXGZ2I$83@K"J5, M2?8MRBIF@IS(;EH+T`T`@N!W@%O'G@/;C_-18@UP"0$2OX$Z",KZB-\#HZ^K M01(6Q%;(Z(QT'?/>X1`YC8-6`-D4F*@D_O`\((G$N\X%)P,H7:'WA M2YH2SGR3W00W>*2$63.!-OHHLP,:=,+,@@3F9@C[#D#S8SR7`#8A^IL<,C-P M^)$7TS(J[V+3#7WR&8)H#C-[,6`35#S@[ZG]_VP&`1C##C_<:-M(G0AU`@JI M$5L]!!%.1R4J-//Y)_(?&+%I8J%PKG4\XD;B)P#.8N36S@F7&6DSB>]!7X13 M>^2X_'(#U@!Z%X<].9/"=*[;\U/%G!5@SJ(7BUNII"LO%JDV12#-^B5S^N[< MT^@5_38+P9[KR9G1S7S@Z`<9985L308T@#Y&XZ=8LFX8)ZPSUA#$B]EFLP@PJ-=SN]!(67Q[5)='C^/"#2L#9!@^6F5`)MYP+M M@DXMC_$DG&0_PHD*!Z69=2:4G\E"4BV4(GEA,3&=HJX-QK0([*AP MYP$D[_3N8J]M)F-OV8O(Y'KSKA"/(++6%\4:B+H'J\:=40+YL#,GU(`/^L9@ M\8OB%<"Z#F0<;CX0CHN`(GC)VYFA7DJ_GX.\S$7V_%%W"R:%D*T$)H8-H658 MDA+/@X"^KISNAB%B3=WHY^_^@B\CP-GY^7W8=O?P$+OZQ.`O>) M9_('OSF>'X"$EG%O/$\_,PH7X-_`!//M]"1:9T.TC4XQ"O#-P-TC5.+F[O?Z M;87*35$IJK!T>PJ5FZ*2A*[1:;6(Y[\#P=D9WNNM'E?>;0\*8!<' MW1%TB-.!43SQY@+'ZUFDN5\8CUU>V`*+`L*N$+'I5\D7*Y_(@Z&>!V_1\#L# M%,X[71]T2FJ#5`Q22FSK&.A\]Q_WE*`*Y4HK0'WH9G=7!YMT@RJOZ\,([JR-PT!VT\F<$'^G5)N7K-]HM8]&LLO*2 M%O#:5B\?]O(+40QK=>G4?RFMM3##KF`E^?2B,C4?V$G`,'V=LMJ!]\TQAE;] MF_XP6U\K?1E^=AG^`"QZDOEFC?S`?K]89NOE:2JS`(-.AVYM%X"L/N@54LKJ MM`#D_V&[VU]_`5RD9<-E.2JW MC#D2?>EUI"7_9`CFFAEIFQ38Z_;:JV75+:Q=N*.%("7Z>"NZX4*N\;[+L65K M* M/X[5(<'.+RH$Z7AO``1'AU$H9%X*Q!?3";1_E!5,P"?TX!O=[M$E[84WB:/P M8-,TAQ^U+R<7-]H_3K[^=JY2@A;7[TL82\LP$!<)*0-I=_[$L63TP)>3V\_: MR>TIUB`"4\L)'U&&:",&(LUQ"EZ]!XK.I$E M..9Y,+89F0V>860^F8Z+SW@M*$J%@3/QWV((A_@;XU'26E,1LQX]YU\QWI2' M/'1IS!>4!4S$(*19?989L0?:W!\KQRF<+ZH:D%(^I!SA=CJ&/=S0@,C.*!N? M,VC_5!*)1F$[*__T%^Q'=,%OVA@=Q.QL=I-CHY,`"TXY M5"F6\SHE/U`D&.?$]3,`%"OLEA6,,E;(9K;(QNEET$%Q'?+F*BV$O9*%L>$$R!>#P1 ME2<1,G^2)I2*0,#J,5FUM"S*F`T<2G'PJ>(![M`%J7I.&J"9=EBAE&5?FXAB MF#BB9SD3$$K``:Y(F';^C42;.LRU>4PV9NMD*.]BPA/Y.ZD2<@BFS=,Y/R,VU&%3FY%.6,*J2K^%8(69,B MRTT;DX03[8]#)J?%#%\'/2$(3,BH+">\[8+2Y]@9^`E)]XQWK&&IR4ZCA2SW M)DYKN<#B@!U1FA0VE-0K!(%*%=M[9IFHRE*N%PY#+V0*_98N55AGQ M!9D/MJ#KG/66PU;6BJH2TDJ--6;]I-,VRU&]KP>GG1@R(_;G3=H1OF*SI2R]I3DE%NX M5_*=/>>T:.U6IT5K:=-18_)="WW7L>> M(C80NW,8Q#8V)W:%FB^O2VSC,(C=WLK.3C'5KCWA]7TG/%UT[\<>S[4"KPI< MF9;<4:#=/P`S^<$O1_]M68R-1D<+,+LM_5$?S#!AD__M];T<98C[1CX!4=7L M"_D$LBZL+PX6_HBF#>VWQ5VU:J-H+$-8O7IVP4K8>+]HA5?%S@X]8;Z\#UX>EV M37BZ_\84K!5_]_:)O;>D=.Q<6,\QFYX?G8@=HM%T,??&-&L[/<$S/PZU>]/[ M,VQH?_,#9NZG!EH5/EW?P[2G.F.G,>SMJ=4S:^@HGJL$S^V]G5(A=7.KG*@YH#(O;(%MG04[UP@[OX*Q>A7RQK(U@W83UWKT.](%@FU#@@U MVX_O778P&I[>:@R'@\-A]4.Z3%&L?EC&S*%?NFR7WY4)52<32EW.O-(^V"O# M;5O:SLZEO[K%*:1*4'I6*-(FJ:'>XGH"M55JJ\*!"T"K@A^_?A2M,-:J3-$* M;X0JZDDO:+=5@[/"**R:MWX.F'/TMZJ!N?-MO'M?>-5T*JRXQ^LR%Q+Y]U.Q M.G3'^(%X`7N-=J=[.!Q\2/[N`^%@Y<=6?*S\TS4S&I1_>D7^WBN_\Y:4CIT+ M:^5V+A1WF%<[?3\5S*JPH8K3G@E(['6W4V)DYX2ML'=<\=Q!F2$5TB95;L#! M&@X5O6U0N0&O>Q3O7"!6\SYDN./4@/W4L0[]ZD,%2JN<`,7JA\CJ>V_$'/I= MBLH).%S32=VYO-(^V"N#;1]S`GZD=@W%I:0]+E=J6IDTP3SW(FRSBXW??4^C MWK@-[18[]X;:%7P;F1[V=)`=,FWF?.2?\"_H`_YZYNUAUAJU.K_?SC\M-4`3_B^.R0#OE?0>GL\#2<_FXM&'G"=C`\(Z)ESWT=A:4 MW.=I_U`_8,`THK^K-=6BP/1"5_20:FHP9#R.71I2=(+UQY.`/3(OQ&XU0)(P M_Q:U;:7N+NE;%QY\-=.AE-[,O'\=^$]."&3\ MH-TSCXVI$[(`;N:;>5+O*WPFY=CJ+E/7]?96EI?&R=ALQ`+J)0<09=K-%1=W)MZ#4;ZF;UWZ MGK5.XWNDE=XO'(0O35$9Z*E/_=!HKP<]UV'DQ`N`S@QSNBZ2V^U.)P_G[*AO M#QDBL&/T^L-E(/O/__CYQ^_W@0N__/]02P,$%`````@`TEMD/;A?<14Y#0`` M.+T``!4`'`!M=&5X+3(P,3`P.3,P7V-A;"YX;6Q55`D``YO1TDR;T=),=7@+ M``$$)0X```0Y`0``[5U9<^.X$7Y/5?Z#HGW6R)[9W<13XVSYFBE7>48NVY/= MMRV:A"QD24(!05O.KP]`D1()XI1("^#FQ0?9W>CC(X[&]>F751*/G@'.($I/ MQ\?OCL8CD(8H@NG3Z?C[_>3L_N+Z>OS+/__ZET]_FTQ&7T`*<$!`-'I\'7W. M_PU)EH]^^S5(H]'YT?'[GT>3"2.-8?K'1_;C,WKU\>(?PT_3]T='Q]+>O-_?A`B3!!*89"=(0C$>4_F-6/+Q!84`*_6KL MJT<<5P(^3#=E22G8?Y.*;,(>38[?3SX!S$K]'X!`,EHT84L\KH$I^,,)LL85,\6 M&,Q/Q\P]D\H1S&\_R(5-]]?NGM"?"4A)-IM?!-GB]M92++1C;6=+]I%0 MQ':J;DUJ7=\`AY7*Y9]UK3Y/10$1 M81_43X7V3;EU1<,@#O.XL."&_M\H$JP(2",0584R%7=#<5%@562,PD8Q,:M) M$!::1H(52E$"0;:V,,^F>39Y"H(E,_1D"F*R><+,/9D<'9?UQP_EX]_/LJSV M)<7!(XA/Q\V'!!)F6OEPZH"Z%SG&%&%"K;EW#>6K=TT;:E$^PTUS*/0J024* M%35BA=,L3Y)"V@32+Z'BGV.4M#R+U%K7-/LX6A.."!IQ+'E&2=&2407Q>(1P M!'#9,+X`^+0@ZW\.&SA6G/#U!A0RA&#X>]N@>$6HR7` MY/4V#E)".Z&L`[ID::AV]6U"6GI-27IH/-2!8&&3)*F@EN!%GYVEV`C.0Z;E M=4H->L(@R[Y@E/$)+@/**I^@H'0)`.862>*O%.!%![W6D'U#::AK\MLT[5:_ M1N-2L$VLD(19PNI%AT[42DDC;4:L:/8=C;V571(0Z&1XT?W3Y9VDR+!G-$P$ M.HJ8G>V5H,=&GIMC^QL8/,(8$BJ$JG]/4/C'`L54TXR905XYP)B2EV[3DCMC MO-Q.N4D'A+9Q')#*E@:J=2(9WANBO)@MJ6DL'A#+"=H!/_SP5Q1+9&"$+-)< M4'V;2%U"$L0W(,C`[#&&3^L%%N(XFQ%OIDZ5Q$[$7SAQ:F&C#!*-:5.U/"]0 M4LVWW`:O+.>NGK@2$W%35AR1JV@PLLD`!3(Y7B1"J/(X!Y&V&=#2;3$@H7,8 M!D:6F2%!)JJ_M$A[C1U[\OL%2A*8L96OK+MRG894#?@,*I2VLEQ&U)M,EYK: MU5#;66G2`.@$>C%_6J$0WW)CVFK?B+:=&?.H M^K>QT``6&G%>I,LJ&^[`,TAS296@)N(@P1&YC@6E318@X.5X,3TJ1K!)\EQ) MKJPDG$B'2G('E@:J,@EZ45[T%XJ)(1-LZ`GK\VB>X,'8*!425$*\Z$1(4A]2 M*!C3JS-,+@/#UD05/@QDN9E/:.?%Z:@HSMF6RUN$B_`0@N%C3EC'^0$QBU!* MJ,^I/D_7*0$89#QXNA5:NK\CH4[`4#O'T8L'K:='NM+"B\S:`Z8?;XY?"Z-% M6TWD!-68NDUP.+1UC"!D8'\#7]V47XS4:C,LFAX?4+2X[D%),*2@VZQ3; M%$-"E=X#/<%*6+`7(SZ6Q42I%%.RU[5D<./UD-"DL;TG*+5+%>/H'V[AZ"R* MX%K#VP!&UVG9B>5GDM14U3R2A&I(X#+S1$\8DQ8NAMJ)6U"[`R2`*8BN`IQ2 MP[*S,,P3YB4078(Y#&%[)9\IPV8%GY9A2%BT]D]/L#310[*LXL@MB-8T+[(] MM%)?8K``:0:?P7J[XPW*V'K:V?PA6+7GVW?AWL["6W$/":ZOVM96*0G& M)6N'/DWYP-W0_]_@>!K)$3X'_?"H$[<>Y3XKX;LR],UWA]Y27"GRF7XFU.,$ MICG%U-;'YV".,*AMF_X*4X0+B*YAMUZ04).R1O!70!8H8GMT,U($CO/0`4IN M['9_FY(/5^&)$8@.Z?A&G=?0;[LS_XWT\F+%9&DYJ^$EU8R"HIKQ$E`<#I2' MP!XR<5,#FF^H93%')]+."X`66S%O,9JWAD&"-Z6GZV\.!T05(I!*_090!%)8 M0!O<7@3R/HC9>2C%*I(O"$59>XNZBJ2:Z1*1'"[&HB`B(T,:0:Z)*>:6A.Q> M1/D"9;3;7RA]3P<;K?2K\.TF^]I\ZUQ8U>JK(MKB-)CVDL"&7Y4P.MCW&,*T;,H@2G,"+/C M&91V\#UB,^JJEZRA=@`1K9`C6R/%Z*CD%CUIG3PO^EV78(E!"`M#Z=\Q*`)% M;4I8_Q7,.+38LFQ7/!BR.XF8'<_7@,1/J1Y.RSN47>872Q(W)?.MB0%I? M#2TC=10I%N;I$:(6YL\)4]^HF&;C*FZ#S(CKZ)`3__F2B#;..V@^4:.H%[BN M#&_HWLY*5>14'3G+GPZJ1EYQM+.T<46IZCGM`K;SRQHJ_EQKCLK963F=028S M:`(9=N,I)R;YM]<*.7A'R"W`D'U\(5OA#2[!^C>?X=F!57ECB(3UL)\K.Y67 MJGF+T3.D83]__9X!JN.F&W46TO':>M^JH/9KKYKH0-AVF<4^P@Z88-L%.*AC M[S5S=!8:L8IH7TV\&-7WL?SGC9NB+N""U-;R+=8>19;(\FZ6_/_IGT[1MF^N M:'\0#BBQM+E#XUGVE@,YZ1#P9>&+CI&F+MF+@T&^!##-6`\`9+.T6)`S MF]=.D>=GWLRHJYDW#?40P&?GD8[QIRW3W+$!"Y@V\Z'UF8:.#%QO^V*88WH-IP21'JVBVI?8+4 M^J+5/G!J=5>K8P<'B*Q9C_#;EYP8T2I@N:4=*AAEWG@#"-:*[O$\`,EB\EL, ME@&LUB:QU=#K)4OKL_F$HUT;ENU137J6(4!K!]]TGGPQT.Y0Y_#45;S&.,;C4 MHL]!C.8*C&/'IDN$AG"7N9@`4L*BPB3/,EA8JGWS%LAL:2`!IV/S*E);:B,Q MBTI3S:F#JH!ST(C5>NJM@"M21(+?+B9E)$.?MGIV-TWMS+_=>>OFU5-]0G&/ MBZOZ`.2.UUX=.S:KTS:,N[A%"UT)O;0*Y>F'B5:U5WI'9ZMX"1H=F^"1N&*] ME:2C%=N6PM0KMDV%#6;%]F[>ZV/%MK$F7BQVI,U&L;OD`9V%U"D84'.I#>3U M-@[28@\H?;I,VI?*V#-6F55S1N>J:%L4HCW\9%)7&^I39%DM]#!80N[`61/4 M@!"`J-@`R-9,S>;T290S3P#)-(`IPW;%I8YA$!"U]4O7T#0HWXO*M-T?NJ,^ MP#`DH&AVM'U:,;FT2\N1#P&+EC[I&(GZT@W6G[M0-?*5O?S,81-26GNNY33=2R(M5[A+??(9ID(8=Y0HLA:ES!:;"!I,KV,U[?>0*C#7Q8EO; MU2H$6?80K,K5V\6W+=Q:(+";`WXGLLK([2?+N>K?%KZH6V^:-`2&*K(O8T_5 MO-C-WFCLV+TULT+A[&H%<`@SP!\KK:`$\E5YQR^=N#<7.1G MSCD$/.[NJ8YQ:J6()^F%TJ#/"%/K._/AG!]9JN&/#ZM^@?@_/ M[#6$MRO7ZDP0Z>F1Y0OVXY&J09_\#U!+`P04````"`#26V0]DCPFLUP&``"] M00``%0`<`&UT97@M,C`Q,#`Y,S!?9&5F+GAM;%54"0`#F]'23)O1TDQU>`L` M`00E#@``!#D!``#E7%MSFS@4?M^9_0^L^TRPD[9;9YKMN+FTGDF33ISN]JTC MP[&M5DA>223._OJ5N#B`!<8Q!';[X@`Z.K?O.^(@S>3MNY5/K#O@`C-ZTAL< M]'L64)=YF,Y/>E\F]FAR.A[WWOWQZR]O?[-MZP-0X$B"9TT?K(O@.Y8BL+[^ MA:AGO>\/#E];MJU%":8_CO7/%`FPE`DJCE<"G_064BZ/'>?^_O[@_NB`\;ES MV.\/G*^?+B?N`GQD8RHDHB[T+"5_+,*'E\Q%,O0O-7TUY211<.2L;15*Z#L[ M$;/U(WMP:!\-#E;"Z\4N^A)6:R,^HE1%ZBX.7.8K'8-^?WC43T2UI@K^).)Z M%)?(I\*.Y#?TQ^D:#(=#)QQ-1)?]M5Q:YZOPSI,]A8=E18AP1N`&9I;^^^5F M7!"J'G5.&16,8$]C/9'JUP3!>*P8,13C#G_.\#R842]4^8OU5.@`M_! M6+''UW&$%N7#$DYZ`OM+LGZVX#`[Z>E0&(2<(UMUZ%`6EM-3BEKG6S%!`9(TN;NJNUV'F M(TR;\3=278>[H2;;!W\*O$Y?,WIK<'2A?.)N,`5[G88:W35I3SNM"((IUNOP MI;K-V(65!.J!EUC6WC:YN(1>)7X1YF:<(?IMP;@Q"Q*M&&4^!A$E(Q!.(.PY M0DN=DZ$#1*Z?Z,P,[?X@?D>\B!]_6SNLT@!C=2D24P1-@9STB@4DECHQ!@&G M&R'=HNDC?_+A9`;SH42#V3`>&3/BV8`4HQ-%,;EW6IMGG/FE>69;W'[T[-C: M5&-)9N6G,ZY8&3=(R_ZQRZAZ?\ES$LJHRH.YON@*CE'UZ-)A5-V*T0H7LK1, M-H^R4;9)T$N6O!P)LC"SW0(T\B'4F.&"65.*&NW"GW/O+//RC6$OE8FS899I M$N:BCB&'<2F2K%IP1JA-BC7R!0K_^XA_.^P2YMFVM@[0-^*K`_8EQXRK`87\ MF@.'K7-`N>DS.I',_?$IT\+&^!>.QYG9'&\4=5.S'2%>7KUL>R1IC(W*-+8& M)8%0D]E23T2D0]4]\CP<.?4986],3]$22T2,*%>2C?-4+MM5]'>)L!(3MB@T MLZ+]>K\!J0(`[QQQBNE<&.E0+A1GJ4"HJP2H%%,EY(LTF2$_:AWRD>L&?D#T MY_*U7``W?!.;%X5=YR4+1.5Y7>7*4R.OMG!45VYFU,O6&77+`8F`/Q2W#242 M<:Y,$EWEP_9H*B%O5&/&^%7K&(=.9K;3%#=)H(]V/C,>HB(EQ]-`Z@_=6W;% MJ-[64+E6_LS'5`('(7.TJ%?I>G^A%J4MD6_;/E0#":NR?U6/V:YV0>%>L1@+ M$3QN.R<4-0PE1$L/=9,NQUJ=Q4NOE$9G@5< M+[G`,?/^1"2`<.PZ]%FATM[<9 M2O1*V(-T%124LZY,06NT>RJQBEE9/4]96N[H20EK2SWH[A[G]G=!&-@TO_S? M@&IK!98P`7Z'78B2<`,NFT?9#9/XA"ZA#G,[M`][F>ODNOW,2:ZGX=C/(7-Y MO6Z]O$ZCC2I\!U$W=3T;:[\1&7F1M]>SB_'5RS?Y,Z,=IR5'256G=9*V3PQZ M._VJ*S;3Z/?6:72&[[`'U!.IT[,<9?)Z455KFF_#!7S+#UBBDZ M^[E@'/"HNE!9]S`!G$/W-E=!S MFXT)\&QF6RJRILN(M89/<*I*MGAT7!?J'*<8+_`>\C(SJ9'Q2U+ID0UW0" M;L`5#"!&'`LUE-YX2_)0L5CK,K.E8O M.KG\*W]^Z'^J$#W7/_J80CWY%U!+`P04````"`#26V0]FZJ0LF@Z``"X^@(` M%0`<`&UT97@M,C`Q,#`Y,S!?;&%B+GAM;%54"0`#F]'23)O1TDQU>`L``00E M#@``!#D!``#M?6USW#:R[N=[J^Y_P/5-U295DBU;OHF=VO#46"_)U)$U6DE. M3BIU*D7-8"3N4L0LR9&M_/H#@.20!/%*@`2EY,-N++*[@4$_W0"!1O??_^/+ M?0P>8)I%*/GAQ>N7!R\`3)9H%26W/[SX=+4_NSJ:SU_\1_!__O??_^_^/O@1 M)C`-<[@"-X_@=/O/*,^VX+]^"9,5^'#P^LVW8'^?D,91\J_OR?_=A!D$N(DD M^_Y+%OWPXB[/-]^_>O7Y\^>7GP]?HO3VU9N#@]>O_NOCV=7R#MZ'^U&2Y6&R MA"\`IO\^HP_/T#+,:?\:[%]NTK@2)_#+[M&[L,DP;]T>?=RB>ZQC-<'!^\/#RI2(DFC/Q4Y>1M)Z!L_NZ#O MR"^'Z_7[]^]?T;E9`_;N`/+[+H?A/#ZME="M?\+L=I6L@JI9#A?+>/1[08 MSO]7"7]5=Y&V>H;_U6H0?LEALJJ[081*1JGH?_7;*\EHV9(9$[2@E/LK\O`+ M2M!]!+.7[-C@!MZ_@G&^>T)^U/O]@]?5CRH?_WZ5X]]V#Y-\L3Z-$JRT*(PO M4!81A,YNLCP-EWG5./W5/[PP8^_OZJ' M@QW`6=H&4Y@NJQ^%_ZD8B)+BU1)A2][D^ZTQ6:?HWA`)J(^RFF/_/=#A!#D" M!NV\FH+M78$*#<_S/3`3%#@$+QYK`!20[S3F"95.N!C1K\B8\R5-` M'T\#HUW=='$JTA^+U1T=!Z\"%8^,V5F6P3P3+%#X+\O?RKRTP"F_&3N,=F2* M\CP6`C3IEAVO=IL1PUY,0D/<`TP'ZCP8E MF.6@H@64V*>IF.$!]=)8V["T6&M[FP;X?G]C`K\#Z]@^`&WD9)0MP@6H.B M]\\6EH?/"99OS6%YDJS\@_*M!B@A?O?\X?C6%QQ'7B)?0KQ.CY8Y7/59+/?D M+L?4E-O";'MVU,%:QKQEL1&;R@IJ!FK./JVU+U20I0K;]FLHI+;DZ6+5;.4M M_O#S"%2R$&]`]8E\&8Z-:-'*W0^FQ]Y&7"[1%O?I$BXA[M]-#,]A?K1-4]Q1 M=E-1@[3:8I21VFPX:G3!@)/"Z9ZFC5F2B`68_ M4\+1V-WT@!BG>RN#`(^1YLD3W\#K\`AM]8[`M MI2E'@T]C84K21NV\KDBTV&KX'$'Q&-#G#5_K$_!R72&MT6T#G$M:(WL)7B;VP$=/'U M-'0G=A]FVAO962SR.Y@6X0[\+U$Q0?D[.006CC;*.W2U5@=6L%.O8ZUGHD'NDCA)HQ6`'[9P"3#JUOR:8>H^I?E MZ(24Y^FI7^2F;``PLLLZAFN(>['":ZZB4\)=-`W*!OX$H;:`K3AX24P5;"%+/'ZSKSY`#.UOO-FYN=K ME(?QA!RTPC=KS,H"?SR,]@RG83+8DAW:?DHDD^]35J-PF]18D2,[DHL4;6": M/UY@+>6S9$5.T#8D`+^[AZ!#6OYZ*:D%;G6Z8.>$%"V(X2QE#*JW=$$)JU?> MOW*U5(I,1K\-?QE';0WZ:!D[!!\E69YNE^0JWSS!W;S%Z,Q^3%'&WEW2H*S" M[264-J%]Z@Y8AM9+&Y#$[DGX@N9+J?(UMI)[JG\!FDM"IZ1%+MI3<8%ZO M&^XWEC1M0,$:G*'D=A][VGNPFOY&D\PRC.`@V6[B68H)>KQL.G%WF[C;3/8[ M%"XWEC0V(ZH]"/^(9$85\8>%M]?`;C+8*V&`_2$-7=0[0E/7AGSO1ZZ/D2WX M+`IOHCC*L1#\G7V5H^6_[E"\PHM?\LV=/PHR'9BRE>.@S68!4=.NV7D2@];$ M^-86$IS-9Q_F9_/K^VUP^*HV=\V$3$><(P@XN;.+JE"?P$ISQZQ+L<#U)BJRNE.MVP MS>J@:$-VS5\(N9/DX&8$OUF'-R(Z#:CO0C`L]1V(3?%B"A<8!.KJ M7%V0JK5:CW%INY<5AM:^JTTJ9ZIO78`I7TTASLT.!*J;*S8P&-_#I5NX:BQB MA$Y.3E?[.0&='=CEC5NC72A>"G@!5U"^VL7Z>4:Z0G%(>Y@[:.>3MP"O@X:1 M,4\O5DBG=`E%.08\"@N$2QIT,)/SI8NAS:,/BCM9$YC`9U$K=4)9X=(AA.V MG'/WO=XZ0(I+0J]7KO54RSM"TIW*I2S<`R074SHI[[!?%7*@P"=/?C]"]_=1 M1@I@D`VU.1Z6A%Q[KPR3W:S2H]Z%2,FIK<*DM#IB&RJE:D06+B7G#1H$-,U, M35+-"'Z#I_04C0P5P@9129F:@52^D.0VI>AP@*)I1!N0(O&I40VI":PD74-* MF$/T"8#**&/H"BVW)(J6[M2.CBN:(K3,=O5`4S>%&=E>IZE!PYCF4\GN(,1S M>9C#Z@VJMY8)#+?%''^7HNWM'?YO6%(3E);0!&N4@BR,,5B78AS#,$W@ZB7X ME!%Y"."I+8;+(B=D%8+1.`,@C^-Z\@1?KW#_/T?Y781?)Q`\8GD`MUL^(N0) M2N_#&)!(9MQ__*.7CTOU/>%,]611L5-^^6H*^Q1V(!`M'%S`P%\<$-^[*;])W6Y)#+4/8;CYP-MQ M:-]*;"P*)A)X(P2Q[K:";"]A:"T[#2VT5G;W$NJ35K?(7]DH?!)[JSIA^E)R MZ0ZK\U!]:5>&V&MH!>1\@:N[V*G6.!,!*6_,>8L:Y5J&NXAQI*RAUJFZ.JM7ID],:QIK4`V] MC9[VX?X^RLG6.=F;/$()V<^%R1(+)1R\LTTU=?-L4T)M>WB@[HB#LTUI(XHC M`PEOT"`HJC@U2;QOGVOH&!GJ@K-Y+F9B-L]U031ZF6?V;LT\6<;;%>[A17'` M,LOS-+K9YF2?_QJ110'^`5@#N#^W\P0OH&"6"RZB#2-\5U[:J7"KTM1#_$P[ MPW?>)UE);*=-!5=W80I+>7^CV9?\A@H-A&(T+'S8(MXNVV@6`!_."$=/K59N M!]#?Q*M`)Z'8)5+K4ECE3Q,V:)LVC2=8EBVM2Q_L'H*,/-T#7QV\/'@--F%: M1!#L@==[!P<'Y'\@(S:-5PG;_`ZET1]PM0<25#V-LHQ$]J,4H&V>Y7@I@;'A M-\^:6-%(0SEL5K4.83.9F@(Q'A;3*!&:@.AU8[G<>FVY/N8U9;\@9J3*5\`M MXJ!XT@3\01OR[]_+,/_FN[UOWW^W]_^_/6"P3VL2?;OW]OW!WMMOOZU>-LRA M7;T(BWGWW=Z[=V\$8MX=['WW[IU0S,%[WZMS+H:02O7=]7>3JKW@%L-P[-M@ MJU5$)L(PO@BCU3PIK^8RF%=053?!!%0V]\#D#5O>`A,*E]P!$_`$]0M`LK[O M8RB7E[^]W@53*`YI#C1S#XQ/W+@%IH.$T>O[YF&4P-5)F))"XMELN=S>;^,P MAZMCN(Z6$?M]J,^PJ^*K9+`JAJK;'3NKT&I'5O!4R1Y4-#22DA#Y+5ZJK69D MK@NV0*F*KUF3U`Q-XU\CKKI#CV;PK+;!'\8PR:('6)2S.D,923BV6%^'7]@) MI1]W?>78B-ON(G*?CKI)QF#8LO3FLI&LH,%0E2QILH`8^H@AZB#')[Z/S2=TF'I M"(>D55A1]BR/2($\N:SQBU+KEFEOPAL^.[6>UJM-(_&SXG\)U^DTYMQ:JM=>T<^'S[ M5''IY[R?4'#<19@N4KSFR^&*?G1?P)0&;4KCY51,W!`Z(9.SJ#I5MUP&VDG: MTHV]$XKHAN/MHI*F$TJGQ(`@NDX3.Z7-Z?&*8O#T(#>R_16[^[17Y!Z!(-Y> M056.DHC*PJ04#=O9D%BXV&A$/$%Y++5[`WZKWOVW3S-1:0YICG3;$`3$-?*U MH##V)BI)#E8F7_D1H576+6TM(ZDV.'DD-A]]DB8M-Q_YDB5?83R&@)RQTKQJ M7K^A9(I!.F/)?-UP*!O?*B/HV.E54B>J)GM43US9PKTB2W6/'BN?Y8MUV2,& M4=QWNRCYYCNK$'E.([;Q\6V1LN#X)F5`_B0;.=YAR1]Y)!TS-K"\0=*,*A>J M;8#,S!T\R;93+O)<>MWOJ\\2+6G3.0I0BJ?6IVX\+&2+F0^\'CD&R?1/=A&L6/((4;_!-I5@-EBF)P M\PA@'-U&)%MNE*S@!N+_PY^589:A982_JS)P$Y(LQHCF'8Y2L(I2DLJX$%?^ M4;=#T^XFU?)NDDF(#:!IF';8%)I>UGMTZ7F%XE5GAN:^;:WYZK?6J[Y.0R[6 M?4VAJI5?35ME89S6"K"K":080=XJ<$?$K@.'4*73CTT+C=;YBZI5_=53TZEX M5NRCU9$=S8\IRK*+%*T[-^8X;\K?UWQC@4A.`W:.I2U0#,$F74#_`!OZET_4 M\88;28:JC;4&08TS]WIRZC5ZJ(MXBZ>F,)%[,%/9V"E!JV(5)V4-3,$QD)*N M2@@JI+/)!ZIJW,Z=R,1+LH$*N8+=JUUET>^])@%5Z@YICS23`E1$WL@`J@>( ML6=#F.!NQ?@[8+:ZCY*(=(E\#)2=9&=(/>IJUE10VWAHO8Y8SJ[*1B0N7,$; M7$$:U$4_5<,6R22J\.IJ&AEJA)D1Y$R-6<($2J,G9M^DD&Q'X`]J_.\8TD`^ MW--[$M/W1VN;I02Q"+2&TSN"NZ8+EH MD[>@R.(N8BSSN#=*N&%"_QG<5(NX&#RN&OAQ/?WB^J[1?6]XO0[ M9:#O$[/ODFK?#76^2B;U4:+Q,:+Y$2+Y^'"J7:>;))9*KK=7G[Z:11LI_17M MRRG5"31$;JE+P3JF!H4+\'8;=.2<6H(UD-N@#VA&%P*8"KTHF09J.>KIXE:H M0Q:W-2$'N8/I>1@WU5_=-!/%,U&XTE7U4KF/3XMS+*;=+_Y>F!YQ\_-"3&S[ M@:'LAH.8(65#BB\-,6OYK1$5MP>^+F?K;_9(J(;W+PZUAI&9*CA?'4(>YKO# M,8`JV.,_%?)[9543X.%W/6O[O?C=E/?-,X"(T6"C=`73'UZ\?GDP@8M1Q"V? MXE];U%;9XNXN=E/5![A&:9D>[3K\`K./48)2>K&YK#Y``XP:4HK[EA]A?H?P MFP=,0FNW,-#TT'+K`M_*B43_ MM^'&-2WD$;:\6WNC=("]"?B73ZF[Z?13[$_H6G:?CG\Y%R_.1?2Y^^=R+UZ6 MH[C_Y4+Y`TQ@-XI30=5:YG6IK-VGL&$7RR>><)4_ZO($Y3\`!L7$/(=8;4AS MF'GVV"%F;6<,'+A-@^L0#V0N^?HB10\1N1+R#9Y2GA\ZY/[:%A\C^\%SF`O/ M4[CORM_!<&XC#K886;EB*+9)QE6=TX5.\JNBKM\-";\63)V5YHEN3YNH;V>E7=92J MC%F"ZPDJLO)7"\DL$*IJV@ZJ$NEBU`J9=FZ'Y$8M\B=ZO9F@5!O2'>4VK$74 M-<+UD.`9[!_"+%HJD-ZB$<"\H'&(\5:C#E9`(OGZ$"\X`OJ?*2&ZK1XAG'E: M%&"9DHJ!/(RN7168_9BQU&\;7S/"_P8 M0R7P9!650WPS#0_@S>H6]&%>\03E/Z:$:E950ESS=2K`=4DL1O9PNA_*NUDH M7N#AG@$:=/U[$[`&FX2T\W][?P'2QIOW+%G6-=-Y*KA=O M.69FO!86TZN3#GRH:;MB`S.3Y'\%V0\6R$IA;4LT$E';YS0QZP(DF0$P`BR:3\2$\C8FGG!,['=:;>E3<\LE'R.W>U%4= M'6X"DK1L;/%"65-8]/>%B,J.-3$FMV.1$*4E3P"C`T](8P"43$I_0H@:3C8# M@W3T.K1E00<\'7;J"`E.98QX=E5D=7BL2NT9=,K.1'6;DE7'TY$0U*5'2%[% M!N'?0%D2:AHE2Y-UPI&="9K0L"\N9VU7>Y4=U138I##--,Q)JM^N&6G`@34?'@O' M;-3@&?LPHMVA8W0?1FQ:*BE-=1#!I;'9BI8U:KD-+1`MV83F<@0LYL%OQ1NO MH)=K"VF-+[/SS"-M[#NK53]ZTO#[>Y28E$TTX&A4_5!Q6.;TU^R0G3'H-23/ M[Z_B#RZJLHBDPG=1AMAWEGU=;:,>&NEFWEX7:X<-7_8LT26I'O*4T/76'%TGRX1>BKW0X(T'1YC[%H(4QF$9FT379&4]KF5#HD\/-YK5H+'!V?:L0[=:N^5Q M'@B@!N%_?[9'_?T?___T>]B'9!BY)-O_X M<8_>QUF67WD$1UXSM,GT_K])H5WV(JQ@HJ[<*RF/G"1\*$ZGR#D5 MO(T2&_W2K=A^JCULJA:OII^T4@6; M]*9*G>#6*,FHM%[CSSZ2;*ZZK]O>,.BQ`VH@U6"C4T?JP/N9!C]L^&U+O<[8 M[4[JM!%@HEVVLJ^S.Y3FZS".ORGJ*<`OFZA(?TCKIM-O;;3QOAAW#6.CG4=S M^S#88-00;K:/:&QWH_LY;K<_0A*]WO%>&K0[GR2CM?(T&IVP]1_R)F1>0<89 MU*_!!K\G6XG+@L*O->NH%1DI@+4\"4O3GK0Q,[*57,(\C!*XJFZM<\U#3E2. MB(#(PB#DS=I9@E"VV`0$+$'U?)<:P"?D%:I">F/;!CF?MD:WCN;'=O[+Y?9^ M2T\_1;L^_(G`E*^:%+3Y;"8(T\XYB!PT:5,R>VA+"1JD`-&R,LLFL?=LE.8( M0;WUQ\PUNNR->6=2L'1UI71D3)+]J"8JBV)'+?(RU^9SQZ5H&VL\9(X\C5R3 M_?QM^DA/>[D3AH2B'",>A86U21JTLRJ^8+']\.B#ZF'Q1>_3'F2*01J#V48X MA[#&LE+#_NY`'X79W6F,/F?JJ\]"TNZ-YRZIFXO.PBXXN]_,:T'K6G.7L7V; MF;P'E&`2-RUEZN3=5U8IO]K:EG!P;R\* MG:W=Q47'`TN_H)G)XM?KD" MIY>+CV!Q<7(YNYZ?_PAF1]?SG^?7\Y,KKSFE+:"$[/7;2:]N**>5@]T*T3Y/ MOTAX:[*,8MA*)'^-[)S$D$WPSL5<->'JD,SQ3W9X8N:N9YK'9ZX:#!I2B>FE ME5Q28;?(E(^?DG\OR3ID4XH&-X_@ZRT)^8^2;ZH2YLDM"*L&O'K`0>V$?_`V MC#7R3N$#B= M+MAY*D4+8H\C90QV;VG%L%7Y'H0E@4\'H*569**!MD'*.&K#TD?,Z`45'["U MH_3QES3*X3'ZS,;(NRP]@.5E&V05D8D[VID+[S:06Z"D:&BFC;AX*I-A8C M!/F(WU=%6VH%A[F/A1PRM+%'I*(H\+"Q&:1"22$J+>8X\U M@@E-8@-5H7X3C-P[AFN8IG"E5U%:D[JZ_JN@MKD)K-<1RTO!RD8D]X,5O$%% M,)G"PKJZ188Z8"[^RID:=X!-P#-^^?76);3&AW\9;2C8KC1GK(NTZS+:U>LV M[)[MUXA!>])JWKIB2+:.Y)9<5DN:>W3%FB5,5B".PILH]K]AUP,IJ+\:.Z7` M-?E;U<%[`=2[Y5;;#Y=P":.'\"9F3<.$16BM'!:G=BKNDFL+Y;9D8IL<`<%N MIRC=/9R6\4E4+C$[)5"$!M?EE)F:"EW>C6PWB4,3.Y-R"4V-S^74VJ0=H?EQF646J`&Z"1AAL6V)Q6J87H=68G`U MK6,SZW3"092]JATSNZHY@\8?4[.AKC*EEB/2O<1>=BQR*QD>*:X"WP>""0EP MKPC`+FW*/`'/$#VB$';W^-'QK?\BNYFP>MOO'G)DW7J'EED3="+?8QT$?\='7=T6\UY+N%X'5 M-J5EVN[(^<8&I73;J$RF0@J#X.?A/?D&(V>`J%'8[1XE\'%W3SM"NL^4*\_'E\S0?T>2*"XA:C__G*4/6R#64U9,2;R1Q>Z4:R%Z0-]QTQ M$,R$7Q8%^G;48/;,<:C_V>$>B=XG@&HK^")\-#K+8.B5!QD5_2"G&$QG!G'V MW;;Z'&)4W/4)QJ9X,BWS$FE9X^R"#PSEP47)IG-J,0:4AO/F3G%4IC]XUDC2 M=\^NL#0%IYQNX>JLCBW0\@7MLUN(3K[PIS#=KG"3LCS^X0>%/Q[XU#8(/E MMYQ3Y>TYG$,8I;B#0_I^;JL]K)0C)Z!_37:-I0"%VBR5B%+99E>`AHEZ0^/@ M,\5P4*2G#7\V,!I/%8/`T>+8N-LFJ5459>1B)#DIP.]A0BIY":8"3*U!7!=> MEQ';%9;5Z(:=32G;D-:0E;'RUUL-10#,!FH^<.'?PC05C\PTU"DO*^%I59;U M@BO7I\*#(:SG2?#M;0IOP[QY)KQL@+(XM]V!$O]S2V\"W6QS>FK[B%LC!X]> M#V?=XE12PGW:2#4JY:)8YPX'T\,7P9$88!-85SA&D[ADNW,T>?^XK"["7<(' MF'2J86O3"S\D67JG"W9!9P;Y:.RV9;(^9[GK"YII\61:RW*1EB6+<3DPA`MP MADVV[!X32L-]\3G%D7!7<`>OR^<)+_TO/%<`FVR"TR-$$B1L\;/R)9YX&-"[ M$6:<^)0K;)0DJ+*?,59"5$$?7"1'Y8H.SJND@66>P&;0YH[U:21*E<*P1])4 M#5B7#L1.9I]DJM.R$K.)+T=Y&(M749,U%C)OGFOGV/S+>"0PF;[Y3&/F)K>+ M,IO4Y!H"Y#.T3(![?Z/1W4%F8GF[Q@Y%)JZ3FGQ^_O/)U1-(3:X#)96CT(>C MW#5(Y"C=@3:BQTZ(&SY6%3>7_]Y&*<0=Q\XI?[S`X,MGR>H$/]T0$L:BS!FK M&X#ZC#9WLHR[9WD;T*0]R:TL?3'!!?[Q=R&Y$DCJ69=T=,L35D1>+S69`P3U MUQYSO4F;OW'):6*X%"QO64NO]\.6V=P M[]&P-+&[L;R`$!(;C^J'GG.\]T8/3,FF$ND^22 M`ZIT]X;NQ$_KD%J@9,D9M106P@/J-I?L?'H\'+EUOH/BB3CA/PFB](,>W&!J ML@#(49'ZB,=)AK^#/&.FAQ=8JK*UIUAAM5P_2^K#1T1CZ<%S=Q=,O]\.S! M68Z3":>%(?3HH)V!F#4H-AP3.<&.N#`I2@5B>CT&U70^K:L/4)"%$MO6:""@ MMM+>")WL"K3_3I*A,..5Z4A?Q88_8ZP5JZO/85W1W4L41G]07^IU^26KF`ICO=T M"R1=K.>X9I%^D'I0.Y'+#%TK5EFJYM&OWY;9X:YRM/S7U5V(437;YGR"C)"#7\30RNVO!Q7?9L%= M8BFH1.9@O[A2-.S8##2652(>/OS]+ZA4FA/#7K:4$A!+X#Z!152G3^(5E`ZI M"/2.UDXZ77`,?]U5DY21;P@362]IZ55L$LJ5DHQ#8AQ362-=DQ.V;?K8Z!J# M30E%.1(\"@LSD#1HAWZ^8#'H>?1!];"-=I\(ERD(:0QJ&\\5V0RF@HF>5Y&MUL_:U[/\+[&YAV/1O_?7>%6[YWLZQM-^9L+;L3 MJ[6`+:FK52M]!A:36ZTRBN$M4;FZZZY+"S+N8I2GW9&QNDAOPZ0,Q3A"28;B M:$7_F"6K"PRL*B!EL2ZO*(3Q%7Y2Q'@<1]D2^]5M"J_AE_P#[NN_&`P.);X< M;>?B+0QMJ)]J9Z<#]$ILYLX;"YH2?7J&P7",AH9/VR^Y;J5V:\.:XLA>\2JZ M3:)UM"19Y9=+$AI'EQ]QM,1B1;[.C*G4BR:3A5\RZY:=M]%N2^Q#-$4$5]O[ M^S!])"&+#190\X"*R:??,,0$ZJ>TMHWK\=:6VP>"HX>K8<+3TBDR%G`QK%',W0QO$AXJZB M\0#X*.H8E^]!30!^(R2`TOSW\\"-.*C;+7)\A77K^%(U*1OJ[=Q0U%UP%/YM M;B82QBHDG$9%3R((7-,>M#6^LP8Q!R=$?&K6!JG'+1`02\9*L`T*NX`QE&<#/`7WA-5>`4FU(>Y"9+``B\L:5?STL MC(SXV@(7:[+K#I.,?IA?PIC4!3A"69[1[GX(,[C:E081V(4C:>78VDJSL#%' M/\3.$NT[(;976]D!W;+>IV]!4X!/^W8%/^08!FU?82FT]BA.[B7:C[EQGF;`;'G89MY-^Y,XHS;EQW0&HH*CQ<>/\^N/)^?7 M5V!V?@R.%N>DIO;)^='\Y,KW05X/N"`[/7:/`/5EM,\'^Z)U[&UR>$OZ>0DW MY&0^N57;L0%'M4&NP6&S.Z[?(P=4VQO/\U?8F@__>XLZ>/,A6X@8?U_QGN0O%Z]4$O\*Z'Z%:8'<`"0!5=LU!&UTSFX-<14KD!>=;(+SV1 MG4Q^L-U8AD1]"_ZW9>-F>4J;$3`"^/_NP.G]7@PK%?S&RAR>AP6XTS5*5S#] MX<7KEP=>5_VS.$:?0SQRIR@]1MN;?+V-RXYGES1?&[E-8STR;%TY>9I&!'3M-)5@R5-6:@9O%IC?U@@ZP4VIYMC$34DXL% M9D>O_=8LB=Y-:$SNAG%-VIQQ5_E-F]&J\)MI]^PLV:@]6=DW;3$!*4JVCZ?W M>Y#NN&CN6;^%WHQA@?KKC"WSILO?K/+6#XVC5Y3@%IX36J*@F_ M9F=LJT2HFY'EV5=Q!T>M7.![I.9+<:NV3NY<7*_UFT]?5_/(6#]LWGP%6S-9 MOA&\+'9NSE&.5\^(!]I&YBICZ9TJ^1HTS0Y"-GML3+2%<9:=X$&E,VV)##?KD M"TR74=;)Q5;QX7YI\/8RGUT3^)-;V42OZR&BS1/M06&V2)3T/@W#3&,-&S'5 M@VAW8Q"]'SK?.>NE_,-:^8`,=Y&*":""!:\K_C0`.)S,]A;M7I'Q[YA6[2A* M^?P<#^IF(: MA[IV4)Z&X1?)X2PL7T.`W/1E`MS;OD9W!S%^>;O&UB\3IV?^X.LH*9,B?C-! M5Z`#*Y4OT(>FW!E(Y"B]@3:Z_64>.XY(@>EDM;M]1LM.AY$DT[22I9N?3,SB M)F69LDL.\BAH-J>5W4PL(#B&RS@DA0U6%0TIIU88J^^[$MH`X.5!TX5-M?.F MP>[U:KI,2TAG8)D+Z1S*QEUTI<)'Q_`13'!7XGFR@E_^$SYR02R@::&8I;&& ML:!1%SCNBE8!F>6HD%P^!_0%P&_\8UFD+*0UO#PT,Z0LG*6:'Q'/92S,:90M MP_A7&*8GR>HXS%F,J[_^+$("*`A0D_EV_2KO(2`^\J4#`PDX) M6M`9W5!^1O$VR)'2M`R#I;$V"$&C+@RA*UIE`"Q'!?S=TNSY,`CRT?U7+2]CJ>3VJ_G)=VPR*7P<$[84_EZ.S_M=`S.C&02WT""_. M;E'*_ZCE4K1,H4UA;0'';@7VYLX6I[&*&3#3(7O6Z!MOK>&+*.A7%-5G:"]"!JHNJM\=)PN2OI5&-=AWBY-&`:<] M4-8JG$@A)P/ELTL5XQ*D:K[.LL5'.5*5@1VCY9;$:%_CEA@$\UZ58]!Z99-] ME=.$92K5MD1)7M0F85#]!6.8./9(.6AMS+9+& MA6*QWGR@[AAFRS2B85LB\'%(6`PV25Q`D=.D(T2V)6L`L\G0P&?C\21@RE-2 M%ZUB5;*@;5!RL"O4MXVE^F4F?9;I-WY7Z+YL4-6M_?;.,RC!WBR7L-EOEC/DRB/PGBV M*J*;%^O3^?G;=YVS=#.VW=FZ)IO56;M9UVS/WK5;DYW%:PH):DH0W6_(M4^T M!B%8TA1W($I`6.=$(ME9HJ(,#D8*("GQTCR,\$O\I;C9IMDV+.Y98]G@[3N_ M1_N&<$)]M_>MQ-T,!^B!X[*K"^1U,.26]C^$Z2N#J`TSP/_(+C,9LMOKG M-J/ISJMZWX5OP@PIN7%_#(O_,J8V8`NEAH9HP2:#X7`_V#*MX2`=D^0Z'*"] MX()(PNL^5.=WV`,)I-Z-^*ZOWNV!K]Y\B__O]1OBY?#`?+='_O\="/$Z@I@! M262SP0:).Q1[/<08TC30"'!L>\@!&FKD41S:QB?B=S\EN&]Q]`=<_81BLLWX M(YZ&296N17(%E]LT(E/R+(TRD@F_<<^I^JF:SM=5,PH/;-W,`&[8U4\?QA<[ MZ)VY0[9N-*@E@%O,6]Q\C)('6!AB!I9QF&71.L($80;"AS"*26ZZ?;SRW,_" M ]^!1=LC.#4?IEQZ:I<,ZVK:D]M%L?,!$WS9EV])VOG-E\43N0HY1W<[2E M:%^G)A"E6D!.T?DH`--GJ6?L*/@R>BW0?!MU*UU,2*H"X">K+?T@F&49S-D` M27V&SXOJ^>>HO02;K`MWI'\K^M&\!8[GVLS5/.YFL%F/M?NCN5\KM..9#Y7 MLP?U"V+$51H+\L[K;*ZO;V2N%&8V5_(U9G-#6(V>#3R[.XW19Y(_&?]S3K=S MB-DG*XX+J.MR"E(@NQ)7'1#;BK-*->[FI]AF(K?NA2Q1N:7PH"K%@QT!"9\WJ[DCB"+72&$.HRVE-E.FN[2BD1U4O;58[RG. MZTUGQG0UJ`_-CM@Y!W4C8MM7\;+;_5EGO]^G$>OJ&1GJHVV""J;: MPHR`-/H]'5$U2<';U@T<)_4>!0VYN%NC5Y&1I:UNS4RE6J)($T@Q@KR[+YP" MA5)5>HB8G2=KE-[3[TP1-G5(F?A9+JF#,%I9%]Q$TPI:4`?5JC$S\G+G-(Q2FMWZ(PS)&JSHY&:;-]9E(IOIQ5N. MGAFOA57UZJ2=F9DV*;8[,TD!(0>4WJ?%]8,%LE)8VR:-1-1&:H')\4\;-S#- M'\G19XX_JTC5MPV]V2O31G4[TM-&%7MP<;FX.+F\ M_A7,SH_!R3\^S2\^GIQ?>SYGU-4U,E=(YYQ1P=/L-V-M.N"7LU$<\F[>HJ4'S3J`DZE?F)_ MU'%K*]J">+?':"&27Y/1TB3&KD1>5E*^"!])J"KV@OA)NH6KLRB\B6)F0U3D M7BRE5)>9>TJQN>]LUW'+*]&]&Y?SZY-C<#&[O)Z?7-'OA-GI MZ?QLCA]?^2UX;@X99*'.MGT;"&C6/.^)U;$_T(N`<.QS:`SS!)L\>O)"?APTQC:#$[!;U'&O9>.O$+S*N)4>/"7P\QQ_M'1J M%Y7/;4RP(]K.IJH>R4RD;C*HAX%$Z]0#,9F3H>[((^'(M4%:OJXQYT!9FJC1 M4>&J/&P*16F/-!J3G`4J>(6*GZBN-0>>.?63,S4._A32AT.,F=DKJB0."!CB M*YXZ2$2.8AB8^*@R?(?B%88(V;//'\]1KK$);LR7-VH*:_'9EA(VZ9S=W&G2 MG*)PL):4X.JGV>7)3XNSXY/+J[_11@_P,LIPNK#D@F$`NYP=713R?'G\Y.P'P.]L'/L[-/,[+-23]W=<(%`Y!`-S(S47V!CCG)E&KX"#A?KXG+Y;(EG MV!2RE>DK>MP?"4\O(]^)#F_$HGMMF@@L[W?EC_^]4"IE>],,Y`.+-2@O[%>T M/@U+3RL-$](=:Y3BQ=8/+UZ_/!A0IT;+F=87L1/%XJ4-HTJ0WZ5H>WL'6O$D M7@^#A]'PH5C#(_N?7V!T>Y?#U>P!IN$M/-_>W\!TL>Z4XA`LNONRES.`,;O% M*J9O5^V6+CU:%:]7C(4%%<=^6+#L[HL7%6I0S>/U4FAO&"%;[;:7(J92ZO6' M'9+'_K;9;C8Q_7@,X^IV:N,JAL#6#;FJ;Q9-+IOO$[..67Z+:#[0E!%< M?;JX.#LA$=2S,W`\OSHZ6UQ]NCP!BU-P-+OZ"9R>+7X!\_/3Q>5'^O'AU8A- M\8%ZZH_Y>M!C;GPI]`'DV,'7W21O5:Y&_%>\)9[D@I3YQ/W-\S2ZV>8DINL: MD3OF*,FQJG#';N<)7K7!+!=EBQBVE2I@>Z!6;$*YA_WAED'>@W5.$OX]4)L! M$8P2NDM9)*NIFP'X,]QS*HJ!\8]&PAL35#Y,8XUP\S$,VL.UZ-,H6X;QKS!, M3_$3-K6%@HJY#,U2.;@'+6C8S17HKG#U[6>6I[[X7+P!Y!6@[Z9PXUFDN,YE M9[F&JZ-L/G'WBK,4"=Y07N1_5N.<0\=%>I/.&=8YC;M$>UN\+MZ;7!W$E]6T M)H9YGA(%J!?KFXO[!KD(^4)DC+RDKJ:;8L(J[YG@>4NRSRYDL=Z2%4D>9)== MU!BSR5Z1E56JIK+IJM(;N^H;_A7]O]0C_WTV80?SD?P!02P,$%`````@`TEMD/5C=C_H-4\JZ6V9V?=#O=.J%N2MV+471I)MF>? M'%01)=%F$3(/M>1?OP"O(D$<"1`L`M5ZZ:.82&0FO@025^*'OS]OXH,GE&81 M3MX?OGUS%/-T>G-Q\7B\.__\]__/L/_WET=/`C2E`:Y"@\ MN'LYN"A^B_*L./C7+T$2'GPX>?O-WPZ.CBAI'"6_?T__N`LR=$"J2++OG[/H M_>%#GC]^?WS\Y'O_KT^7-Z@%M@J,HR?(@6:'#`T+_ M?5;^>(E705[*URG^?)?-OC]NZA!3T?T<-V1']Z>CM-T??OGWSG(6'M8B; M'#VWE6R")"&:KA[>K/"&\'A[<9#B.0MJ&'X*8UGGS@%"> MD9I+7OG+(WI_F$6;QQ@UOSVD:/W^D%KGJ+$#-=M?Q,R.1PMWDY,_-RC)E^N; MAR!%#S@."4S/_RBB_.4T"3_BS2/Y%259](06!+(;-%8%DRHM*IHMUQ^#[.$B MQE]&MP:?J5UAEX^T*R!^:57:#E>J\A(3H10T^")9XW13 M>JV):!PNAN)$]TFT)G[94Y3T,BM#+,D9&@J9X]7O'TAL4(XG9#`QMQN?DZ%8 MQ5V&_BA(.YP_F6)LP`,@2AD'%=EQD1W=!\%C)4R(5P6%Q/%9_0\MA-6<\^"9 M0'Q#6NH-6PF)N=X=HS@O?Z$U9C0B?'=T\K:."/\21N.%/R=PR5]V+CJIVECV M.+A#\7&"[NE0!A:W%\_&:5KQJKE0\;X[(N%V+5[#W`RFR_0^2*(_2W.2D.RF MV&R"](4$;+9=WZPBJR'+CD/A":0P,P>Q:UJ@\/R9]FEFK<>R,(Q\@\E#8?\U0,*BQ@M M%G2^T/1T_RR".%J_$'/7_9M9*`#E;2CZH`*GZS69()+?C(RIP[ZC`.F.,^)`I?$OR0^]FM%SCI)P.\A3 M/:Q-JZD,M1`Q7O7JC>EB'DY'A3WT%S;JJ7_^M3-,740)D2D*XBN<124"[[(\ M)79L*B^CG?>'.D5(1$?M!"IR/*,93K.,-(1`8?['6C7F8U>)+J!.T[Y"0;IJ M&)%_]M`T7.ZL*8X?2U`=K1ZBN`7B.L4;S3;!"I6Z$!3DFW\?[PFSCCT6: M=F*$!@;SZNWLZ,JW)QH374>N'4"O4-T*P$*S`782 M`&)#8[&0M2DH5/?3%,C%"01 M'Z7_18]I/C8(OZR`(#1[:7-2?X9*2E?PK0@Z`91#/.]_N`DWRP[Q"PTT_^9. M[RJ),A54(M3M:WP),\?.T2:/+/_;-:2)PTH(J0AS>QU0:AAFY^@#A)+?S0S! MVQ0%69&^=*1FD">AJ.W*H]@[G*G-,#6\N!+P4?6N0=4/QX,6N"0_[';W?\S9 M,#?."`P;4WU(0%UF>$I`4L:1<>HL>HI"`HKVZ#J]-W(51)+P2%ED.&Z)B\R_ MSP9H5VRDOW#[3%PC,^I(:A*OZ7H[163[BL^(V.HV>+:X`SUQ+5O@3U*+1[ZR M`RN;N]S%7CNO$E)/_!6LK)F_RM@[-4KVKJ2_ MNIT=MSL/TH2$5*UA13ZGI*O5%=-YX6U0-4U<3<+;*3\37,E_]3@['K?M:)?K MKH'K"W$?<99G)3[*)K@*7DK117YIB5MMNK'2QR#-U<&Q4MC:+7EDOG'V,.4Q<6[,^]O3ZCD?Z8=*B M5Q>VM#U;F?8:/=+US.1>[;@:)9JM64`)+YQ47W43UP35XM3(.LA%]>J=EKRS MSNRQ7+,F%GHGO$3CG8`2?GBGMNI&W@FIQ2GO5&0C?/55V[[Z&7T169N>SWH( MDGN4+9(N340T>HP1P*UM,A_T`%:8>]993�YI1UPW4Z"8C4Y:A9I1!U9H[X!O9"S;,+QPQE^M+E&4(J:-=*[R:VSNC>'GAX3;-9>+$^N?MU]@'QEX[0\L MI32N<^5>!2_T"@O-;UY9^C(*[J(XHDG/U3W!2"Y-FF-#+EYXOQT3F?B]<B2!O&"N-KS/]`+ MMV4%-+VF96E<;5NY+L#&'3#9??)65>O6*>PO2$<=Q/^'@O0\"<](=\_&Y`JR M)MP6D;G7S$"-E"TMYK/[A*DP5_X%Q?$_$OPEN2$A.TY06.;A2KDNK:#MN;:( MUKVVU]$-Z.I"9KM/4@I#P<\X)M%;D+Y<1#%*V;Q24II>J[,TKK:V7!=@*P^8 MB)-[SCQ<5[U2>]B3AO`%OY'EI/W!FT_J:I.#-(,.Y0)>N\^2"0-`"="/9!RZ MQRD_6N-2])J[3^%J*\OT`#8NPV+W^2AA;7I5W,71ZB+&`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`N>YC\8Y"FM/^HTO4S MZRDZ9=KL`I`R,Z%%T/K83-4^7/J\JRP`()[>9WJ[1D3G:$6?J3``F6'I=N=- MK[1SP!NGO@J"VMR]?V>YB8-H*F:BY5U,WQ.M;ZJPPQN`E,F7P"5U#E,:BJD` M)&?5.57C)UHZSS9N-61@(J7)F4<%>S3.`0.BB@H1`AZ=@S:^0J%^II0`?("` MX:>VX3N?'&QOH>#J9NX6[5SB]+-URYWF2DO^8"`FR#NO?_<)G&MOI1*J5NC6E:N]D]6IA<\W&%186M6V;P61MQ8UX3;4,+?1E_8+`?0&7?=Q8Z;&[`3S? MG_T]D\&9J$6RBHNP?.XB+=LI)TK=%3E=A[S%5`>$@Q&^XFP1&& MF(&%F4U)JODV1P(WGY/J)(OBGA`1?.[E]WCLP*0PP-9*&U9MOX,>SAXFG M81A5^+\*HG"1U,]HL(&_G*J9"0BH]@Z!,'-,#42A%#M(O`&;@>1!E*#P/$@3 MHD)VNEH5FZ*\=DYFP=$J&LX\H`7:&8>RP-YA3]M(4\,0(M`.TDT##RHUHI7K M=J0K)]9YH'>CGU!UR.(29W1)9KF^#9Z'9Y=,2F^/,VF5WCO@CC/?Y)VIKG3> M'\^X35&0%>F+,-`4$]1MPB'8.]0JC3`U,'D"=';]1=CCYH8L&_8X0?<4YGNP MQ#3)TM(D2TK[YQB3&'MJ9[(E]`XR>$.\J//$&7W2>*`V^VR>NB_\=EY0YA\]A!&W MM^BDQ#.!21L<6%/M/HR@U;$O[O*J<60YG7D@5'XOB4_$W$ABB#Q"!DA-#(<%3>R9+V+!**9AF%0^$1#-0* MF@.`R]O[E;?.&4!ECP*B'1ZL]+MGT5':'%R*6L:\H2?(J52F:LQH(E8J'9D> MDHJBIQ;AG(U^`'4WEZ:$VJ/FUU-\1`"KJL?["[8-Q*_1$TH*P0@E)V+Z%H;( M(U2!U!S?F[#L`6OU;F-(.40INVB_!Z,)1R#)L./O14'^L`JY.B(EE\8X\Q\M MMQ?F`(^:CX]T7#QZ7NZ]0V"C)NS>1?,>*F!US4$BJZ)[G\+:DGM)F>Y+*.IQZ8*Z;6G>;-WBYIA?[+F+\Q944NZT\ZM2Z0M)A M2MTAZ9P.3%/A$(&N4OP4D2;\\/)3AL)%LGQ$:9"7&9KSZ*GJM00O#Q@S:%XB MT&+VQM;,(FP$QA42YW?I#HWT_T23;8'A8GI^![&GX6Y%5`^`MOD8K$BE%9=;/K=*W>%Q'-V45[?6O M":KPTAUV8&P;7C6-F.+.V;O+D6>(2$RB5JH+^7>,2N0EX>F&'NC\L_Q]L)P) M+](N:0**S)4Q8THD8R-S,1DW)A"P6C*%".9]'OG2*G0']`*G9[BXR]=%W+XD MU$4]#I&6DW"%3* MY,AU\_*%S0\!48G>)D9)Q@L8Y43-`AR?:$\Q!S+);J`F$L61!%3-QG[[0,3Y M,Q42U2^Z"XY:**B9DQ8BZCT%GYZ1=C494<@TYJRJW:==Z&UU=(:JOSN*U9N" M@M4I_8+;1V"@!;U<23(VC(WU(9W*W;PM.-1@^+B2$HKB(D(0RY.W MFG0/#[Z!:"5PVM)Z#R*1VK:ATZEGGM?X!->+KE+T&$1A'1S2LS15*JOJU!5W M#42GR#9AK;J(5U@R,,(82,&J?9BI;_O&W)U9'(50!`H*"(# M(5O$?QS*C6`=BH/JO+^B*52S,\W1Z!;E)578Y)3<#X@J33()4GFUCK@C:G_6 M,91<.\V!5I8#!Y,B%?1U+[Q7P=-6W MVZ\-ZNJ^?NDG_N#;*]7EIH+\5G\D3LF`TPXS[>LI7&9>[IE9-:"EVPNC!!)? M?_/SNH/`'G1A-1MS:PO`0.X6,@9^WMJ"F\3*K2UI=6YN$9,HJ#ZP<;KZHXA2 M)'R9FUTZUR[8+*##"[K5_T+`A$<8!M372H0H%]HX1N5SX]ER71FM-,Q@`\B8P_:POS8'/W$]VE16`&XB MA2/'%0?.*<$E@%34G_J/-+CRD_29/.S(PDW'>\GA'+3_*K-R=8!/+EP<8,B] MA*"F$6S`4%TEX+2%XU"$6\9\I4"3F?:4R(.5`B#(K1K0A@N,%6C$OJH;2P-L M=+-8H`4$X2JG@)=8UC;$%,$HKU)'SE0*%*P34YDO.@$8R'M8 M&0,_%YW@)K&RZ"2M3I$Z;.:)T')]%E%=DE`T_^%0,-.>+H5;/1<$!QBB*JBK MDM36G>3T:G%D#?(:/;;27>+D_A:E&T$6108F!B7;M[/A);V$E;EI;,!-JW9' M>B6XIN:3$TUFVD.G!Y,3('ZM&M`&I,<*Q!^*]V2N0C/B+DO=LO-GE*ZB;)M1 MM/:(^"X&E/$2JS#5[*4&<^3=F#.#8D4&'%5ZUMX_C MY24";9K/1F1?LVJ>!K?TI&@S1](1W_ST$\.,X.*O/K-R!PLC5YB4J5ZC8`.6@2 M/A(-+I4]EE`G4J7Y'N/QJT7C#%A\)("B9\3(A&+,Y;$*F.=)Z`8LJ7'HHT+D MG]MMRB3DQ,AG4;:*<5:D2+"W9XM=!\RCV'F`!<94+GH\XF3E&_2DA M,4T<_8E"FN"4)@M<)N(#DD#JVL0JZID`9PU(6-<@?P`8N8)[MUA]4SP^QF7'&L2-&1?)&J>;JN$$KX3I ME6KR%0-+.3[.F2FO-YR!ZW#DS<1>/H(H_(PXN5P%!-L#TRS!7#C0;%\,T(YI M?5@-]?'G`6?Q0U?VLC>0[HGTH;1*NJBW/:$PS%^CI&P;6$SI4TM#]1W1Y)(J M%(_#S+09;+RUZ$Y\C:,<+]UB;5Z7YS%Q$R'"MW5O]'"9$XIH^0AILH MB:BT=."KY6?[!!AUTT\HJ&?"A;K1L:ZF?7P(*RC[%!5C1TYIOCY3#,+)Z+>& MI6#1>C!X[LNPU8,#)&"B"9$J95KEV#$%0-H,*S)2EY&AH:,&(N1<'=D-'&B@ M"BE4H83;#:W01J=UAZR\3\S8ZK1]KU`$AR$%"X@.A0=1I5`?_7BRRXH?29HD M[G8$(;1/^TS8])7EAZ`PXN[@(29V&$(Z6L+1I.`JV!F4Y3(4("N>'51;AZ&W MI'B71S^@-:9IR=H=TD]14IYH;';0JH7`#A=Z.C)_^83R!WIJ7'2(:H::>]M, MNZG97=^9S_Y@1]RIB`*O]G=+JK6*]&%J!15[;L2-AZC!\-9[0UH)10X[`6S\ MSI,GC$&YW[:)(KR(.V4Z@/'`,!&@P-_IR'F0)J2GI7>_RJO3@E5O%5ES]U-$ MYBY*@)J!`2/F)\".P9;)_.$DJ^6'((M6"LST:`2`J6AF0HL2"ARX\)3J8T7$ ME0>6FAL@:;K;F^JL7F=17.2#T^\**@%$&BJ/0,)7S!PF+3_O#\S_@J+[!Z+* MZ1.)]._1YV)SA]+ENM0R6Q9YE@=)2.\;\(4&975!-FL0Y\Q?#2@IQXJ=:70`61=N_BT_UYUH/4(,;`"#->J MTG)D"TOO#[:!!IH,W>+Z]^U&7;.^UUN:'Q[-I_<,A:3NCMI2L65WJ,TGC`[< M::DQ_X!CHE!6+=263^ML2-T/1/WHJ5[JG?/""T<8GIO%B:)^DEMFW23F*7>"4 M=)K)QX)X1[)ZN4V#)`M6]4FA\G]QY?WA;T6U*="8`I2J:M?5]L_]3%_M7)?. M)_8#/%O+,5D0IM&SLSOO*%44UYL=\]-M'QS8`;[A!P\F!"7HX(*_ MUW:[BPDTZ79_,4&09TFG3)/0`53&"4O<4FB(5.Y]9'6K/LZ?*`K0*EBADS`Q ME)AWF;R"X>G(E*85ZY($@0OR3[:[%1.P;;PEF+N=^\V&`4H(&K5DU&N]#@-' M@MTA[$PZ]D&KVV3:(L4*T[G1-<00GLA@`E2V`E3(M%-QC>:3-V^]SG3ML#<, M$IB_^H.VR7;I$7N??GN[S)/=XM,PC"I5:1Z[19/'KMQ'NV-?.[I&Q*Y9E*,; ME#Y%*U3-*J_1"M\G)1=>0OE=55=#9?+JG/2['1L9XH_3B^1()-8^2?M1^+*6 MC*3)T,`C<1)K`&4@^."SZ:Q$>7=VO3HUL\BR8G`BF?>I"0>ZGYQL<(GPH(&Y M5[P-.+_Q.^"$M?4P^/.JM`( MPM5)X$YC,ENA#JAF1U8'+>\>3'LR;=H3:6Y"?5H30B!O78).GL?9%Y*JL:N[ M\-&KH^U?W[H(LBIP&H$R``,YS&0,9L.9 M*9+$,(3;B<6AIBP2F$IE<"4.*#9%7&7-K)\17M`%F"`^#:N(?KF^6'S^ZW?L M`*]9K!FYH<6<[/$,E0:-M6#6[8K86T>-M)-+"3/$+X-;J7^=/8ZIM:ZV0JBZ M.*$3E-/G2+C7+Z-EM_VYM'.#3GP"`*`:^#``GY!!&[N""E:;(C M<&GF;F!I,V*89H)VYK$NW/:7$]5F$1"YVN(@G8!-+>+ER.GH MT]6J"@11*#H8SG=[W7)-%P`NYRHX3#6'=@UP]MX?B[ZE-W^*]*6V;][ZXVITH38&-RV+!QH#@- M0OV%_D&/O)!?_A]02P,$%`````@`TEMD/8"][E;"!P``HC<``!$`'`!M=&5X M+3(P,3`P.3,P+GAS9%54"0`#F]'23)O1TDQU>`L``00E#@``!#D!``#M6DMS MVS80/K_+Z(0?:0B83$_;W2.V@U$>1"/&9^>-T9> MT_!,C!N_O_KA^[,?FTUT03D51-(QNKE#_?1O)I,47;\E?(RZ['*Z2)9\;F]O MCVZ/CV(Q!2;M3NOZRO;TR@5M).GBP54STC1IRKLY73%?W(CP*$U:Q8!:XJ39 M[C2/.\6,`#+$D$G:$ZLFZYG/&)[%N?W>FJ$\+X8=T@O3\ M4X7">2-AT3Q4Z^J^F:"3\X:"N5D`^M=6/W<+9@ON+*0J_:"I';=!W/M7'/\*T>ZAJVX9@6\BXMR_?. M6MLLK>-0;]+FCKMG3MY5(/U8]`=$@$8S*AF( MV2.2^+%"G.TVR%XSJFS4V;;1P!A:CG]I^=@T;`2F,I#O(NAXLEZ-L[-$,G$G M[ESY,K#\/8=H!]UN2SU[X#1Y/OQ<@>4\Y/:1.["&AH^!`.A&CC'J82!ZLM(V M^N[$F\%)FL7A&'Q4ZT/*Y)W!QV8<`0(S"@?J(\7@KT:TPH1[,-EMW^.][.M= MPBF]=.V>-?20]7J$_7?(<'HPY6H``Y;CX3<6P@ZT+?2S[7K>+T\;X8'C:I)D MU@_CVP=.ZXILMS&?[V5,T_`N4=]VWSX=UL)&'IMR"+H"PJ41!''*)02,`S!' M`.Y.9I]JDIVV47&:LDV/)4$8)ZF@RE#XPL%]>/`<'QFFZ8X<'SL7:``&,[%U MV*\;YA]!HU@L@5_OV'T$7@+2VS!CYPWL>7?X!*EZ#'RR6$&ZZJB"]/@>2/45 M[QO7!XZI'2?)@`K]$F>@;O14H?J\A*IZ,!&X4-D[>]"X>C(.WG])>>]:%\J+@UNX[PZOGK:ME]XD M]$,*6EG*1R@\M>W>*N>L[#5XHZX'(8["V5+^PV&_R3E@Y"?B^-(B+NW$F-^.5Q M4ZML5XYKW.&%X>`_]<6D\P/>Z.K*&+[3*82GF&???.QGIX^^`-^JC%+-W.Y3 MGNG+;*+L_QEE.&7!N;)!O@WN&ZEZ%,MQ']S!$)_DUE"&&2B;'33>)IDS24*; M0D#BWH1LNI%[WS%8A7HY+C2-`?;AY-@6A"O([=KX(LNR'S3P\$R)E(ZMA0H! MB^=MN[,*Z')0"`_2<`2WD76MXL$#?XU\02"T#O2&?Q MC:'[L.UF1?,POJ.T2SFL*`T>J+%%VRZVK@>V^LRS4M1RKCWTTL(T# MOX?`/8J8U#&.=I:TYTSYRN6N(JA"OYQ8`7_G"ON9FY3Y0]I[MIR#=YUM6&.Z MEF-9:U?%+N6KQL9^_KH>-)[E0"!/JI3[*_.N+TIIE377_J?JRD19-(^%1+Q4T+M6*SLE9+Y1*IO5 M`MMQH%DMITBRB'DYXG>T2,99F5TM@<:4_1O"\)AG+>#W M>&$*EIQ.E3^H6/_6;!]7";91N1@*D1V5G$%SQ:"F)%6%Q'4DT%-4JUG,4S(< M-SO/'B_#\Y90I9OPSCX1F MN',;YD7T6J;?ZL]8NY7UU92>,/E`.SB\O5L5K*A5P755];@4?]W^'0A MNV$,(8"5?UA0:L+$@@U_2M0[QN M6^@#Q6MK0W(FA3:?KUWAT-95L";]-Z7C*I1R)ZL0][[M^B#E?[T?M6^=>0#0 M^@=02P$"'@,4````"`#26V0]A?B<<^Z"``#A:08`$0`8```````!````I($` M````;71E>"TR,#$P,#DS,"YX;6Q55`4``YO1TDQU>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#26V0]N%]Q%3D-```XO0``%0`8```````!````I($Y@P`` M;71E>"TR,#$P,#DS,%]C86PN>&UL550%``.;T=),=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`TEMD/9(\)K-`Q0````(`-);9#V;JI"R:#H``+CZ`@`5`!@```````$```"D@6R7 M``!M=&5X+3(P,3`P.3,P7VQA8BYX;6Q55`4``YO1TDQU>`L``00E#@``!#D! M``!02P$"'@,4````"`#26V0]5S,!6,4>``!WYP$`%0`8```````!````I($C MT@``;71E>"TR,#$P,#DS,%]P&UL550%``.;T=),=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`TEMD/8"][E;"!P``HC<``!$`&````````0```*2! M-_$``&UT97@M,C`Q,#`Y,S`N>'-D550%``.;T=),=7@+``$$)0X```0Y`0`` 64$L%!@`````&``8`&@(``$3Y```````` ` end XML 23 R16.xml IDEA: Document Information 2.2.0.7 false Document Information 995200 - Document - Document Information true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 3 Document Type 1 dei_DocumentType dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 10-Q 10-Q false false false us-types:SECReportItemType na The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type should be limited to the same value as the supporting SEC submission type. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, NCSR, N-Q, and Other. No authoritative reference available. false 4 Amendment Flag 1 dei_AmendmentFlag dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 false false false false false xbrli:booleanItemType na If the value is true, then the document as an amendment to previously-filed/accepted document. No authoritative reference available. false 5 Document Period End Date 1 dei_DocumentPeriodEndDate dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 2010-09-30 2010-09-30 false false false xbrli:dateItemType date The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements this will be the filing date. The format of the date is CCYY-MM-DD. No authoritative reference available. false 1 3 false UnKnown UnKnown UnKnown false true XML 24 R9.xml IDEA: LOSS PER SHARE 2.2.0.7 false LOSS PER SHARE 006040 - Disclosure - LOSS PER SHARE true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Loss Per Share 1 us-gaap_EarningsPerShareTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 4: LOSS PER SHARE</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Basic Earnings (Loss) Per Share (“EPS”) calculations are based on the weighted-average number of the Company’s common shares outstanding during the period. Diluted EPS calculations are based on the calculated weighted-average number of common shares and dilutive common share equivalents outstanding during each period.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MA RGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following data shows the amounts used in computing the Company’s EPS and their effect on the Company’s weighted-average number of common shares and dilutive common share equivalents for the three months ended September 30, 2010 and 2009. For the three months ended September 30, 2010, approximately 1.6 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average closing price of $2.41 per share, as their effect was antidilutive. For the three months ended September 30, 2009, approximately 1.6 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average close price of $3.73 per share, as their effect was antidilutive. The amounts below are rounded to the nearest thousands, except for per sha re amounts.</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="58%" colspan="15"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For the three months ended September 30,</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne w roman">  </font></td></tr><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt ; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss</font></div><div style="DISPLAY: block; M ARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(numerator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(denominator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE : 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Per share</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">amount</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY : inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(numerator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times ne w roman">(denominator)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Per share</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">amount</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" w idth="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic EPS:</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-F AMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="le ft"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss available to</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">common shareholders</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY : times new roman">(1,278</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,490</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font>&l t;/div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.05</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9,207</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,464</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.35</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of dilutive securities:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT : 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock options</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; M ARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted EPS:</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font sty le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font&g t;</td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss available to</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">common shareholders plus</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">assumed conversions</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,278</font></div ></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,490</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" ali gn="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.05</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inlin e; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9,207</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,464</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.35</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLA Y: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following data shows the amounts used in computing the Company’s EPS and their effect on the Company’s weighted-average number of common shares and dilutive common share equivalents for the nine months ended September 30, 2010 and 2009. For the nine months ended September 30, 2010, approximately 1.6 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average close price of $2.93 per share, as their effect was antidilutive. For the nine months ended September 30, 2009, approximately 1.5 million shares of the Company’s common stock subject to options were excluded from diluted EPS calculations using an average close price of $3.48 per share, as their effect was antidilutive. The amounts below are rounded to the nearest thousands, except for per share amounts.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="58%" colspan="15"><div style="DISPLAY: block; M ARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For the nine months ended September 30,</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new ro man">2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr><td valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td&g t;<td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(numerator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares&l t;/font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(denominator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Per share</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">amount</font></div></td><td valign ="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(numerator)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN- RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(denominator)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Per share</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DI SPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">amount</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic EPS:</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne w roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </fon t></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss available to</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">common shareholders</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7,874</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,487</font></div></td><td valign="bottom" width="1%"><font style ="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.30</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(19,519</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,462</font></div></td><td valign ="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.74</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bot tom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of dilutive securities:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock options</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10 pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FON T-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: i nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">—</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT : 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted EPS:</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA MILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="8% "><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="22%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA MILY: times new roman">Net loss available to</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">common shareholders plus</font></div><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">assumed conversions</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$& lt;/font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7,874</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,487</font></div>< /td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.30</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="le ft"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(19,519</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FO NT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,462</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right " width="5%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.74</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr></table></div> NOTE 4: LOSS PER SHAREBasic Earnings (Loss) Per Share (“EPS”) calculations are based on the weighted-average number of the Company’s common false false false us-types:textBlockItemType textblock This element may be used to capture the complete disclosure pertaining to an entity's earnings per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 false 1 2 false UnKnown UnKnown UnKnown false true XML 25 R6.xml IDEA: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 2.2.0.7 false ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 006010 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Organization And Summary Of Significant Accounting Policies 1 mtex_OrganizationAndSummaryOfSignificantAccountingPoliciesTextBlock mtex false na duration No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mannatech, Incorporated (together with its subsidiaries, the “Company”), headquartered in Coppell, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the NASDAQ Global Select Market under the symbol “MTEX”. The Company develops, markets, and sells high-quality, proprietary nutritional supplements, topical and skin care products, and weight-management products that are primarily sold to independent associates and members located in the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, Singapore, Austria, the Netherlands, Norway, and Sweden.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Independent associates purchase the Company’s products at published wholesale prices to either sell to retail customers or consume personally. Members purchase the Company’s products at a discount from published retail prices primarily for personal consumption. The Company cannot distinguish its personal consumption sales from its other sales because it has no involvement in its products after delivery, other than usual and customary product warr anties and returns. Only independent associates are eligible to earn commissions and incentives.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the Company’s consolidated financial statements and footnotes contained herein do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) to be considered “complete financial statements”. However, in the opinion of the Company’s management, the accompanying unaudited consolidated financial statements and footnotes contain all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company’s consolidated financial information as of, and for, the periods presented. The Company cautions that its consolidated results of operations for an interim period are not necessarily indicative of its consolidated results of operations to be expected for its fiscal year. The December 31, 2009 consolidated balance sheet was included in the audited consolidated financial statements in the Company’s annual report on Form 10-K for the year ended December 31, 2009 and filed with the United States Securities and Exchange Commission on March 11, 2010 (the “2009 Annual Report”), which includes all disclosures required by GAAP. Therefore, these unaudited consolidated financial statements should be read in conjunction with the consolidated financ ial statements of the Company included in the 2009 Annual Report.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Principles of Consolidation</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</font></div><div style ="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Use of Estimates</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The preparation of the Company’s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. Actual results may differ from these estimates under different assumptions or conditions.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered to be the most significant are described in this note to the consolidated financial statements, <font style="DISPLAY: inline; FONT-STYLE: italic">Organization and Summary of Significant Accounting Policies</font>.</fo nt></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Cash and Cash Equivalents</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivables are generally received with in 24 to 72 hours. As of September 30, 2010 and December 31, 2009, credit card receivables were $3.6 million and $2.8 million, respectively. Additionally, as of September 30, 2010 and December 31, 2009, cash and cash equivalents held in bank accounts in foreign countries totaled $10.5 million and $10.2 million, respectively.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"></font> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Restricted Cash</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div ><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company is required to restrict cash for (i) direct selling insurance premiums and credit card sales in the Republic of Korea, (ii) a reserve on credit card sales in the United States and Canada, and (iii) collateral for its Australia building lease. As of September 30, 2010 and December 31, 2009, our total restricted cash was $6.9 million and $8.5 million, respectively. The decrease in restricted cash was primarily related to the partial refund of direct selling insurance premiums in Korea.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Accounts Receivable</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. Receivables consist primarily of amounts due from members and independent associates. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time they are past due, and writes-off receivables when they become uncollectible. At September 30, 2010 and December 31, 2009, the Company held an allowance for doubtful accounts of less than $0.1 million.</font> </div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Inventories</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories consist of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off.</font></div ><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Assets</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of September 30, 2010 and December 31, 2009, other assets of $2.2 million and $2.5 million primarily consisted of deposits for building leases in various locations and certain intangible assets.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0 pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Commissions and Incentives</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Independent associates earn commissions and incentives based on their direct and indirect commissionable net sales over 13 business periods. Each business period equals 28 days. The Company accrues commissions and incentives when earned by independent associates and pays commissions on product sales three weeks following the business period end and pays commissions on its pack sales five weeks following the business period end.</font></div&g t;<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Long-Term Liabilities</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In August 2003, the Company entered into a Long-Term Post-Employment Royalty Agreement with Dr. Bill McAnalley, the Company’s former Chief Science Officer, pursuant to which the Company is required to pay Dr. McAnalley, or his heirs, royalties for ten years beginning September 2005 and contin uing through August 2015. Quarterly payments related to this Long-Term Post-Employment Royalty Agreement are based on certain applicable annual global product sales by the Company in excess of $105.4 million. At the time the Company entered into this royalty agreement, it was considered a post-employment benefit and the Company was required to measure and accrue the present value of the estimated future royalty payments related to this benefit, and recognize it over the life of Dr. McAnalley’s employment agreement, which was two years. As of September 30, 2010, the Company’s liability related to this royalty agreement was $1.3 million, of which $0.3 million was currently due and included in accrued expenses.  As of December 31, 2009, the Company’s long-term liability related to this royalty agreement was $1.6 million, of which $0.3 million was currently due and included in accrued expenses.</font></div><div style="DISPLAY: block ; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain operating leases for the Company’s regional office facilities contain a restoration clause that requires the Company to restore the premises to its original condition. As of September 30, 2010 and December 31, 2009, accrued restoration costs related to these leases amounted to $0.4 million. At September 30, 2010 and December 31, 2009, the Company also recorded a long-term liability for an estimated deferred benefit obligation related to a deferred benefit plan for its Japan operations of $1.1 million and $0.8 million, respectively.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Comprehensive Income (loss) and Accumulated Other Comprehensive Income (loss</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">)</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company’s comprehensive income (loss) consists of the Company’s net income (loss), foreign currency translation adjustments from its Japan, Republic of Korea, Taiwan, Norway, and Sweden operations, and changes in the pension obligation for its Japanese employees.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Revenue Recognition</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company’s revenue is derived from sales of individual products, sales of its starter and renewal packs , and shipping fees. Substantially all of the Company’s product and pack sales are made to independent associates at published wholesale prices and to members at discounted published retail prices. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company recognizes revenue from shipped packs and products upon receipt by the customer. Corporate-sponsored event revenue is recognized when the event is held. The Company defers certain components of its revenue. At September 30, 2010 and December 31, 2009, the Company’s deferred revenue was $2.9 million and $2.8 million, respectively, and consisted primarily of revenue rece ived from: (i) sales of packs and products shipped but not received by the customers by period end; and (ii) prepaid registration fees from customers planning to attend a future corporate-sponsored event.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six- month period. If actual results differ from our estimated sales return reserve due to various factors, the amount of revenue recorded each period could be materially affected. Historically, our sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days after the original sale. Sales returns have averaged 1.5% or less o f our gross sales. For the nine months ended September 30, 2010 our sales return reserve was composed of the following <font style="DISPLAY: inline; FONT-STYLE: italic">(in thousands)</font>:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="65%"><tr><td valign="bottom" width="51%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 30, 2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" wid th="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales reserve as of January 1, 2010</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">595</font></div> ;</td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision related to sales made in current period</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,591</font></div></td><td valign="bottom" width="1%"><font style="DISPL AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision related to sales made in prior periods</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">112</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160 ; </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Actual returns or credits related to current period</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,128</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Actual returns or credits related to prior periods</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(710</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" alig n="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales reserve as of September 30, 2010</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="D ISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">460</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Shipping and Handling Costs</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN - -RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company records freight and shipping fees collected from its customers as revenue. The Company records inbound freight as cost of sales and records shipping and handling costs associated with shipping products to customers as selling and administrative expenses. Total shipping and handling costs included in selling and administrative expenses were approximately $2.7 million and $3.6 million for the three months ended September 30, 2010 and 2009, respectively, and $8.8 million and $10.6 million for the nine months ended September 30, 2010 and 2009, respectively.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style= "DISPLAY: inline; TEXT-DECORATION: underline">Reclassifications</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain reclassifications have been made to the financial statements for prior periods to conform to the current period presentation.</font></div> NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIESMannatech, Incorporated (together with its subsidiaries, the “Company”), false false false us-types:textBlockItemType textblock No definition available. No authoritative reference available. false 4 Organization 2 us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mannatech, Incorporated (together with its subsidiaries, the “Company”), headquartered in Coppell, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the NASDAQ Global Select Market under the symbol “MTEX”. The Company develops, markets, and sells high-quality, proprietary nutritional supplements, topical and skin care products, and weight-management products that are primarily sold to independent associates and members located in the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, Singapore, Austria, the Netherlands, Norway, and Sweden.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Independent associates purchase the Company’s products at published wholesale prices to either sell to retail customers or consume personally. Members purchase the Company’s products at a discount from published retail prices primarily for personal consumption. The Company cannot distinguish its personal consumption sales from its other sales because it has no involvement in its products after delivery, other than usual and customary product warr anties and returns. Only independent associates are eligible to earn commissions and incentives.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the Company’s consolidated financial statements and footnotes contained herein do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) to be considered “complete financial statements”. However, in the opinion of the Company’s management, the accompanying unaudited consolidated financial statements and footnotes contain all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company’s consolidated financial information as of, and for, the periods presented. The Company cautions that its consolidated results of operations for an interim period are not necessarily indicative of its consolidated results of operations to be expected for its fiscal year. The December 31, 2009 consolidated balance sheet was included in the audited consolidated financial statements in the Company’s annual report on Form 10-K for the year ended December 31, 2009 and filed with the United States Securities and Exchange Commission on March 11, 2010 (the “2009 Annual Report”), which includes all disclosures required by GAAP. Therefore, these unaudited consolidated financial statements should be read in conjunction with the consolidated financ ial statements of the Company included in the 2009 Annual Report.</font></div> NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIESMannatech, Incorporated (together with its subsidiaries, the “Company”), false false false us-types:textBlockItemType textblock Description containing the entire organization, consolidation and basis of presentation of financial statements disclosure. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS140-4 and FIN46(R)-8 -Paragraph 8, C1, C7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 2-6 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 94-6 -Paragraph 10 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 46R -Paragraph 4, 14, 15 false 5 Summary of Significant Accounting Policies 2 us-gaap_SignificantAccountingPoliciesTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Principles of Consolidation</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RI GHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Use of Estimates</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The preparation of the Company’s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company&#8 217;s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. Actual results may differ from these estimates under different assumptions or conditions.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered to be the most significant are described in this note to the consolidated financial statements, <font style="DISPLAY: inline; FONT-STYLE: italic">Organization and Summary of Significant Accounting Policies</font>.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0 pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Cash and Cash Equivalents</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivables are generally received within 24 to 72 hours. As of September 30, 2010 and December 31, 2009, credit card receivables were $3.6 million and $2.8 million, respectively . Additionally, as of September 30, 2010 and December 31, 2009, cash and cash equivalents held in bank accounts in foreign countries totaled $10.5 million and $10.2 million, respectively.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"></font> </div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Restricted Cash</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company is required to restrict cash for (i) direct selling insurance premiums and credit card sales in the Republic of Korea, (ii) a reserve on credit card sales in the United States and Canada, and (iii) collateral for its Australia building lease. As of September 30, 2010 and December 31, 2009, our total restricted cash was $6.9 million and $8.5 million, respectively. The decrease in restricted cash was primarily related to the partial refund of direct selling insurance premiums in Korea.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Accounts Receivable</font></font></div><div style="DISPLAY: bl ock; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. Receivables consist primarily of amounts due from members and independent associates. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time they are past due, and writes-off receivables when they become uncollectible. At September 30, 2010 and December 31, 2009, the Company held an allowance for doubtful accounts of less than $0.1 million.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TE XT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Inventories</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories consist of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDEN T: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Assets</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of September 30, 2010 and December 31, 2009, other assets of $2.2 million and $2.5 million primarily consisted of deposits for building leases in various locations and certain intangible assets.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: i talic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Commissions and Incentives</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Independent associates earn commissions and incentives based on their direct and indirect commissionable net sales over 13 business periods. Each business period equals 28 days. The Company accrues commissions and incentives when earned by independent associates and pays commissions on product sales three weeks following the business period end and pays commissions on its pack sales five weeks following the business period end.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Long-Term Liabilities</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In August 2003, the Company entered into a Long-Term Post-Employment Royalty Agreement with Dr. Bill McAnalley, the Company’s former Chief Science Officer, pursuant to which the Company is required to pay Dr. McAnalley, or his heirs, royalties for ten years beginning September 2005 and continuing through August 2015. Quarterly payments related to this Long-Term Post-Employment Royalty Agreement are based on certain applicable an nual global product sales by the Company in excess of $105.4 million. At the time the Company entered into this royalty agreement, it was considered a post-employment benefit and the Company was required to measure and accrue the present value of the estimated future royalty payments related to this benefit, and recognize it over the life of Dr. McAnalley’s employment agreement, which was two years. As of September 30, 2010, the Company’s liability related to this royalty agreement was $1.3 million, of which $0.3 million was currently due and included in accrued expenses.  As of December 31, 2009, the Company’s long-term liability related to this royalty agreement was $1.6 million, of which $0.3 million was currently due and included in accrued expenses.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align ="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain operating leases for the Company’s regional office facilities contain a restoration clause that requires the Company to restore the premises to its original condition. As of September 30, 2010 and December 31, 2009, accrued restoration costs related to these leases amounted to $0.4 million. At September 30, 2010 and December 31, 2009, the Company also recorded a long-term liability for an estimated deferred benefit obligation related to a deferred benefit plan for its Japan operations of $1.1 million and $0.8 million, respectively.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Comprehensive Income (loss) and Accumulated Other Comprehensive Income (loss</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">)</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company’s comprehensive income (loss) consists of the Company’s net income (loss), foreign currency translation adjustments from its Japan, Republic of Korea, Taiwan, Norway, and Sweden operations, and c hanges in the pension obligation for its Japanese employees.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Revenue Recognition</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company’s revenue is derived from sales of individual products, sales of its starter and renewal packs, and shipping fees. Substantially all of the Company’s product and pack sales are made to independent associates at published wh olesale prices and to members at discounted published retail prices. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company recognizes revenue from shipped packs and products upon receipt by the customer. Corporate-sponsored event revenue is recognized when the event is held. The Company defers certain components of its revenue. At September 30, 2010 and December 31, 2009, the Company’s deferred revenue was $2.9 million and $2.8 million, respectively, and consisted primarily of revenue received from: (i) sales of packs and products shipped but not received by the customers by period end; and (ii) prepaid registration fees from customers planning to attend a future corporate-sponsored event.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six- month period. If actual results differ from our estimated sales return reserve due to various factors, the amount of revenue recorded each period could be materially affected. Historically, our sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days after the original sale. Sales returns have averaged 1.5% or less of our gross sales. For the nine months ended September 30, 2010 our sales return reserve was composed of the following <font style="DISP LAY: inline; FONT-STYLE: italic">(in thousands)</font>:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="65%"><tr><td valign="bottom" width="51%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 30, 2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr> ;<tr bgcolor="#cceeff"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales reserve as of January 1, 2010</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">595</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#1 60; </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision related to sales made in current period</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,591</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff">< ;td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision related to sales made in prior periods</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">112</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: b lock; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Actual returns or credits related to current period</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,128</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="#cceeff"><td valign="bottom " align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Actual returns or credits related to prior periods</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(710</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font st yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales reserve as of September 30, 2010</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">460</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Shipping and Handling Costs</font></font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company records freight and shipping fees collected from its customers as revenue. The Company records inbound freight as cost of sales and records shipping and handling costs associated with shipping products to customers as selling and administrative expenses. Total shipping and handling costs included in selling and administrative expenses were approximately $2.7 million and $3.6 million for the three months ended September 30, 2010 and 2009, respectively, and $8.8 million and $10.6 million for the nine months ended September 30, 2010 and 2009, respectively.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Reclassifications</font></font></div><div style="DISPLAY: block; TEXT - -INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain reclassifications have been made to the financial statements for prior periods to conform to the current period presentation.</font></div> Principles of ConsolidationThe consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All false false false us-types:textBlockItemType textblock This element may be used to describe all significant accounting policies of the reporting entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 22 -Paragraph 8 false 1 4 false UnKnown UnKnown UnKnown false true XML 26 R5.xml IDEA: CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED 2.2.0.7 false CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED (USD $) 004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED true false In Thousands false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 3 CASH FLOWS FROM OPERATING ACTIVITIES: 1 us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities include all transactions and events that are not defined as investing or financing activities. Operating activities generally involve producing and delivering goods and providing services. Cash flows from operating activities are generally the cash effects of transactions and other events that enter into the determination of net income. false 4 Net loss 2 us-gaap_NetIncomeLoss us-gaap true credit duration No definition available. false false false false false false false false false false false totallabel false 1 true true false false -7874000 -7874 false false false 2 true true false false -19519000 -19519 false false false xbrli:monetaryItemType monetary The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 true 5 Adjustments to reconcile net loss to net cash provided by (used in) operating ativities: 2 us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract us-gaap true na duration No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 6 Depreciation and amortization 3 us-gaap_DepreciationDepletionAndAmortization us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 8691000 8691 false false false 2 false true false false 9357000 9357 false false false xbrli:monetaryItemType monetary The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. No authoritative reference available. false 7 Provision for inventory losses 3 us-gaap_InventoryWriteDown us-gaap true debit duration No definition available. false false false false false false false false false false false false 1 false true false false 1538000 1538 false false false 2 false true false false 821000 821 false false false xbrli:monetaryItemType monetary Charge to cost of goods sold that represents the reduction of the carrying amount of inventory, generally attributable to obsolescence or market conditions. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 4 -Section 7 -Paragraph 14 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 86 false 8 Provision for doubtful accounts 3 us-gaap_ProvisionForDoubtfulAccounts us-gaap true debit duration No definition available. false false false false false false false false false false false false 1 false true false false 28000 28 false false false 2 false true false false -7000 -7 false false false xbrli:monetaryItemType monetary Amount of the current period expense charged against operations, the offset which is generally to the allowance for doubtful accounts for the purpose of reducing receivables, including notes receivable, to an amount that approximates their net realizable value (the amount expected to be collected). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 5 -Article 5 false 9 Loss on disposal of assets 3 us-gaap_GainsLossesOnSalesOfOtherAssets us-gaap true credit duration No definition available. false false false false false false false false false false false false 1 false true false false 61000 61 false false false 2 false true false false 94000 94 false false false xbrli:monetaryItemType monetary The net gain or loss resulting from the sale or disposal of assets not required to be reported separately in the statement of income. No authoritative reference available. false 10 Accounting charge related to stock-based compensation expense 3 us-gaap_ShareBasedCompensation us-gaap true debit duration No definition available. false false false false false false false false false false false false 1 false true false false 464000 464 false false false 2 false true false false 437000 437 false false false xbrli:monetaryItemType monetary The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock options, amortization of restricted stock, and adjustment for officers compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 11 Deferred income taxes 3 us-gaap_DeferredIncomeTaxExpenseBenefit us-gaap true debit duration No definition available. false false false false false false false false false false false false 1 false true false false -2024000 -2024 false false false 2 false true false false -1556000 -1556 false false false xbrli:monetaryItemType monetary The component of income tax expense for the period representing the net change in the entity's deferred tax assets and liabilities pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph b Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 289 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 false 12 Changes in operating assets and liabilities: 2 us-gaap_IncreaseDecreaseInOperatingCapitalAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 13 Accounts receivable 3 us-gaap_IncreaseDecreaseInAccountsReceivable us-gaap true credit duration No definition available. false false false false false false false false false false false false 1 false true false false 478000 478 false false false 2 false true false false 12000 12 false false false xbrli:monetaryItemType monetary The net change during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 14 Income tax receivable 3 us-gaap_IncreaseDecreaseInIncomeTaxesReceivable us-gaap true credit duration No definition available. false false false false false false false false false false false false 1 false true false false 7079000 7079 false false false 2 false true false false 517000 517 false false false xbrli:monetaryItemType monetary The net change during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 15 Inventories 3 us-gaap_IncreaseDecreaseInInventories us-gaap true credit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 4411000 4411 false false false 2 false true false false 1265000 1265 false false false xbrli:monetaryItemType monetary The net change during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 16 Prepaid expenses and other current assets 3 mtex_PrepaidExpensesAndOtherCurrentAssets mtex false na duration The net change during the reporting period in the amount of outstanding money paid in advance for goods or services that... false false false false false false false false false false false false 1 false true false false 53000 53 false false false 2 false true false false 2220000 2220 false false false xbrli:monetaryItemType monetary The net change during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods and in other operating assets not otherwise defined in the taxonomy. No authoritative reference available. false 17 Other assets 3 us-gaap_IncreaseDecreaseInOtherOperatingAssets us-gaap true credit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 428000 428 false false false 2 false true false false -1022000 -1022 false false false xbrli:monetaryItemType monetary The net change during the reporting period in other operating assets not otherwise defined in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 18 Accounts payable 3 us-gaap_IncreaseDecreaseInAccountsPayable us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false -6062000 -6062 false false false 2 false true false false 1630000 1630 false false false xbrli:monetaryItemType monetary The net change during the reporting period in the aggregate amount of obligations due within one year (or one business cycle). This may include trade payables, amounts due to related parties, royalties payable, and other obligations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 19 Accrued expenses 3 us-gaap_IncreaseDecreaseInAccruedLiabilities us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 592000 592 false false false 2 false true false false -2635000 -2635 false false false xbrli:monetaryItemType monetary The net change during the reporting period in the aggregate amount of expenses incurred but not yet paid. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 20 Taxes payable 3 us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 699000 699 false false false 2 false true false false 774000 774 false false false xbrli:monetaryItemType monetary The net change during the period in the amount of cash payments due to taxing authorities for taxes that are based on the reporting entity's earnings. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 21 Commissions and incentives payable 3 mtex_IncreaseDecreaseInCommissionsAndIncentivesPayable mtex false na duration The net change during the reporting period in the aggregate amount of commissions and incentives incurred but not yet paid. false false false false false false false false false false false terselabel false 1 false true false false -3697000 -3697 false false false 2 false true false false 2505000 2505 false false false xbrli:monetaryItemType monetary The net change during the reporting period in the aggregate amount of commissions and incentives incurred but not yet paid. No authoritative reference available. false 22 Deferred revenue 3 us-gaap_IncreaseDecreaseInDeferredRevenue us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 72000 72 false false false 2 false true false false 399000 399 false false false xbrli:monetaryItemType monetary The net change during the reporting period, excluding the portion taken into income, in the liability reflecting services yet to be performed by the reporting entity for which cash or other forms of consideration was received or recorded as a receivable. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 23 Net cash provided by (used in) operating activities 2 us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations us-gaap true na duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 4937000 4937 false false false 2 false true false false -4708000 -4708 false false false xbrli:monetaryItemType monetary The net cash from (used in) the entity's continuing operations. This element specifically EXCLUDES the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in operating activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -Footnote 10 true 24 CASH FLOWS FROM INVESTING ACTIVITIES: 1 us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 25 Purchases of property and equipment 2 us-gaap_PaymentsToAcquirePropertyPlantAndEquipment us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false -1529000 -1529 false false false 2 false true false false -2500000 -2500 false false false xbrli:monetaryItemType monetary The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 17 -Subparagraph c false 26 Change in restricted cash 2 us-gaap_IncreaseDecreaseInRestrictedCash us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false 1687000 1687 false false false 2 false true false false 389000 389 false false false xbrli:monetaryItemType monetary The net cash inflow (outflow) for the net change associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 16, 17 false 27 Net cash provided by (used in) investing activities 2 us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations us-gaap true debit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 158000 158 false false false 2 false true false false -2111000 -2111 false false false xbrli:monetaryItemType monetary The net cash from (used in) the entity's investing activities specifically EXCLUDING the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in investing activities. Such reporting would necessitate the entity to use the Net Cash Provided by (Used in) Discontinued Operations, Total element provided in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -Footnote 10 true 28 CASH FLOWS FROM FINANCING ACTIVITIES: 1 us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 29 Proceeds from stock options exercised 2 us-gaap_ProceedsFromStockOptionsExercised us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 28000 28 false false false 2 false true false false 66000 66 false false false xbrli:monetaryItemType monetary The cash inflow associated with the amount received from holders exercising their stock options. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph i Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 19 -Subparagraph a false 30 Payment of cash dividends 2 us-gaap_PaymentsOfDividends us-gaap true credit duration No definition available. false false false false false false false false false false false false 1 false true false false 0 0 false false false 2 false true false false 1058000 1058 false false false xbrli:monetaryItemType monetary The cash outflow from the entity's earnings to the shareholders. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 20 -Subparagraph a false 31 Repayment of capital lease obligations 2 us-gaap_RepaymentsOfLongTermCapitalLeaseObligations us-gaap true credit duration No definition available. false false false false false false false false false false false false 1 false true false false 917000 917 false false false 2 false true false false 273000 273 false false false xbrli:monetaryItemType monetary The cash outflow for the obligation for lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26, 31 false 32 Net cash used in financing activities 2 us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations us-gaap true debit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false -889000 -889 false false false 2 false true false false -1265000 -1265 false false false xbrli:monetaryItemType monetary The net cash from (used in) the entity's financing activities specifically EXCLUDING the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in financing activities. Such reporting would necessitate the entity to use the Net Cash Provided by (Used in) Discontinued Operations, Total element provided in the taxonomy. No authoritative reference available. true 33 Effect of currency exchange rate changes on cash and cash equivalents 1 us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents us-gaap true debit duration No definition available. false false false false false false false false false false false false 1 false true false false 107000 107 false false false 2 false true false false -284000 -284 false false false xbrli:monetaryItemType monetary The effect of exchange rate changes on cash balances held in foreign currencies. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 25 false 34 Net increase (decrease) in cash and cash equivalents 1 us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease us-gaap true na duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 4313000 4313 false false false 2 false true false false -8368000 -8368 false false false xbrli:monetaryItemType monetary The net change between the beginning and ending balance of cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 true 35 Cash and cash equivalents at the beginning of period 1 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant No definition available. false false false false false false false false true false false periodstartlabel false 1 false true false false 17367000 17367 false false false 2 false true false false 30945000 30945 false false false xbrli:monetaryItemType monetary Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 36 Cash and cash equivalents at the end of period 1 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant No definition available. false false false false false false false false false true false periodendlabel false 1 false true false false 21680000 21680 false false false 2 false true false false 22577000 22577 false false false xbrli:monetaryItemType monetary Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 37 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: 1 us-gaap_SupplementalCashFlowInformationAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 38 Income taxes received, net 2 us-gaap_IncomeTaxesPaidNet us-gaap true credit duration No definition available. false false false false false false false false false false false false 1 false true false false 7228000 7228 false false false 2 false true false false 2721000 2721 false false false xbrli:monetaryItemType monetary The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 29 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 27 -Subparagraph f false 39 Interest paid on capital leases 2 mtex_InterestPaidOnCapitalLeases mtex false na duration The amount of cash paid during the current period for interest on leasing arrangements meeting the criteria for... false false false false false false false false false false false false 1 true true false false 69000 69 false false false 2 true true false false 29000 29 false false false xbrli:monetaryItemType monetary The amount of cash paid during the current period for interest on leasing arrangements meeting the criteria for capitalization. No authoritative reference available. false 2 37 false Thousands UnKnown UnKnown false true XML 27 defnref.xml IDEA: XBRL DOCUMENT No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Disclosure of Litigation No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The net change during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods and in other operating assets not otherwise defined in the taxonomy. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales commissions and incentives earned. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The net change during the reporting period in the aggregate amount of commissions and incentives incurred but not yet paid. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Primarily represents commissions and incentives earned by eligible independent associates based on their direct and indirect commissionable net sales. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The amount of cash paid during the current period for interest on leasing arrangements meeting the criteria for capitalization. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. XML 28 R13.xml IDEA: RECENT ACCOUNTING PRONOUNCEMENTS 2.2.0.7 false RECENT ACCOUNTING PRONOUNCEMENTS 006070 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Recent Accounting Pronouncements 1 us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 8: RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In October 2009, the FASB issued Accounting Standards Update No. 2009-13, “<font style="DISPLAY: inline; FONT-STYLE: italic">Revenue Recognition—Multiple Deliverable Revenue Arrangements”</font> (“<a id="keyword" name="keyword"></a>ASU 2009-13”). ASU 2009-13 updates the existing multiple-element revenue arrangements guidance currently included in FASB AS C 605-25. The revised guidance provides for two significant changes to the existing multiple element revenue arrangements guidance. The first change relates to the determination of when the individual deliverables included in a multiple-element arrangement may be treated as separate units of accounting. The second change modifies the manner in which the transaction consideration is allocated across the separately identified deliverables. The revised guidance also expands the disclosures required for multiple-element revenue arrangements. The revised multiple-element revenue arrangements guidance will be effective for the first annual reporting period beginning on or after June 15, 2010. The adoption of ASU <a id="lastkeyword" name="lastkeyword"></a>2009-13 is not expected to have a material impact on the Company’s financial position or results of operations.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></di v><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In January 2009, the Securities and Exchange Commission issued Release No. 33-9002, <font style="DISPLAY: inline; FONT-STYLE: italic">“Interactive Data to Improve Financial Reporting.”</font> The final rule requires companies to provide their financial statements and financial statement schedules to the Securities and Exchange Commission in interactive data format using the eXtensible Business Reporting Language (“XBRL”). The rule was adopted by the Securities and Exchange Commission to improve the ability of financial statement users to access and analyze financial data. The Securities and Exchange Commission adopted a phase-in schedule indicating when registrants must furnish interactive data. Under this schedule, the Company will be required to subm it filings with financial statement information using XBRL commencing with our June 30, 2011 quarterly report on Form 10-Q. We began furnishing financial information in XBRL format starting with our quarterly report on Form 10-Q for the period ended September 30, 2009. As an early XBRL adopter, the Company may choose to discontinue furnishing XBRL data in the future until the required compliance date of June 30, 2011.</font></div> NOTE 8: RECENT ACCOUNTING PRONOUNCEMENTSIn October 2009, the FASB issued Accounting Standards Update No. 2009-13, “Revenue false false false us-types:textBlockItemType textblock Represents disclosure of any changes in an accounting principle, including a change from one generally accepted accounting principle to another generally accepted accounting principle when there are two or more generally accepted accounting principles that apply or when the accounting principle formerly used is no longer generally accepted. Also disclose any change in the method of applying an accounting principle, or any change in an accounting principle required by a new pronouncement in the unusual instance that a new pronouncement does not include specific transition provisions. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 154 -Paragraph 2, 17, 18 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 28 -Paragraph 23, 24 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 01 -Paragraph b -Subparagraph 6 -Article 10 false 1 2 false UnKnown UnKnown UnKnown false true XML 29 R1.xml IDEA: CONSOLIDATED BALANCE SHEETS 2.2.0.7 false CONSOLIDATED BALANCE SHEETS (USD $) 001000 - Statement - CONSOLIDATED BALANCE SHEETS true false In Thousands false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 3 ASSETS 1 us-gaap_AssetsAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 4 Cash and cash equivalents 2 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 true true false false 21680000 21680 false false false 2 true true false false 17367000 17367 false false false xbrli:monetaryItemType monetary Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 5 Restricted cash 2 us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 1282000 1282 false false false 2 false true false false 1288000 1288 false false false xbrli:monetaryItemType monetary The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Audit and Accounting Guide (AAG) -Number AAG-BRD -Chapter 4 -Paragraph 80 -Subparagraph Exhibit 4-8, 3 -IssueDate 2006-05-01 false 6 Accounts receivable, net of allowance of $14 and $17 in 2010 and 2009, respectively 2 us-gaap_AccountsReceivableNetCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 163000 163 false false false 2 false true false false 664000 664 false false false xbrli:monetaryItemType monetary Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a(1) -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 false 7 Income tax receivable 2 us-gaap_IncomeTaxesReceivable us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 999000 999 false false false 2 false true false false 8075000 8075 false false false xbrli:monetaryItemType monetary Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 5 -Subparagraph c -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Section Appendix E -Paragraph 289 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 10 -Article 9 false 8 Inventories, net 2 us-gaap_InventoryNet us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 25389000 25389 false false false 2 false true false false 31290000 31290 false false false xbrli:monetaryItemType monetary Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer). No authoritative reference available. false 9 Prepaid expenses and other current assets 2 us-gaap_OtherAssetsCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 3515000 3515 false false false 2 false true false false 3139000 3139 false false false xbrli:monetaryItemType monetary Aggregate carrying amount, as of the balance sheet date, of current assets not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 false 10 Deferred tax assets 2 us-gaap_DeferredTaxAssetsNetCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false false 1 false true false false 2823000 2823 false false false 2 false true false false 2662000 2662 false false false xbrli:monetaryItemType monetary The current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. An unrecognized tax benefit that is directly related to a position taken in a tax year that results in a net operating los s carryforward should be presented as a reduction of the related deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42, 43 false 11 Total current assets 2 us-gaap_AssetsCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 55851000 55851 false false false 2 false true false false 64485000 64485 false false false xbrli:monetaryItemType monetary Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 9 -Article 5 true 12 Property and equipment, net 2 us-gaap_PropertyPlantAndEquipmentNet us-gaap true debit instant No definition available. false false false false false false false false false false false false 1 false true false false 19963000 19963 false false false 2 false true false false 27144000 27144 false false false xbrli:monetaryItemType monetary Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, and production equipment. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 12 -Paragraph 5 -Subparagraph b, c Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false 13 Construction in progress 2 us-gaap_ConstructionInProgressGross us-gaap true debit instant No definition available. false false false false false false false false false false false false 1 false true false false 1507000 1507 false false false 2 false true false false 317000 317 false false false xbrli:monetaryItemType monetary Carrying amount at the balance sheet date of long-lived asset under construction that include construction costs to date on capital projects that have not been completed and assets being constructed that are not ready to be placed into service. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 false 14 Long-term restricted cash 2 us-gaap_RestrictedCashAndCashEquivalentsNoncurrent us-gaap true debit instant No definition available. false false false false false false false false false false false false 1 false true false false 5632000 5632 false false false 2 false true false false 7201000 7201 false false false xbrli:monetaryItemType monetary Cash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 15 Other assets 2 us-gaap_OtherAssetsNoncurrent us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 2162000 2162 false false false 2 false true false false 2503000 2503 false false false xbrli:monetaryItemType monetary Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false 16 Long-term deferred tax assets 2 us-gaap_DeferredTaxAssetsNetNoncurrent us-gaap true debit instant No definition available. false false false false false false false false false false false false 1 false true false false 693000 693 false false false 2 false true false false 652000 652 false false false xbrli:monetaryItemType monetary The noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42, 43 false 17 Total assets 2 us-gaap_Assets us-gaap true debit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 85808000 85808 false false false 2 false true false false 102302000 102302 false false false xbrli:monetaryItemType monetary Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 true 18 LIABILITIES AND SHAREHOLDERS' EQUITY 1 us-gaap_LiabilitiesAndStockholdersEquityAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 19 Current portion of capital leases 2 us-gaap_CapitalLeaseObligationsCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 1197000 1197 false false false 2 false true false false 847000 847 false false false xbrli:monetaryItemType monetary Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid within one year (or one operating cycle, if longer) of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 13 -Paragraph 7, 10, 13 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Article 5 false 20 Accounts payable 2 us-gaap_AccountsPayableCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 5309000 5309 false false false 2 false true false false 11319000 11319 false false false xbrli:monetaryItemType monetary Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 false 21 Accrued expenses 2 us-gaap_AccruedLiabilitiesCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 13271000 13271 false false false 2 false true false false 14231000 14231 false false false xbrli:monetaryItemType monetary Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 false 22 Commissions and incentives payable 2 mtex_CommissionsAndIncentivesPayable mtex false na instant Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales commissions... false false false false false false false false false false false terselabel false 1 false true false false 7097000 7097 false false false 2 false true false false 10624000 10624 false false false xbrli:monetaryItemType monetary Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales commissions and incentives earned. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). No authoritative reference available. false 23 Taxes payable 2 us-gaap_TaxesPayableCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 3265000 3265 false false false 2 false true false false 2577000 2577 false false false xbrli:monetaryItemType monetary Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20 -Article 5 false 24 Current deferred tax liability 2 us-gaap_DeferredTaxLiabilitiesCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 423000 423 false false false 2 false true false false 274000 274 false false false xbrli:monetaryItemType monetary Represents the current portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A current taxable temporary difference is a difference between the tax basis and the carrying amount of a current asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42, 43 false 25 Deferred revenue 2 us-gaap_DeferredRevenueCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 2881000 2881 false false false 2 false true false false 2807000 2807 false false false xbrli:monetaryItemType monetary The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 3 -Section A -Paragraph 7, 8 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section A false 26 Total current liabilities 2 us-gaap_LiabilitiesCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 33443000 33443 false false false 2 false true false false 42679000 42679 false false false xbrli:monetaryItemType monetary Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 true 27 Capital leases, excluding current portion 2 us-gaap_CapitalLeaseObligationsNoncurrent us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 1402000 1402 false false false 2 false true false false 1068000 1068 false false false xbrli:monetaryItemType monetary Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 13 -Paragraph 7, 10, 13 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 false 28 Long-term deferred tax liabilities 2 us-gaap_DeferredTaxLiabilitiesNoncurrent us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 1736000 1736 false false false 2 false true false false 3923000 3923 false false false xbrli:monetaryItemType monetary Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42 false 29 Other long-term liabilities 2 us-gaap_OtherLiabilitiesNoncurrent us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 5189000 5189 false false false 2 false true false false 3348000 3348 false false false xbrli:monetaryItemType monetary Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet due to materiality considerations. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 24 -Article 5 false 30 Total liabilities 2 us-gaap_Liabilities us-gaap true credit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 41770000 41770 false false false 2 false true false false 51018000 51018 false false false xbrli:monetaryItemType monetary Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. No authoritative reference available. true 31 Commitments and contingencies 1 us-gaap_CommitmentsAndContingencies2009 us-gaap true na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0     false false false 2 false false false false 0 0     false false false xbrli:stringItemType string Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. This caption alerts the reader that one or more notes to the financial statements disclose pertinent information about the entity's commitments and contingencies. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 25 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 17 -Article 9 false 32 Shareholders' equity 1 us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 33 Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding 2 us-gaap_PreferredStockValue us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 0 0 false false false 2 false true false false 0 0 false false false xbrli:monetaryItemType monetary Dollar value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) whether issued at par value, no par or stated value. This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false 34 Common stock, $0.0001 par value, 99,000,000 shares authorized, 27,697,560 shares issued and 26,490,466 shares outstanding in 2010 and 27,687,882 shares issued and 26,480,788 shares outstanding in 2009 2 us-gaap_CommonStockValue us-gaap true credit instant No definition available. false false false false false false false false false false false label false 1 false true false false 3000 3 false false false 2 false true false false 3000 3 false false false xbrli:monetaryItemType monetary Dollar value of issued common stock whether issued at par value, no par or stated value. This item includes treasury stock repurchased by the entity. Note: elements for number of common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 35 Additional paid-in capital 2 us-gaap_AdditionalPaidInCapital us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 41934000 41934 false false false 2 false true false false 41442000 41442 false false false xbrli:monetaryItemType monetary Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of APIC associated with common AND preferred stock. For APIC associated with only common stock, use the element Additional Paid In Capital, Common Stock. For APIC associated with only preferred stock, use the element Additional Paid In Capital, Preferred Stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 false 36 Retained earnings 2 us-gaap_RetainedEarningsAccumulatedDeficit us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 17869000 17869 false false false 2 false true false false 25743000 25743 false false false xbrli:monetaryItemType monetary The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 false 37 Accumulated other comprehensive loss 2 us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false -977000 -977 false false false 2 false true false false -1113000 -1113 false false false xbrli:monetaryItemType monetary Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at fiscal year-end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, and unrealized gains and losses on certain investments in debt and equity securities as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 26 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 false 38 Less treasury stock, at cost, 1,207,094 shares in 2010 and 2009 2 us-gaap_TreasuryStockValue us-gaap true debit instant No definition available. false false false false false false false false false false true negated false 1 false true false false -14791000 -14791 false false false 2 false true false false -14791000 -14791 false false false xbrli:monetaryItemType monetary Value of common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. Treasury stock is issued but is not outstanding. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Note: number of treasury shares concept is in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Technical Bulletin (FTB) -Number 85-6 -Paragraph 3 false 39 Total shareholders' equity 2 us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 false true false false 44038000 44038 false false false 2 false true false false 51284000 51284 false false false xbrli:monetaryItemType monetary Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 25 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 26 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A false 40 Total liabilities and shareholders' equity 2 us-gaap_LiabilitiesAndStockholdersEquity us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 true true false false 85808000 85808 false false false 2 true true false false 102302000 102302 false false false xbrli:monetaryItemType monetary Total of all Liabilities and Stockholders' Equity items. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 false 2 38 false Thousands UnKnown UnKnown false true XML 30 R2.xml IDEA: PARENTHETICAL DATA TO THE CONSOLIDATED BALANCE SHEETS 2.2.0.7 false PARENTHETICAL DATA TO THE CONSOLIDATED BALANCE SHEETS (USD $) 001010 - Statement - PARENTHETICAL DATA TO THE CONSOLIDATED BALANCE SHEETS true false In Thousands, except Share data false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 3 ASSETS 1 us-gaap_AssetsAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 4 Allowance for Doubtful Accounts Receivable 2 us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false false 1 true true false false 14000 14 false false false 2 true true false false 17000 17 false false false xbrli:monetaryItemType monetary A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 false 5 Shareholders' equity 1 us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 6 Preferred stock, par value 2 us-gaap_PreferredStockParOrStatedValuePerShare us-gaap true na instant No definition available. false false false false false false false false false false false true 1 true true false false 0.01 0.01 false false false 2 true true false false 0.01 0.01 false false false us-types:perShareItemType decimal Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 false 7 Preferred stock, shares authorized 2 us-gaap_PreferredStockSharesAuthorized us-gaap true na instant No definition available. false false false false false false false false false false false false 1 false true false false 1000000 1000000 false false false 2 false true false false 1000000 1000000 false false false xbrli:sharesItemType shares The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 false 8 Preferred stock, shares issued 2 us-gaap_PreferredStockSharesIssued us-gaap true na instant No definition available. false false false false false false false false false false false false 1 false true false false 0 0 false false false 2 false true false false 0 0 false false false xbrli:sharesItemType shares Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false 9 Preferred stock, shares outstanding 2 us-gaap_PreferredStockSharesOutstanding us-gaap true na instant No definition available. false false false false false false false false false false false false 1 false true false false 0 0 false false false 2 false true false false 0 0 false false false xbrli:sharesItemType shares Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false 10 Common stock, par value 2 us-gaap_CommonStockParOrStatedValuePerShare us-gaap true na instant No definition available. false false false false false false false false false false false terselabel true 1 true true false false 0.0001 0.0001 false false false 2 true true false false 0.0001 0.0001 false false false us-types:perShareItemType decimal Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 11 Common stock, shares authorized 2 us-gaap_CommonStockSharesAuthorized us-gaap true na instant No definition available. false false false false false false false false false false false false 1 false true false false 99000000 99000000 false false false 2 false true false false 99000000 99000000 false false false xbrli:sharesItemType shares The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 12 Common stock, shares issued 2 us-gaap_CommonStockSharesIssued us-gaap true na instant No definition available. false false false false false false false false false false false false 1 false true false false 27697560 27697560 false false false 2 false true false false 27687882 27687882 false false false xbrli:sharesItemType shares Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 13 Common stock, shares outstanding 2 us-gaap_CommonStockSharesOutstanding us-gaap true na instant No definition available. false false false false false false false false false false false false 1 false true false false 26490466 26490466 false false false 2 false true false false 26480788 26480788 false false false xbrli:sharesItemType shares Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Excludes common shares repurchased by the entity and held as Treasury shares. Shares outstanding equals shares issued minus shares held in treasury. Does not include common shares that have been repurchased. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 14 Treasury stock, shares 2 us-gaap_TreasuryStockShares us-gaap true na instant No definition available. false false false false false false false false false false false false 1 false true false false 1207094 1207094 false false false 2 false true false false 1207094 1207094 false false false xbrli:sharesItemType shares Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false 2 12 false Thousands NoRounding NoRounding false true XML 31 FilingSummary.xml IDEA: XBRL DOCUMENT 2.2.0.7 true Sheet 001000 - Statement - CONSOLIDATED BALANCE SHEETS CONSOLIDATED BALANCE SHEETS http://mannatech.com/role/ConsolidatedBalanceSheets false R1.xml false Sheet 001010 - Statement - PARENTHETICAL DATA TO THE CONSOLIDATED BALANCE SHEETS PARENTHETICAL DATA TO THE CONSOLIDATED BALANCE SHEETS http://mannatech.com/role/ParentheticalDataToConsilidatedBalanceSheets false R2.xml false Sheet 002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED http://mannatech.com/role/ConsolidatedStatementsOfOperations false R3.xml false Sheet 003000 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE INCOME (LOSS) - UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE INCOME (LOSS) - UNAUDITED http://mannatech.com/role/ConsolidatedStatementOfShareholdersEquityAndComprehensiveIncome false R4.xml false Sheet 004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED http://mannatech.com/role/ConsolidatedStatementsOfCashFlows false R5.xml false Sheet 006010 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES http://mannatech.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies false R6.xml false Sheet 006020 - Disclosure - INVENTORIES INVENTORIES http://mannatech.com/role/Inventories false R7.xml false Sheet 006030 - Disclosure - INCOME TAXES INCOME TAXES http://mannatech.com/role/IncomeTaxes false R8.xml false Sheet 006040 - Disclosure - LOSS PER SHARE LOSS PER SHARE http://mannatech.com/role/LossPerShare false R9.xml false Sheet 006050 - Disclosure - STOCK BASED COMPENSATION STOCK BASED COMPENSATION http://mannatech.com/role/StockBasedCompensation false R10.xml false Sheet 006055 - Disclosure - SHAREHOLDERS' EQUITY SHAREHOLDERS' EQUITY http://mannatech.com/role/ShareholdersEquity false R11.xml false Sheet 006060 - Disclosure - LITIGATION LITIGATION http://mannatech.com/role/Litigation false R12.xml false Sheet 006070 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS RECENT ACCOUNTING PRONOUNCEMENTS http://mannatech.com/role/RecentAccountingPronouncements false R13.xml false Sheet 006080 - Disclosure - FAIR VALUE FAIR VALUE http://mannatech.com/role/FairValue false R14.xml false Sheet 006090 - Disclosure - SEGMENT INFORMATION SEGMENT INFORMATION http://mannatech.com/role/SegmentInformation false R15.xml false Sheet 995200 - Document - Document Information Document Information http://xbrl.us/us-gaap/role/document/DocumentInformation false R16.xml false Sheet 995400 - Document - Entity Information Entity Information http://xbrl.us/us-gaap/role/document/EntityInformation false R17.xml false Book All Reports All Reports false 1 25 5 0 3 123 false false c00002 1 c00024 1 c00019 1 c00007 1 c00000 46 c00004 2 c00020 2 c00012 1 c00009 1 c00021 19 c00001 1 c00016 2 c00018 1 c00014 1 c00022 19 c00003 44 c00015 44 c00006 1 c00008 2 c00010 75 c00017 1 c00023 1 c00011 2 c00005 1 c00013 1 true true EXCEL 32 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\T9F8X9C,Q-5]F,#!A7S0V,SE?.#(P8E\Y,#`W M-S8Y9#$S-F4B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7 M;W)K#I7;W)K#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-(05)%2$],1$524U]%455)5%D\+W@Z3F%M93X-"B`@("`\>#I7 M;W)K#I%>&-E;%=O#I%>&-E M;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-%1TU%3E1?24Y&3U)-051)3TX\+W@Z3F%M93X-"B`@("`\>#I7 M;W)K#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE M#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T M#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\ M8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@ M36EC'1087)T7S1F9CAF,S$U7V8P,&%?-#8S M.5\X,C!B7SDP,#'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA"!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XY.3D\6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA M"!L:6%B:6QI='D\+W1D/@T*("`@("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T9F8X9C,Q-5]F,#!A7S0V,SE? M.#(P8E\Y,#`W-S8Y9#$S-F4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-&9F.&8S,35?9C`P85\T-C,Y7S@R,&)?.3`P-S'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\T9F8X9C,Q-5]F,#!A7S0V,SE?.#(P8E\Y,#`W-S8Y M9#$S-F4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&9F.&8S,35? M9C`P85\T-C,Y7S@R,&)?.3`P-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!S=&]C:SQB'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!T'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQAF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#8Y,3QS M<&%N/CPO2!L;W-S97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW M+#`W.3QS<&%N/CPO2`H=7-E9"!I;BD@ M;W!E2`H=7-E9"!I;BD@:6YV97-T:6YG(&%C=&EV:71I97,\+W1D/@T* M("`@("`@("`\=&0@8VQA&5R8VES960\+W1D/@T*("`@("`@("`\=&0@ M8VQA6UE;G0@;V8@8V%S:"!D:79I9&5N9',\ M+W1D/@T*("`@("`@("`\=&0@8VQA2!E>&-H86YG M92!R871E(&-H86YG97,@;VX@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`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`P<'0G(&%L:6=N M/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^5&AE M(&%C8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N2!A8V-E<'1E M9"!I;B!T:&4@56YI=&5D(%-T871E2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E M2!C M875T:6]N65A M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P M=#L@34%21TE.+5))1TA4.B`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`[/"]D:78^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,S9P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^5&AE($-O;7!A;GD@:7,@ M2X@5&AE(&1E8W)E87-E(&EN(')E6UE;G0@:7,@2!O M9B!A;6]U;G1S(&1U92!F2!E=F%L=6%T97,@ M:71S(')E8V5I=F%B;&5S(&9O2!B87-E9"!O;B!H M:7-T;W)I8V%L(&5X<&5R:65N8V4L(')E8V5N="!A8V-O=6YT(&%C=&EV:71I M97,L(&%N9"!T:&4@;&5N9W1H(&]F('1I;64@=&AE>2!A2!B96-O;64@ M=6YC;VQL96-T:6)L92X@070@4V5P=&5M8F5R(#,P+"`R,#$P(&%N9"!$96-E M;6)E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,S9P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^26YV M96YT;W)I97,@8V]N2!P97)I;V1I8V%L;'D@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@5$585"U$14-/4D%424]..B!U;F1E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<^26YD97!E;F1E;G0@87-S;V-I871E7,N(%1H92!#;VUP86YY(&%C8W)U97,@8V]M;6ES6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\ M+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P=#L@34%21TE.+5))1TA4.B`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`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;B<^0V5R=&%I;B!O<&5R871I;F<@;&5A28C.#(Q-SMS(')E9VEO;F%L(&]F9FEC92!F86-I;&ET:65S(&-O;G1A M:6X@82!R97-T;W)A=&EO;B!C;&%U2!T;R!R97-T;W)E('1H92!P2X\+V9O;G0^ M/"]D:78^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1% M3E0Z(#!P="<^/&)R("\^/"]D:78^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@5$585"U$14-/4D%424]..B!U;F1E M2!O9B!A(&)U&-E<'0@=&AO6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@5$585"U$14-/4D%424]..B!U;F1E28C.#(Q-SMS(')E=F5N=64@:7,@9&5R:79E9"!F2!A;&P@;V8@=&AE($-O;7!A;GDF(S@R,3<[2!R96-O9VYI>F5S M(')E=F5N=64@9G)O;2!S:&EP<&5D('!A8VMS(&%N9"!P2!D969E28C.#(Q-SMS(&1E9F5R2!P97)I;V0@96YD.R!A;F0@*&EI*2!P6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^5V4@97-T:6UA=&4@82!S86QE'!E"T@;6]N=&@@<&5R:6]D+B!)9B!A8W1U86P@7,@869T97(@ M=&AE(&]R:6=I;F%L('-A;&4N(%-A;&5S(')E='5R;G,@:&%V92!A=F5R86=E M9"`Q+C4E(&]R(&QE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E(&-O;'-P86X],T0R/CQD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^4V5P=&5M8F5R(#,P+"`R,#$P/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z("TQ M.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY386QE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT('=I9'1H/3-$,3`E/CQD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY06QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@ M5$585"U)3D1%3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`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`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXI/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$,B4^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[(%1%6%0M24Y$14Y4 M.B`M,3AP=#L@34%21TE.+5))1TA4.B`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`P<'0G(&%L:6=N/3-$;&5F M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^0V5R=&%I;B!R M96-L87-S:69I8V%T:6]N'0^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;B<^5&AE(&%C8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N M2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E2!A8V-E<'1E9"!I M;B!T:&4@56YI=&5D(%-T871E2!C875T:6]N65A6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@5$585"U$14-/4D%424]..B!U;F1E2!A;F0@:71S('=H;VQL>2UO=VYE9"!S=6)S:61I87)I97,N M($%L;"!I;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[(%1% M6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SY56QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,S9P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^5&AE('!R97!A2P@86-T=6%L(')E28C.#(Q-SMS(&5S=&EM871E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,S9P=#L@34%21TE.+5))1TA4.B`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`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`Q M,'!T.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN92<^0V]M<')E:&5N6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,S9P=#L@34%21TE.+5))1TA4.B`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`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^5&AE($-O;7!A;GDF(S@R M,3<[&5S(&%N9"!R96-O M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P=#L@34%21TE.+5)) M1TA4.B`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`[(#PO9F]N=#X\+W1D/CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@+3$X<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$,3`E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ,3(\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$ M,3`E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXH,2PQ,C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E/CQD:78@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z M("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY!8W1U86P@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z("TQ.'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SY386QE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$,3`E/CQD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXT M-C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;B<^5&AE($-O;7!A;GD@2`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`W-S8Y9#$S-F4-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-&9F.&8S,35?9C`P85\T-C,Y7S@R,&)?.3`P-S'0O M:'1M;#L@8VAA6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^3D]412`R.B!) M3E9%3E1/4DE%4SPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,S9P=#L@34%21TE.+5))1TA4.B`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`[(#PO9F]N M=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D M/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`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`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SY287<@;6%T97)I86QS/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$ M,B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C$L.#0T/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/"]T6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$,B4^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24^/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!T:6UE3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\T9F8X9C,Q-5]F,#!A7S0V,SE?.#(P8E\Y,#`W M-S8Y9#$S-F4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&9F.&8S M,35?9C`P85\T-C,Y7S@R,&)?.3`P-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<^3D]412`S.B!)3D-/344@5$%815,\+V9O;G0^ M/"]D:78^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1% M3E0Z(#!P="<^/&)R("\^/"]D:78^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#,V<'0[($U! M4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^/&9O;G0@"!B96YE9FET(&]F(&%P<')O>&EM871E;'D@)FYB M"!J=7)I28C M.#(Q-SMS(&5F9F5C=&EV92!T87@@2X@1F]R('1H92!T:')E92!A;F0@;FEN92!M;VYT M:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$P(&%N9"`R,#`Y+"!T:&4@0V]M M<&%N>28C.#(Q-SMS(&5F9F5C=&EV92!I;F-O;64@=&%X(')A=&4@=V%S(&1E M=&5R;6EN960@8F%S960@;VX@=&AE(&5S=&EM871E9"!A;FYU86P@969F96-T M:79E(&EN8V]M92!T87@@"!R871E M(&EN8VQU9&5D(')E9'5C=&EO;G,@9'5E('1O(&-H86YG97,@=&\@;6%N86=E M;65N="8C.#(Q-SMS(&5S=&EM871E"!J=7)I2!R871E('=E&5S(&1U M92!T;R!C:&%N9V5S(&EN(&UA;F%G96UE;G0F(S@R,3<[7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE28C.#(Q-SMS(&-O;6UO;B!S:&%R M97,@;W5T28C.#(Q-SMS($504R!A;F0@=&AE:7(@969F M96-T(&]N('1H92!#;VUP86YY)B,X,C$W.W,@=V5I9VAT960M879E28C.#(Q-SMS(&-O;6UO M;B!S=&]C:R!S=6)J96-T('1O(&]P=&EO;G,@=V5R92!E>&-L=61E9"!F28C.#(Q-SMS(&-O;6UO M;B!S=&]C:R!S=6)J96-T('1O(&]P=&EO;G,@=V5R92!E>&-L=61E9"!F6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#4X)2!C;VQS<&%N/3-$,34^/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E' M2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^1F]R('1H92!T:')E92!M;VYT:',@96YD960@4V5P=&5M M8F5R(#,P+#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0R,B4^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C`Q,#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D M/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!4 M15A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^*&YU;65R871O6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M*&1E;F]M:6YA=&]R*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^86UO=6YT/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`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`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M('=I9'1H/3-$-"4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^*#`N,#4\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F="!W M:61T:#TS1#$E/CQD:78@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXH.2PR,#<\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E/CQD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!4 M15A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C8L-#8T M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M('=I9'1H/3-$-"4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^*#`N,S4\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F="!W M:61T:#TS1#$E/CQD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SY%9F9E8W0@;V8@9&EL=71I=F4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$."4^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0R)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H="!W:61T:#TS1#8E/CQD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$."4^/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/CPO='(^/'1R(&)G8V]L;W(],T1W:&ET93X\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS1#(R)3X\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP M=#L@5$585"U)3D1%3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY$ M:6QU=&5D($504SH\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS1#(R)3X\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z M("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`T<'@@9&]U8FQE)R!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H="!W:61T:#TS1#@E/CQD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C8L-#DP/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`T<'@@9&]U8FQE)R!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H="!W:61T:#TS1#@E/CQD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C8L M-#8T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`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`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,CDE(&-O;'-P86X],T0W/CQD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C`P.3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N M=#X\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R M,B4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$."4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`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`[(#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1% M3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY"87-I8R!%4%,Z/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#@E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#0E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#8E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#@E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#0E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$ M,R4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^*#6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXI M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT('=I9'1H/3-$."4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M('=I9'1H/3-$-B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXI/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$ M,B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^*#$Y+#4Q.3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1L969T('=I9'1H/3-$ M,24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H="!W:61T:#TS1#@E/CQD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXR-BPT-C(\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$ M-B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0T)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H="!W:61T:#TS1#8E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S@R,3([/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-B4^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0R)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0T)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H="!W:61T:#TS1#4E/CQD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&YO M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-B4^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F="!W M:61T:#TS1#$E/CQD:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$."4^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M5T5)1TA4.B!N;W)M86P[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U7 M14E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^*#`N,S`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`P<'0G M(&%L:6=N/3-$"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,B4^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M5T5)1TA4.B!N;W)M86P[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^*#`N-S0\+V9O;G0^/"]D:78^/"]T M9#X\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E/CQD:78@7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;B<^3D]412`U.B!35$]#2RU"05-%1"!#3TU0 M14Y3051)3TX\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^/"]D:78^/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U) M3D1%3E0Z(#,V<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^ M/&9O;G0@2!H87,@;VYE(&%C=&EV92!S=&]C:RUB87-E9"!C;VUP96YS M871I;VX@<&QA;BP@=VAI8V@@=V%S(&%P<')O=F5D(&)Y('-H87)E:&]L9&5R M65E65A28C.#(Q-SMS(&-O;6UO;B!S=&]C:R!O;B!T:&4@9&%T92!O9B!G M65A M2`R,#`X M+"!T:&4@0V]M<&%N>28C.#(Q-SMS($)O87)D(&]F($1I65E2!S:&%R97,@2!S:&%R97,@=6YD97)L>6EN9R!O=71S=&%N M9&EN9R!O<'1I;VYS('5N9&5R('1H92!T:&5N+65X:7-T:6YG('-T;V-K(&]P M=&EO;B!P;&%N('1H870@=&5R;6EN871E('=I=&AO=70@:&%V:6YG(&)E96X@ M97AE28C.#(Q-SMS('-H87)E:&]L9&5R&-H86YG92!/9F9E M2`Q-BP@,C`Q,"P@=&AE($-O;7!A M;GD@8V]M;65N8V5D('1H92!O<'1I;VX@97AC:&%N9V4@<')O9W)A;2`H=&AE M("8C.#(R,#L\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M5T5)1TA4.B!B;VQD.R!&3TY4+5-464Q%.B!I=&%L:6,G/D5X8VAA;F=E(%!R M;V=R86T\+V9O;G0^)B,X,C(Q.RD@=VAE2!E;7!L;WEE97,@*&EN8VQU M9&EN9R!O9F9I8V5R&-H86YG M92!06QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<^5&AE($-O;7!A;GD@9FEL960@=VET:"!T:&4@ M4V5C=7)I=&EE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@2!T:&4@0V]M<&%N>2!I;B!E>&-H86YG92!F;W(@=&AE(&=R86YT(&]F M(&%N(&%G9W)E9V%T92!O9B`T-#`L-34X(')E<&QA8V5M96YT(&]P=&EO;G,N M/"]F;VYT/CPO9&EV/CQD:78@2!I;B`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`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#8Q)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^3FEN92!M M;VYT:',\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$."4@8V]L M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C`Q,#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C`P M.3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M(#PO9F]N=#X\+W1D/CPO='(^/'1R(&)G8V]L;W(],T0C8V-E969F/CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1L969T('=I9'1H/3-$-C$E/CQD:78@'!E;G-E/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)3X\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M('=I9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ M,C4\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXU,30\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXT,S<\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D'!E;G-E/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,3`\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXR-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0R)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M(#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R<'@@6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY4;W1A;"!N970@ M8V]M<&5N"<@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$;&5F="!W:61T:#TS1#$E/CQD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!4 M15A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,3$S/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-R4^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M;F)S<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT('=I9'1H/3-$."4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4G('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-R4^ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X M<'0[(%1%6%0M24Y$14Y4.B`M,3AP=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\ M+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<^07,@;V8@4V5P=&5M8F5R(#,P+"`R,#$P+"!T M:&4@0V]M<&%N>2!E>'!E8W1S('1O(')E8V]R9"!C;VUP96YS871I;VX@97AP M96YS92!I;B!T:&4@9G5T=7)E(&%S(&9O;&QO=W,Z/"]F;VYT/CPO9&EV/CQD M:78@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS M1#@P)3X\='(^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8Q)2!R;W=S M<&%N/3-$,CX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!R;W=S<&%N/3-$,CX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R<'@@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M96YD:6YG/"]F;VYT/CPO9&EV/CQD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E M(&-O;'-P86X],T0X/CQD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U7 M14E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R M(&)G8V]L;W(],T0C8V-E969F/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1L969T('=I9'1H/3-$-C$E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I M9'1H/3-$,3$E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXQ,3(\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,B4^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXS M-S4\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,B4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ.#0\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXW,3PO9F]N=#X\+V1I=CX\+W1D/CPO M='(^/'1R(&)G8V]L;W(],T1W:&ET93X\=&0@"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F="!W:61T M:#TS1#8Q)3X\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SY487@@8F5N969I="!AF5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`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`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXR,#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N M=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M"<@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS1#8Q)3X\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z M("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY4;W1A;"!N970@=6YR96-O M9VYI>F5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,S(V/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!! M1$1)3D6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,38T/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-C4\+V9O;G0^/"]D M:78^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T9F8X9C,Q-5]F,#!A7S0V,SE?.#(P M8E\Y,#`W-S8Y9#$S-F4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-&9F.&8S,35?9C`P85\T-C,Y7S@R,&)?.3`P-S'0O:'1M;#L@8VAA M6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^ M3D]412`V.B!32$%214A/3$1%4B8C.#(Q-SM3($5154E463PO9F]N=#X\+V1I M=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)SX\9F]N="!S='EL93TS1"=-05)'24XM3$5&5#H@,S9P M="<^/"]F;VYT/D]N(%-E<'1E;6)E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E' M2%0Z(&)O;&0[($9/3E0M4U193$4Z(&ET86QI8R<^26YV97-T;65N="!!9W)E M96UE;G0\+V9O;G0^)B,X,C(Q.RD@=VET:"!$=71C:&5S2!&=6YD+"!)22P@3%`L(&$@1&5L87=A2!M87D@9')A=R!O;B!T M:&4@17%U:71Y($QI;F4@9G)O;2!T:6UE('1O('1I;64L(&%S(&%N9"!W:&5N M(&ET(&1E=&5R;6EN97,@87!P2!V;VQU;64@;V8@=&AE($-O M;7!A;GDF(S@R,3<[28C.#(Q M-SMS(&-O;6UO;B!S=&]C:R!D=7)I;F<@=&AE(#4@8V]N2!O9B!T:&4@87!P;&EC86)L92!D2!I2!,:6YE('5N;&5S3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX\9F]N="!S='EL93TS1"=- M05)'24XM3$5&5#H@,S9P="<^/"]F;VYT/E1H92!);G9E2P@<&5R9F]R;6%N8V4@;W(@96YF;W)C96UE;G0@;V8@=&AE M($EN=F5S=&UE;G0@06=R965M96YT(&]R('1H92!296=I3XF(S$V,#L\ M+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)SX\9F]N="!S='EL93TS1"=-05)'24XM3$5&5#H@,S9P="<^/"]F;VYT/E1H M92!);G9E2!R97!R97-E;G1A=&EO;G,@86YD('=A2!A;F0@=&AE($EN=F5S=&]R("AT:&4@)B,X,C(P.SQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M M4U193$4Z(&ET86QI8R<^4F5G:7-T2!T:&4@26YV97-T;W(@<'5R6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@6QE/3-$ M)TU!4D=)3BU,1494.B`S-G!T)SX\+V9O;G0^26X@8V]N;F5C=&EO;B!W:71H M('1H92!P'1087)T M7S1F9CAF,S$U7V8P,&%?-#8S.5\X,C!B7SDP,#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;B<^3D]412`W.B!,251)1T%424]./"]F;VYT/CPO9&EV/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@5$585"U$14-/4D%424]..B!U M;F1E"P@26YC+CL@5D1&($9U M='5R94-E=71I8V%L61R871E3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@ M,S9P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^06=R965D($IU9&=M96YT6EN9R!O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@2!,:69E+"!,3$,N($]N($IU;F4@,CDL($UA;FYA=&5C:"8C.#(Q M-SMS(&UO=&EO;B!W87,@9W)A;G1E9"!A;F0@0V]U;G1R>2!,:69E($UA;G5F M86-T=7)I;F"!F:6QE9"!A(&UO=&EO;B!T;R!S979E2`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`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4U193$4Z(&ET86QI8R<^ M36%R:6YO=F$@4'1Y+B!,:6UI=&5D('8N($UA;FYA=&5C:"P@26YC;W)P;W)A M=&5D("9A;7`[($UA;FYA=&5C:"`H26YT97)N871I;VYA;"D@3&EM:71E9#PO M9F]N=#XL($-A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;B<^3VX@1&5C96UB97(@,3`L(#(P,#DL($UA M2X@3&EM:71E9"`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`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<^26X@2!F86QS96QY('=A3XF M(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P=#L@34%21TE.+5))1TA4 M.B`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`W-S8Y9#$S-F4-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&9F.&8S,35?9C`P85\T-C,Y M7S@R,&)?.3`P-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O M;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;B<^3D]412`X.B!214-%3E0@04-#3U5.5$E.1R!04D].3U5.0T5-14Y4 M4SPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@ M,S9P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^26X@3V-T;V)E2!B92!T2!I9&5N=&EF:65D(&1E;&EV97)A8FQE'!A;F1S('1H92!D:7-C;&]S=7)E7=O28C.#(Q-SMS(&9I;F%N8VEA M;"!P;W-I=&EO;B!O2!T:&4@4V5C=7)I=&EE7IE(&9I;F%N8VEA;"!D871A M+B!4:&4@4V5C=7)I=&EE2!W:6QL(&)E(')E<75I2!R97!O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T9F8X9C,Q-5]F M,#!A7S0V,SE?.#(P8E\Y,#`W-S8Y9#$S-F4-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-&9F.&8S,35?9C`P85\T-C,Y7S@R,&)?.3`P-S'0O:'1M;#L@8VAA'0^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,S9P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^1F%I6UB;VPL('-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,S9P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;B<^/&9O;G0@6UB;VPL('-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,S9P=#L@34%21TE.+5)) M1TA4.B`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`P<'0G(&%L M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`[(#PO M9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M<'@@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E(&-O;'-P86X] M,T0R/CQD:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1'1O<"!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1&QE9G0@=VED=&@],T0Q)3X\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$,3(E/CQD:78@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXV+#`R.3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO M9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1L969T('=I M9'1H/3-$,B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`[(#PO9F]N=#X\ M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1L969T('=I9'1H/3-$ M,R4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`[(#PO M9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1L969T('=I M9'1H/3-$-R4@8V]L6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXV+#`R.3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CPO='(^/'1R(&)G8V]L;W(],T1W M:&ET93X\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS M1#,T)3X\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,3AP=#L@5$585"U)3D1%3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`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`[(#PO9F]N=#X\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0S)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S@R M,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`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`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY4;W1A;"!A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0S)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1L969T('=I9'1H/3-$-R4@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ,"PY.3@\+V9O;G0^/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$R)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0S)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q,"4@8V]L6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SY#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)3X\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S M<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT('=I9'1H/3-$,3(E/CQD:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXV+#,T-3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U)3X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1L969T('=I9'1H/3-$,B4^/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`[(#PO9F]N=#X\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1L969T('=I9'1H/3-$-R4@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXV+#,T-3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N M=#X\+W1D/CPO='(^/'1R(&)G8V]L;W(],T1W:&ET93X\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS1#,T)3X\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1% M3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY,;VYG+71E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`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`[ M(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!C M;VQS<&%N/3-$,CX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R<'@@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1&QE9G0@=VED=&@],T0R)3X\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4G('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$ M,3(E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1&QE9G0@=VED=&@],T0S)3X\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$,3`E(&-O;'-P M86X],T0R/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1&QE9G0@=VED=&@],T0W)2!C;VQS<&%N/3-$,CX\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I M9'1H/3-$-B4@8V]L'1087)T7S1F9CAF,S$U7V8P,&%?-#8S.5\X,C!B7SDP,#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^3D]412`Q,#H@4T5'345.5"!) M3D9/4DU!5$E/3CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,S9P=#L@34%21TE.+5))1TA4.B`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`R<'@@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,36QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C`Q,#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\ M+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&QE M9G0@=VED=&@],T0R,B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^56YI=&5D(%-T871E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S M<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-#,N-3PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1L969T('=I M9'1H/3-$,B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H="!W:61T:#TS1#$E/CQD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF;F)S<#LD/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$ M-B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^-#6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF;F)S<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-#0N M.3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1L969T('=I9'1H/3-$-"4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H="!W:61T:#TS1#,E(&-O;'-P86X],T0R M/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M;F)S<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT('=I9'1H/3-$."4^/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1&QE9G0@=VED=&@],T0R,B4^/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^.2XY/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT('=I9'1H/3-$-B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M,C4N.#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H="!W:61T:#TS1#6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXQ-"XY/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1&QE9G0@=VED=&@],T0T)3X\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXE/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E(&-O;'-P86X] M,T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M('=I9'1H/3-$."4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,30N,SPO9F]N=#X\+V1I=CX\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1L969T('=I9'1H/3-$,B4^ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N M=#X\+W1D/CPO='(^/'1R(&)G8V]L;W(],T0C8V-E969F/CQT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1L969T('=I9'1H/3-$,C(E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I M9'1H/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXY+C,\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS1#(E/CQD:78@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^-BXY/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT('=I9'1H/3-$-B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ M-BXR/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT('=I9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXQ.2XR/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SY#86YA9&$\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-"XV/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H M/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXU+C@\+V9O;G0^/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M."XQ/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1&QE9G0@=VED=&@],T0S)3X\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXE/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXE/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#,E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$."4^/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXE/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&QE9G0@=VED M=&@],T0R,B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^075S=')A;&EA/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`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`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-B4^/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXQ-"XX/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-R4^/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ-BXW/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!4 M15A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXE/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I M9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`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`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXE/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-B4^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXR+C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS1#,E/CQD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-2XP/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H M/3-$-R4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`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`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXE/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`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`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-B4^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXE/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#,E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$."4^/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ M+C4\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$;&5F="!W:61T:#TS1#(E/CQD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY' M97)M86YY/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-B4^/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXE/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E(&-O M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT('=I9'1H/3-$."4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ+C(\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS M1#(E/CQD:78@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1&QE9G0@=VED=&@],T0R,B4^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`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`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXE/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-R4^ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^,BXU/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,"XQ/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H M/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXE/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXP+C(\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M;&5F="!W:61T:#TS1#0E/CQD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,2XU/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H M/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SY3:6YG87!O6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^,"XU/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXE/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT('=I9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M,"XR/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT('=I9'1H/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S@R M,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT('=I9'1H/3-$-B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,"XY/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-R4^/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S@R,3([/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H M/3-$-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1&QE9G0@=VED=&@],T0R,B4^/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^3F]R=V%Y/&9O;G0@'0M=&]P)SXH,2D\+V9O;G0^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`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`[(#PO M9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H="!W M:61T:#TS1#8E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT('=I9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`[(#PO9F]N=#X\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H="!W:61T:#TS1#4E M/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1&QE9G0@=VED=&@],T0R,B4^/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^5&AE($YE=&AE'0M=&]P)SXH,2D\+V9O;G0^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$ M-24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`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`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H="!W:61T:#TS1#8E/CQD:78@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$-R4^/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`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`[(#PO9F]N M=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H="!W:61T M:#TS1#4E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1'1O<"!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`W,"4[(%9%4E1)0T%,+4%,24=..B!T97AT+71O<"<^*#$I/"]F;VYT M/CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,B4^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXE/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`[(#PO9F]N=#X\ M+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`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`P<'0G(&%L:6=N M/3-$6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT('=I9'1H/3-$-B4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`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`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^,3`P/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&YO6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@-S`E.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`G/B@Q*2`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`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24@8V]L6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C`P.3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S)3X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N M=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&QE M9G0@=VED=&@],T0U-"4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`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`[(#PO9F]N=#X\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1L969T('=I9'1H/3-$,24^ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)FYB M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXU,BXS/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$,R4^/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXQ-3DN,3PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CPO='(^ M/'1R(&)G8V]L;W(],T1W:&ET93X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,B4^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SY#;VYS;VQI9&%T960@<&%C:R!S86QE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXW M+C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,R4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^,34N-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0S)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H="!W:61T:#TS1#@E/CQD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXR-2XQ/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$."4^/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[(%1% M6%0M24Y$14Y4.B`M,3AP=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,B4^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F="!W:61T:#TS1#4T M)3X\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY# M;VYS;VQI9&%T960@;W1H97(L(&EN8VQU9&EN9R!F6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`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`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`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$58 M5"U)3D1%3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,3`N,SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`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`[(#PO9F]N=#X\+W1D/CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1L969T('=I9'1H/3-$,24^/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P M=#L@34%21TE.+5))1TA4.B`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`M,3AP=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT('=I9'1H/3-$."4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[(%1%6%0M24Y$14Y4.B`M,3AP=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX\9F]N="!S='EL93TS1"=- M05)'24XM3$5&5#H@,S9P="<^/"]F;VYT/DQO;F6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS M1#@P)3X\='(^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&QE9G0@=VED M=&@],T0W,24^/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^4V5P=&5M8F5R(#,P+#PO9F]N=#X\+V1I=CX\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`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`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`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT('=I9'1H/3-$,R4^/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP M=#L@5$585"U)3D1%3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`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`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$,3`E/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXP+CD\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT('=I9'1H/3-$,3`E/CQD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXP+C0\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1% M3E0Z("TQ.'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY486EW86X\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT('=I9'1H/3-$,3`E/CQD:78@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXP+C$\+V9O M;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!4 M15A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,"XQ/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&YO6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT('=I9'1H/3-$,3`E/CQD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C$N-3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S)3X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H="!W:61T:#TS1#,E/CQD:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&YO6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT('=I9'1H/3-$,3`E/CQD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^,C'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^9F%L'0^,C`Q,"TP.2TS,#QS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$"!+97D\+W1D/@T*("`@("`@("`\ M=&0@8VQA2!796QL+6MN;W=N(%-E87-O;F5D($ES'0^3F\\2!6;VQU;G1A M2!#=7)R96YT(%)E<&]R=&EN9R!3=&%T=7,\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!#;VUM;VX@ M4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\T9F8X9C,Q-5]F,#!A7S0V,SE?.#(P8E\Y,#`W-S8Y9#$S M-F4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&9F.&8S,35?9C`P M85\T-C,Y7S@R,&)?.3`P-S&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A M8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U XML 33 R7.xml IDEA: INVENTORIES 2.2.0.7 false INVENTORIES 006020 - Disclosure - INVENTORIES true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Notes To Financial Statements [Abstract] 0 mtex_NotesToFinancialStatementsAbstract mtex false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Inventories 1 us-gaap_InventoryDisclosureTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 2: INVENTORIES</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories consist of raw materials and finished goods, including promotional materials. The Company provides an allowance for any slow-moving or obsolete inventories. Inventories at September 30, 2010 and December 31, 2009, consisted of the following <font style="DISPLAY: inline; FONT-STYLE: italic">(in thousands)</font>:</font></div><div align="center"><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" wi dth="65%"><tr><td valign="bottom" width="31%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 30, 2010</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="cen ter"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="31%"><div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Raw materials</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,223</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDE NT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,819</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="white"><td valign="bottom" align="left" width="31%"><div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Finished goods</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="9%"><div sty le="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,156</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,844</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" align="left" width="31%"><div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventory reserves for obsolescence</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT- SIZE: 10pt; FONT-FAMILY: times new roman">(1,990</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,373</font></div></td ><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div></td></tr><tr bgcolor="white"><td valign="bottom" width="31%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" ali gn="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,389</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31,290</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">  </font></td></tr></table></div> NOTE 2: INVENTORIESInventories consist of raw materials and finished goods, including promotional materials. The Company provides an allowance for any false false false us-types:textBlockItemType textblock This element represents the complete disclosure related to inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 3 -Section A -Paragraph 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph a, b, c -Article 5 false 1 2 false UnKnown UnKnown UnKnown false true XML 34 R17.xml IDEA: Entity Information 2.2.0.7 false Entity Information (USD $) 995400 - Document - Entity Information true false false false 1 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 false false u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 false 3 USD false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ 3 Entity Registrant Name 1 dei_EntityRegistrantName dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 MANNATECH INC MANNATECH INC false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false xbrli:normalizedStringItemType normalizedstring The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false 4 Entity Central Index Key 1 dei_EntityCentralIndexKey dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 0001056358 0001056358 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false us-types:centralIndexKeyItemType na A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false 5 Current Fiscal Year End Date 1 dei_CurrentFiscalYearEndDate dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 --12-31 --12-31 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false xbrli:gMonthDayItemType monthday End date of current fiscal year in the format --MM-DD. No authoritative reference available. false 6 Entity Well-known Seasoned Issuer 1 dei_EntityWellKnownSeasonedIssuer dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 No No false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false us-types:yesNoItemType na Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A. No authoritative reference available. false 7 Entity Voluntary Filers 1 dei_EntityVoluntaryFilers dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 Yes Yes false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false us-types:yesNoItemType na Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. No authoritative reference available. false 8 Entity Current Reporting Status 1 dei_EntityCurrentReportingStatus dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 No No false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false us-types:yesNoItemType na Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure. No authoritative reference available. false 9 Entity Filer Category 1 dei_EntityFilerCategory dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 Accelerated Filer Accelerated Filer false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false us-types:filerCategoryItemType na Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure. No authoritative reference available. false 10 Entity Public Float 1 dei_EntityPublicFloat dei false credit instant No definition available. false false false false false false false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 true true false false 31365883 31365883 false false false xbrli:monetaryItemType monetary State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K. No authoritative reference available. false 11 Entity Common Stock, Shares Outstanding 1 dei_EntityCommonStockSharesOutstanding dei false na instant No definition available. false false false false false false false false false false false false 1 false false false false 0 0 false false false 2 false true false false 26490466 26490466 false false false 3 false false false false 0 0 false false false xbrli:sharesItemType shares Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument No authoritative reference available. false 12 Document Fiscal Year Focus 1 dei_DocumentFiscalYearFocus dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 2010 2010 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false xbrli:gYearItemType positiveinteger This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006. No authoritative reference available. false 13 Document Fiscal Period Focus 1 dei_DocumentFiscalPeriodFocus dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 Q3 Q3 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false us-types:fiscalPeriodItemType na This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY. No authoritative reference available. false 3 11 false NoRounding NoRounding UnKnown false true -----END PRIVACY-ENHANCED MESSAGE-----

Date: November 4, 2010	/s/ Robert A. Sinnott
	Robert A. Sinnott Co-Chief Executive Officer and Chief Science Officer